Session » ACR Convergence 2024
- 9:15AM-10:45AM
-
Abstract Number: 0774
A Multicenter, Randomized, Controlled Trial to Evaluate the Effects of Low-dose Glucocorticoids Compared to Stopping Glucocorticoids to Maintain Remission of Granulomatosis with Polyangiitis: The TAPIR Trial
- 9:15AM-10:45AM
-
Abstract Number: 0773
Anti-Citrullinated Histone Antibody CIT-013 Targets NETs in Inflamed Joints and Halts NET-mediated Joint Deterioration
- 9:15AM-10:45AM
-
Abstract Number: 0771
Arid5b Controls Pathologic Inflammatory versus Invasive Fibroblast Behavior
- 9:15AM-10:45AM
-
Abstract Number: 0770
Efficacy and Safety of Upadacitinib in Patients with Giant Cell Arteritis (SELECT-GCA): A Double-Blind, Randomized Controlled Phase 3 Trial
- 9:15AM-10:45AM
-
Abstract Number: 0772
Global Recruiting Patterns Are Associated with Placebo Response Rates in Clinical Trials of Psoriatic Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0255
“Rheum” to Improve: Have Patients Attending the Young Adult Systemic Erythematosus (YASLE) Clinic Received All Appropriate Vaccinations? A Quality Improvement Initiative
- 10:30AM-12:30PM
-
Abstract Number: 0574
14-3-3 Eta (η) Auto-Antibody as a Diagnostic Marker in Axial Spondyloarthritis: A Longitudinal Study
- 10:30AM-12:30PM
-
Abstract Number: 0506
24-week, Post-Marketing Surveillance Analysis of Upadacitinib in Japanese Patients with Rheumatoid Arthritis: The 2024 Interim Report
- 10:30AM-12:30PM
-
Abstract Number: 0640
7000-Plex Proteomic Screen of Urine for Flare Monitoring and Treatment Response Biomarkers in Active Lupus Nephritis
- 10:30AM-12:30PM
-
Abstract Number: 0223
A Comparative Study of Difficult-to-Treat vs Non-Difficult-to-Treat Psoriatic Arthritis for Disease Burden and Comorbidities: An Ultrasound Study
- 10:30AM-12:30PM
-
Abstract Number: 0492
A Machine Learning Model for the Early Identification of Rheumatoid Arthritis: Development and Validation
- 10:30AM-12:30PM
-
Abstract Number: 0760
A Macrophage-smooth Muscle Cell Axis Influences Vascular Remodeling Through Activation of the EGFR Pathway in Giant Cell Arteritis
- 10:30AM-12:30PM
-
Abstract Number: 0174
A Nationwide Analysis of Gender and Racial Disparities in Patients with Systemic Sclerosis and Acute Coronary Syndrome
- 10:30AM-12:30PM
-
Abstract Number: 0092
A New Generation Mesenchymal Stromal Cell (MSC)-based Cell Therapy Using Design of Experiments Halts Pristane Induced Glomerulosclerosis
- 10:30AM-12:30PM
-
Abstract Number: 0019
A Novel Product Candidate (CPTX2309) for In Vivo mRNA Engineering of Anti-CD19 CAR T Cells Utilizing Novel CD8-Targeted Lipid Nanoparticles
- 10:30AM-12:30PM
-
Abstract Number: 0021
A Novel Small Molecule Screening Assay Using Normal Human Chondrocytes Toward Osteoarthritis Drug Discovery
- 10:30AM-12:30PM
-
Abstract Number: 0085
A Novel, Potent and Selective TLR7/8 Small Molecule Inhibitor Blocks TLR7/8 Pathway in the Presence of HCQ and Demonstrates Robust Preclinical Efficacy in Lupus Models
- 10:30AM-12:30PM
-
Abstract Number: 0536
A Population Modeling and Simulation of the Effect of Obexelimab Exposure on the QTc Interval in Healthy Volunteers and Patients with Rheumatoid Arthritis or IgG4-Related Disease
- 10:30AM-12:30PM
-
Abstract Number: 0448
A Pregnant Lupus Patient’s Journey: Single-Center Outcomes and Opportunities
- 10:30AM-12:30PM
-
Abstract Number: 0441
A Qualitative Improvement Project to Incorporate the Mycophenolate Risk Evaluation and Mitigation Strategies in an Academic Lupus Clinic
- 10:30AM-12:30PM
-
Abstract Number: 0670
A Randomized, Open-Label, Phase III Trial Comparing Efficacy and Safety of Intravenous Cyclophosphamide, Mycophenolate Mofetil, or Tacrolimus as Induction Therapy in Lupus Nephritis
- 10:30AM-12:30PM
-
Abstract Number: 0544
A Two-year Comparison of Spinal and Hip Mobility Between Axial Spondyloarthritis and Chronic Back Pain Patients in the SPondyloArthritis Caught Early (SPACE) Cohort
- 10:30AM-12:30PM
-
Abstract Number: 0694
A Unified Vascular Phenotype Score Identifies Systemic Sclerosis Endotypes and Predicts Prognostic Outcomes: Results from the EUSTAR Database
- 10:30AM-12:30PM
-
Abstract Number: 0387
Absolute Agreement and Inter-rater Reliability of a Web-based Standardized Scoring Tool for Magnetic Resonance Images from Children with Chronic Nonbacterial Osteomyelitis (CNO) Amongst Radiologists
- 10:30AM-12:30PM
-
Abstract Number: 0582
Achievement of Minimal and Very Low Disease Activity Among Patients with Psoriatic Arthritis Initiating Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drugs in the CorEvitas PsA/SpA Registry
- 10:30AM-12:30PM
-
Abstract Number: 0587
Achieving Stringent Disease Control Criteria Was Associated with Greater Work Productivity Improvements in Patients with Active Psoriatic Arthritis: Results from Two Phase 3 Studies of Bimekizumab
- 10:30AM-12:30PM
-
Abstract Number: 0498
ACPA Subtypes, RF Isotypes, and the Risk of Rheumatoid Arthritis-Associated Interstitial Lung Disease
- 10:30AM-12:30PM
-
Abstract Number: 0055
Activating STAT3 Mutations in CD8+ T Cells Correlate to Serological Positivity in Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0069
Activation of Cardiovascular Inflammation and Wnt Signaling in Spondyloarthritis: Insights from the HLA-B27 Transgenic Rat Model
- 10:30AM-12:30PM
-
Abstract Number: 0227
Active Hand Inflammation: Differing Clinical and Ultrasound Patterns in Patients with Rheumatoid Arthritis and Psoriatic Arthritis. A Cross-Sectional and Multicenter Study
- 10:30AM-12:30PM
-
Abstract Number: 0637
Active Implementation of Low Disease Activity State as Treatment Endpoint in a Large Cohort of Adolescents and Young Adults with Childhood Onset Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 0768
Addressing Gaps in Polymyalgia Rheumatica: A Systematic Literature Review
- 10:30AM-12:30PM
-
Abstract Number: 0023
Adenosine and Guanosine-based Oligonucleotide Attenuates Catabolic Phenotypes in Chondrocytes and Slows Progression of Surgically Induced Osteoarthritis
- 10:30AM-12:30PM
-
Abstract Number: 0244
Adjunctive Belimumab Exerts Favorable Ferritin Recovery and Survival for Post-COVID Interstitial Lung Disease in Patients with Immune Mediated Inflammatory Diseases Treated with Rituximab: A Case Series
- 10:30AM-12:30PM
-
Abstract Number: 0370
Adolescents’ and Providers’ Perceptions of the Transition from Pediatric to Adult Rheumatology
- 10:30AM-12:30PM
-
Abstract Number: 0749
Age at Disease Onset Influences the Clinical Phenotype and Outcome of Patients with Takayasu Arteritis: Results from a Monocentric Cohort of 167 Patients
- 10:30AM-12:30PM
-
Abstract Number: 0203
Agreement of Administrative Pharmacy Dispensing with Patient-Reported Use of Oral Glucocorticoids in a Rheumatoid Arthritis Cohort
- 10:30AM-12:30PM
-
Abstract Number: 0702
AISA 021, a Novel Calcium Channel Antagonist in Development for Raynaud’s & Systemic Sclerosis, Has Antagonistic Activity at Sodium Channel Targets for Pain Relief and Treats Scleroderma Pain Better Than Current Calcium Channel Blockers in a Phase 2A Study
- 10:30AM-12:30PM
-
Abstract Number: 0567
Alteration of JAK-STAT Signaling in an Axial Spondyloarthritispatient with TYK2 Variants
- 10:30AM-12:30PM
-
Abstract Number: 0577
AMH Titers in Women with Axial Spondyloarthritis Are Significantly Lower Compared to the General Population: An Analysis of the 10-year Follow-up of the DESIR Cohort
- 10:30AM-12:30PM
-
Abstract Number: 0493
An Algorithm Pipeline for Automated Metrical Analysis of Joint Swelling in Rheumatoid Arthritis via Smartphone Hand Photographs
- 10:30AM-12:30PM
-
Abstract Number: 0229
An Early Inflammatory Cardiac Phenotype and Association with Future Coronary Plaque Burden in Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0532
An Immune-molecular Signature Specifically Modulated by JAK Inhibitors Ex Vivo May Serve as a Predictor of Therapy Response In Vivo to These Drugs
- 10:30AM-12:30PM
-
Abstract Number: 0343
An Interlaboratory Variability Study of Detection Methods for Myositis-Specific and Myositis-Associated Autoantibodies in Sera from Patients with Idiopathic Inflammatory Myopathies
- 10:30AM-12:30PM
-
Abstract Number: 0761
An Observational Study of Lifetime Prevalence of Thromboembolism Among Patients with Giant Cell Arteritis
- 10:30AM-12:30AM
-
Abstract Number: PP01
An OCEAN of Change: The Impact of an RA Diagnosis on My Big Five Personality Traits
- 10:30AM-12:30PM
-
Abstract Number: 0500
An Update on the Integrated Safety Analysis of Filgotinib in Patients with Moderate to Severe Active Rheumatoid Arthritis over a Median of 4.3 Years
- 10:30AM-12:30PM
-
Abstract Number: 0266
Analysis of Gout Remission Definitions in a Randomised Controlled Trial of Colchicine Prophylaxis for People with Gout Initiating Allopurinol
- 10:30AM-12:30PM
-
Abstract Number: 0408
Analysis of Protein Biomarkers for the Prediction of IL-1 Inhibitor Treatment Response in the CARRA First-line Options for Systemic Juvenile Idiopathic Arthritis Treatment (FROST) Study
- 10:30AM-12:30PM
-
Abstract Number: 0652
Analysis of Relapses in a Single Center Cohort of Patients with Lupus Nephritis
- 10:30AM-12:30PM
-
Abstract Number: 0139
Analysis of Rheumatoid Arthritis Epidemiology in Mexico Using the GBD 2019 Study and Forecasting Future Trends for 2030 and 2040
- 10:30AM-12:30PM
-
Abstract Number: 0335
Analysis of the Prevalence of Diabetes Mellitus in Patients with Adult-onset Dermatomyositis
- 10:30AM-12:30PM
-
Abstract Number: 0553
Analyzing the Utilization of HLA-B27 Testing in a Large Rural Health System: Implications for Diagnostic Appropriateness
- 10:30AM-12:30PM
-
Abstract Number: 0735
ANCA-associated Vasculitis (AAV) and Long-term Risk of Cardiovascular Disease: Large-scale Propensity-matched Global Retrospective Cohort Study
- 10:30AM-12:30PM
-
Abstract Number: 0035
Anti-CCP Generation in the Female Genital Tract Is Increased During the Postpartum Period in Women Without RA
- 10:30AM-12:30PM
-
Abstract Number: 0064
Anti-Citrullinated Protein Antibodies Arise During Affinity Maturation of Germline-Encoded Antibodies to Carbamylated Proteins in Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0098
Anti-HSP90α as a Protective Natural Antibody Against Secondary Antiphospholipid Syndrome in Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 0338
Anti-MDA5 Antibody-positive Dermatomyositis Associated Interstitial Lung Disease – Survival Benefit of Treatment with Rituximab, Janus Kinase Inhibitor and Glucocorticoid Combination in a Prospective Cohort
- 10:30AM-12:30PM
-
Abstract Number: 0713
Anti-muscarinic 3 Antibodies in SSc Associate with a More Significant GI and Extraintestinal Clinical Phenotype
- 10:30AM-12:30PM
-
Abstract Number: 0642
Anti-Myxovirus Resistance Protein 1: A Novel Biomarker for Autoimmune Myositis and Interstitial Lung Disease in Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 0241
Anti-Spike Antibodies in SARS-CoV-2-Vaccinated SLE Patients
- 10:30AM-12:30PM
-
Abstract Number: 0285
Anti-THSD7A Antibodies Are Not Broadly Associated with IgG4-Related Disease or IgG4-Related Membranous Nephropathy
- 10:30AM-12:30PM
-
Abstract Number: 0256
Anti-TNF Therapy as a Potential Risk of Leishmania Infections
- 10:30AM-12:30PM
-
Abstract Number: 0442
Anti-U1-RNP Related Pregnancy Loss in Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 0732
Antineutrophil Cytoplasmic Antibodies and Associated Vasculitis According to Clinical Phenotypes: A Single-Center Retrospective Cohort Study
- 10:30AM-12:30PM
-
Abstract Number: 0510
Applying Machine Learning Tools for Personalized Healthcare: Predicting Responses to Biologics in Rheumatoid Patients Through Comorbidity and Blood Test Analysis
- 10:30AM-12:30PM
-
Abstract Number: 0178
Are Participants in Gout Clinical Trials Representative of People with Gout in the General Population?
- 10:30AM-12:30PM
-
Abstract Number: 0689
Arrhythmic Burden, Myocardial Markers, and Long-term Survival in Distinct Cardiac Magnetic Resonance Subsets of Systemic Sclerosis
- 10:30AM-12:30PM
-
Abstract Number: 0034
Arthritogenic Subdoligranulum (S. Dido 7) Is Increased in Individuals At-Risk for and with Early RA and Decreases over Time During Development of Inflammatory Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0525
Assess the Effect of Increasing the Dose of Folic Acid Supplementation in Patients of Rheumatoid Arthritis with Methotrexate Intolerance – A Randomised Controlled Trial
- 10:30AM-12:30PM
-
Abstract Number: 0395
Assessment of Enthesitis by Pediatric Rheumatology Providers
- 10:30AM-12:30PM
-
Abstract Number: 0293
Assessment of Skin Cancer Risk in Autoimmune Diseases: A Multivariate Analysis Using a National Inpatient Database
- 10:30AM-12:30PM
-
Abstract Number: 0730
Assessment of the Quality of Life in a Single-center Cohort of Patients with ANCA-Associated Vasculitis on Targeted Therapy: Characterization of Global, Disease and Organ-specific Parameters Using Patient Reported Outcomes
- 10:30AM-12:30PM
-
Abstract Number: 0116
Assessment of Triple Antiphospholipid Antibody-positive Patients Based on Clinical and Laboratory Domains of 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria
- 10:30AM-12:30PM
-
Abstract Number: 0560
Association Between a Self-Report Screening Tool for Sarcopenia (SARC-F) and Disease Activity, Muscle Strength and Muscle Power Measures, Patient-Reported Outcomes and Body Composition in Patients with Spondyloarthritides
- 10:30AM-12:30PM
-
Abstract Number: 0066
Association Between Gut Microbiota, Inflammation, and Epigenetics in Rheumatoid Arthritis Patients
- 10:30AM-12:30PM
-
Abstract Number: 0474
Association Between Rheumatoid Arthritis and Survival After Cancer: A Systematic Literature Review and Meta-analysis
- 10:30AM-12:30PM
-
Abstract Number: 0100
Association Between the Active Form of Plasminogen Activator Inhibitor 1 (PAI-1) and Endothelial Cell Activation in Antiphospholipid Syndrome
- 10:30AM-12:30PM
-
Abstract Number: 0697
Association of ANCA-Associated Vasculitis and Development of SSc and SSc-Associated Antibodies: Impact of Pulmonary Arterial Hypertension
- 10:30AM-12:30PM
-
Abstract Number: 0488
Association of Anti-CarP Levels with Clinical Activity and Serological Profile in Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0122
Association of Cognitive Impairment Measured by Montreal Cognitive Assessment and Plasma Levels of Growth Differentiation Factor 15 in Patients with Antiphospholipid Antibody Syndrome
- 10:30AM-12:30PM
-
Abstract Number: 0170
Association of General Physical Functioning, Valued Life Activity (VLA) Disability, and Use of Accommodations with Depressive Symptoms Among Individuals with Systemic Lupus Erythematosus (SLE)
- 10:30AM-12:30PM
-
Abstract Number: 0427
Association of Menopause and Systemic Rheumatic Disease Severity in Peri-Menopausal and Menopausal Women with Systemic Rheumatic Disease
- 10:30AM-12:30PM
-
Abstract Number: 0056
Association of Soluble Immune Checkpoint Proteins with the Risk of Developing RA in ACPA-positive At-risk Individuals
- 10:30AM-12:30PM
-
Abstract Number: 0698
Association of Systemic Sclerosis with ANCA-Associated Vasculitis and Large Vessel Vasculitis: Impact of Pulmonary Arterial Hypertension
- 10:30AM-12:30PM
-
Abstract Number: 0579
Association of the Presence of Active Acute Anterior Uveitis with Disease Activity in Axial Spondyloarthritis
- 10:30AM-12:30PM
-
Abstract Number: 0548
Associations and Impact of Kinesiophobia on Patient Reported Outcomes and Performance-based Mobility Measures in Patients with Axial Spondyloarthritis
- 10:30AM-12:30PM
-
Abstract Number: 0717
Associations Between Calendar Time and Age at Diagnosis with Mortality in a National Cohort of Veterans with ANCA-Associated Vasculitis from 2001-2020
- 10:30AM-12:30PM
-
Abstract Number: 0171
Associations Between Discrimination Experiences and Patient-Reported Outcomes Among Asian Individuals with Systemic Lupus Erythematosus (SLE)
- 10:30AM-12:30PM
-
Abstract Number: 0486
Associations Between Frailty and Incident Cancer and Cancer-related Mortality in Veterans with Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0192
Associations Between Social Determinants of Health and Acute Care Use Among Individuals with Lupus, Rheumatoid Arthritis and Osteoarthritis in the All of Us Research Program
- 10:30AM-12:30PM
-
Abstract Number: 0196
Associations Between Systemic Lupus Erythematosus (SLE) and the Social Vulnerability Index (SVI)
- 10:30AM-12:30PM
-
Abstract Number: 0047
Asthma Is Associated with Increased Serum IgA Antibodies to Citrullinated Peptide Antigenscompared to Healthy Controlsin Discovery and Validation Cohorts
- 10:30AM-12:30PM
-
Abstract Number: 0005
Autoantibodies Identified in Myositis-Specific Autoantibody Negative Juvenile Myositis Patients
- 10:30AM-12:30PM
-
Abstract Number: 0411
Axial Radiographic Structural Damage in Enthesitis-Related Arthritis in Children and Young Adult Patients
- 10:30AM-12:30PM
-
Abstract Number: 0561
Axial Spondyloarthritis Patients with Comorbid Fibromyalgia Feel Worse, Work Less and More Often Try Multiple Biological DMARDs − Results from a Population-Based Cohort
- 10:30AM-12:30PM
-
Abstract Number: 0476
Baricitinib in Rheumatoid Arthritis – Interstitial Lung Disease. National Multicenter Study of 72 Patients
- 10:30AM-12:30PM
-
Abstract Number: 0273
Barriers and Facilitators for Outpatient Follow-Up After an Acute Gout Flare: A Qualitative Research Study
- 10:30AM-12:30PM
-
Abstract Number: 0262
Bartonella Endocarditis as an Important Mimic of ANCA Associated Vasculitis: Results of a Large Single Center Descriptive Analysis
- 10:30AM-12:30PM
-
Abstract Number: 0769
Baseline Evaluation of Diagnoses and Prescribing Patterns in Polymyalgia Rheumatica
- 10:30AM-12:30PM
-
Abstract Number: 0330
Baseline Interstitial Lung Disease (ILD) Characteristics and Outcomes in Patients with Anti-synthetase Syndrome Related ILD (ASSD-ILD): Analysis from the “Classification Criteria for Anti-synthetase Syndrome (CLASS)” Project Database
- 10:30AM-12:30PM
-
Abstract Number: 0673
BCMA-CD19 Compound CAR-T (cCAR) Safely Provides a Complete Humoral Reset Eliminating All Autoantibodies Resulting in Long-term Medication-Free Complete Remission Among Systemic Lupus Erythematosus (SLE) and Lupus Nephritis (LN) Patients
- 10:30AM-12:30PM
-
Abstract Number: 0595
bDMARD Drug Survival in Combination Therapy with Methotrexate in Psoriatic Arthritis: A Systematic Literature Review and Meta-analysis
- 10:30AM-12:30PM
-
Abstract Number: 0143
Behavioral Factors and Chronic Conditions Associated with Rheumatoid Arthritis, KNHANES 2010 to 2021
- 10:30AM-12:30PM
-
Abstract Number: 0693
Behind the Bronchiectasis in Systemic Sclerosis. Prevalence and Risk Factors
- 10:30AM-12:30PM
-
Abstract Number: 0149
Beliefs on Self-Management in Rheumatoid Arthritis Compared to Other Chronic Diseases Using the Nationally Representative Medical Expenditure Panel Survey
- 10:30AM-12:30PM
-
Abstract Number: 0665
Belimumab Induces Early and Sustained Resolution of Lupus Thrombocytopenia and Lupus Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0004
Beyond Antibodies and CAR-T: Topologically Engineered, Superdimeric Antibody NK Engagers and T Cell Engagers for B Cell Depletion Demonstrating Cooperative Binding to Target and Effector Cells
- 10:30AM-12:30PM
-
Abstract Number: 0031
Beyond Pain and Inflammation: Intra-articular Liraglutide’s Comprehensive Benefits on Synovial Health and Cartilage in Osteoarthritis Compared to Dexamethasone
- 10:30AM-12:30PM
-
Abstract Number: 0191
Beyond the Symptoms: Exploring Cognitive Bias in Lupus Diagnosis Within Primary Care
- 10:30AM-12:30PM
-
Abstract Number: 0602
Bimekizumab Impact on Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) Core Domains for Patients with Psoriatic Arthritis: Results up to 2 Years of Treatment Duration
- 10:30AM-12:30PM
-
Abstract Number: 0591
Bimekizumab Maintained Efficacy Responses in Patients with Active Psoriatic Arthritis: Up to 2-Year Results from Two Phase 3 Studies
- 10:30AM-12:30PM
-
Abstract Number: 0597
Bimekizumab Maintained Stringent Clinical Responses over 2 Years in Patients with Axial Spondyloarthritis: Results from Two Phase 3 Studies
- 10:30AM-12:30PM
-
Abstract Number: 0600
Bimekizumab-Treated Patients with Active Psoriatic Arthritis Showed Sustained Reductions in Disease Impact Assessed by the Psoriatic Arthritis Impact of Disease (PsAID)-12 Questionnaire: Up to 2‑Year Results from Two Phase 3 Studies
- 10:30AM-12:30PM
-
Abstract Number: 0110
Binding Characteristics of Patient Clusters Among Anticardiolipin and Anti-β2-Glycoprotein I ELISA and Non-ELISA Assays: A Survey by the Association of Medical Laboratory Immunologists
- 10:30AM-12:30PM
-
Abstract Number: 0401
Biologic Abatement and Capturing Kids Outcomes and Flare Frequency in Juvenile Spondyloarthritis: Baseline Characteristics and Enrollment
- 10:30AM-12:30PM
-
Abstract Number: 0485
Biomarkers for Disease Activity and Response to Treatment in Early Rheumatoid Arthritis: Metabolomics and Machine Learning Analyses in NORD-STAR Cohort
- 10:30AM-12:30PM
-
Abstract Number: 0039
Blockade of Soluble and Cell Surface PAD Activity Prevents the Generation of Citrullinated Autoantigens Recognized by RA Patients’ Serum
- 10:30AM-12:30PM
-
Abstract Number: 0215
BP Connect Improves Follow-up of High Blood Pressure in Urban Rheumatology and Non-Rheumatology Clinics
- 10:30AM-12:30PM
-
Abstract Number: 0058
Bradykinin Receptor B1 Blockade Suppresses Soluble CD13-Induced Differentiation of Osteoclasts from Monocytes
- 10:30AM-12:30PM
-
Abstract Number: 0614
Bridging the Gap Between Patient’s Perception on Quality of Life and Disease Activity and Damage in Systemic Lupus Erythematous Patient
- 10:30AM-12:30PM
-
Abstract Number: 0179
Bridging the Gap: Enhancing Diversity in Lupus Clinical Trials Through Investigator and Research Staff Engagement
- 10:30AM-12:30PM
-
Abstract Number: 0007
Bromodomain 2 of BET Proteins Plays a Crucial Role in Follicular/peripheral Helper T Cell and Plasma Cell Differentiation
- 10:30AM-12:30PM
-
Abstract Number: 0272
Calcifications of the Transverse Ligament of the Atlas in Patients Diagnosed with Calciumpyrophosphate Crystal Arthritis – a Retrospective Observational Study
- 10:30AM-12:30PM
-
Abstract Number: 0216
Can Immune Checkpoint Inhibitors Safely Combat Cancer in Patients with Rheumatoid Arthritis?
- 10:30AM-12:30PM
-
Abstract Number: 0690
Can Immunosuppression or Vasodilation Prevent the Onset of Interstitial Lung Disease in Systemic Sclerosis? An Association Analysis from the EUSTAR Database
- 10:30AM-12:30PM
-
Abstract Number: 0369
Can Treatment Expectations or Treatment Itself in Patients with Arthralgia Suspicious for Progression to Rheumatoid Arthritis Improve Illness Perceptions?
- 10:30AM-12:30PM
-
Abstract Number: 0480
Can’t Sleep, Won’t Sleep: A Systematic Review and Meta-Analysis of Insomnia Prevalence in 70,105 Rheumatoid Arthritis Patients
- 10:30AM-12:30PM
-
Abstract Number: 0699
Cardiac Biomarkers for Predicting Cardiopulmonary Toxicity of Autologous Haematopoietic Stem Cell Transplantation for Systemic Sclerosis
- 10:30AM-12:30PM
-
Abstract Number: 0331
Cardiac Manifestations in Patients with Anti-Synthetase Syndrome: Analysis from the “Classification Criteria for Anti-synthetase Syndrome (CLASS)” Project Database
- 10:30AM-12:30PM
-
Abstract Number: 0313
Cardiac Sarcoidosis Is Associated with a High Mortality: Retrospective Analysis of a Cohort at Mayo Clinic Florida
- 10:30AM-12:30PM
-
Abstract Number: 0598
Cardio-metabolic Effects of Apremilast in Patients with Psoriatic Arthritis: A Prospective Cohort Study
- 10:30AM-12:30PM
-
Abstract Number: 0205
Cardiovascular Event Risks Among Members with Rheumatoid Arthritis, Psoriatic Arthritis, and Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 0306
Cardiovascular Risk Estimated with the New PREVENT Calculator and Disease Activity in Patients with Rheumatoid and Psoriatic Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0460
Cartilage Damage or (sub)luxation of Finger Joints: Impact on Physical Function in Patients with Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0027
Cation Channel TRPC1 Regulates Mesenchymal Stem Cell Differentiation and Bone Formation
- 10:30AM-12:30PM
-
Abstract Number: 0103
CD10highLow-Density Granulocytes Is a Potential Marker of Disease Activity in Antiphospholipid Syndrome
- 10:30AM-12:30PM
-
Abstract Number: 0020
CD14 Deficiency Protects Against TLR4/LPS-mediated Inhibition of Osteoclastogenesis
- 10:30AM-12:30PM
-
Abstract Number: 0240
Cellular and Humoral Responses Following a Fifth, Updated SARS-CoV-2 Vaccine Dose and Hybrid Immunity in Patients on TNF Inhibitors: A Prospective Cohort Study
- 10:30AM-12:30PM
-
Abstract Number: 0580
Cellular Immune Activation Signatures at Baseline Predict Response to TNF Inhibitors in Axial Spondyloarthritis
- 10:30AM-12:30PM
-
Abstract Number: 0744
Cerebrovascular Accidents (CVA) in Giant Cell Arteritis: Identification of Predictive Factors from the ARTESER Registry
- 10:30AM-12:30PM
-
Abstract Number: 0263
Characteristics and Coinfections of Diffuse Alveolar Hemorrhage in Rheumatic Patients
- 10:30AM-12:30PM
-
Abstract Number: 0309
Characteristics and Factors Associated with Treatment Response Among Patients with Eosinophilic Fasciitis: A Systematic Review and Meta-analysis
- 10:30AM-12:30PM
-
Abstract Number: 0755
Characteristics Associated with Long-Term Glucocorticoids Use in Patients with New Onset Polymyalgia Rheumatica
- 10:30AM-12:30PM
-
Abstract Number: 0297
Characteristics of Adult-Onset Still’s Disease Skin Eruption in Individuals of Sub-Saharan Ancestry
- 10:30AM-12:30PM
-
Abstract Number: 0077
Characteristics of Axial Spondyloarthritis in Patients with Onset Chronic Low Back Pain After Age 45
- 10:30AM-12:30PM
-
Abstract Number: 0573
Characteristics of Difficult-to-Treat Ankylosing Spondylitis- Results from Real-World Data
- 10:30AM-12:30PM
-
Abstract Number: 0211
Characteristics of Hospitalizations and Outpatient Follow-up for Patients with SLE at an Academic Hospital Setting in Austin, Texas
- 10:30AM-12:30PM
-
Abstract Number: 0209
Characteristics of Ordering Providers and Patients with Positive Antinuclear Antibodies: A Pragmatic, Risk Model Study
- 10:30AM-12:30PM
-
Abstract Number: 0344
Characteristics of Patients with Antisynthetase Antibodies
- 10:30AM-12:30PM
-
Abstract Number: 0337
Characterization of Statin Induced Myopathy in the Hospital Setting
- 10:30AM-12:30PM
-
Abstract Number: 0079
Characterization of the Tissue Resident Memorial T Cells in Autoimmune Arthritis: A Comparative Study of Psoriatic Arthritis and Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0197
Characterizing Diet and Neighborhood Resources in Patients with Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 0517
Characterizing Infusion-Related Reactions in Patients with Rheumatoid Arthritis Treated with Biologic DMARDs: Observations from the KOBIO Registry
- 10:30AM-12:30PM
-
Abstract Number: 0646
Chart Audit of over 1,000 SLE Patients Reveals Biologic Treatment Choice Driven by Disease Manifestations
- 10:30AM-12:30PM
-
Abstract Number: 0606
Choice of Biologic Immunotherapy for Psoriasis or Psoriatic Arthritis Not Associated with Risk of Major Adverse Cardiac Events
- 10:30AM-12:30PM
-
Abstract Number: 0154
Chronic Sinusitis Predicting Interstitial Lung Disease in Sjögren’s Syndrome: A Comprehensive USA Population Study (2004-2024)
- 10:30AM-12:30PM
-
Abstract Number: 0462
Circulating Mediators of Endothelial Dysfunction as Predictors of Incident Heart Failure in Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0327
Clinical and Immunological Risk Factors Associated with Fybromialgia in Patients with Idiopathic Inflammatory Myopathies
- 10:30AM-12:30PM
-
Abstract Number: 0119
Clinical and Serological Distinctions and Evolutionary Predictors in Antiphospholipid Syndrome and Systemic Lupus Erythematosus: A Multicenter Cohort Analysis
- 10:30AM-12:30PM
-
Abstract Number: 0647
Clinical Associations and Outcomes of Pericarditis in Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 0147
Clinical Characteristics and Biomarkers Associated with Detectable High-Sensitivity Cardiac Troponin in Patients with Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0339
Clinical Characteristics Associated with Inpatient Mortality in Dermatomyositis Patients: A Single Center Retrospective Cohort Study
- 10:30AM-12:30PM
-
Abstract Number: 0754
Clinical Characterization of Aortitis and Periaortitis in a Cohort of 134 Patients from a Single Universitary Center. A Model-based Cluster Analysis
- 10:30AM-12:30PM
-
Abstract Number: 0627
Clinical Conditions Associated with Presence of a High-titer Antinuclear Antibody in Individuals Without Autoimmune Disease
- 10:30AM-12:30PM
-
Abstract Number: 0680
Clinical Correlates of Physical and Mental Health in Early Systemic Sclerosis: Data from the Collaborative National Quality and Efficacy (CONQUER) Registry
- 10:30AM-12:30PM
-
Abstract Number: 0620
Clinical Efficacy and Patient-Reported Outcomes in Anti-Ro/Sjögren’s Syndrome–Related Antigen a Antibody–Positive Patients with Active SLE Treated WithDeucravacitinib in the Phase 2 PAISLEY Trial
- 10:30AM-12:30PM
-
Abstract Number: 0610
Clinical Evaluation on IFI44L Gene Methylation Detection for Diagnosis of Systemic Lupus Erythematosus by Methylation Sensitive High Resolution Melting (MS-HRM)
- 10:30AM-12:30PM
-
Abstract Number: 0539
Clinical Expression of Radiographic Axial Spondyloarthritis and Its Association with HLA-B27 in European and Ibero-American Populations: Data from the REGISPONSER and RESPONDIA Registries
- 10:30AM-12:30PM
-
Abstract Number: 0563
Clinical Features of Patients with SpA, with or Without IBD: Results from the METEOR Cohort
- 10:30AM-12:30PM
-
Abstract Number: 0261
Clinical Implications, Bacterial Profiles, and Patient Outcomes in Hospitalized Patients with Autoimmune Rheumatic Diseases
- 10:30AM-12:30PM
-
Abstract Number: 0634
Clinical Relevance of the Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS) in Predicting Lupus Outcomes: A 5-Year Longitudinal Cohort Study
- 10:30AM-12:30PM
-
Abstract Number: 0264
Clinical Value of Metagenomic Next-generation Sequencing in Patients with Connective Tissue Disease Co-infections: A Single-center Study from Southern Hospital in China
- 10:30AM-12:30PM
-
Abstract Number: 0003
CLN-978, a CD19-directed T Cell Engager (TCE), Leads to Rapid and Deep B Cell Depletion and Has Broad Potential for Development in Autoimmune Diseases
- 10:30AM-12:30PM
-
Abstract Number: 0747
Clofutriben to Improve the Benefit-Risk Profile of Prednisolone in Patients with Polymyalgia Rheumatica
- 10:30AM-12:30PM
-
Abstract Number: 0037
Clonal Haematopoiesis of Indeterminate Potential (CHIP) Is Associated with Disease Activity in Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0346
Clonally Expanded and Total B Cells in Patients with Idiopathic Inflammatory Myopathies Show Skewed B Cell Subset Distribution and Reduced Somatic Hypermutation Relative to Healthy Controls
- 10:30AM-12:30PM
-
Abstract Number: 0430
Clues from Early Gestational Mean Arterial Pressure in Predicting Preeclampsia Risk in Systemic Lupus Erythematosus (SLE)
- 10:30AM-12:30PM
-
Abstract Number: 0484
Cluster Analysis Based on Joint Characteristics: A Study of Joint Involvement Profiles in Early Rheumatoid Arthritis (ERA) Patients in China
- 10:30AM-12:30PM
-
Abstract Number: 0512
Co-stimulatory Blockade Causes Targeted Quantitative and Clonotypic Contractions in Extrafollicular B-cell Subsets in Seropositive RA Patients
- 10:30AM-12:30PM
-
Abstract Number: 0568
Coexistence of Raynaud’s Phenomenon, Morphea or Scleroderma in Spondyloarthritis Patients: Insights from a Retrospective Cohort Study Highlighting a Unique Phenotype
- 10:30AM-12:30PM
-
Abstract Number: 0624
Coexisting Tubulointerstitial Inflammation and Damage Is a Risk Factor for Chronic Kidney Disease in Patients with Lupus Nephritis
- 10:30AM-12:30PM
-
Abstract Number: 0180
Collaborative Solutions to Lupus Trial Challenges for Underrepresented Participant Recruitment & Engagement: Perspectives from the Lupus Clinical Investigators Network (LuCIN)
- 10:30AM-12:30PM
-
Abstract Number: 0575
Combined Testing of anti-CD74 IgA and Anti-UH-axSpA Antibodies Increases the Diagnostic Potential for axSpA
- 10:30AM-12:30PM
-
Abstract Number: 0145
Community Mobility in a Diverse Cohort of Individuals with Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 0519
Comparable Malignancy Risk of Janus Kinase Inhibitors with Conventional Synthetic and Biologic DMARDs in Asian Patients with Rheumatoid Arthritis: A Comprehensive Analysis from Two Medical Centers
- 10:30AM-12:30PM
-
Abstract Number: 0155
Comparative Analysis and Outcomes of COVID 19: Unveiling Trends in Rheumatological vs. Non-Rheumatological Disease Patients
- 10:30AM-12:30PM
-
Abstract Number: 0382
Comparative Analysis of Tear-based S100 Proteins, Cytokines, and Chemokines Levels in Juvenile Idiopathic Arthritis Associated-uveitis: Insights into Eye Laterality and Severity of Ocular Inflammation
- 10:30AM-12:30PM
-
Abstract Number: 0082
Comparative Immunology of Entheseal Anchorage Sites Between Spine, Hip and Knee Demonstrates up to 70-fold Greater IL-23 Induction from Axial Enthesis Bone: A New Angle on the Failure of IL-23 Blockade in Ankylosing Spondylitis
- 10:30AM-12:30PM
-
Abstract Number: 0111
Comparative Performance of ELISA and CLIA Against the 2023 ACR/EULAR APS Classification Criteria
- 10:30AM-12:30PM
-
Abstract Number: 0363
Comparative Risk of Demyelinating Diseases Among Patients on TNF-Alpha Inhibitors: A Cohort Study Using the TriNetX Database
- 10:30AM-12:30PM
-
Abstract Number: 0061
Comparative Transcriptional Profiling of IPF and RA-ILD Lung Tissue Demonstrates Both Overlapping and Distinct Cell-specific Signaling Pathways
- 10:30AM-12:30PM
-
Abstract Number: 0320
Comparative Transcriptional Profiling Reveals Shared Pathway Activation Between Human Jo-1+ Anti-Synthetase Syndrome and Murine Histidyl-tRNA Synthetase-Induced Myositis
- 10:30AM-12:30PM
-
Abstract Number: 0403
Comparing Domains Reported by Patients and Other Collaborators in CNO and SAPHO: A Qualitative Study and Scoping Review Using the OMERACT Process
- 10:30AM-12:30PM
-
Abstract Number: 0526
Comparing Immunogenicity and Safety Following Transition from Reference Rituximab to Biosimilar Rituximab (DRL_RI) in Patients with Rheumatoid Arthritis: A Randomized, Double-blind, Phase 3 Study
- 10:30AM-12:30PM
-
Abstract Number: 0767
Comparing Large Vessel Uptake of 68Ga-HA-DOTATATE to 18F-FDG Using PET/CT Imaging in Patients with Active Giant Cell Arteritis
- 10:30AM-12:30PM
-
Abstract Number: 0679
Comparing Raynaud’s Phenomenon Measurement Tools: Results of the Optimizing Raynaud Phenomenon Outcome Measures in Systemic Sclerosis (ROSS) Study
- 10:30AM-12:30PM
-
Abstract Number: 0618
Comparison of Cell Type-Specific Polygenic Risk in Systemic Lupus Erythematosus Patient and Healthy Controls
- 10:30AM-12:30PM
-
Abstract Number: 0233
Comparisons of Ga-FAPI and FDG PET/CT with X-ray Imaging in the Assessment of Rheumatoid Arthritis Patients
- 10:30AM-12:30PM
-
Abstract Number: 0461
Complete Description of the Three Pathways of the Complement System in a Series of 430 Patients with Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0009
Comprehensive Autoantibody Profiling Highlights Clinical Relevance of Autoantibodies to G Protein-coupled Receptors in Systemic Sclerosis: Insights from a B-cell Depletion Clinical Trial
- 10:30AM-12:30PM
-
Abstract Number: 0707
Comprehensive Skin Assessment in Systemic Sclerosis Using Spatial Frequency Domain Imaging (SFDI)
- 10:30AM-12:30PM
-
Abstract Number: 0528
Consequences of Switching Originator Biological Therapies to Its Biosimilars in Patients with Immune-mediated Diseases in a Mexican Cohort
- 10:30AM-12:30PM
-
Abstract Number: 0026
Conserved Pro-Fibrotic Fibroblast Signatures in Osteoarthritis Synovium and Systemic Sclerosis Skin
- 10:30AM-12:30PM
-
Abstract Number: 0479
Constructing and Using a Novel Nucleotide Transformer for Patients with Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0439
Contraception Counseling and Contraception Use Among SLE and RA/JIA Patients at a Public Medical Center in Los Angeles: Investigating Teratogenic Medication Use and Language Preferences
- 10:30AM-12:30PM
-
Abstract Number: 0455
Contraception Counseling for Patients with Rheumatic and Musculoskeletal Diseases (RMDs) at a Tertiary Care Rheumatology Clinic: A Quality Improvement Project
- 10:30AM-12:30PM
-
Abstract Number: 0417
Contraception in Community Rheumatology Practices
- 10:30AM-12:30PM
-
Abstract Number: 0654
Corneal Confocal Microscopy: An Ophthalmic Imaging Biomarker for Small Fiber Neuropathy in Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 0495
Correlation Between Triglyceride/Glucose Index and Functional Capacity in Rheumatoid Arthritis Patients
- 10:30AM-12:30PM
-
Abstract Number: 0324
Correlative Studies of CABA-201, a Fully Human, Autologous 4-1BB Anti-CD19 CAR T Cell Therapy in Patients with Immune-Mediated Necrotizing Myopathy and Systemic Lupus Erythematosus from the RESET-MyositisTM and RESET-SLETM Clinical Trials
- 10:30AM-12:30PM
-
Abstract Number: 0750
Corticosteroid Withdrawal Using Tocilizumab and Its Association with Autoantibody Profile in Takayasu Arteritis: A Multicenter, Single-arm, Prospective Study
- 10:30AM-12:30PM
-
Abstract Number: 0274
Cost-effectiveness of Low Dose Colchicine Prophylaxis When Starting Allopurinol Using the “Start-Low Go-Slow” Approach for Gout
- 10:30AM-12:30PM
-
Abstract Number: 0531
Costs and Clinical Outcomes of the Rheumatoid Arthritis Medication Tapering Cohort
- 10:30AM-12:30PM
-
Abstract Number: 0212
Costs of Hospitalization in Patients with SLE: An Analysis of the National Inpatient Sample
- 10:30AM-12:30PM
-
Abstract Number: 0198
COVID-19 Vaccination and Hospitalization Rates Differ Between People with Diagnosed Immune Mediated Inflammatory Disease and the General Population: A Population-based Study
- 10:30AM-12:30PM
-
Abstract Number: 0161
Cross Country Burden of Osteoarthritis in Latin America and Caribbean from 1990-2021: A Comparative and Consistent Benchmarking Analysis for the Global Burden of Disease Study 2022
- 10:30AM-12:30PM
-
Abstract Number: 0385
Cross-cultural Validation of the “Effects of Youngsters-Eyesight on Quality of Life (EYE-Q)”: A Measure of Vision-related Quality of Life and Function in Childhood Uveitis
- 10:30AM-12:30PM
-
Abstract Number: 0083
Culturing and Comparative Analysis of Small Intestinal Organoids from SKG and MIFKO-SKG Mice
- 10:30AM-12:30PM
-
Abstract Number: 0632
Cutaneous Lupus Erythema and Scale Have Similar Six-month Trends Without Significant Impact from Race/ethnicity or Disease Subtype
- 10:30AM-12:30PM
-
Abstract Number: 0585
Cycling to TNFi vs. Switching to IL-17Ai After a First TNFi Discontinuation Among Patients with PsA and axSpA: The CorEvitas PsA/SpA Registry
- 10:30AM-12:30PM
-
Abstract Number: 0286
Damage Associated with Disease-Specific Effects and Diagnostic or Therapeutic Procedures Is Highly Prevalent in IgG4-Related Disease
- 10:30AM-12:30PM
-
Abstract Number: 0128
Damage Index in Patients with Thrombotic Antiphospholipid Syndrome (DIAPS) Version 2.0: One Single Center Pilot Study
- 10:30AM-12:30PM
-
Abstract Number: 0657
Data-driven Bayesian Network Analysis for Predicting Difficult-to-treat (DTT) Lupus Nephritis
- 10:30AM-12:30PM
-
Abstract Number: 0084
DB-2304, an Immunomodulatory Antibody‒drug Conjugate (ADC) Targeting BDCA2, Displays Strong In Vivo Efficacy in Pharmacodynamic and Psoriasis Models
- 10:30AM-12:30PM
-
Abstract Number: 0444
Deep Serologic Profiling Identifies Novel Autoantibodies Associated with Fetal Atrioventricular Block
- 10:30AM-12:30PM
-
Abstract Number: 0036
Deep Topic Modeling Deconvolves Cell States in Spatial Transcriptomic Profiles of Rheumatoid Arthritis Synovial Tissue
- 10:30AM-12:30PM
-
Abstract Number: 0406
Delayed Diagnosis and Accrual of Joint Damage in Incident Cases of Juvenile Idiopathic Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0639
Delayed Diagnosis in Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 0199
Delivery of Guideline Concordant Care in Childhood-Onset Lupus Nephritis
- 10:30AM-12:30PM
-
Abstract Number: 0269
Delphi Survey to Establish Consensus on the OMERACT Core Domain Set for Long-Term Studies of Calcium Pyrophosphate Deposition Disease
- 10:30AM-12:30PM
-
Abstract Number: 0136
Demographic and Clinical Characteristics of Patients with SLE Across 5 Registries – the LupusNet Federated Data Network
- 10:30AM-12:30PM
-
Abstract Number: 0130
Depression Genetic Risk, Diagnoses, and Treatments in Association with Cardiovascular Disease Events Among Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis in the All of Us Research Program
- 10:30AM-12:30PM
-
Abstract Number: 0347
Dermato-polymyositis Mortality in U.S. Population: Declining Cancer and Cardiovascular Diseases Among the Leading Underlying Causes of Death over Two Decades
- 10:30AM-12:30PM
-
Abstract Number: 0437
Describing Maternal Outcomes Among Veterans with a History of Systemic Lupus Erythematosus and Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0290
Deucravacitinib Long-term Efficacy Through 4 Years in Week 16 Placebo Crossover Patients in the Phase 3 POETYK PSO-1, PSO-2, and LTE Program
- 10:30AM-12:30PM
-
Abstract Number: 0662
Deucravacitinib, a First-in-Class, Oral, Selective, Allosteric Tyrosine Kinase 2 Inhibitor, in SLE: Efficacy by Baseline Demographics and Disease Characteristics in the Phase 2 PAISLEY Trial
- 10:30AM-12:30PM
-
Abstract Number: 0316
Development and Evaluation of the Adult-onset Still’s Disease Activity Index Based on Whole RNA-seq Analysis: A Novel Approach Independent of Tocilizumab Treatment
- 10:30AM-12:30PM
-
Abstract Number: 0368
Development and Validation of a Patient-centered Self-evaluation Questionnaire in Systemic Lupus Erythematosus: LUPIN®
- 10:30AM-12:30PM
-
Abstract Number: 0186
Development of a Novel Dried Blood Spot Method to Improve Capacity for ANA Testing in Lower-Resource Settings
- 10:30AM-12:30PM
-
Abstract Number: 0362
Development of a Theory-based Digital Messaging Program to Reduce Fatigue in Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 0701
Diagnostic Performances of Vascular Biomarkers Soluble Fms-like Tyrosine Kinase (sFlt-1) and Placental Growth Factor (PlGF) in Scleroderma Renal Crisis: A Case Control Study
- 10:30AM-12:30PM
-
Abstract Number: 0012
Dichotomous Expression of CXCR3 and CCR9 and Relationship to Intestinal Permeability in B Cells in Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0409
Differences in Clinical Presentation and Outcomes Between Down Syndrome-Associated Arthritis and Juvenile Idiopathic Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0762
Different Giant Cell Arteritis Phenotypes May Present Distinct Types of Ischemic Complications
- 10:30AM-12:30PM
-
Abstract Number: 0554
Different Prevalence of Intestinal Inflammation in Radiographic and Non-radiographic Axial Spondyloarthritis. Data from EISER Study
- 10:30AM-12:30PM
-
Abstract Number: 0481
Differential Effect of Comorbidities on the Clinical Evolution of Early Arthritis by Sex
- 10:30AM-12:30PM
-
Abstract Number: 0731
Differentiating Primary Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis from Secondary Forms
- 10:30AM-12:30PM
-
Abstract Number: 0219
Differentiation of Nail Psoriasis from Healthy Nails Using Ultrasound: A Cross-Sectional Study with a Novel Nail Matrix Measurement Technique
- 10:30AM-12:30PM
-
Abstract Number: 0758
Difficult to Treat Takayasu Arteritis: Comparative Efficacy of Colchicine and Tofacitinib
- 10:30AM-12:30PM
-
Abstract Number: 0715
Diffuse Alveolar Hemorrhage in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Revisited
- 10:30AM-12:30PM
-
Abstract Number: 0321
Diffusion Weighted Imaging in Muscle MRI Can Detect Quantitative Improvements in Muscle Edema: A Post-hoc Analyses of the Study of Tofacitinib in Refractory Dermatomyositis
- 10:30AM-12:30PM
-
Abstract Number: 0529
Discontinuation of Targeted Disease-Modifying Antirheumatic Agents in Older Patients with Rheumatoid Arthritis: Retrospective Analysis of Medicare Data
- 10:30AM-12:30PM
-
Abstract Number: 0041
Disease Activity and Serological Inflammatory Markers Are Associated with TNF-a and IL-6-Induced Osteoclasts, but Not with RANKL-Induced Osteoclasts in Peripheral Blood Monocytes from Patients with Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0432
Disease Activity During Pregnancy in Patients with Rheumatoid Arthritis or Spondyloarthritis: Results from the Multicentre Prospective GR2 Study
- 10:30AM-12:30PM
-
Abstract Number: 0520
Disease Duration Differentially Affects the Clinical Efficacy of Biologics and JAK Inhibitors in Rheumatoid Arthritis: The ANSWER Cohort Study
- 10:30AM-12:30PM
-
Abstract Number: 0556
Disease Duration, Age and Clinical Features Related to Aortic Valve Sclerosis in Patients with Spondyloarthritis
- 10:30AM-12:30PM
-
Abstract Number: 0378
Disparate Disease Activity Outcomes Associated with Demographic Variables in Patients with Juvenile Idiopathic Arthritis in the Pediatric Rheumatology Care and Outcomes Improvement Network Registry
- 10:30AM-12:30PM
-
Abstract Number: 0616
Disparities in Health-Related Quality of Life Among Patients with Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 0496
Dissecting Early RA Patient Trajectories Through Time-independent Disease State Identification Identifies Distinct Patterns Dissected by Inflammation in Blood or Joints
- 10:30AM-12:30PM
-
Abstract Number: 0523
Distinct Peripheral Blood Immune Cell Sub-population Signatures at Baseline of Tofacitinib or Adalimumab Initiation Are Associated to Clinical Responses at 6 Months
- 10:30AM-12:30PM
-
Abstract Number: 0511
Do High Rheumatoid Factor Levels Impact Response to Certolizumab Pegol in Patients with Inadequately Controlled Rheumatoid Arthritis? A Post Hoc Analysis of a Phase 3b Trial
- 10:30AM-12:30PM
-
Abstract Number: 0228
Do Imaging Tests Have a Role in Predicting Progression to Rheumatoid Arthritis in People with Clinically Suspect Arthralgia? A Systematic Review & Meta-Analysis
- 10:30AM-12:30PM
-
Abstract Number: 0175
Do Knee Strength and Pain Relate to Developing Stair Climbing Difficulty for Knee Osteoarthritis?
- 10:30AM-12:30PM
-
Abstract Number: 0721
Does Serial ANCA Testing Help Predict the Risk of Relapse in Granulomatosis with Polyangiitis? A Single-center Cohort Study
- 10:30AM-12:30PM
-
Abstract Number: 0076
Early (3-Month) and Maintained (12-Month) Comparative Effectiveness of 5 Different Classes of Advanced Therapies in a Large Multinational Cohort of Real-World PsA Patients
- 10:30AM-12:30PM
-
Abstract Number: 0601
Early Improvement of Pain, Long-Term Disease Control, and Quality of Life Outcomes in Patients with Psoriatic Arthritis Treated with Upadacitinib
- 10:30AM-12:30PM
-
Abstract Number: 0667
Early Introduction of Biologic Agents in Systemic Lupus Erythematosus Reduces Relapse and Glucocorticoid Maintenance Dose: A Cohort Study from the PLEAJURE J Registry
- 10:30AM-12:30PM
-
Abstract Number: 0671
Effect of Litifilimab on Cutaneous Lupus Erythematosus Disease Area and Severity Index–Activity (CLASI-A) Subcomponents and Physician Global Assessment–Skin (PGA–Skin) in Patients with Cutaneous Lupus Erythematosus (CLE) in a Phase 2 Study
- 10:30AM-12:30PM
-
Abstract Number: 0029
Effect of Metformin on the Incidence of Total Knee Replacement: A Systematic Review and Meta-Analysis
- 10:30AM-12:30PM
-
Abstract Number: 0379
Effectiveness and Safety of Baricitinib for the Treatment of Juvenile Idiopathic Arthritis Associated Uveitis or Chronic Anterior Antinuclear Antibody Positive Uveitis in Children
- 10:30AM-12:30PM
-
Abstract Number: 0756
Effectiveness and Safety of Tocilizumab in the Treatment of Polymyalgia Rheumatica: A Meta-Analysis
- 10:30AM-12:30PM
-
Abstract Number: 0748
Effectiveness of Interleukin-6 Receptor Inhibitors versus Conventional Synthetic Immunomodulatory Therapy for Treatment of Frail Patients with Polymyalgia Rheumatica
- 10:30AM-12:30PM
-
Abstract Number: 0172
Effectiveness of mRNA COVID-19 Vaccines in Patients with Rheumatologic Conditions on Immunosuppressive Therapies
- 10:30AM-12:30PM
-
Abstract Number: 0289
Effectiveness of Rituximab in IgG4 Related Disease
- 10:30AM-12:30PM
-
Abstract Number: 0393
Effectiveness of Secukinumab in TMJ Symptoms in Children with JPsA and ERA: A Secondary Data Analysis of JUNIPERA
- 10:30AM-12:30PM
-
Abstract Number: 0584
Effectiveness of Tofacitinib Monotherapy versus Combination Therapy in Patients with Psoriatic Arthritis: Results from the CorEvitas Psoriatic Arthritis/Spondylarthritis Registry
- 10:30AM-12:30PM
-
Abstract Number: 0250
Effectiveness of Tuberculosis Preventive Treatment in Patients with Rheumatic Diseases: A Global Meta-analysis of Cohort Studies
- 10:30AM-12:30PM
-
Abstract Number: 0513
Effects of Cumulative Rituximab Exposure in Patients with Rheumatoid Arthritis: Results from Cohort at a Tertiary Academic Health Care Setting
- 10:30AM-12:30PM
-
Abstract Number: 0278
Efficacy and Safety of Genakumab versus Compound Betamethasone in Gout: The GUARD-1 Study
- 10:30AM-12:30PM
-
Abstract Number: 0341
Efficacy and Safety of Nintedanib in Patients with Idiopathic Inflammatory Myopathy-related Interstitial Lung Disease
- 10:30AM-12:30PM
-
Abstract Number: 0669
Efficacy of Belimumab in Systemic Lupus Erythematosus: A Single-Centre Retrospective Study
- 10:30AM-12:30PM
-
Abstract Number: 0413
Efficacy of Intra-articular Glucocorticoids as a Treatment for Oligoarticular Juvenile Idiopathic Arthritis: A Bicentric Retrospective Study in Japan
- 10:30AM-12:30PM
-
Abstract Number: 0410
Efficacy of Modified Dosing/interval Timing of Adalimumab in Patients Affected by Chronic Non Infectious Uveitis: A Retrospective Monocentric Study
- 10:30AM-12:30PM
-
Abstract Number: 0712
Efficacy of Sacubitril/Valsartan in Patients with Systemic Sclerosis and Heart Failure: A Retrospective Analysis
- 10:30AM-12:30PM
-
Abstract Number: 0590
Efficacy of Secukinumab Across the Axial Spondyloarthritis Spectrum Among Patients Grouped by Age (≥40 Years vs < 40): A PostHoc Analysis of 6 Phase 3 Trials
- 10:30AM-12:30PM
-
Abstract Number: 0514
Efficacy, Safety and Mechanism of Butyrate in the Treatment of Rheumatoid Arthritis (RA)
- 10:30AM-12:30PM
-
Abstract Number: 0112
Efforts to Harmonize ELISA and Non-ELISA Anticardiolipin and Anti-β2-glycoprotein-I Levels Based on ISTH SSC LA/aPL and APS ACTION International Multicenter Cohorts
- 10:30AM-12:30PM
-
Abstract Number: 0125
Electronic Health Record Rule-Based Computable Phenotype of Antiphospholipid Syndrome
- 10:30AM-12:30PM
-
Abstract Number: 0282
Electronic Health Record-Based Calcium Pyrophosphate Deposition Disease Registry: A Feasibility Study
- 10:30AM-12:30PM
-
Abstract Number: 0213
Electronic Medical Record Inbox Volume Association with Physician Gender, Physician Burnout, and the COVID-19 Pandemic at an Academic Rheumatology Center
- 10:30AM-12:30PM
-
Abstract Number: 0050
Elucidating Androgen Effects on Osteoclast Precursor Populations and Osteoclastogenesis
- 10:30AM-12:30PM
-
Abstract Number: 0351
Empowering Lupus Communities: Evaluating a National Peer Support Program for Lupus Teen, Young Adult Patients and Their Families
- 10:30AM-12:30PM
-
Abstract Number: 0482
Endothelial Dysfunction and QRISK3 in Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0080
Enhanced Cytotoxicity of Aging Associated NKG2C+ CD8+ T Cells in Ankylosing Spondylitis via HLA-B27
- 10:30AM-12:30PM
-
Abstract Number: 0322
Enhanced Detection of Myocarditis in Idiopathic Inflammatory Myopathies Utilizing Multiparametric Cardiac Magnetic Resonance Imaging
- 10:30AM-12:30PM
-
Abstract Number: 0068
Enhanced Expression of GPR65 in Inflammatory Sites and Bone Formation Regions in Ankylosing Spondylitis: Evidence from ScRNA-seq Analysis
- 10:30AM-12:30PM
-
Abstract Number: 0247
Enhanced Immunogenicity of the Recombinant Herpes Zoster Vaccine After One-Week of Mycophenolate Mofetil Discontinuation in Patients with Autoimmune Rheumatic Diseases: Interim Results from a Prospective Randomized Phase 4 Study
- 10:30AM-12:30PM
-
Abstract Number: 0373
Enhancing Lupus Patient Education and Support at Kings County Hospital
- 10:30AM-12:30PM
-
Abstract Number: 0146
Enhancing Pre-Biologic Response Modifier Screening for Coccidioidomycosis in Endemic Regions
- 10:30AM-12:30PM
-
Abstract Number: 0399
Eosinophilia and Exposure to IL-1 and IL-6 Blocking Biologic Medications in a Systemic Juvenile Idiopathic Arthritis Patient Cohort
- 10:30AM-12:30PM
-
Abstract Number: 0167
Epidemiology of Falls in a Diverse Cohort of Adults with SLE
- 10:30AM-12:30PM
-
Abstract Number: 0547
EspANDE Project: Improvement of Primary Care-Rheumatology Coordination in Spondyloarthritis in a Health Area in Northern Spain
- 10:30AM-12:30PM
-
Abstract Number: 0016
Establishment of a Human 3D In-Vitro Lymphoid Model to Evaluate Germinal Center Biology
- 10:30AM-12:30PM
-
Abstract Number: 0140
Estimation of 10-year Cardiovascular (CV) Risk and Traditional CV Risk Factors Distribution in Patients with Rheumatoid Arthritis from Three Italian Macro-areas
- 10:30AM-12:30PM
-
Abstract Number: 0445
Evaluating Clinical Reasoning in Randomized Surveys of Lupus Nephritis and Preeclampsia Pregnancy Case Workups: A Clinical Conundrum
- 10:30AM-12:30PM
-
Abstract Number: 0524
Evaluating Dose Reduction of Biologic Treatments in Rheumatoid Arthritis: Predicting Flares Using Clinical and Molecular Biomarkers
- 10:30AM-12:30PM
-
Abstract Number: 0357
Evaluating Meaningful Within-Person Change Thresholds in PROMIS-Fatigue Scores from Three Phase 3 Clinical Trials of Sarilumab for Rheumatoid Arthritis Using Empirical Cumulative Distribution Function (eCDF) Curves
- 10:30AM-12:30PM
-
Abstract Number: 0449
Evaluating Premenstrual Dysphoric Disorder in Women with Rheumatoid Arthritis and Healthy Female Subjects
- 10:30AM-12:30PM
-
Abstract Number: 0629
Evaluating the Concordance Between SRI4 and BICLA Using Placebo Data from Randomized Controlled Trials of Patients with Active Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 0200
Evaluating the Effectiveness of Educational Initiatives on Recruiting Underrepresented Participants into SLE Clinical Trials
- 10:30AM-12:30PM
-
Abstract Number: 0086
Evaluating the Efficacyof B Cell Targeting Drug Candidates Using a Humanized BAFF Transgenic SLE Mouse Model
- 10:30AM-12:30PM
-
Abstract Number: 0454
Evaluating the Rate of Cervical Cancer Screening and HPV Vaccination in Women with Systemic Lupus Erythematosus Within a Large Urban Healthcare System
- 10:30AM-12:30PM
-
Abstract Number: 0537
Evaluating the Usage of Janus Kinase Inhibitors in Rheumatology and Its Impact on Cardiovascular Risk
- 10:30AM-12:30PM
-
Abstract Number: 0392
Evaluation for the Presence of Antibodies to Malondialdehyde-Acetaldehyde Adduct in Juvenile Idiopathic Arthritis and Its Subtypes
- 10:30AM-12:30PM
-
Abstract Number: 0740
Evaluation of an Accelerated Physical Aging Phenotype in Newly Diagnosed Patients with Polymyalgia Rheumatica
- 10:30AM-12:30PM
-
Abstract Number: 0636
Evaluation of Clinical, Histological and Biomarker Response After Induction Treatment of Lupus Nephritis (LN)
- 10:30AM-12:30PM
-
Abstract Number: 0463
Evaluation of Inflammatory Indices as Predictive Biomarkers of Carotid Plaque in Patients with Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0551
Evaluation of Instruments Assessing Peripheral Arthritis in Spondyloarthritis: An Analysis of the ASAS-perSpA Study
- 10:30AM-12:30PM
-
Abstract Number: 0300
Evaluation of Long-term Primary Patency of Iliocaval Stenting in Patients with Retroperitoneal Fibrosis/chronic Periaortitis
- 10:30AM-12:30PM
-
Abstract Number: 0692
Evaluation of the New Criteria for Progressive Pulmonary Fibrosis in Patients with Systemic Sclerosis
- 10:30AM-12:30PM
-
Abstract Number: 0065
Evidence of Membranolytic Targeting and Intracellular Citrullinationin Neutrophils Isolated from Patients with Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0095
Expansion of Brain T Cell Subsets Outside of the Choroid Plexus in Murine Models of Neuropsychiatric Manifestations of Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 0364
Exploring 24-Hour Temporal Trends in Symptoms and Treatment of Rheumatic Disease Through Google Search Trends
- 10:30AM-12:30PM
-
Abstract Number: 0165
Exploring Changes in Daily Behaviors with Changes in Physical Function over 24 Weeks in Adults with Knee OA
- 10:30AM-12:30PM
-
Abstract Number: 0429
Exploring the Impact of Autoimmune Rheumatic Diseases on Human Milk Macronutrient Composition
- 10:30AM-12:30PM
-
Abstract Number: 0276
Exploring the Prevalence of Crowned Dens Syndrome in a Polymyalgia Rheumatica Veterans Affairs Patient Cohort
- 10:30AM-12:30PM
-
Abstract Number: 0354
Factors Associated with Health Information Technology Use Among United States Adults with Arthritis from 2012-2017: Analysis of the National Health Interview Survey
- 10:30AM-12:30PM
-
Abstract Number: 0420
Factors Associated with Infant Feeding Behaviors Among Women with Systemic Rheumatic Diseases
- 10:30AM-12:30PM
-
Abstract Number: 0366
Factors Associated with Participation in Rheumatology Clinical Trials: A UK-based Study
- 10:30AM-12:30PM
-
Abstract Number: 0729
Factors Associated with Pauci-immune Glomerulonephritis in Patients Undergoing Renal Biopsy with Positive ANCA Results
- 10:30AM-12:30PM
-
Abstract Number: 0722
Factors Associated with Relapses and Performance of the French Vasculitis Study Group Relapse Score in a Cohort of Mexican Patients with ANCA-Associated Vasculitis
- 10:30AM-12:30PM
-
Abstract Number: 0538
Factors Associated with Upadacitinib Persistence and Risk Minimization Measures in Patients with Rheumatic Diseases in a Real-world Setting. UPAreal Study
- 10:30AM-12:30PM
-
Abstract Number: 0436
Family Planning in Rheumatology: A Single Center Quality Improvement Project
- 10:30AM-12:30PM
-
Abstract Number: 0352
Fast-tracking Axial Spondyloarthritis Diagnosis: A Novel Approach to Public Health Advocacy and Awareness
- 10:30AM-12:30PM
-
Abstract Number: 0053
Fasting Reduces an IL-17+/IFNg+ T Helper Cell-inducing Gut Pathobiont in Patients with Rheumatoid Arthritis
- 10:30AM-12:30AM
-
Abstract Number: PP09
Finding the Balance: Regaining My Strength While Living with Sjögren’s & POTS
- 10:30AM-12:30PM
-
Abstract Number: 0057
Flow Cytometry of Cells Within Induced Sputum from Individuals At-Risk for RA Reveals Relative Expansion of Small Macrophages
- 10:30AM-12:30PM
-
Abstract Number: 0059
Fragment Crystallizable (Fc)-Free Certolizumab Pegol Is Not Bound by Rheumatoid Factors, While Fc Containing Biological DMARDsAre, Driving ImmuneComplex Formation and Cellular Clearance
- 10:30AM-12:30PM
-
Abstract Number: 0153
Frequencies and Rates of All-Cause Emergency Visits and Hospitalizations in Persons with Inflammatory Arthritis Conditions and Gout: A Systematic Review
- 10:30AM-12:30PM
-
Abstract Number: 0578
Gender Differences in Disease Parameters, Adherence to Treat to Target Strategy and Outcomes in Axial Spondyloarthritis (axSpA) in Pakistani Cohort
- 10:30AM-12:30PM
-
Abstract Number: 0571
Gender-specific Performance of Disease Activity Assessment Tools in Axial Spondyloarthritis: Ancillary Analysis of the PREDICT-SpA Study
- 10:30AM-12:30PM
-
Abstract Number: 0628
Genetic Determinants of Childhood Onset Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 0549
Global Distribution and Determinants of Diagnostic Delay Across Diverse Spondyloarthritis Entities: Data from the International ASAS-Perspa Study
- 10:30AM-12:30PM
-
Abstract Number: 0226
Global Ultrasound Scoring Systems for Assessing Synovitis in Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0728
Glomerular Proteomic Signature in ANCA-associated Glomerulonephritis
- 10:30AM-12:30PM
-
Abstract Number: 0422
Greater Use of Assisted Reproductive Techniques but Comparable Obstetric Morbidity in a Population of Women with Spondyloarthritis: A Matched Comparative Analysis of the GR2 Prospective Cohort and the French National Perinatal Surveys
- 10:30AM-12:30PM
-
Abstract Number: 0605
Guselkumab Binding to CD64+ IL-23–Producing Myeloid Cells Enhances Potency for Neutralizing IL-23 Signaling
- 10:30AM-12:30AM
-
Abstract Number: PP12
Healing Together: The Role of Black, Indigenous and People of Color (BIPOC) -Only Chronic Illness Spaces in Comprehensive Care
- 10:30AM-12:30PM
-
Abstract Number: 0522
Hematological Impact Assessment of Tofacitinib, Baricitinib, and Upadacitinib in Rheumatoid Arthritis Treatment
- 10:30AM-12:30PM
-
Abstract Number: 0617
Hereditary C1q Deficiency Is Associated with Type 1 Interferon-pathway Activation and a High Risk of Central Nervous System Inflammation
- 10:30AM-12:30PM
-
Abstract Number: 0546
Hiding in Plain Sight: The Impact of Implementing an Automated Inflammatory Back Pain Screening Tool on the Identification of Axial Spondyloarthritis in a Community Rheumatology Practice
- 10:30AM-12:30PM
-
Abstract Number: 0257
High Prevalence of Strongyloides Antibodies in Patients at Risk for Dissemination. A Call for Action
- 10:30AM-12:30PM
-
Abstract Number: 0710
High S100A4 Levels Associate with Inflammation and Vasculopathy in Systemic Sclerosis
- 10:30AM-12:30PM
-
Abstract Number: 0743
Higher Baseline FDG Musculoskeletal Uptake at PET/CT Is Associated with a Higher Remission Rate in Polymyalgia Rheumatica: A Retrospective 3-year Observational Study
- 10:30AM-12:30PM
-
Abstract Number: 0423
Higher Risk of Preterm Delivery in Women with Rheumatoid Arthritis: A Matched Comparative Analysis of the GR2 Prospective Cohort and the French National Perinatal Surveys
- 10:30AM-12:30PM
-
Abstract Number: 0389
Histopathological Features of Liver Tissue Biopsies in SJIA Patients with and Without Clinical Macrophage Activation Syndrome
- 10:30AM-12:30PM
-
Abstract Number: 0224
How Accurate Are Assessments by Local Radiologists of Sacroiliac Joint MRIs in Axial Spondyloarthritis and Psoriatic Arthritis in Routine Clinical Practice?- Evidence from 873 Patients in Five European Countries
- 10:30AM-12:30AM
-
Abstract Number: PP03
How Completing a Systematic Literature Review Improved How I Research My Own Rheumatoid Arthritis and Comorbidities
- 10:30AM-12:30PM
-
Abstract Number: 0374
How Do Patient Decision Aids Enable Purposeful Shared Decision-Making in Rheumatology? An Integrative Review
- 10:30AM-12:30PM
-
Abstract Number: 0566
How Early Is Early? Unveiling Time to Diagnosis Since Symptom Onset and Its Determinants in Patients Suspected of Early Axial Spondyloarthritis: Data from the SPondyloArthritis Caught Early (SPACE) Cohort
- 10:30AM-12:30PM
-
Abstract Number: 0501
How Fast Do JAK-inhibitors, TNF-inhibitors, Abatacept and IL-6 Inhibitors Act in Rheumatoid Arthritis? An International Collaboration of Registers of Rheumatoid Arthritis Patients (the “JAK-pot” Study)
- 10:30AM-12:30PM
-
Abstract Number: 0028
Human Meniscus Histopathological and Transcriptomic Changes at Early and Advanced Stages of Knee Osteoarthritis
- 10:30AM-12:30PM
-
Abstract Number: 0243
Humoral Response to SARS-CoV-2 Vaccination and Breakthrough COVID-19 Disease in Patients with Immune-mediated Inflammatory Diseases Receiving Biological Treatment
- 10:30AM-12:30PM
-
Abstract Number: 0152
Hydroxychloroquine and Chloroquine Retinopathy in Hispanic Patients with Rheumatic Diseases
- 10:30AM-12:30PM
-
Abstract Number: 0675
Hydroxychloroquine Induced Cardiomyopathy: A Biopsy Proven Case Series
- 10:30AM-12:30PM
-
Abstract Number: 0674
Hydroxychloroquine Screening Adherence: Insights from Highmark Claims Data
- 10:30AM-12:30PM
-
Abstract Number: 0660
Hydroxychloroquine Users at Lower Risk of Kidney Function Decline in Lupus Nephritis
- 10:30AM-12:30PM
-
Abstract Number: 0288
Hypersensitivity Pneumonitis with Autoimmune Features: A New Entity?
- 10:30AM-12:30PM
-
Abstract Number: 0310
I-CARE Program: Interest of Multidisciplinary Systematic Screening Program for Comorbidities for Patients Suffering from Arthritis Rheumatoid DiseasE: A Real Life Study
- 10:30AM-12:30PM
-
Abstract Number: 0284
Identification of Calcium Pyrophosphate Deposition Using Ultrasonography in Patients with a Suspected Diagnosis of Seronegative Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0383
Identification of Protein Biomarkers in Tear Fluid of Children with Uveitis That Distinguishes the Ocular Inflammatory State
- 10:30AM-12:30PM
-
Abstract Number: 0705
Identification of Risk Factors for Incident Cardiomyopathy in Patients with Systemic Sclerosis
- 10:30AM-12:30PM
-
Abstract Number: 0353
Identifying Solutions to Address Racial and Ethnic Health Disparities in Lupus: A Consensus-Based Approach
- 10:30AM-12:30PM
-
Abstract Number: 0328
IFI27 Is Differentially Upregulated in Anti-MDA5 Dermatomyositis and Correlates with the Presence of Interstitial Lung Disease
- 10:30AM-12:30PM
-
Abstract Number: 0106
IgM and IgG Phosphatidylserine Antibody Detection May Improve Classification Accuracy of SLE and APS
- 10:30AM-12:30PM
-
Abstract Number: 0267
IL-17 Participates in the Pathogenesis of Chronic Gouty Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0231
Imaging Characteristics and Demographic Variations in Patients with Axial Spondylarthritis, Axial Psoriatic Arthritis, and Inflammatory Bowel Disease-Related Arthritis with Axial Involvement: Insights from a Single Center at Cleveland Clinic Abu Dhabi
- 10:30AM-12:30PM
-
Abstract Number: 0473
Immune Checkpoint–Induced Arthritis: A Comprehensive Single Cohort Descriptive Analysis from Clinical Evaluation to Histology
- 10:30AM-12:30PM
-
Abstract Number: 0151
Immunoproteomic Profiling of Antibodies in Autoimmune Diseases
- 10:30AM-12:30PM
-
Abstract Number: 0596
Impact of a Multidisciplinary Rheumatology-Dermatology-Gastroenterology Center in the Management of Patients with Psoriatic Arthritis: Analysis of the First 5-years of Implementation
- 10:30AM-12:30PM
-
Abstract Number: 0412
Impact of Approval of Biologic DMARDs on JIA Outcomes in a Single Center
- 10:30AM-12:30PM
-
Abstract Number: 0631
Impact of Baseline Proteinuria Level on Long-term Outcomes in Lupus Nephritis
- 10:30AM-12:30PM
-
Abstract Number: 0664
Impact of Hydroxychloroquine and Belimumab on Early Glucocorticoid Reduction in New-Onset Systemic Lupus Erythematosus: A Retrospective Analysis of Risk and Protective Factors
- 10:30AM-12:30PM
-
Abstract Number: 0653
Impact of Lupus Nephritis on Neuropsychiatric SLE Outcomes
- 10:30AM-12:30PM
-
Abstract Number: 0542
Impact of Peripheral Arthritis on Disease Activity Outcomes in Patients with Axial Spondyloarthritis, Peripheral Spondyloarthritis and Psoriatic Arthritis. Data from the ASAS-PerSpA Study
- 10:30AM-12:30PM
-
Abstract Number: 0543
Impact of Peripheral Manifestations on Function, Health, and Work Productivity in Patients with Axial Spondyloarthritis, Peripheral Spondyloarthritis and Psoriatic Arthritis. Data from the ASAS-PerSpA Study
- 10:30AM-12:30PM
-
Abstract Number: 0583
Impact of Prior Tumor Necrosis Factor Inhibitor Treatment and Baseline Psoriatic Arthritis Disease Activity on Minimal Clinically Important Improvement Thresholds for Efficacy Outcomes: Post Hoc Analysis of Three Phase 3 Studies of Guselkumab in Patients with Active Psoriatic Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0169
Impact of Sense of Control Among People Living with SLE
- 10:30AM-12:30PM
-
Abstract Number: 0187
Impact of Sex on Medication Adherence in Members with Rheumatoid Arthritis, Psoriatic Arthritis, or Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 0236
Impact of Socioeconomic Status on Infection-Related Hospitalization Risk in Patients with Systemic Autoimmune Diseases
- 10:30AM-12:30PM
-
Abstract Number: 0720
Impact of Systemic Vasculitides on Sexual Function: An Overlooked Aspect of Patient Care
- 10:30AM-12:30PM
-
Abstract Number: 0626
Impact of the Lupus Foundation of America Rapid Evaluation of Activity in Lupus (LFA-REAL) Patient Reported Outcome (PRO) in Systemic Lupus Erythematosus Patients from the Almenara Lupus Cohort
- 10:30AM-12:30PM
-
Abstract Number: 0349
Impact of the Stanford University Chronic Pain Self-Management Education Program on Pain Severity, Pain Self-Efficacy, and Pain Disability in a Population with a High Prevalence of Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0051
Impact of Tight Junction Proteins on Inflammatory Processes and Microbial Imbalance in Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0472
Impaired Cardiac Function in Contemporary Rheumatoid Arthritis Patients: A Comparative Pilot Study with Cardiovascular Magnetic Resonance-derived Strain Analysis
- 10:30AM-12:30PM
-
Abstract Number: 0046
Impaired Neutrophil Extracellular Trap (NET) Degradation in Rheumatoid Arthritis (RA) and Pre-clinical RA Is Mediated by Anti-NET Antibodies
- 10:30AM-12:30PM
-
Abstract Number: 0355
Improvements in Patient-Reported Outcomes After Treatment with SEL-212 in Adults with Refractory Gout: Results from Two Randomized Phase 3 Trials
- 10:30AM-12:30PM
-
Abstract Number: 0490
Improvements in Peri-fracture Care in Rheumatoid Arthritis (RA) Have Offset Increased Mortality
- 10:30AM-12:30PM
-
Abstract Number: 0184
Improving Age Disparities in Contraceptive Counseling in Women with Lupus: A Quality Improvement Initiative
- 10:30AM-12:30PM
-
Abstract Number: 0418
Improving Documentation of Contraception and Pregnancy Intention in Rheumatology Practice
- 10:30AM-12:30PM
-
Abstract Number: 0377
Improving Self-Management Support in Patients with Juvenile Idiopathic Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0718
Incidence and Patient Profile Changes in ANCA-Associated Vasculitis Following the SARS-CoV-2 Pandemic
- 10:30AM-12:30PM
-
Abstract Number: 0724
Incidence of ANCA-Associated Vasculitis in a Northern Spanish Health Region Between 2000-2023: A Populatio-based Study
- 10:30AM-12:30PM
-
Abstract Number: 0218
Incidental Findings on Whole Body 18F-FDG PET/CT in a Rheumatoid Arthritis Clinical Trial Population
- 10:30AM-12:30PM
-
Abstract Number: 0032
Increased Expression of Malondialdehyde-Acetaldehyde and Citrullinated Proteins in Myocardial Tissues During the Early Evolution of Collagen-Induced Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0464
Increases in Paraoxonase-1 Activity over Time Associates with Reduced Risk of Incident Inflammatory Arthritis in an Anti-Citrullinated Protein Antibody-Positive Population
- 10:30AM-12:30PM
-
Abstract Number: 0043
Inflammatory and Angiogenic Serum Profile of Refractory Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0396
Inflammatory Markers of Autoimmune Uveitis in the Eye, Tears and Blood
- 10:30AM-12:30PM
-
Abstract Number: 0049
Inflammatory Priming by Anti-MAA Antibodies in Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0305
Inflammatory T Cell Expansion in Yao Syndrome
- 10:30AM-12:30PM
-
Abstract Number: 0681
Influence of Occupational Exposure to Pollutants on Clinical and Serological Phenotypes in Systemic Sclerosis
- 10:30AM-12:30PM
-
Abstract Number: 0078
Inhibition of the Deubiquitinase TRABID in a Pre-clinical Mouse Model of Axial Spondyloarthritis Decreases Disease Severity
- 10:30AM-12:30PM
-
Abstract Number: 0733
Inpatient Outcomes in ANCA-Associated Vasculitis: An In-Depth Cross-Sectional Analysis Using NIS Data (2016-2020)
- 10:30AM-12:30PM
-
Abstract Number: 0466
Inpatient Outcomes of Rheumatoid Arthritis in Hospitalized Patients Using Cannabis: Data from the National Inpatient Sample
- 10:30AM-12:30PM
-
Abstract Number: 0734
Insights into Readmissions of ANCA-Vasculitis Patients: A Nationwide Analysis
- 10:30AM-12:30PM
-
Abstract Number: 0181
Integrated Multidisciplinary Lupus Social Work Program to Manage Social Determinants of Health in SLE and Lupus Nephritis – Preliminary Results
- 10:30AM-12:30PM
-
Abstract Number: 0271
Intercritical Gout Represents a Systemic Inflammatory State
- 10:30AM-12:30PM
-
Abstract Number: 0666
Interferon-stimulated Genes on Peripheral CD8+ T Cells of SLE Patients Were the Keys for Early Response to BAFF/APRIL-targeted Therapy
- 10:30AM-12:30PM
-
Abstract Number: 0308
Interstitial Lung Disease as the First Clinical Manifestation of Connective Tissue Diseases
- 10:30AM-12:30PM
-
Abstract Number: 0281
Intra-articular Treatment Combining Sustained Release Colchicine Encapsulated in Microspheres, and Ropivacaine, Is Effective in Inflammatory Arthritis in Rats
- 10:30AM-12:30PM
-
Abstract Number: 0121
Intra-renal Involvement in Primary Antiphospholipid Antibodies Syndrome: Data from Two Italian Centers
- 10:30AM-12:30PM
-
Abstract Number: 0207
Investigation of Delays in Cancer Screening in RA
- 10:30AM-12:30PM
-
Abstract Number: 0311
Investigation of Sarcoidosis-associated Neuropathy: Challenges with Diagnosis of Small Fiber Neuropathy
- 10:30AM-12:30AM
-
Abstract Number: PP04
Involving Pediatric Patients in Their Own Care
- 10:30AM-12:30PM
-
Abstract Number: 0550
Is the Diagnostic Delay Getting Shorter with Time for Patients with Spondyloarthritis? Data from the International ASAS-PerSpA Study
- 10:30AM-12:30PM
-
Abstract Number: 0504
Janus Kinase Inhibitors Persist Longer Than Biologics in Rheumatoid Arthritis: Retrospective Analysis of Real-world Outpatient Data from the German Rhadar Database
- 10:30AM-12:30PM
-
Abstract Number: 0380
Joint Acoustic Emissions as a Digital Biomarker for Knee Inflammation in Juvenile Idiopathic Arthritis: A Pilot Study Using Musculoskeletal Ultrasound as Ground Truth
- 10:30AM-12:30PM
-
Abstract Number: 0287
Joint Involvement in Cystic Fibrosis: Description of Clinical Phenotypes
- 10:30AM-12:30PM
-
Abstract Number: 0685
KL-6 and IL-18 Biomarkers in Systemic Sclerosis-associated Interstitial Lung Disease: Enhancing Prognostic Insights into Early Detection, Progression, Lung Volume Changes,and Mortality Risk
- 10:30AM-12:30PM
-
Abstract Number: 0157
Knowledge and Attitudes About Delta-9-tetrahydrocannabinol (THC) Impact Real-world Practice in an International Group of Rheumatologists
- 10:30AM-12:30PM
-
Abstract Number: 0450
Knowledge, Attitudes, and Intention Towards HPV Vaccination Among Reproductive-Age Women with Rheumatic Diseases
- 10:30AM-12:30PM
-
Abstract Number: 0576
Less Than 15% Unfavourable Pregnancy Outcomes in Patients with Recent-onset Axial Spondyloarthritis: The Analysis of the 10 Years DESIR Cohort Follow-up
- 10:30AM-12:30PM
-
Abstract Number: 0166
Limitations in Activities of Daily Living Among Individuals with SLE
- 10:30AM-12:30PM
-
Abstract Number: 0709
Linear Combination of Principal Components Achieves Top Performance in Identifying Rheumatologist-Diagnosed Systemic Sclerosis from Electronic Health Records
- 10:30AM-12:30PM
-
Abstract Number: 0292
Liver Disease Complicating Familial Mediterranean Fever: A Study on 57 Patients from the French Adult JIR Cohort
- 10:30AM-12:30AM
-
Abstract Number: PP02
Living Well with a Rare Rheumatic Disease – Becoming a “Precision” Patient on the Horizon of Precision Medicine
- 10:30AM-12:30AM
-
Abstract Number: PP11
Living Well with Chronic Illness: Decades with MCTD
- 10:30AM-12:30PM
-
Abstract Number: 0530
Long-term Effectiveness of a Lifestyle Intervention for Rheumatoid Arthritis: Two-year Follow-up After the “Plants for Joints” Randomized Clinical Trial
- 10:30AM-12:30PM
-
Abstract Number: 0458
Long-Term Outcomes in Seronegative Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0238
Longitudinal Assessment of CD8+ T Cell Responses to SARS-CoV-2 Pre- and Post-breakthrough Infection and Its Association with COVID-19 Severity in Immunosuppressed Individuals
- 10:30AM-12:30PM
-
Abstract Number: 0270
Longitudinal Patterns of C-Reactive Protein Values in Calcium Pyrophosphate Deposition (CPPD) Disease
- 10:30AM-12:30PM
-
Abstract Number: 0565
Low Vitamin D Serum Level Is a Risk Factor for Ankylosis in Axial Spondyloarthritis: Evidence from a Nested-Case-Control Study
- 10:30AM-12:30PM
-
Abstract Number: 0467
Lung Involvement in Early Rheumatoid Arthritis, Analysis of ERA UCLouvain Brussels FINDRA Cohort
- 10:30AM-12:30PM
-
Abstract Number: 0630
Lupus Lymphocyte Activation Score of Pathologic T and B Cell Phenotypes Increased in Patients at Risk of Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 0656
Lupus Myocarditis: Clinical Characteristics, Cardiac Magnetic Resonance Imaging Findings and Outcomes
- 10:30AM-12:30PM
-
Abstract Number: 0194
Machine Learning Methods to Predict Cardiovascular Risk in Hispanic Patients with Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 0279
Macrophage Intracellular Fates of Monosodium Urate and Calcium Pyrophosphate Crystals: Phagocytosis, Exchanged/expulsion and Dissolution of Crystals
- 10:30AM-12:30PM
-
Abstract Number: 0759
Macrophage-Lineage Cells in Giant Cell Arteritis Express MMP12, Phagocytosis and Osteoclast-associated Molecules That May Contribute to Destruction of the Tunica Media
- 10:30AM-12:30PM
-
Abstract Number: 0451
Macrophages and Interferon Upregulation in Placentas from Patients with Systemic Lupus Erythematosus, Primary Sjögren’s Disease and Antiphospholipid Syndrome
- 10:30AM-12:30PM
-
Abstract Number: 0204
Making Rheum for Palliative Care in Rheumatology: Perspectives of Rheumatology and Palliative Care Clinicians
- 10:30AM-12:30PM
-
Abstract Number: 0433
Male Perspective on Reproductive Health in Rheumatology Patients: A Cross-sectional Study
- 10:30AM-12:30PM
-
Abstract Number: 0726
Management of ANCA Vasculitis-Associated Orbital Inflammatory Disease: A Systematic Literature Review
- 10:30AM-12:30PM
-
Abstract Number: 0516
Management of Elederly Patients with Rheumatoid Arthritis Treated with Tocilizumab : Comparison of Patients over and Under 75 Years Old
- 10:30AM-12:30PM
-
Abstract Number: 0361
Maternal and Fetal Outcomes in Those with Autoimmune Connective Tissue Disease
- 10:30AM-12:30PM
-
Abstract Number: 0307
Mean Metacarpophalangeal Extension to Clinically Quantify Flexor Fibro-inflammatory Hand Involvement in Diabetes
- 10:30AM-12:30PM
-
Abstract Number: 0342
Measurement of Serum Cytokine and Chemokine Level to Predict Poor Treatment Response in Patients with Idiopathic Inflammatory Myositis
- 10:30AM-12:30PM
-
Abstract Number: 0541
Measurement Properties of Disease Activity Instruments in Peripheral Spondyloarthritis. an Analysis in the CRESPA Trial
- 10:30AM-12:30PM
-
Abstract Number: 0635
Medical Record Natural Language Processing and Patient Biometric and Self-Reported Measures Inform an Artificial Intelligence Augmented Remote Care Management Strategy for Lupus Patients
- 10:30AM-12:30PM
-
Abstract Number: 0277
Mesenchymal Stem Cells Derived from Human Bone Marrow Ameliorate Monosodium Urate Crystal-induced Inflammation
- 10:30AM-12:30PM
-
Abstract Number: 0457
Metabolic Syndrome, Adipokines, and Response to Advanced Therapies in Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0101
Metabolomic Profiling Reveals a Role for Citric Acid Cycle Dysfunction in Antiphospholipid Syndrome Neutrophils
- 10:30AM-12:30PM
-
Abstract Number: 0404
Methotrexate Adherence in JIA: Use of Electronic Health Record-Linked Pharmacy DispensingData
- 10:30AM-12:30PM
-
Abstract Number: 0131
Methotrexate and Tumor Necrosis Factor Inhibitors Independently Decrease Neutralizing Antibodies After SARS-CoV-2 Vaccination: Updated Results from the SUCCEED Study
- 10:30AM-12:30PM
-
Abstract Number: 0075
Micro-RNAs as Biomarkers for Methotrexate Treatment Response in Patients with Psoriatic Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0315
Microvascular Abnormalities Are Present in Autonomic Dysfunction: Results of a Prospective Study
- 10:30AM-12:30PM
-
Abstract Number: 0314
Microvascular Differences Between Acute and Chronic Cutaneous Graft versus Host Disease
- 10:30AM-12:30PM
-
Abstract Number: 0545
Missing Data in Observational Studies: Investigating Cross-sectional Single Imputation Methods for Assessing Disease Activity in Axial Spondyloarthritis
- 10:30AM-12:30PM
-
Abstract Number: 0163
Modification of 2017 EULAR/ACR Myositis Classification Criteria for Dermatomyositis, Clinically Amyopathic Dermatomyositis, and Immune-mediated Necrotizing Myopathy
- 10:30AM-12:30PM
-
Abstract Number: 0042
Modulating Inflammation and Angiogenesis in an Advanced 3D Rheumatoid Arthritis Synovial Tissue Model
- 10:30AM-12:30PM
-
Abstract Number: 0099
Modulating Pentose Phosphate Pathway Metabolism to Temper Neutrophil Hyperactivity in Antiphospholipid Syndrome
- 10:30AM-12:30PM
-
Abstract Number: 0711
Molecular Signatures in the Skin as Predictors of Longitudinal Clinical Trajectories in Patients with Systemic Sclerosis
- 10:30AM-12:30PM
-
Abstract Number: 0144
More Than a Monolith: Disaggregating Rheumatoid Arthritis Prevalence Among Asian American Subgroups
- 10:30AM-12:30PM
-
Abstract Number: 0645
Mortality and Ethnicity in Adults with Systemic Lupus Erythematosus: A Systematic Literature Review and Meta-Analysis
- 10:30AM-12:30PM
-
Abstract Number: 0336
Mortality: Comparison, Causes and Determinants in Subgroups of Idiopathic Inflammatory Myopathies
- 10:30AM-12:30PM
-
Abstract Number: 0696
MRI DAVIX Index Is an Imaging Biomarker for Endothelial Damage of Systemic Sclerosis Digital Ulcers
- 10:30AM-12:30PM
-
Abstract Number: 0234
MRI of Sacroiliac Joints: Is Contrast Necessary for the Detection of Sacroiliitis?
- 10:30AM-12:30PM
-
Abstract Number: 0296
Musculoskeletal Manifestations in Patients Diagnosed with Marfan Syndrome
- 10:30AM-12:30AM
-
Abstract Number: PP07
My Journey with Diffuse Scleroderma and Interstitial Lung Disease: A Pharmacist’s Perspective
- 10:30AM-12:30PM
-
Abstract Number: 0295
Mycophenolate Mofetil in the Treatment of Patients with Isolated Cardiac Sarcoidosis
- 10:30AM-12:30PM
-
Abstract Number: 0688
Mycophenolate Mofetil Treatment in Limited Cutaneous Systemic Sclerosis Reduces the Risk of Vascular Complication Leading to Treatment Escalation: Emulation of a Target Trial Using Time-dependent Propensity Score-matching
- 10:30AM-12:30PM
-
Abstract Number: 0260
National Survey on Patient’s Knowledge and Drivers of Human Papillomavirus (HPV) Vaccination in Immune-mediated Inflammatory Diseases (IMIDs)
- 10:30AM-12:30PM
-
Abstract Number: 0258
Nationwide Analysis of Adult Non-Gonococcal Bacterial Septic Arthritis Hospitalizations from the National Inpatient Sample 2016 to 2020
- 10:30AM-12:30PM
-
Abstract Number: 0109
Natural History and Clinical Implications of Lupus Autoantibodies in Primary Antiphospholipid Antibody Positive Patients: Results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (“Registry”)
- 10:30AM-12:30PM
-
Abstract Number: 0239
Neutralising Antibody Responses to Bivalent SARS-CoV-2 Vaccines and Hybrid Immunity in Patients on TNF Inhibitors: A Prospective Cohort Study
- 10:30AM-12:30PM
-
Abstract Number: 0507
Neutrophil Activation Markers Can Predict Rheumatoid Arthritis Treatment Response to the Janus Kinase 1/2 Inhibitor Baricitinib
- 10:30AM-12:30PM
-
Abstract Number: 0766
Neutrophil Transcriptomics in VEXAS Syndrome
- 10:30AM-12:30PM
-
Abstract Number: 0185
New and Severe Damage in a Prevalent Lupus Cohort Through the Lens of Demographic and Neighborhood Disparities
- 10:30AM-12:30PM
-
Abstract Number: 0470
New Approach for Early and Accurate Diagnosis of Rheumatoid Arthritis-related Interstitial Lung Disease: Matrix Metalloproteinases 7 and 9 as Novel Blood Biomarkers
- 10:30AM-12:30PM
-
Abstract Number: 0193
New York City Lupus Clinical Trials Education Program
- 10:30AM-12:30PM
-
Abstract Number: 0752
Non-classical Organ Involvement in Giant Cell Arteritis
- 10:30AM-12:30PM
-
Abstract Number: 0540
Nonsteroidal Anti-Inflammatory Drug Use and Incident Hypertension Among Patients with Axial Spondyloarthritis
- 10:30AM-12:30PM
-
Abstract Number: 0334
Normal Creatine Kinase in Idiopathic Inflammatory Myopathies- Patient Characteristics and Disease Activity
- 10:30AM-12:30PM
-
Abstract Number: 0105
Novel Autoantibodies Identified in the Antiphospholipid Syndrome
- 10:30AM-12:30PM
-
Abstract Number: 0633
Novel LINE-1 Reverse Transcriptase Inhibitors Can Suppress Type I Interferon Responses and Are Promising Therapeutics for Lupus
- 10:30AM-12:30PM
-
Abstract Number: 0006
NX-5948, a Clinical-Stage BTK Degrader, Achieves Deep Suppression of BCR, TLR, and FcR Signaling in Immune Cells and Demonstrates Efficacy in Preclinical Models of Arthritis and Other Inflammatory Diseases
- 10:30AM-12:30PM
-
Abstract Number: 0294
Obesity and Risk of Autoimmune Diseases: Insights from the National Inpatient Sample
- 10:30AM-12:30PM
-
Abstract Number: 0483
Obesity, Prednisone Use, and Patient-Reported Outcomes Are Predictors of Becoming Difficult-to-Treat in an RA Population Treated with a First-Line Biologic DMARD
- 10:30AM-12:30PM
-
Abstract Number: 0659
Obinutuzumab Benefits Patients with Active Lupus Nephritis Irrespective of Baseline Proteinuria Severity: A Post Hoc Analysis of a Phase II Trial
- 10:30AM-12:30PM
-
Abstract Number: 0405
Olokizumab, a Monoclonal Antibody Against IL-6, in Polyarticular-course Juvenile Idiopathic Arthritis (pcJIA): Results of 24 Weeks of the Phase 2 Open-label Clinical Trial
- 10:30AM-12:30PM
-
Abstract Number: 0739
One Year Outcomes in Those with Isolated PMR Recruited via a Fast Track PMR Clinic
- 10:30AM-12:30PM
-
Abstract Number: 0367
Opinions from Rheumatoid Arthritis Patients and Providers on Discontinuing Methotrexate in Stable Disease
- 10:30AM-12:30PM
-
Abstract Number: 0535
Oral Glucocorticoid Premedication Is at Least as Effective as Intravenous Glucocorticoid Premedication for Prevention of Infusion-related Reactions to Rituximab in Rheumatoid Arthritis Patients
- 10:30AM-12:30PM
-
Abstract Number: 0400
Osteoclastogenesis from Peripheral Blood Mononuclear Cells in Children with Chronic Nonbacterial Osteomyelitis Are Similar to Those from Healthy Children
- 10:30AM-12:30PM
-
Abstract Number: 0716
Outcomes of COVID-19 in Patients with ANCA-Associated Vasculitis (AAV)
- 10:30AM-12:30PM
-
Abstract Number: 0708
Outcomes of Intermittent Intravenous Steroid Use During Infusion Therapy in Systemic Sclerosis
- 10:30AM-12:30PM
-
Abstract Number: 0253
Outcomes of Respiratory Syncytial Virus Infection in Patients with Systemic Autoimmune Rheumatic Diseases
- 10:30AM-12:30PM
-
Abstract Number: 0093
Overexpression of Epidermal Ifnk Promotes Systemic CD8+ T Cell Maturation After UV-exposure
- 10:30AM-12:30PM
-
Abstract Number: 0438
Overweight and Obesity Are Key Modifiable Risk Factors for Adverse Outcomes in SLE Pregnancies
- 10:30AM-12:30PM
-
Abstract Number: 0323
Pain Prevalence and Factors Associated with Pain Levels in Patients with Idiopathic Inflammatory Myopathies
- 10:30AM-12:30PM
-
Abstract Number: 0090
Parenchymal and Hematopoietic IFNγ Signaling Exhibits Dichotomous Effects in Murine Lupus
- 10:30AM-12:30PM
-
Abstract Number: 0301
Path to Diagnosis in Familial Mediterranean Fever (FMF)
- 10:30AM-12:30PM
-
Abstract Number: 0558
Patient Diagnostic Journey and Time to Diagnosis in Axial Spondyloarthritis: A Retrospective Cohort Study Using US Claims Data
- 10:30AM-12:30PM
-
Abstract Number: 0375
Patient Outcomes During the Implementation of a Patient Decision-Aid for a Diverse Population of Systemic Lupus Erythematosus: A Study in 15 U.S. Rheumatology Clinics
- 10:30AM-12:30PM
-
Abstract Number: 0534
Patient Reported Outcomes and Disease Activity from a Phase 1 Double-Blind Randomized Clinical Trial of Allogeneic Mesenchymal Stem Cells in Early Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0356
Patient Satisfaction and Experience After a Switch to a Citrate-free High-concentration Adalimumab Biosimilar. Results from a Prospective Multicentric Real-world Study
- 10:30AM-12:30PM
-
Abstract Number: 0678
Patients with Interstitial Lung Disease Due to Systemic Sclerosis or Rheumatoid Arthritis Need Monitoring More Frequently Than Annually
- 10:30AM-12:30PM
-
Abstract Number: 0132
Patients with Systemic Autoimmune Rheumatic Diseases Remain at Risk for Hospitalization for COVID-19 Infection in the Omicron Era (2022-2024): A Retrospective Cohort Study
- 10:30AM-12:30PM
-
Abstract Number: 0365
Patients’ Behaviors and Beliefs Around Dietary Changes Among a Cohort of Patients with Rheumatic Disease
- 10:30AM-12:30PM
-
Abstract Number: 0687
Patterns of Disease Progression in Early Systemic Sclerosis Patients with Interstitial Lung Disease
- 10:30AM-12:30PM
-
Abstract Number: 0677
Patterns of Raynaud’s Phenomenon Management in Patients with Systemic Sclerosis: A Real-World Data from Community-Based Practices in the United States
- 10:30AM-12:30PM
-
Abstract Number: 0499
PD-1hiCXCR5-CD4+T Peripheral Helper Cells Enrich in Rheumatoid Arthritis and Predict Clinical Response to Anti-TNF Treatment
- 10:30AM-12:30PM
-
Abstract Number: 0118
Performance of the 2023 ACR/EULAR Classification Criteria for Antiphospholipid Syndrome in a Mexican Cohort
- 10:30AM-12:30PM
-
Abstract Number: 0612
Performance of the Systemic Lupus Erythematosus Risk Probability Index (SLERPI): Results from the Egyptian College of Rheumatology (ECR) Study Cohort
- 10:30AM-12:30PM
-
Abstract Number: 0265
Performance of Two Gout Remission Definitions in a Two-Year Randomized Controlled Trial of Nurse-led Care
- 10:30AM-12:30PM
-
Abstract Number: 0672
Pharmacokinetics (PK), Effectiveness and Safety of Open-label (OL) Tofacitinib for the Treatment of Moderate to Severe Skin Involvement in Young Adults with SLE
- 10:30AM-12:30PM
-
Abstract Number: 0384
Pharmacokinetics of Ustekinumab in Patients with Juvenile Psoriatic Arthritis in a Real‑World Opportunistic Study
- 10:30AM-12:30PM
-
Abstract Number: 0303
Phase 2b, Long-term Extension, Dose-ranging Study of Oral JNJ-77242113 for the Treatment of Moderate-to-Severe Plaque Psoriasis: FRONTIER-2
- 10:30AM-12:30PM
-
Abstract Number: 0108
Phenotypic Characterization of Patients with IgM Antibodies in Antiphospholipid Syndrome (APS)
- 10:30AM-12:30PM
-
Abstract Number: 0014
Phenotypic Validation of Humanized IgA1 and CD89 Transgenic Mice as a Model for IgA Nephropathy-Like Autoimmune Disease
- 10:30AM-12:30PM
-
Abstract Number: 0182
Pilot Volunteer Lupus Navigator Program – Leveraging Community Health Workers to Address Social Determinants of Health in SLE
- 10:30AM-12:30PM
-
Abstract Number: 0350
Piloting an Adaptation of the Making It Work Program for Systemic Sclerosis: Promising Effects on Job Related Self-efficacy and Risk of Work Disability
- 10:30AM-12:30PM
-
Abstract Number: 0428
Placental Characteristics in Systemic Lupus Erythematosus Pregnancies Resulting in Small for Gestational Age Infants
- 10:30AM-12:30PM
-
Abstract Number: 0419
Placental Weights of Offspring Born to Women with Rheumatoid Arthritis and Juvenile Idiopathic Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0468
Plasma Calprotectin Assessed in Multiple Biological Treatment Strategies for Early Rheumatoid Arthritis over 48 Weeks
- 10:30AM-12:30PM
-
Abstract Number: 0607
Plasma Proteomic Analysis Reveals Type I Interferon Blockade Effects of Anifrolumab in Lupus Nephritis: Insights from a Phase 2 Trial
- 10:30AM-12:30PM
-
Abstract Number: 0113
Plasma Proteomics Analysis Identifies Thromboinflammatory Signature Associated with Clinical Antiphospholipid Syndrome: Results from Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Registry
- 10:30AM-12:30PM
-
Abstract Number: 0010
Precision Editing of Cyclophilin a to Engineer Cyclosporine- and Voclosporin- Resistant Human CAR-T Cells
- 10:30AM-12:30PM
-
Abstract Number: 0018
Preclinical Analysisof CB-010, an Allogeneic anti-CD19CAR-T Cell Therapywith a PD-1 Knockout, for the Treatment of Patients with Refractory Systemic Lupus Erythematosus (SLE)
- 10:30AM-12:30PM
-
Abstract Number: 0008
Preclinical Development and Manufacturability of KYV-201, an Investigational Allogeneic Anti-CD19 Chimeric Antigen Receptor T Cell for the Treatment of Autoimmune Disease
- 10:30AM-12:30PM
-
Abstract Number: 0002
Preclinical Evaluation of BCMA And/or CD19 Nanobody-based Single or Compound CAR-T Cells Targeting B and Plasma Cells Associated with Autoimmune Disorders
- 10:30AM-12:30PM
-
Abstract Number: 0011
Preclinical Manufacturability and Activity of KYV-102 from Patients with Systemic Lupus Erythematosus Using Ingenui-T: A Rapid, Autologous Chimeric Antigen Receptor T-Cell Manufacturing Solution Utilizing Whole Blood
- 10:30AM-12:30PM
-
Abstract Number: 0013
Preclinical Polypharmacology of S-1117, a Novel Engineered Fc-fused IgG Degrading Enzyme, for Chronic Treatment of Autoantibody-mediated Diseases
- 10:30AM-12:30PM
-
Abstract Number: 0559
Predicting Disease Flares in Axial Spondyloarthritis Using Machine Learning in the METEOR-SpA Registry
- 10:30AM-12:30PM
-
Abstract Number: 0225
Prediction of Response to Therapies and Flares Based on Ultrasound Findings at Baseline in Psoriatic Arthritis: An Analysis on a Joint Level
- 10:30AM-12:30PM
-
Abstract Number: 0613
Prediction of Spontaneous Abortion in Women with Systemic Lupus Erythematosus (SLE) Based on Machine Learning Model: Insights from the Egyptian College of Rheumatology (ECR)–SLE Cohort
- 10:30AM-12:30PM
-
Abstract Number: 0621
Predictive Parameters of Disease-related Damage Accrual in Patients with Systemic Lupus Erythematosus: A Machine Learning Analysis
- 10:30AM-12:30PM
-
Abstract Number: 0641
Predictive Validity of Coronary Artery Calcium Scoring in Low Risk Systemic Lupus Erythematous Patients
- 10:30AM-12:30PM
-
Abstract Number: 0332
Predictors of Long-term Radiographic Changes in Patients with Idiopathic Inflammatory Myopathies Using Quantitative Imaging Analysis: Real World Experience from a Single Center Longitudinal Cohort
- 10:30AM-12:30PM
-
Abstract Number: 0691
Predictors of Response and Long-term Efficacy and Safety of Nintedanib in Systemic Sclerosis-Interstitial Lung Disease: Data from an Italian Multicentre Study
- 10:30AM-12:30PM
-
Abstract Number: 0333
Predictors of Transplant-Free Survival in Idiopathic Inflammatory Myopathies- associated Interstitial Lung Disease
- 10:30AM-12:30PM
-
Abstract Number: 0440
Pregnancy Outcome Disparities Among Women with Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 0447
Pregnancy Outcomes in Women Exposed to Guselkumab: Review of Cases Reported to the Manufacturer’s Global Safety Database
- 10:30AM-12:30PM
-
Abstract Number: 0434
Pregnancy Outcomes of Biosimilars and Non-TNF Inhibitor Biologic Disease-Modifying Antirheumatic Drugs: A Scoping Review
- 10:30AM-12:30PM
-
Abstract Number: 0703
Preliminary Results from the RECONNOITER Trial, a Phase 2 Study of AISA 021 in the Treatment of Secondary Raynaud’s, Primarily Due to Systemic Sclerosis
- 10:30AM-12:30PM
-
Abstract Number: 0376
Preliminary Results of the Ondansetron Pre-medication Trial in Juvenile Idiopathic Arthritis: A Pragmatic Randomized Controlled Trial Nested in the CAPRI Registry
- 10:30AM-12:30PM
-
Abstract Number: 0552
Presence of MAIT Cells in Synovial Tissue of Patients with Axial Spondyloarthritis: A Comparative Study
- 10:30AM-12:30PM
-
Abstract Number: 0619
Prevalence and Factors Predicting Hemophagocytic Lymphohistiocytosis in Hospitalized Patients with Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 0159
Prevalence and Potential Factors Associated with Polypharmacy in Individuals with Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 0415
Prevalence and Risk Factors of Low Bone Mineral Density in Children with Juvenile Idiopathic Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0407
Prevalence of Autoimmune Diseases in 8244 Family Members of Children with Juvenile Idiopathic Arthritis: A Study from India
- 10:30AM-12:30PM
-
Abstract Number: 0570
Prevalence of Comorbidities and Racial Disparities in Anterior Uveitis Risk Among Ankylosing Spondylitis Patients
- 10:30AM-12:30PM
-
Abstract Number: 0648
Prevalence of Pulmonary Complications Among Patients with Systemic Lupus Erythematosus (SLE): A Systematic Review and Meta-analysis
- 10:30AM-12:30PM
-
Abstract Number: 0764
Primary Treatment Failure to Tocilizumab in Giant Cell Arteritis
- 10:30AM-12:30PM
-
Abstract Number: 0062
Pro-Fibrotic Effects of Malondialdehyde-Acetaldehyde-Adducted and/or Citrullinated Proteins on Macrophages and Human Lung Fibroblasts
- 10:30AM-12:30PM
-
Abstract Number: 0015
Profiling of B and T Cells in Kidney Biopsies from ANCA-associated Vasculitis Patients with Glomerulonephritis at Single-Cell Resolution
- 10:30AM-12:30PM
-
Abstract Number: 0088
Profound B Cell Depletion and Repopulation with Predominantly Naïve B Cells in Non-Human Primates Achieved Through a Novel In Vivo CD8-Targeted Lipid Nanoparticle mRNA CAR
- 10:30AM-12:30PM
-
Abstract Number: 0695
Prognostic Value of Serum Type I Interferon in Predicting Morbi-Mortality Outcomes in Systemic Sclerosis: Insights from the STRIKE Basket Cohort
- 10:30AM-12:30PM
-
Abstract Number: 0683
Prognostic Value of Systemic Sclerosis-associated Primary Heart Involvement
- 10:30AM-12:30PM
-
Abstract Number: 0704
Progression of Global Longitudinal Strain and Identification of Left Ventricular Dysfunction in Systemic Sclerosis Patients
- 10:30AM-12:30PM
-
Abstract Number: 0317
Progressive Fibrosing Intersticial Lung Disease of Autoimmune Origin and Antifibrotic Medication: NEREA Registry
- 10:30AM-12:30PM
-
Abstract Number: 0340
Progressive Pulmonary Fibrosis Predicts Mortality in Myositis-Associated Interstitial Lung Disease
- 10:30AM-12:30PM
-
Abstract Number: 0283
Prophylaxis of Gout Flares in Patients with Renal Impairment: Dosing Adjustments with Colchicine Oral Solution Informed by a Pharmacokinetic Model
- 10:30AM-12:30PM
-
Abstract Number: 0727
Prospective Cellular Biomarkers in ANCA Associated Vasculitis: A Pilot Study
- 10:30AM-12:30PM
-
Abstract Number: 0700
Prospective Evaluation of Capillaroscopy in Healthy Children
- 10:30AM-12:30PM
-
Abstract Number: 0252
Prospective Study of Severe Infectious Events and Immune Reconstitution After Rituximab in Autoimmune Diseases
- 10:30AM-12:30PM
-
Abstract Number: 0104
Proteomic Analysis Identifies Neutrophil Defensin 1 as a Biological Marker for Antiphospholipid Syndrome
- 10:30AM-12:30PM
-
Abstract Number: 0045
Proteomic Analysis of the Rheumatoid Arthritis Citrullinome Reveals an Enrichment of Citrullinated Complement Proteins
- 10:30AM-12:30PM
-
Abstract Number: 0416
Proteomic Signatures of Synovial Fluid in Different Subtypes of Juvenile Idiopathic Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0156
Psoriasis and Psoriatic Arthritis Are Independent Risk Factors for Non-Fatal Cardiovascular Admissions in Transition-Age Young Adults
- 10:30AM-12:30PM
-
Abstract Number: 0067
Psoriasis Patients at Risk for Psoriatic Arthritis Have Increased Levels of Circulating Pro-migratory Dendritic Cells
- 10:30AM-12:30PM
-
Abstract Number: 0426
Quality Improvement Initiative to Increase Contraception Screening and Documentation for Reproductive-Aged Women Prescribed Teratogenic Medications in an Academic Rheumatology Center
- 10:30AM-12:30PM
-
Abstract Number: 0738
Quantitative Vascular US Has Additional Diagnostic and Prognostic Value in GCA
- 10:30AM-12:30PM
-
Abstract Number: 0176
Race-Based Differences in Immune Responses Following an Episode of Acute Low Back Pain Among Those Who Develop Chronic LBP and Those Who Do Not
- 10:30AM-12:30PM
-
Abstract Number: 0189
Racial Discrimination Among African American Women with and Without Systemic Lupus Erythematosus (SLE)
- 10:30AM-12:30PM
-
Abstract Number: 0329
Racial, Ethnic, Sex, and Geographical Diversity in Myositis Clinical Trials: Future Steps for Equitable Representation by the MIHRA Global Equity and Clinical Trial Readiness Cores
- 10:30AM-12:30PM
-
Abstract Number: 0114
Rare Germline Variants in Complement Regulatory Genes in Antiphospholipid Antibody Positive Patients: Prospective Results from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (“Registry”)
- 10:30AM-12:30PM
-
Abstract Number: 0298
RAY121, a Novel Recycling Monoclonal Antibody Against Complement C1s: Safety, Pharmacokinetic and Pharmacodynamic Data from a Phase 1a First in Human Clinical Trial in Healthy Adults
- 10:30AM-12:30PM
-
Abstract Number: 0372
Readability Analysis of the American College of Rheumatology Patient Education Material
- 10:30AM-12:30PM
-
Abstract Number: 0586
Real World Effectiveness of Upadacitinib in Patients with Psoriatic Arthritis Previously Treated with TNF Inhibitors: Data from the OM1 Registry
- 10:30AM-12:30PM
-
Abstract Number: 0249
Real World Evidence on the Safety of the Adjuvanted Recombinant Zoster Vaccine in Patients with Rheumatic Diseases – Preliminary Results from a Prospective Multicenter Observational Greek Study
- 10:30AM-12:30PM
-
Abstract Number: 0508
Real-World Evidence for GP2015 in Patients with Rheumatoid Arthritis: Safety Outcomes from German Observational Data
- 10:30AM-12:30PM
-
Abstract Number: 0594
Real-world Experience of Bimekizumab for Plaque Psoriasis in Adult Patients with Prior Exposure to Interleukin-17 Inhibitors: A 16-week Multicenter Retrospective Review
- 10:30AM-12:30PM
-
Abstract Number: 0168
Real-world Glucocorticoid Prescription Patterns in Patients with Lupus Nephritis: A Retrospective Study Using a Healthcare Insurance Claims Database
- 10:30AM-12:30PM
-
Abstract Number: 0299
Real-World Tolerability of Nintedanib in Connective Tissue Disease-Associated Interstitial Lung Disease
- 10:30AM-12:30PM
-
Abstract Number: 0214
Real-World Treatment Patterns of Clinical Practice Guideline Therapies in Rheumatoid Arthritis-Associated Interstitial Lung Disease
- 10:30AM-12:30PM
-
Abstract Number: 0248
Recombinant Herpes Zoster Vaccine in a Large Cohort of Autoimmune Rheumatic Diseases Patients: An Interim Analysis of a Prospective Randomized Phase 4 Study
- 10:30AM-12:30PM
-
Abstract Number: 0033
Refined Autoantibody Profiles in RA Reveal That Primarily ACPAs Binding Non-glycine Citrulline Motifs Are Associated with Shared Epitope Alleles
- 10:30AM-12:30PM
-
Abstract Number: 0115
Regional and Ethnoracial Differences Among Antiphospholipid Antibody-Positive Patients with No Other Systemic Autoimmune Rheumatic Diseases: Results from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Registry
- 10:30AM-12:30PM
-
Abstract Number: 0757
Regulation of Macrophage Differentiation by Serum Adiponectin: A Novel Mechanism to Increase Alternatively Activated Macrophages During the Remission Phase of Giant Cell Arteritis
- 10:30AM-12:30PM
-
Abstract Number: 0414
Relationship Between Culture Negative Infectious Osteomyelitis and Chronic Nonbacterial Osteomyelitis
- 10:30AM-12:30PM
-
Abstract Number: 0655
Relationship Between Patient-Reported Outcomes to Hospitalization in Patients Living with SLE: A Retrospective Cohort Study Utilizing the FORWARD Lupus Registry
- 10:30AM-12:30PM
-
Abstract Number: 0497
Relationship Between the Complement System and Subclinical Carotid Atherosclerosis in Patients with Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0651
Renal Survival and Mortality in Patients with Proliferative and Membranous Lupus Nephritis
- 10:30AM-12:30PM
-
Abstract Number: 0402
Reporting of Clinical Features and Outcome Measures in Still’s Disease: A Systematic Literature Review of sJIA and AOSD Cohorts
- 10:30AM-12:30PM
-
Abstract Number: 0431
Reproductive Health in Women with Rheumatic Diseases: Knowledge and Behaviors
- 10:30AM-12:30PM
-
Abstract Number: 0452
Reproductive Health Needs of Women with Rheumatic Disease: An EMR-Based Online Survey Study
- 10:30AM-12:30PM
-
Abstract Number: 0358
Residual’ Fatigue and Its Severity in Patients with Rheumatoid Arthritis in Clinical Remission: Prevalence and Associated Factors
- 10:30AM-12:30PM
-
Abstract Number: 0682
Results from Outcomes Selection and Development of a Patient-reported Outcome Measure for a Combined Response Index for Limited Cutaneous SSc: The CRISTAL Project
- 10:30AM-12:30AM
-
Abstract Number: PP05
Reunion with Forgotten Relationships and Memories
- 10:30AM-12:30PM
-
Abstract Number: 0446
Rheum for Improvement: Contraception Counseling and Adherence in Patients with Lupus and Rheumatoid Arthritis on Teratogenic Medications
- 10:30AM-12:30PM
-
Abstract Number: 0254
Rheumatic Manifestations in Patients with Hansen’s Disease Treated with Multidrug Antibiotic Therapy
- 10:30AM-12:30PM
-
Abstract Number: 0475
Rheumatoid Arthritis – Progressive Interstitial Lung Disease with Abatacept: Data from a Large National Multicenter Cohort
- 10:30AM-12:30PM
-
Abstract Number: 0135
Rheumatoid Arthritis Associated Risk of Venous Thromboembolism Is Not Dependent on Disease Duration: United Kingdom Based Population Study
- 10:30AM-12:30PM
-
Abstract Number: 0158
Rheumatoid Arthritis Testing Patterns by Physicians and Advanced Practice Providers from a National Commercial Laboratory, 2014 – 2023
- 10:30AM-12:30PM
-
Abstract Number: 0210
Rheumatology, Heal Thyself: The Experience of Underrepresented Physicians in Rheumatology
- 10:30AM-12:30PM
-
Abstract Number: 0527
Risk Factors for Leukopenia in Asian Patients with Rheumatoid Arthritis Undergoing Tocilizumab
- 10:30AM-12:30PM
-
Abstract Number: 0453
Risk of Active Disease Determines the Expert Opinion Use of Biologics in Pregnancy, but Less in Breastfeeding, and in Men Planning a Family
- 10:30AM-12:30PM
-
Abstract Number: 0719
Risk of Vertebral Fracture in Individuals with Granulomatosis with Polyangiitis and End-Stage Renal Disease
- 10:30AM-12:30PM
-
Abstract Number: 0048
Role of the Chemokine CCL22 in Rheumatoid Arthritis Development
- 10:30AM-12:30PM
-
Abstract Number: 0177
Rural-urban Disparities in the Myocardial Infarction Hospitalizations in People with Systemic Lupus Erythematosus in the US
- 10:30AM-12:30PM
-
Abstract Number: 0737
Rurality and Delayed Diagnosis of Giant Cell Arteritis – a Single Center Experience
- 10:30AM-12:30PM
-
Abstract Number: 0291
Safety of Biologic Therapy in Kidney Transplant Recipients with Inflammatory Diseases: Real-world Experience from a Tertiary Medical Center
- 10:30AM-12:30PM
-
Abstract Number: 0138
SARS-CoV-2 Vaccine Acceptance, Hesitancy and Uptake in a Cohort of Patients with Inflammatory Rheumatic Diseases (IRD)
- 10:30AM-12:30PM
-
Abstract Number: 0515
Scavenging Isolevuglandins with 2-HOBA Decreases In Vitro Neutrophil Extracellular Traps in Cells from Patients with Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0644
Scoping Literature Review to Identify Candidate Domains for the SLE OMERACT Core Outcome Set
- 10:30AM-12:30PM
-
Abstract Number: 0469
SCORE2 Is Superior to SCORE in Predicting the Presence of Carotid Plaques and Intima-media Thickness in Rheumatoid Arthritis Patients: A Cross-sectional Study with Carotid Ultrasound
- 10:30AM-12:30PM
-
Abstract Number: 0107
Screening for Non-criteria Antiphospholipid Autoantibodies in Patients Younger Than 50 Years Old Admitted for Venous Thromboembolism: A Cross-sectional Study
- 10:30AM-12:30PM
-
Abstract Number: 0195
Screening for Social Determinants of Health in Patients with SLE: A Point-of-Care Feasibility Study
- 10:30AM-12:30PM
-
Abstract Number: 0604
Secular Trends in Biologic Prescribing for Psoriasis and Psoriatic Arthritis, 2014-2024
- 10:30AM-12:30PM
-
Abstract Number: 0623
Select Patient Reported Outcome Measure Domains Enhance Immune Mediator Based Indexes That Inform Flare Risk and Disease Activity in Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 0246
Selectively Targeting TRBV11-2+ T Cells in Multisystem Inflammatory Syndrome in Children (MIS-C) Using Bispecific T Cell-Engaging Antibodies
- 10:30AM-12:30PM
-
Abstract Number: 0073
Self or Bacteria-reactive Th17 Expand from Conventional and Regulatory T Cells in Parabacteroides Goldsteinii Gnotobiotic Arthritic SKG Mice, in Context of Interferon-driven Synovial Inflammatory Macrophages and Reduced Bacterial Immune Regulation
- 10:30AM-12:30PM
-
Abstract Number: 0183
Sensitivity of 2019 EULAR/ACR SLE Criteria and Initial Organ Manifestations for Black and Hispanic Children with Juvenile Systemic Lupus Erythematosus (jSLE) at a Large Tertiary Care Center
- 10:30AM-12:30PM
-
Abstract Number: 0725
Serum Glial Fibrillary Acidic Protein Could Assess Cross-sectional Vasculitis Activity by Reflecting Renal Involvement in Patients with Antineutrophil Cytoplasmic Antibody-associated Vasculitis
- 10:30AM-12:30PM
-
Abstract Number: 0562
Serum Interleukin IL-40 as a Potential Biomarker Associated with Pro-inflammatory Activity in Inflammatory Bowel Diseases and Spondyloarthritis: A Preliminary Study
- 10:30AM-12:30PM
-
Abstract Number: 0741
Serum Markers of Disease Activity in Polymyalgia Rheumatica
- 10:30AM-12:30PM
-
Abstract Number: 0304
Severe Infection in COVID-19 Vaccinated Patients with Systemic Autoimmune Rheumatic Diseases on B Cell Targeted Therapies: Association with Neutrophil-lymphocyte Ratio
- 10:30AM-12:30PM
-
Abstract Number: 0599
Sex- related Differences in Efficacy of Biologics in Axial Spondyloarthritis: A Systematic Review and Meta-analysis
- 10:30AM-12:30PM
-
Abstract Number: 0588
Sex-Related Differences in Baseline Patient and Disease Characteristics: Post Hoc Analyses of Three Phase 3, Randomized, Double-blind, Placebo-Controlled Studies in Patients with Active Psoriatic Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0124
Sexual Health Challenges in Primary Antiphospholipid Syndrome: Exploring Prevalence and Clinical Correlates
- 10:30AM-12:30PM
-
Abstract Number: 0070
Shared and Unique Fecal and Plasma Metabolic Signatures and Increased Inflammatory Markers in Ankylosing Spondylitis, Psoriatic Arthritis and Acute Anterior Uveitis
- 10:30AM-12:30PM
-
Abstract Number: 0443
Significance of anti-Ro52 Antibody in Pregnancy Complicated with Anti-SS-A Antibody Positive Rheumatic Disease Patients
- 10:30AM-12:30PM
-
Abstract Number: 0502
Similar Efficacy, PK, Safety, and Immunogenicity of Tocilizumab Biosimilar (CT-P47) and Reference Tocilizumab in Patients with Moderate-to-Severe Active Rheumatoid Arthritis: Week 52 Results from the Phase III Single Transition Study
- 10:30AM-12:30PM
-
Abstract Number: 0096
Simultaneous Contribution of Brain-Intrinsic and Peripheral Disease Mechanisms to Neuropsychiatric Symptoms of Systemic Lupus Erythematosus (NPSLE)
- 10:30AM-12:30PM
-
Abstract Number: 0052
Single Cell RNA-sequencing Analysis Revealed Peripheral Blood and Synovial Alterations of Dendritic Cells in Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0706
Single Center Prospective Cohort of Systemic Sclerosis Patients Who Are At-Risk for Pulmonary Hypertension
- 10:30AM-12:30PM
-
Abstract Number: 0102
Single-cell Profiling of Dermal Endothelial Cells Identifies Unique Molecular Pathways Associated with Small-Vessel Events and Nephropathy in Antiphospholipid Syndrome
- 10:30AM-12:30PM
-
Abstract Number: 0089
Single-Cell RNA Sequencing Outlines the Mechanisms of Vgll3-Driven Myofibroblasts Differentiation in Promoting Fibrosis in Cutaneous Lupus
- 10:30AM-12:30PM
-
Abstract Number: 0746
Single-cell RNA-Seq Analysis Reveals Distinct Compositional Characterizations and Transcriptomic Profiles of Macrophages in Takayasu’s Arteritis
- 10:30AM-12:30PM
-
Abstract Number: 0478
Skin Sodium in Patients with Rheumatoid Arthritis: Association with Blood Pressure and Disease Activity
- 10:30AM-12:30PM
-
Abstract Number: 0164
Sleep Quality Is Associated with Perceived Memory Performance in Females with Osteoarthritis: A Population-based Cross-sectional Study
- 10:30AM-12:30PM
-
Abstract Number: 0094
Small GTPase Rab4A Regulates Mouse Behavior Through Altered Serum Serotonin Levels and Microglial mTORC1 Activation in Lupus-prone B6.TC Mice
- 10:30AM-12:30PM
-
Abstract Number: 0491
Small Molecule Metabolites, Potential Disease-specific Biomarkers for Predicting Treatment Response in Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0188
Social Support in African American Women with and Without Systemic Lupus Erythematosus (SLE)
- 10:30AM-12:30PM
-
Abstract Number: 0723
Sociodemographic Factors Associated with Clinic Non-attendance and Unscheduled Emergency Care Episodes in ANCA-associated Vasculitis
- 10:30AM-12:30PM
-
Abstract Number: 0615
Socioeconomic Determinants of Lupus Hospitalization Outcomes: A Review of Current Knowledge and Analysis of the 2016-2019 NRD Database
- 10:30AM-12:30PM
-
Abstract Number: 0190
Socioeconomic Disparities in Functional Status by Neighborhood Deprivation in a National Sample of Patients with Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 0638
Soluble TNF RII in Lupus Nephritis as a Biomarker of Disease Activity and Treatment Response
- 10:30AM-12:30PM
-
Abstract Number: 0359
SpA Disk©: A New Tool to Monitor the QoL of Spondyloarthritis Patients
- 10:30AM-12:30PM
-
Abstract Number: 0060
Spectral Cytometry Shows Increased CD56hi NK Cells and New HLA-DR+CD56+ Phenotypes in RA
- 10:30AM-12:30PM
-
Abstract Number: 0230
Spine and Sacroiliac Joint Involvement in Newly Diagnosed Patients with Inflammatory Bowel Disease – Clinical and MRI Findings from a Population-Based Cohort Study
- 10:30AM-12:30PM
-
Abstract Number: 0235
Spine Structural Lesions in Ankylosing Spondylitis: Comparison Between Radiographic (RASSS) and Opportunistic Thoraco-abdomino-pelvic CT Assessment
- 10:30AM-12:30PM
-
Abstract Number: 0063
Splicing into Action:Investigating the Role of Alternative Splicing in Rheumatoid Arthritis Neutrophils
- 10:30AM-12:30PM
-
Abstract Number: 0319
Sporadic Inclusion Body Myositis Novel Autoantibody and Biomarker Research Utilizing Proteome Microarray and Mass Spectrometry Proteomics Analysis
- 10:30AM-12:30PM
-
Abstract Number: 0071
Stage-Specific Roles of Interleukin-23/Interleukin-17 Axis and Type 1 Regulatory T Cells Dynamics in Axial Spondyloarthritis
- 10:30AM-12:30PM
-
Abstract Number: 0162
Statewide Burden of Low Back Pain in the United States and Its Trend from 1990-2021: A Systematic Analysis for the Global Burden of Disease Study 2022
- 10:30AM-12:30PM
-
Abstract Number: 0611
Subclinical Atherosclerosis Is Associated with Future Cardiovascular Events in Systemic Lupus Erythematosus Patients at Apparent Low Risk for Cardiovascular Disease: A Longitudinal Prospective Study
- 10:30AM-12:30PM
-
Abstract Number: 0232
Subjective and Objective Measures of Disease Activity in Difficult-to-Treat Rheumatoid Arthritis Patients at Baseline and Follow-up After an Advanced Therapy: An Ultrasound Study
- 10:30AM-12:30PM
-
Abstract Number: 0603
Superior Effectiveness and Comparable Drug Retention of Anti-TNF Therapy versus Anti-IL-17A in Ankylosing Spondylitis After First Anti-TNF Failure: A Propensity Score-Matched Analysis from the Czech ATTRA Registry
- 10:30AM-12:30PM
-
Abstract Number: 0054
Supernatants from Macrophages Stimulated with Citrullinated and MAA-Modified Fibrinogen Contain PDGF-BB and TGF-b and Upregulate Fibrotic Markers in Human Lung Fibroblasts
- 10:30AM-12:30PM
-
Abstract Number: 0160
Supplement Use in a Diverse Cohort of Individuals with SLE
- 10:30AM-12:30PM
-
Abstract Number: 0202
Survival in Patients with Rheumatoid Arthritis and Early-Stage Colorectal, Lung, or Prostate Cancer Receiving Tumor Necrosis Factor Alpha Inhibitors
- 10:30AM-12:30PM
-
Abstract Number: 0751
Sustained Drug-free Remission in Giant Cell Arteritis: Results Results of the Spanish ARTESER Registry
- 10:30AM-12:30PM
-
Abstract Number: 0592
Sustained Improvements with Bimekizumab in Patient-Reported Symptoms of Axial Spondyloarthritis: 2-Year Results from Two Phase 3 Studies
- 10:30AM-12:30PM
-
Abstract Number: 0518
Sustained Patient Meaningful Outcomes of Pain and Fatigue Relief and Improved Physical Functioning with Filgotinib in Rheumatoid Arthritis: A Post Hoc Analysis
- 10:30AM-12:30AM
-
Abstract Number: PP06
Sweat It Out: How the Sauna Has Helped Me Cope with Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0087
SYNCAR: An Engineered IL-2/IL-2R-system That Selectively Enhances CD19 CAR T Cells to Deplete B Cells and Provide Therapeutic Benefit in SLE and RA Mouse Models Without Lymphodepletion
- 10:30AM-12:30PM
-
Abstract Number: 0017
Syndecan-1 Plays a Role in the Pathogenesis of Sjögren’s Syndrome by Inducing B-cell Chemotaxis Through CXCL13-heparan Sulfate Interaction
- 10:30AM-12:30PM
-
Abstract Number: 0572
Synergistic Impact of the Non-radiographic Axial Spondyloarthritis Subtype and Female Sex on First-Line Biologic Discontinuation : A Study of Interaction Effects
- 10:30AM-12:30PM
-
Abstract Number: 0044
Synovial Phosphoproteomic Profiling in Early and Advanced Rheumatoid Arthritis (R4RA Trial) Identifies Specific Signaling Pathways Linked to Distinct Pathotypes
- 10:30AM-12:30PM
-
Abstract Number: 0608
Systematic Analysis Demonstrates the Added Value of CB-CAPs to SLE Diagnosis in a Large Validation Cohort
- 10:30AM-12:30PM
-
Abstract Number: 0173
Systemic Lupus Erythematosus Mortality—United States, 2018–2022
- 10:30AM-12:30PM
-
Abstract Number: 0251
T-SPOT.TB and TST in Diagnosing Active Tuberculosis in Patients with Rheumatic Immune Diseases: A Fully Paired Comparative Diagnostic Test Accuracy Study
- 10:30AM-12:30PM
-
Abstract Number: 0040
Targeting Complement Factor B (CFB) via a Novel siRNA Therapy (AZD6912) to Treat Inflammatory Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0091
Targeting Endothelial Dysfunction in Lupus Nephritis: Effect of Sepiapterin, a Drug That Restores Endothelial Nitric Oxide Synthase Function, in a Murine Model of Lupus Nephritis
- 10:30AM-12:30PM
-
Abstract Number: 0275
Targeting IRAK4 in Monosodium Urate Crystals Induced Inflammation
- 10:30AM-12:30PM
-
Abstract Number: 0072
The Association Between Activation of Inflammasome and HLA-B27 in Dendritic Cells of Patients with Axial Spondyloarthritis
- 10:30AM-12:30PM
-
Abstract Number: 0388
The Association Between Body Composition and Disease and Treatment Outcomes in Patients with Juvenile Idiopathic Arthritis: Results from the CAPRI Registry
- 10:30AM-12:30PM
-
Abstract Number: 0133
The Association Between Gout and Gallstone Disease: US General Population Analysis
- 10:30AM-12:30PM
-
Abstract Number: 0081
The Axial Spondyloarthritis Risk Variant CARD9 S12N Enhances Neutrophil-mediated Th Responses
- 10:30AM-12:30PM
-
Abstract Number: 0150
The Characteristics of a Northern Israeli Cohort of Patients with Behcet’s Syndrome
- 10:30AM-12:30PM
-
Abstract Number: 0424
The Clinical Utility of Serum BAFF Levels in Pregnant Patients with SLE
- 10:30AM-12:30PM
-
Abstract Number: 0684
The Diagnostic Accuracy of Ultrasound for Low Muscle Mass in Women with Systemic Sclerosis
- 10:30AM-12:30PM
-
Abstract Number: 0555
The Effect of Alcohol Consumption on Clinical Outcomes and Structural Damage in Patients with Axial Spondyloarthritis: A Systematic Literature Review and Meta-Analysis
- 10:30AM-12:30PM
-
Abstract Number: 0421
The Effect of Biologic Treatment for Psoriatic Arthritis and Axial Spondyloarthritis on Semen Parameters – a Longitudinal Study
- 10:30AM-12:30PM
-
Abstract Number: 0141
The Effect of Systemic Immunosuppressive Therapies on Cardiovascular Risk in Psoriatic Arthritis Patients
- 10:30AM-12:30PM
-
Abstract Number: 0129
The Efficacy and Safety of Telitacicept Following Rituximab Immunotherapy on Antiphospholipid Syndrome, a Prospective 24- Week Study
- 10:30AM-12:30PM
-
Abstract Number: 0477
The Global Prevalence of Interstitial Lung Disease in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-analysis
- 10:30AM-12:30PM
-
Abstract Number: 0097
The Human Lupus TREX1 D18N Mutation Engineered in C. Elegans Leads to Cell Death. What Can We Learn About Lupus Using C. Elegans?
- 10:30AM-12:30PM
-
Abstract Number: 0245
The Impact of COVID-19 and ‘Long COVID’ on Self-Reported Disease Activity, Disability, and Quality of Life in Patients with Inflammatory Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0142
The Impact of Hospital Region on Mortality and Other Outcomes in Patients with Gout: A Two-Year Nationwide Analysis
- 10:30AM-12:30PM
-
Abstract Number: 0325
The Impact of Polymyositis and Dermatomyositis in Patients Hospitalized with Inflammatory Bowel Disease: A Nationwide Inpatient Database Analysis
- 10:30AM-12:30PM
-
Abstract Number: 0123
The Impact of Sedentary Behavior and Physical Activity Level on Clinical Parameters and Quality of Life in Patients with Primary Antiphospholipid Syndrome (PAPS)
- 10:30AM-12:30PM
-
Abstract Number: 0030
The Impact of Treadmill Exercise on Various Stages of Osteoarthritis Progression in a Murine Osteoarthritis Model
- 10:30AM-12:30PM
-
Abstract Number: 0148
The Incidence and Prevalence of Sarcoidosis in England
- 10:30AM-12:30PM
-
Abstract Number: 0569
The Longitudinal Association Between Disease Activity, Function and Health-Related Quality of Life in Axial Spondyloarthritis: Results from the DESIR Cohort
- 10:30AM-12:30PM
-
Abstract Number: 0609
The Mediating Role of Trust in Usual Rheumatologists on the Relationship Between Multidimensional Health Literacy and Medication Adherence Among Japanese Systemic Lupus Erythematosus Patients
- 10:30AM-12:30PM
-
Abstract Number: 0222
The Prediction of Response to Advanced Therapies on a Joint Level in Rheumatoid Arthritis: The Interpretation of Tenderness and Doppler Ultrasound
- 10:30AM-12:30PM
-
Abstract Number: 0137
The Problem of Pain in Rheumatology: Sociodemographic and Disease-related Correlates of Agreement Between Structured Data Elements and Clinical Notes in Chronic Pain Documentation Practices in EHR
- 10:30AM-12:30PM
-
Abstract Number: 0318
The Relevance of a Positive ANA in New Patient Referrals to Rheumatology
- 10:30AM-12:30PM
-
Abstract Number: 0564
The Risk of Venous Thromboembolism in Axial Spondyloarthritis: A Population-based Study
- 10:30AM-12:30PM
-
Abstract Number: 0038
The Role of Dual Specificity Phosphatase 22 (DUSP22) in Rheumatoid Arthritis: Mechanism and Genetic Investigations
- 10:30AM-12:30PM
-
Abstract Number: 0686
The Role of Inflammation in Systemic Sclerosis: CRP-Associated Phenotypes and Prognostic Implications
- 10:30AM-12:30PM
-
Abstract Number: 0221
The Significance of Tenderness with or Without Swelling of Finger Joints in Relation to Magnetic-resonance-imaging, Ultrasound and X-ray in Psoriatic Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0487
The Triglyceride to HDL Ratio, a Surrogate Marker of Insulin Resistance, Predicts All Cause and Cardiovascular Mortality in Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0312
The Use of Electromyography as a Screening Tool in Sarcoidosis-associated Neuropathy
- 10:30AM-12:30PM
-
Abstract Number: 0714
Therapeutic Dilemmas in Patients with ANCA-associated Vasculitis: Diffuse Alveolar Hemorrhage, Venous Thromboembolism and Anticoagulation
- 10:30AM-12:30PM
-
Abstract Number: 0465
Therapeutic Drug Monitoring of the Adalimumab Biosimilar (AMJEVITA™, Adalimumab-atto) Using Originator Adalimumab and Anti-Adalimumab Antibody Assays
- 10:30AM-12:30PM
-
Abstract Number: 0668
There Are No Shortcuts: Electronic Health Record-Generated Tool Does Not Reflect Medication Adherence in Patients with SLEin Bronx, NY
- 10:30AM-12:30PM
-
Abstract Number: 0371
This Is Caring: Enhancing Patient Education Materials for Individuals with Morphea Through Qualitative Inquiry
- 10:30AM-12:30PM
-
Abstract Number: 0589
Time to Clinical Response to Secukinumab Across Disease Domains Among Patients with Psoriatic Arthritis: A Pooled Post Hoc Analysis of 4 Phase 3 Trials
- 10:30AM-12:30PM
-
Abstract Number: 0302
TNFAIP3 Loss-of-function and Missense Mutations Demonstrate Clinically Diverse Presentations: A Multi-center Cohort Experience
- 10:30AM-12:30PM
-
Abstract Number: 0459
Tocilizumab Demonstrates Superior Inhibition of MMP-Mediated Basement Membrane Collagen Degradation Compared to Methotrexate or Placebo
- 10:30AM-12:30PM
-
Abstract Number: 0765
Tocilizumab in Extracranial Large-Vessel Giant Cell Arteritis and Takayasu Arteritis: A Multicentric Observational Comparative Study
- 10:30AM-12:30PM
-
Abstract Number: 0745
Tocilizumab in Monotherapy vs. Combined in Aortitis Associated with Giant Cell Arteritis. Multicenter Open-label Study of 196 Patients
- 10:30AM-12:30PM
-
Abstract Number: 0074
Tofacitinib Therapy Ameliorates Inflammation in a Mouse Model of Psoriasis and Arthritis by Inducing Type 2 Immunity
- 10:30AM-12:30PM
-
Abstract Number: 0237
Tofacitinib: A Retrospective Study on Safety and Adverse Effects
- 10:30AM-12:30PM
-
Abstract Number: 0024
Trans-Signaling by Soluble CD14 Sensitizes Chondrocytes to Lipopolysaccharide Stimuli, Increasing Chondrocyte Inflammatory Responses
- 10:30AM-12:30PM
-
Abstract Number: 0763
Transcriptional Analysis of Both Normal and Abnormal TABs in Biopsy-proven GCA Reveals a Shared Gene Expression Profile Compared to Clinically Diverse Controls
- 10:30AM-12:30PM
-
Abstract Number: 0521
Transcriptome Analysis of Drug Response in a Large Cohort of Immune-Mediated Inflammatory Disease Patients Supports Advanced Combination Therapy in Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0022
Transcriptomic Characterization of Knee Capsule Fibroblasts and Mesenchymal Stromal Cells Reveals an Association Between Flexion Contracture and Alterations in Immune Pathways in People with End-stage OA
- 10:30AM-12:30PM
-
Abstract Number: 0622
Translation, Adaptation and Validation of the Brazilian-Portuguese Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS) Version: Partial Results from a Single Centre
- 10:30AM-12:30PM
-
Abstract Number: 0753
Treatment and Evolution in 134 Patients with Aortitis and Periaortitis. Experience of a Single Referral Centre
- 10:30AM-12:30PM
-
Abstract Number: 0390
Treatment Effectiveness Following Switching from Initial TNF Inhibitor in Juvenile Idiopathic Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0736
Treatment of IgG4-Related Disease (IgG4-RD) with Elotuzumab, an Inhibitor of SLAM-F7: Report of a Phase 2 Clinical Trial
- 10:30AM-12:30PM
-
Abstract Number: 0345
Treatment Patterns and Glucocorticoid Burden of Dermatomyositis Patients: A Cohort Study in the University of Pittsburgh’s Myositis Registry
- 10:30AM-12:30PM
-
Abstract Number: 0663
Treatment Patterns and the Prevalence of Kidney Biopsy-Confirmed LN in Patients with SLE and Proteinuria: A Multicenter Cohort Study
- 10:30AM-12:30PM
-
Abstract Number: 0509
Trends in Initiation of Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis Among Commercially-Insured US Adults, 2001-2021
- 10:30AM-12:30PM
-
Abstract Number: 0280
Trends in Management and Consultations for Gout: A Study of 18 Million Adults Using the OpenSAFELY Platform
- 10:30AM-12:30PM
-
Abstract Number: 0397
Trends in New Use of Disease-Modifying Antirheumatic Drugs in Juvenile Idiopathic Arthritis Among Commercially Insured Children in the United States from 2001-2022
- 10:30AM-12:30PM
-
Abstract Number: 0625
Trends, Outcomes, and Predictors of Mortality in Patients with SLE Hospitalized for Influenza
- 10:30AM-12:30PM
-
Abstract Number: 0650
Tubulointerstitial Inflammation Predicts Tubular Atrophy, Fibrosis, and Renal Function Loss in Lupus Nephritis
- 10:30AM-12:30PM
-
Abstract Number: 0381
Two- and 3-Year Outcomes of the Childhood Arthritis and Rheumatology Research Alliance FROST Study of New-onset Systemic JIA Treatment
- 10:30AM-12:30PM
-
Abstract Number: 0001
Type I Interferon and Anifrolumab Effects on Bone Marrow and Blood Plasma Cells in Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 0220
Ultrasound-assessed Dactylitis as a Biomarker in the Early Diagnosis of Psoriatic Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0126
Underdiagnosis Prediction Fingerprint for Antiphospholipid Syndrome Derived from Electronic Health Record Data
- 10:30AM-12:30PM
-
Abstract Number: 0676
Understanding the Patient Burden of Lupus: Insights from Multi-Faceted Ethnography Research
- 10:30AM-12:30PM
-
Abstract Number: 0471
Understanding the Role of the Complement System in Insulin Resistance and Metabolic Syndrome in Patients with Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0217
Understanding Treatment Goals and Factors Influencing Decisions About Clinical Trial Participation in Lupus Patients from Diverse Backgrounds
- 10:30AM-12:30PM
-
Abstract Number: 0208
Unlocking COVID-19 Vaccination Choices in Rheumatoid Arthritis: Insights from a Monocentric Study
- 10:30AM-12:30PM
-
Abstract Number: 0581
Unmet Criteria for Achieving Minimal and Very Low Disease Activity Among Patients with Psoriatic Arthritis Initiating Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drugs in the CorEvitas PsA/SpA Registry
- 10:30AM-12:30PM
-
Abstract Number: 0127
Unsupervised Machine Learning Improves Clinical Stratification and Prognostic Evaluation for Antiphospholipid Syndrome: A Large Cohort Study from China
- 10:30AM-12:30PM
-
Abstract Number: 0394
Unveiling Major Challenges and Unmet Needs in the Therapeutic Approach to Systemic Juvenile Idiopathic Arthritis: The Patient Perspective
- 10:30AM-12:30PM
-
Abstract Number: 0348
Upadacitinib in Interstitial Lung Disease Associated with Idiopathic Inflammatory Myopathies
- 10:30AM-12:30PM
-
Abstract Number: 0206
Urate Lowering Therapy to Acute Treatment Ratio (ULTrA) Index – a Novel Quality Indicator Associated with Reduced Hospital Admissions for Gout
- 10:30AM-12:30PM
-
Abstract Number: 0649
Urinary Acetylated Albumin as a Biomarker of Nephritis in Patients with Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 0425
Use of bDMARDs During Pregnancy After Preconceptional Counseling in Spanish Patients with Rheumatic Diseases
- 10:30AM-12:30PM
-
Abstract Number: 0489
Use of Chair Sit-to-Stand as a Pragmatic Alternative to Assess Frailty in Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0435
Use of Contraception in Women of Childbearing Age with Immune-Mediated Rheumatic Diseases: Experience from an Italian Centre
- 10:30AM-12:30PM
-
Abstract Number: 0742
Use of FDG-PET to Monitor Disease Activity in Patients with Giant Cell Arteritis on Tocilizumab
- 10:30AM-12:30PM
-
Abstract Number: 0201
Use of Infrared Thermography for Expedited Rheumatology Referral in a Primary Care Center
- 10:30AM-12:30PM
-
Abstract Number: 0503
Use of Janus Kinase Inhibitors Before and After European Medicines Agency Safety Recommendations
- 10:30AM-12:30PM
-
Abstract Number: 0456
Use of Machine Learning to Evaluate Incremental Value of Actigraphy Data for Classifying Treatment Response in Patients with Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0134
Use of Oral Contraceptives in Females with Rheumatoid Arthritis Is Not Associated with an Increased Risk of Venous Thromboembolism: United Kingdom-population Based Study
- 10:30AM-12:30PM
-
Abstract Number: 0242
Use of Outpatient Antiviral Therapy and Severe Outcomes from SARS-CoV-2 Omicron Infection in Patients with Immune Mediated Diseases on B Cell Depleting Agents
- 10:30AM-12:30PM
-
Abstract Number: 0494
Usefulness of the Neutrophil-to-Lymphocyte Ratio, the Platelet-to-Lymphocyte Ratio and the Systemic Immune Inflammatory Index in Assessing Disease Activity in Rheumatoid Arthritis Patients
- 10:30AM-12:30PM
-
Abstract Number: 0505
UseofaMolecularSignatureResponseClassifiertoPredictInadequateResponsetoTNFiResultsinFewer Patients Prescribed TNFi
- 10:30AM-12:30PM
-
Abstract Number: 0533
Using Adalimumab Serum Concentration to Choose a Subsequent DMARD in Rheumatoid Arthritis Patients Failing Adalimumab Treatment (ADDORA-switch): Results of a Blinded Randomized Test Treatment Trial
- 10:30AM-12:30PM
-
Abstract Number: 0643
Using FDG PET Brain Scans and Deep Learning Analyses to Identify a Specific Network Correlated with Cognitive Impairment in SLE
- 10:30AM-12:30PM
-
Abstract Number: 0391
Using Machine Learning to Predict Inactive Disease in Juvenile Idiopathic Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0025
Vagus Nerve Stimulation: A Promising Approach to Alleviate Pain and Systemic Inflammation in Slow and Rapid Models of Osteoarthritis
- 10:30AM-12:30PM
-
Abstract Number: 0398
Validation of Patient-Reported Outcomes Measurement Information System® (PROMIS®) Pediatric Measures for Children with Chronic Nonbacterial Osteomyelitis Using the CHOIR Data
- 10:30AM-12:30PM
-
Abstract Number: 0117
Validation of the 2023 American College of Rheumatology/European League Against Rheumatism Antiphospholipid Syndrome Classification Criteria in the Pediatric Population
- 10:30AM-12:30PM
-
Abstract Number: 0326
Validity and Responsiveness of Core Set Measures in Idiopathic Inflammatory Myositis Based on 36-item Short Form Health Survey (SF-36)
- 10:30AM-12:30PM
-
Abstract Number: 0661
Validity, Reliability and Responsiveness of Lupus Impact Tracker and LupusPRO: AURORA Trial
- 10:30AM-12:30PM
-
Abstract Number: 0593
Value of the Routine Assessment of Patient Index Data 3 in Assessing Disease Severity and Treatment Effect in Patients with Early Oligoarticular Psoriatic Arthritis Treated with Apremilast
- 10:30AM-12:30PM
-
Abstract Number: 0386
Variability of Data Completeness and Consensus Treatment Plan Adherence for Polyarticular Juvenile Idiopathic Arthritis Patients Within the Childhood Arthritis and Rheumatology Research Alliance Registry
- 10:30AM-12:30PM
-
Abstract Number: 0120
Vascular Liver Disorders in Patients with Antiphospholipid Syndrome: A Retrospective National Multicentre Study
- 10:30AM-12:30AM
-
Abstract Number: PP10
Walking Away from Arthritis Pain: Exercise Helped Me Manage Sarcoidosis and Osteoarthritis Physically and Emotionally
- 10:30AM-12:30PM
-
Abstract Number: 0268
Weight Loss Induced by Anti-obesity Medications and Gout Among Overweight and Obesity Individuals: A Population-based Cohort Study
- 10:30AM-12:30PM
-
Abstract Number: 0557
What Factors Are Associated with Pain Intensity in Axial Spondyloarthritis? Results from the International Map of Axial Spondyloarthritis (IMAS)
- 10:30AM-12:30PM
-
Abstract Number: 0360
What Happens in Rheumatoid Arthritis Treatment Adherence, Two Years After the Introduction of Targeted Therapy? Results from the STRATEGE2 Study
- 10:30AM-12:30PM
-
Abstract Number: 0259
Whipple’s Disease in Patients Initially Diagnosed with Rheumatic Diseases: A Case Series
- 10:30AM-12:30AM
-
Abstract Number: PP08
Whispers of Resilience: Navigating Life with Rheumatism
- 10:30AM-12:30PM
-
Abstract Number: 0658
Zetomipzomib (KZR-616), a First-in-Class Selective Immunoproteasome Inhibitor, Demonstrated Improvements in SLE/LN Disease Measures and Biomarkers in Patients with Highly Active SLE or Nephrotic Range Proteinuria in the Open-label Phase 1b/2 MISSION Study
- 1:00PM-2:30PM
-
Abstract Number: 0817
2024 Clinical Practice Guideline for the Diagnosis and Treatment of Chronic Nonbacterial Osteitis (CNO) in Adults
- 1:00PM-2:30PM
-
Abstract Number: 0782
30-Color Full Spectrum Flow Cytometry Identifies Sex Differences in the Circulating Immune Landscape of Systemic Sclerosis
- 1:00PM-2:30PM
-
Abstract Number: 0812
A Human Gut Pathobiont Drives Platelet Activation with Microparticle Release and NETosis During Lupus Nephritis Flares
- 1:00PM-2:30PM
-
Abstract Number: 0775
A Phase 3, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study of Inebilizumab in IgG4-Related Disease (MITIGATE): Primary Efficacy and Safety Findings
- 1:00PM-2:30PM
-
Abstract Number: 0823
A Randomized, Double-Blind, Placebo-Controlled Trial of Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis with Polyangiitis
- 1:00PM-2:30PM
-
Abstract Number: 0798
Acute Activation of the Rat Dorsal Root Ganglion Nociceptive Cells by the Serum of Patients Suffering from Fibromyalgia
- 1:00PM-2:30PM
-
Abstract Number: 0781
An Expanded Cytotoxic CD8 T Cell Population Regulated by CD155-CD226 in SSc-ILD
- 1:00PM-2:30PM
-
Abstract Number: 0789
An Online Trial to Assess the Efficacy and Safety of a Supplement Combination in People with Hand Osteoarthritis
- 1:00PM-2:30PM
-
Abstract Number: 0797
Associations Between Discordance of Disease Activity Indices and Quantitative Sensory Testing Measures of Nociplastic Pain in Patients with Early Rheumatoid Arthritis
- 1:00PM-2:30PM
-
Abstract Number: 0800
Associations of Rheumatoid Arthritis Polygenic Risk with Age at Onset, Serostatus, and Interstitial Lung Disease
- 1:00PM-2:30PM
-
Abstract Number: 0825
Biosimilars of Rituximab in ANCA-associated Vasculitis Compared to the Originator (BRAVO): 6-month Outcomes of a Longitudinal Cohort Study
- 1:00PM-2:30PM
-
Abstract Number: 0790
CoLchicine for Treatment of OsteoArthritis of the Knee: Clinical Outcomes from a 90-day Double-Blind, Placebo-Controlled Study
- 1:00PM-2:30PM
-
Abstract Number: 0778
Comprehensive Immune Profiling of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy in Patients with Autoimmune Disease
- 1:00PM-2:30PM
-
Abstract Number: 0808
Confirmation of Second Trimester Trophoblast Transport of Maternal Anti-SSA/Ro52 and 60kD Autoantibodies in Cardiac Neonatal Lupus: Implications for FcRn Blockade
- 1:00PM-2:30PM
-
Abstract Number: 0780
Deep B Cell Tissue Depletion Following Anti-CD19 CART Cells Therapy
- 1:00PM-2:30PM
-
Abstract Number: 0818
Defining BASDAI Cut-offs for Disease Activity States in Axial Spondylarthritis – Results from the EuroSpA Collaboration
- 1:00PM-2:30PM
-
Abstract Number: 0796
Development and Evaluation of Machine Learning Prediction Models for Hospitalizations Due to Opioid-Related Harms Among New Users with Rheumatic and Musculoskeletal Diseases
- 1:00PM-2:30PM
-
Abstract Number: 0802
Disease Activity Is Strongly Associated with RA-related Lung Disease and Interstitial Lung Disease in Early RA: Results from a Multicenter, Prospective Cohort Study
- 1:00PM-2:30PM
-
Abstract Number: 0816
Distinct Transcript and Protein Dysregulation Patterns in Dermatomyositis and Systemic Lupus Erythematosus
- 1:00PM-2:30PM
-
Abstract Number: 0828
Efficacy of Eosinophil-Targeting Therapies on Specific Disease Manifestations of Eosinophilic Granulomatosis with Polyangiitis in the Phase 3 MANDARA Trial
- 1:00PM-2:30PM
-
Abstract Number: 0787
Efficacy of Intra-Articular Hyaluronic Acid Injection for Nonsurgical Management of Carpometacarpal Osteoarthritis: A Systematic Review and Meta-analysis of Randomized Clinical Trials
- 1:00PM-2:30PM
-
Abstract Number: 0807
Evaluating Adverse Pregnancy Outcomes in Systemic Lupus Erythematosus (SLE) and SLE Subgroups: Additional Risks Associated with Cardiovascular Events
- 1:00PM-2:30PM
-
Abstract Number: 0785
Exploring the Link Between Atgl-Dependent Lipolysis and Dermal Fibrosis in Systemic Sclerosis
- 1:00PM-2:30PM
-
Abstract Number: 0786
First Analyses of Transcriptomic Changes in the Skin of SSc Patients upon CD19-targeting CAR T Cell Therapy
- 1:00PM-2:30PM
-
Abstract Number: 0776
Follicular Dendritic Cell PD-L1 Expression Promotes Autoreactive Germinal Center Formation
- 1:00PM-2:30PM
-
Abstract Number: 0810
Glucocorticoids in Pregnancy and Lactation: Results of the Systematic Review Informing the EULAR Task Force on Antirheumatic Drugs in Reproduction, Pregnancy and Lactation
- 1:00PM-2:30PM
-
Abstract Number: 0811
High-Throughput Proteomic Profiling of Longitudinal Serum Samples to Predict Treatment Response in Lupus Nephritis
- 1:00PM-2:30PM
-
Abstract Number: 0815
Interferon-stimulated Gene Expression in Non-lesional Skin Is Similarly Elevated in Incomplete SLE and SLE
- 1:00PM-2:30PM
-
Abstract Number: 0813
Investigating TASL, SLC15A4, & TLR7 Associated Risk SNPs in Systemic Lupus Erythematosus
- 1:00PM-2:30PM
-
Abstract Number: 0822
Investigating the Association Between Alcohol Consumption and Spinal Radiographic Progression in Axial Spondyloarthritis: A Longitudinal Cohort Analysis over a Period of 6 Years
- 1:00PM-2:30PM
-
Abstract Number: 0788
Long-term Effectiveness of a Lifestyle Intervention for Osteoarthritis: Two-year Follow-up After the “Plants for Joints” Randomized Clinical Trial
- 1:00PM-2:30PM
-
Abstract Number: 0801
Neutrophil Activation as a Novel Marker of Lung Disease in Rheumatoid Arthritis
- 1:00PM-2:30PM
-
Abstract Number: 0791
Optimizing Knee Osteoarthritis Treatment with the Precision Medicine Approach in a Clinical Trial Dataset
- 1:00PM-2:30PM
-
Abstract Number: 0827
Oral Corticosteroid-Sparing Effects of Mepolizumab in Eosinophilic Granulomatosis with Polyangiitis (EGPA): Results up to 7.4 Years from the Long-Term Access Programme
- 1:00PM-2:30PM
-
Abstract Number: 0799
Peripheral Biomarker Signatures and a Genetic Risk Score Improve the Identification of RA-ILD Beyond Clinical Risk Factors
- 1:00PM-2:30PM
-
Abstract Number: 0826
Plasma Exchange for Severe Alveolar Hemorrhage in ANCA-Associated Vasculitis: Emulation of a Target Trial
- 1:00PM-2:30PM
-
Abstract Number: 0795
Prevalence of Post-exertional Malaise (PEM) in Adults with Rheumatic Diseases and Relationship with COVID19 Infection
- 1:00PM-2:30PM
-
Abstract Number: 0792
Radiographic and Pain Outcomes from a Phase 3 Trial (OA-07) Evaluating the Efficacy and Safety of Repeat Lorecivivint Injections over 3 Years in Subjects with Knee OA
- 1:00PM-2:30PM
-
Abstract Number: 0814
Rare Variants of PAH Risk Genes Associate with a Distinct Vasculopathy Phenotype and Worse Outcomes in Patients with Systemic Lupus Erythematosus-associated Pulmonary Arterial Hypertension
- 1:00PM-2:30PM
-
Abstract Number: 0805
Results from the Certolizumab-pegol Pregnancy Exposure Registry: An OTIS Autoimmune Diseases in Pregnancy Project
- 1:00PM-2:30PM
-
Abstract Number: 0777
Rheumatoid Factor B Cell Clones Proliferate Predominantly as Atypical Memory B Cells in Reactive Cervical Lymph Node Follicles Compared to Extrafollicular Sites in Affected Salivary Glands of SjS Patients
- 1:00PM-2:30PM
-
Abstract Number: 0806
Rotavirus Vaccine in Offspring Exposed to Tumour Necrosis Factor Inhibitors During the Third Trimester Does Not Increase Diarrhea-Associated Healthcare Events
- 1:00PM-2:30PM
-
Abstract Number: 0784
RUNX1 Is Expressed in a Subpopulation of Dermal Fibroblasts and Is Increased with Systemic Sclerosis Disease Severity
- 1:00PM-2:30PM
-
Abstract Number: 0793
Secular Changes in Widespread Pain Across Two Generations: The Framingham Heart Study
- 1:00PM-2:30PM
-
Abstract Number: 0804
Serologic and Clinical Predictors of Progressive Pulmonary Fibrosis in Rheumatoid Arthritis-associated Interstitial Lung Disease Progression: A Prospective Longitudinal Cohort
- 1:00PM-2:30PM
-
Abstract Number: 0803
Serum Adipokines and Interstitial Lung Disease in a Prospective Rheumatoid Arthritis Cohort
- 1:00PM-2:30PM
-
Abstract Number: 0779
Sex Differences in the B Cell Compartment of Patients with Oligoarticular Juvenile Idiopathic Arthritis
- 1:00PM-2:30PM
-
Abstract Number: 0794
Social Security Work Disability and Its Predictors in Patients with Fibromyalgia: 25 Years of Followup
- 1:00PM-2:30PM
-
Abstract Number: 0783
Spatial Reconstruction of Interstitial Lung Disease
- 1:00PM-2:30PM
-
Abstract Number: 0819
The Assessment of SpondyloArthritis International Society (ASAS) Definition of Difficult-to-Manage Axial Spondyloarthritis
- 1:00PM-2:30PM
-
Abstract Number: 0820
The Classification in Axial Spondyloarthritis Inception Cohort Study: Performance of the 2009 Assessments in Spondyloarthritis International Society Classification Criteria
- 1:00PM-2:30PM
-
Abstract Number: 0824
The Effect of Intranasal Niclosamide on Nasal Symptoms in Patients with ENT Manifestations of ANCA-Associated Vasculitis (AAV): Post Hoc Analysis of Subset of Patients Recruited to the PROTECT-V Trial
- 1:00PM-2:30PM
-
Abstract Number: 0809
The Utility of the sFlt1:PlGF Ratio to Rule out and Predict Preeclampsia in Women with Lupus
- 1:00PM-2:30PM
-
Abstract Number: 0821
Validation of ASAS Preliminary Data-Driven MRI Lesion Cut-offs for a Positive MRI of the Sacroiliac Joints in Patients with Axial Spondyloarthritis and Subgroups with Psoriasis, Iritis, and Colitis
- 3:00PM-4:30PM
-
Abstract Number: 0852
3-dimensional Shape Changes of the Knee over 4 Years Are Linear and Progressive but Much More Rapid in Osteoarthritic Joints: Data from the Osteoarthritis Initiative
- 3:00PM-4:30PM
-
Abstract Number: 0830
Activation of Autoreactive Lymphocytes in the Lung by STING Gain-of-function Mutation Expressing Radioresistant Cells
- 3:00PM-4:30PM
-
Abstract Number: 0855
Addition of Immunosuppressive Agents And/or Intravenous Immunoglobulin to Steroids in the Treatment of Susac Syndrome: A National Cohort Study
- 3:00PM-4:30PM
-
Abstract Number: 0850
Assessment of Correlation Between Composite Ultrasonographic Index (ECODAS) and Disease Activity Score 28 in Patients with Rheumatoid Arthritis
- 3:00PM-4:30PM
-
Abstract Number: 0868
Autoantibodies to Joint-related Proteins Predict Severe Joint Destruction in Difficult-to-treat Rheumatoid Arthritis Patients
- 3:00PM-4:30PM
-
Abstract Number: 0858
Baricitinib in Early Polymyalgia Rheumatica (BACHELOR Study)
- 3:00PM-4:30PM
-
Abstract Number: 0837
Bispecific Autoantigen-T Cell Engagers (BaiTE) to Selectively Target Autoreactive B Cells in Antiphospholipid Syndrome
- 3:00PM-4:00PM
-
Abstract Number: PP15
Breathing Mindfully and How to Control Anxiety in Lupus Patients
- 3:00PM-4:00PM
-
Abstract Number: PP13
Bridging the Gap from Pediatric to Adult Rheumatology Care
- 3:00PM-4:30PM
-
Abstract Number: 0876
C-CAR168 as a Novel Anti-CD20/BCMA Bispecific Autologous CAR-T Therapy for the Treatment of Autoimmune Diseases
- 3:00PM-4:30PM
-
Abstract Number: 0841
Clinical and Biologic Predictors of Thrombosis in Persistently Antiphospholipid Antibody Positive Patients: Prospective Analysis of the International APS ACTION Clinical Database and Repository (“Registry”)
- 3:00PM-4:30PM
-
Abstract Number: 0856
Comparative Effectiveness of Disease Modifying Antirheumatic Drugs for Cardiac Sarcoidosis
- 3:00PM-4:30PM
-
Abstract Number: 0839
Comprehensive Single-cell Analysis Reveals Interferon Pathway Activation and Aberrant B Cell Dynamics in APS Autoimmunity
- 3:00PM-4:30PM
-
Abstract Number: 0866
Cross-sectional Analysis of Erosive Hand Osteoarthritis and Fracture Risk
- 3:00PM-4:30PM
-
Abstract Number: 0869
Deciphering Pathogenic Phenotypes by Multi-modal Deep Single-cell Blood Immunophenotyping in Individuals At-risk for Rheumatoid Arthritis
- 3:00PM-4:30PM
-
Abstract Number: 0874
Defining a Protective Role for Mucosal-associated Invariant T (MAIT) Cells in Spontaneous Cutaneous Lupus Erythematosus
- 3:00PM-4:30PM
-
Abstract Number: 0867
Development of a Remote Patient Monitoring System Based on a Novel Digital Biomarker for Swelling in Rheumatoid Arthritis
- 3:00PM-4:30PM
-
Abstract Number: 0851
Diagnostic Ultrasound Enthesitis Tool (DUET) for Psoriatic Arthritis: The Distribution of Elementary Lesions Is Influenced by Site
- 3:00PM-4:30PM
-
Abstract Number: 0871
Disease-associated Central Nervous System Activation Predicts Good Clinical Response to Tumor Necrosis Factor Inhibition in Rheumatoid Arthritis Patients – “The PreCePRA Study”
- 3:00PM-4:30PM
-
Abstract Number: 0835
Effective Engineering of CD8+ T Cells from Autoimmune Disease Patients Utilizing a CD8-Targeted Lipid NanoparticleEncoding an Anti-CD19 CAR mRNA(CPTX2309)
- 3:00PM-4:30PM
-
Abstract Number: 0844
Effectiveness and Safety of the Recombinant Zoster Vaccine in Patients ≥18 Years of Age with Systemic Lupus Erythematosus or Multiple Sclerosis
- 3:00PM-4:30PM
-
Abstract Number: 0849
Effectiveness of Tocilizumab in Aortitis and Aneurysms Associated with Giant Cell Arteritis. Multicenter Open-label Study
- 3:00PM-4:30PM
-
Abstract Number: 0873
Epigenetic Control of Pathogenic CD4 T Cell Polarization During Progression to Rheumatoid Arthritis (RA)
- 3:00PM-4:30PM
-
Abstract Number: 0829
Epstein-Barr Virus Infection Triggers Hyperinflammation and Cytokine Storm in Healthy Children
- 3:00PM-4:30PM
-
Abstract Number: 0834
Evolution of Lung Inflammation in a Mouse Model of Chronic/Recurrent Macrophage Activation Syndrome
- 3:00PM-4:30PM
-
Abstract Number: 0857
Exploring Clinical Outcomes of Patients with Cardiac Sarcoidosis on TNF Inhibitors: A Nationwide Retrospective Cohort Study
- 3:00PM-4:30PM
-
Abstract Number: 0843
External Validation and Extension of Population-Based Systemic Lupus Erythematosus Risk Prediction Models Using Genetics, and Lifestyle and Environmental Factors
- 3:00PM-4:30PM
-
Abstract Number: 0848
Impact of SGLT2i Initiation on the Need for Urate-Lowering Therapy and Colchicine Among Gout Patients with Type 2 Diabetes:Propensity-Score Matched, Active Comparator, New User Design Study
- 3:00PM-4:30PM
-
Abstract Number: 0859
Incidence of Aortic Aneurysm, Dissection, or Rupture Among Patients with Polymyalgia Rheumatica and Giant Cell Arteritis
- 3:00PM-4:30PM
-
Abstract Number: 0860
Integrated Metabolic and Immunologic Analyses Reveal Distinctive Features of Comorbid Cancer in Patients with Autoimmune Diseases
- 3:00PM-4:30PM
-
Abstract Number: 0872
Investigating the Natural Improvement of Rheumatoid Arthritis During Pregnancy
- 3:00PM-4:30PM
-
Abstract Number: 0831
JDM Proteomic Signature at Disease Onset and Progression Highlights Persistent Dysregulation of Cell Death, Redox and Innate Immune Signaling
- 3:00PM-4:30PM
-
Abstract Number: 0853
Lung Ultrasound in Rheumatoid Arthritis and Systemic Sclerosis: Accuracy of B-line and Pleural Assessment
- 3:00PM-4:30PM
-
Abstract Number: 0836
NF-κB Inducing Kinase Is a Therapeutic Target for Autoimmune Diseases by Orchestrating Both B Cell and T Follicular Helper Cell Responses
- 3:00PM-4:30PM
-
Abstract Number: 0833
Novel Loss of Function Variants in the Death Domain of Tumor Necrosis Factor Superfamily Receptor 1A (TNFRSF1A) in Children with Systemic Juvenile Idiopathic Arthritis (sJIA)
- 3:00PM-4:30PM
-
Abstract Number: 0864
Obesity Subtypes and Trajectories of Functional Change After 7-years of Follow-up: The Multicenter Osteoarthritis (MOST) Study
- 3:00PM-4:30PM
-
Abstract Number: 0847
Sex and Race-Specific Distributions in Medial Fixed Joint Space Width in Healthy Knees from Three Longitudinal Cohorts
- 3:00PM-4:30PM
-
Abstract Number: 0832
Spatial Transcriptomic Assessment of Histologically Damaged and Unaffected Glomeruli in Class III Pediatric Lupus Nephritis Reveals Distinct Transcriptional Programs
- 3:00PM-4:30PM
-
Abstract Number: 0861
Stem Cell Function and Capsule Tissue Composition Are Associated with Symptoms, Joint Range of Motion and Radiographic Severity in People with Knee Osteoarthritis
- 3:00PM-4:00PM
-
Abstract Number: PP14
Support Groups and Chronic Illness: Finding Social Support Among Peers
- 3:00PM-4:30PM
-
Abstract Number: 0875
Targeted IL-15 Muteins Provide Selective Expansion of KIR+ CD8 Regulatory T Cells, with the Potential to Ameliorate Disease in Autoimmune Patients with Deficient CD8 Treg Populations
- 3:00PM-4:30PM
-
Abstract Number: 0863
The Development of Future Radiographic Knee Osteoarthritis Can Be Predicted by Peripheral Blood Epigenetic Models
- 3:00PM-4:30PM
-
Abstract Number: 0870
The Impact of Body Mass Index on Cardiovascular Risk in Rheumatoid Arthritis Varies Across Anticitrullinated Protein Antibody Status and Biologic Use
- 3:00PM-4:30PM
-
Abstract Number: 0842
The Incident Risk and Predictors of Systemic Autoimmune Rheumatic Disease (SARD) Development in Persistently Antiphospholipid Antibody Positive Patients Without SARDs: Prospective Results from the APS ACTION Clinical Database and Repository (“Registry”)
- 3:00PM-4:30PM
-
Abstract Number: 0838
The Mechanistic Impact of IgA anti-beta-2 Glycoprotein I on Accelerated Atherosclerosis in Primary APS
- 3:00PM-4:30PM
-
Abstract Number: 0854
The OMERACT GCA Phantom Project: Validation of 3D Printed Ultrasound Training Models for Giant Cell Arteritis
- 3:00PM-4:30PM
-
Abstract Number: 0840
The Platelet Adenosinergic Axis as a Novel Therapeutic Target for Thrombotic APS
- 3:00PM-4:30PM
-
Abstract Number: 0846
Three Novel Metabolomic Signatures of Inflammation for Female Gout Risk: A Prospective Cohort Study over 26 Years
- 3:00PM-4:30PM
-
Abstract Number: 0862
Two-year’s Worsening of Semi-quantitative MRI Features as Surrogate Outcomes for Long-term Incident Radiographic Knee Osteoarthritis After ACL-rupture
- 3:00PM-4:00PM
-
Abstract Number: PP16
Utilization of My Knee Notes for Enhanced Healthcare Management
- 3:00PM-4:30PM
-
Abstract Number: 0845
Weight Loss, Disease Activity, and Patient Reported Outcomes in Patients with Musculoskeletal and Autoimmune Diseases Taking Weight Loss Therapies
- 3:00PM-4:30PM
-
Abstract Number: 0865
Z’s and Knees: Associations of Participant-reported and Objective Sleep Measures with Pain Among US Veterans with Osteoarthritis of the Knee
- 9:00AM-10:30AM
-
Abstract Number: 1646
A Novel E3 Ligase of GILZ: Validation of a Steroid-sparing Therapeutic Target in SLE
- 9:00AM-10:30AM
-
Abstract Number: 1642
A Urinary Biomarker Panel to Predict the Probability of Histologically Active Lupus Nephritis
- 9:00AM-10:30AM
-
Abstract Number: 1645
Antisynthetase Autoantibodies Disrupt the Function of Their Target Aminoacyl-tRNA Synthetases in Muscle Cells
- 9:00AM-10:30AM
-
Abstract Number: 1647
Improved Fertility in Women with Rheumatoid Arthritis and a Wish to Conceive When Treated According to a Treat-to-target Approach Aimed at Remission
- 9:00AM-10:30AM
-
Abstract Number: 1644
RISE Registry Associated with Significant Gains in Quality Measure Performance: An InterruptedTimes Series Analysis Before and After Participation
- 9:00AM-10:30AM
-
Abstract Number: 1643
Single Nuclei Multiome and Spatial Transcriptomic Analysis of Early, Untreated SSc Skin Identifies Signaling Interactions Between Macrophages and Fibroblasts
- 10:30AM-12:30PM
-
Abstract Number: 1574
Therapeutic Strategy in Patients with Mixed Connective Tissue Disease: A Multicenter Retrospective Study in the French MCTD Cohort
- 10:30AM-12:30PM
-
Abstract Number: 1311
“A Fellow-Driven Voluntary Initiative in Musculoskeletal Ultrasound Training: Interest Does Not Equal Attendance”
- 10:30AM-12:30PM
-
Abstract Number: 1622
18F-FDG PET/CT in LVV During Active and Inactive Disease Phases Is Associated with the Metabolic Profile, but Not with Macrophage-related Cytokines: Results of an Integrated Analysis
- 10:30AM-12:30PM
-
Abstract Number: 1113
2nd Analysis of IgG4-Related Disease in a Diverse Long Island Population: Utilizing Serological and Histological Markers for Assessing Treatment Response
- 10:30AM-12:30PM
-
Abstract Number: 1072
A 2-Year Pilot Project to Identify and Address Disparities in Health Literacy in Patients with Rheumatic Diseases Through Distribution of Surveys and Patient Education Materials
- 10:30AM-12:30PM
-
Abstract Number: 0898
A Blood Transcriptome Signature Distinguishes Between Diverse Systemic Autoimmune Diseases and Infection
- 10:30AM-12:30PM
-
Abstract Number: 1306
A Comparative Analysis of ChatGPT-4, Microsoft’s Bing and Google’s Bard at Answering Rheumatology Clinical Questions
- 10:30AM-12:30PM
-
Abstract Number: 0951
A Feedback Loop Involving mtDNA, Platelets and Neutrophil Extracellular Traps Amplifies Inflammation in Systemic Sclerosis
- 10:30AM-12:30PM
-
Abstract Number: 1399
A First-in-Human Clinical Trial Evaluating the Safety and Pharmacokinetics of SOL-116, a Novel Humanized Monoclonal Antibody Targeting Bile Salt-Stimulated Lipase for the Treatment of RA
- 10:30AM-12:30PM
-
Abstract Number: 0939
A Joint-targeting Peptide Enhances the Therapeutic Efficacy of Liposomal Drug Delivery in Experimental Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 1634
A Lexicon of Signs and Symptoms of Giant Cell Arteritis: An International Expert Consensus
- 10:30AM-12:30PM
-
Abstract Number: 0886
A Longitudinal Cohort Study Uncovers Plasma Protein Biomarkers Predating Clinical Onset and Treatment Response of Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 1128
A Meta-Analysis of Statin Efficacy in Controlling Disease Activity in Psoriasis
- 10:30AM-12:30PM
-
Abstract Number: 1291
A Needs Assessment to Inform the Design of a Musculoskeletal Ultrasound Curriculum for Internal Medicine Residents
- 10:30AM-12:30PM
-
Abstract Number: 1385
A Novel Oral 3D-Printed Delayed- and Extended-Release Tofacitinib (T19) for the Treatment of Rheumatoid Arthritis and Related Inflammatory Diseases
- 10:30AM-12:30PM
-
Abstract Number: 0937
A Novel Quantitative Method Reveals Bone-Structural Changes During Course of Inflammatory Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 1236
A Novel Role for Artificial Intelligence in Detecting Distinctive Scleroderma Facial Features
- 10:30AM-12:30PM
-
Abstract Number: 0879
A Novel, Oral, Allosteric Inhibitor of Tyrosine Kinase 2 (TYK2) Demonstrates In Vitro Potency, Selectivity, and In Vivo Efficacy in Mouse Models of Psoriasis
- 10:30AM-12:30PM
-
Abstract Number: 1243
A Patient-Focused Program for Using Steroids Wisely
- 10:30AM-12:30PM
-
Abstract Number: 1121
A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Single and Multiple Ascending Doses of AMG 329, a Monoclonal Antibody, in Conventional and Plasmacytoid Dendritic Cell-Mediated Rheumatic Diseases
- 10:30AM-12:30PM
-
Abstract Number: 1036
A Pilot Trial of Integrating Patient-Reported Outcome Measurement Information System (PROMIS®) into Rheumatology Care
- 10:30AM-12:30PM
-
Abstract Number: 1428
A Post-hoc Analysis of Two Phase 2 Randomized Controlled Trials in Patients with Active Sjogren’s Disease Exploring the Novel Composite Endpoint Sjögren’s Tool for Assessing Response (STAR)
- 10:30AM-12:30PM
-
Abstract Number: 1043
A Prospective Study on Early Diagnosis of Inflammatory Rheumatic Diseases Using an Enhanced Online Questionnaire System (RhePort 1.3)
- 10:30AM-12:30PM
-
Abstract Number: 1295
A Qualitative Survey of Internal Medicine Residents’ Understanding of Appropriate ANA Testing: An 11-Year Update Since the ‘Choosing Wisely’ Campaign
- 10:30AM-12:30PM
-
Abstract Number: 1065
A Quality Improvement Project to Improve Contraception Management in Patients with Systemic Lupus Erythematosus on Teratogenic Medications
- 10:30AM-12:30PM
-
Abstract Number: 1484
A Retrospective Evaluation of Glucagon-like Peptide-1 Receptor Agonists in SLE Patients
- 10:30AM-12:30PM
-
Abstract Number: 1358
A Step Towards Personalised Medicine – Development and Efficacy of Machine Learning Based Smart-Web Application for Prediction of Steroid Induced Hyperglycemia in Patients with Rheumatoid Arthritis and Other Autoimmune Rheumatic Diseases
- 10:30AM-12:30PM
-
Abstract Number: 1041
A Theory of Change for Patient-Initiated Follow-Up Care in Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 1280
Abnormal Cortical Gyrification Patterns in Adolescents with Childhood-onset SLE: Early Associations with Perceived Fatigue
- 10:30AM-12:30PM
-
Abstract Number: 1320
Acceptability and Satisfaction of an Online Resilience-Building Intervention with Peer Health Coaches for Managing Fatigue and Well-Being in Systemic Sclerosis
- 10:30AM-12:30PM
-
Abstract Number: 1031
Access to Advanced Therapies in Axial Spondyloarthritis in Latin America, Data from the PANLAR-ESPALDA Registry
- 10:30AM-12:30PM
-
Abstract Number: 1472
Achievement of Low Disease Activity/Remission in Guselkumab-Treated Patients with Moderately-Highly Active Psoriatic Arthritis Regardless of Baseline Characteristics: Pooled Post-Hoc Analysis of Two Phase 3/Randomized Studies
- 10:30AM-12:30PM
-
Abstract Number: 1640
ACR/EULAR 2022 Classification Criteria Compared to the ACR 1990 Classification Criteria in the ARTESER Registry of Giant Cell Arteritis
- 10:30AM-12:30PM
-
Abstract Number: 0911
Activating B Cells Facilitates the Discovery of Latent Disease-associated Variants
- 10:30AM-12:30PM
-
Abstract Number: 1283
Acute Transverse Myelitis in Pediatric Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 1000
Adalimumab Biosimilar-to-biosimilar Switch in Patients with Inflammatory Rheumatic Diseases – Real-world Evidence from the Nationwide Danish Registry, DANBIO
- 10:30AM-12:30PM
-
Abstract Number: 1402
Addressing Unmet Needs in Cannabis and Hemp by Improving Knowledge and Data Collection
- 10:30AM-12:30PM
-
Abstract Number: 1613
Adherence to Dietary Recommendations and the Risk of Developing Giant Cell Arteritis; A Nested Case-Control Study
- 10:30AM-12:30PM
-
Abstract Number: 1259
Adverse Childhood Experiences Are Associated with Patient-Reported Outcomes in Adolescents and Young Adults with Systemic Lupus
- 10:30AM-12:30PM
-
Abstract Number: 1636
Age-associated B Cells Contribute to Inflammation of Takayasu’s Arteritis in an Antibody-secreting Cell Differentiation Independent Manner
- 10:30AM-12:30PM
-
Abstract Number: 1063
AI –Driven Precision in Rheumatologic Emergencies: Unveiling the Capability of Top Healthcare Chatbots
- 10:30AM-12:30PM
-
Abstract Number: 1420
Alignment Between Rheumatology and Neurology of Nomenclature for Peripheral Nervous System Neuropathies
- 10:30AM-12:30PM
-
Abstract Number: 1214
All-Cause Mortality in Patients with Chronic Musculoskeletal Pain Using Pregabalin or Duloxetine: A Retrospective Cohort Study in US Veterans
- 10:30AM-12:30PM
-
Abstract Number: 1269
Altered Tryptophan Metabolism in Juvenile Dermatomyositis Is Associated with Muscle Damage and Mental Health
- 10:30AM-12:30PM
-
Abstract Number: 0980
Ambient Air Pollution and Initiation of bDMARDs in Newly Diagnosed Rheumatoid Arthritis: A Nested Case-Control Study of NIH All of Us Cohort
- 10:30AM-12:30PM
-
Abstract Number: 0942
An Aged K/BxA Arthritis Mouse Model Develops Features of Interstitial Lung Disease with Pulmonary Fibrosis and Bronchus-Associated T-Cell Aggregates Without a Pulmonary Insult, and Correlates with Worsening Arthritis Scores
- 10:30AM-12:30PM
-
Abstract Number: 1286
An Analysis of Diversity, Equity, and Inclusion Initiatives in US ACGME-accredited Adult Rheumatology Fellowship Programs
- 10:30AM-12:30PM
-
Abstract Number: 1029
An Analysis of Osteoporosis Screening in Males vs. Females Across Lehigh Valley Health Network
- 10:30AM-12:30PM
-
Abstract Number: 1211
An Evaluation of the Efficacy, Pharmacokinetics and Safety, of the Transient Receptor Potential Vanilloid 1 (TRPV1) Agonist RTX-GRT7039 – a Placebo-controlled Study in Patients with Osteoarthritis Knee Pain
- 10:30AM-12:30PM
-
Abstract Number: 1273
An Investigation of Traumatic Events and Mental Health in cSLE
- 10:30AM-12:30PM
-
Abstract Number: 1423
An Observational Analytical Study on HCV Patients with Sicca Manifestations Before and After Direct-Acting Antivirals in Comparison with Sjogren’s Disease; Infection versus Autoimmunity
- 10:30AM-12:30PM
-
Abstract Number: 1348
Analysis of Body Composition in Patients with Moderate-Severe Rheumatoid Arthritis Treated with Anti-TNF Drugs
- 10:30AM-12:30PM
-
Abstract Number: 1621
Analysis of Hospitalizations of Adult Patients with Kawasaki’s Disease: A United States Population Based Study
- 10:30AM-12:30PM
-
Abstract Number: 1018
Analysis of Medication Usage and Monthly Costs in Hospitalized Patients with Rheumatic Diseases: A Retrospective Observational Study
- 10:30AM-12:30PM
-
Abstract Number: 1044
Analysis of Rheumatic Patients’ Self – Reported Symptoms in Free Written Text Using Natural Language Processing
- 10:30AM-12:30PM
-
Abstract Number: 1272
Angiopoietin-2 and Soluble Tumor Necrosis Factor Receptor Type II Are Elevated in Treatment Naïve JDM Plasma and Associate with Increased Muscle Disease Activity and Decreased Nailfold Capillary Density
- 10:30AM-12:30PM
-
Abstract Number: 1548
Anifrolumab in Systemic Lupus Erythematosus. Spanish National Registry in a Real-world Setting
- 10:30AM-12:30PM
-
Abstract Number: 1056
Annual Cost of Biologic Disease-modifying Antirheumatic Drugs for Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 1266
Anti-Mitochondrial Antibodies Associate with Disease Activity and IFNα Expression in Childhood-onset Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 1610
Anti-neutrophil Cytoplasmic Antibodies Associated Interstitial Pneumonia: A New Clinical Entity?
- 10:30AM-12:30PM
-
Abstract Number: 1159
Anti-synthetase Syndrome (ASSD) Related Interstitial Lung Disease (ILD) in Comparison to Non-ASSD Related ILDs: Analysis from the “Classification Criteria for Anti-synthetase Syndrome (CLASS)” Project Database
- 10:30AM-12:30PM
-
Abstract Number: 1575
Anti-U1RNP Antibodies Are Associated with a Distinct Clinical Phenotype and a Worse Survival in Patients with Systemic Sclerosis
- 10:30AM-12:30PM
-
Abstract Number: 0918
Anti-VISTA Antibody Suppresses Neutrophil-mediated Inflammation
- 10:30AM-12:30PM
-
Abstract Number: 1603
Antineutrophil Cytoplasmic Autoantibody Levels in Patients in the Avacopan Phase 3 Trial
- 10:30AM-12:30PM
-
Abstract Number: 0988
Antinuclear Antibody Positivity and Its Diagnostic Implications for Rheumatic Diseases in Dermatology Patients: A Comprehensive Single Center Analysis
- 10:30AM-12:30PM
-
Abstract Number: 1419
Antiphospholipid Antibodies and Hypercoagulable Events in Patients with Sjogren’s Syndrome
- 10:30AM-12:30PM
-
Abstract Number: 1267
Antiphospholipid Antibody-related Clinical Manifestations Presenting During Childhood versus Adulthood: Descriptive Results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (“Registry”)
- 10:30AM-12:30PM
-
Abstract Number: 0915
APOH Locus Associated with Higher Anti-Beta-2-Glycoprotein 1 Antibody Levels Paradoxically Protects Against Venous Thromboembolism
- 10:30AM-12:30PM
-
Abstract Number: 1265
Approach to Janus Kinase Inhibition for Juvenile Dermatomyositis Among Childhood Arthritis and Rheumatology Research Alliance (CARRA) and Paediatric Rheumatology European Society (PReS) Providers
- 10:30AM-12:30PM
-
Abstract Number: 1466
Apremilast Treatment in Early Oligoarticular Psoriatic Arthritis Improves Clinical and Patient-Reported Outcomes for up to 48 Weeks – Data from a Phase 4 Trial
- 10:30AM-12:30PM
-
Abstract Number: 1612
Arterial Involvement Distribution on 18FFDG PET-CT in Giant Cell Arteritis: Variances Based on Clinical Phenotype
- 10:30AM-12:30PM
-
Abstract Number: 1633
Arthritis Activity Significantly Affects Quality of Life in Behcet’s Disease Patients
- 10:30AM-12:30PM
-
Abstract Number: 1304
Assessing Knowledge and Aptitude in Antinuclear Antibody Testing Among Internal Medicine Residents
- 10:30AM-12:30PM
-
Abstract Number: 1263
Assessing Lupus Low Disease Activity State in the Pediatric Rheumatology Clinic: Baseline Data Collection from a Pediatric Lupus Collaborative
- 10:30AM-12:30PM
-
Abstract Number: 1182
Assessing Male Pelvic Floor Contractions Using a Novel External Pressure Device and Ultrasound
- 10:30AM-12:30PM
-
Abstract Number: 1062
Assessing Musculoskeletal Symptom Burden in a Cohort of Patients with Hidradenitis Suppurativa Using the IDEOM MSK-Q
- 10:30AM-12:30PM
-
Abstract Number: 1452
Assessing Responsiveness of Outcome Measures for Children with Axial Juvenile Spondyloarthritis (JSpA)
- 10:30AM-12:30PM
-
Abstract Number: 1513
Assessing Subjective Cognitive Impairment in a Cohort of Canadian Systemic Lupus Erythematosus Patients: Construct Validity of PDQ-20
- 10:30AM-12:30PM
-
Abstract Number: 1334
Assessing the Performance of Validated Frailty Instruments in Veterans with Rheumatoid Arthritis (RA)
- 10:30AM-12:30PM
-
Abstract Number: 1076
Assessing the Reliability of ChatGPT on Recombinant Zoster Vaccination for Patients with Rheumatic and Musculoskeletal Diseases
- 10:30AM-12:30PM
-
Abstract Number: 1301
Assessment and Comparison of Long-term Skill Retention Following a Teledidactic Musculoskeletal Ultrasound Course for Medical Students– the TELMUS Follow-up Study
- 10:30AM-12:30PM
-
Abstract Number: 0976
Assessment of Current Trends in Demographic and Clinical Characteristics of Male Patients with Rheumatoid Arthritis in North India
- 10:30AM-12:30PM
-
Abstract Number: 1297
Assessment of Knowledge of Osteoporosis Among Female Nursing Students and Staff Nurses in an Urban Medical College in India
- 10:30AM-12:30PM
-
Abstract Number: 1028
Assessment of Patient-Reported Outcomes in Juvenile Idiopathic Arthritis by Race, Ethnicity, and Insurance Type in the Pediatric Rheumatology Care and Outcomes Improvement Network Registry
- 10:30AM-12:30PM
-
Abstract Number: 1379
Association Between Body Mass Index and the Persistence of Non-TNF-Targeted Biologics in Patients with Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0994
Association Between Cardiovascular Risk Factors and the Onset of Giant Cell Arteritis: A Systematic Review and Meta-analysis
- 10:30AM-12:30PM
-
Abstract Number: 1219
Association Between Fibromyalgia and Serum Levels of Calcitonin Gene-Related Peptide and Vascular Endothelial Growth Factor: A Meta-Analysis
- 10:30AM-12:30PM
-
Abstract Number: 1353
Association Between Frailty and Incident Cancer in Newly Diagnosed Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 1138
Association Between Long-Term Exposure to Fine Particles and Its Components and the Onset of Systemic Autoimmune Rheumatic Diseases in Quebec
- 10:30AM-12:30PM
-
Abstract Number: 1003
Association Between Metabolic Markers and Knee Osteoarthritis: A Cross-sectional Study Using the Korea National Health and Nutrition Examination Survey 2009 to 2013
- 10:30AM-12:30PM
-
Abstract Number: 0900
Association Between Serum Urate, Gout, and Prostatic Cancer in European Male Populations: A Mendelian Randomization Study
- 10:30AM-12:30PM
-
Abstract Number: 1512
Association Between the Systemic Immune Inflammatory Index (Sll) and All-cause Mortality in Critically Ill Patients with Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 1356
Association Between Vascular Inflammation and Kidney Function in Patients with Rheumatoid Arthritis: Secondary Analysis of TARGET Trial
- 10:30AM-12:30PM
-
Abstract Number: 1429
Association of Bone Erosion and Microarchitecture with Disease Activity and Damage in Sjögren’s Disease
- 10:30AM-12:30PM
-
Abstract Number: 1433
Association of Contextual Factors with Sonographic Inflammatory and Structural Phenotypes in Psoriatic Arthritis Patients
- 10:30AM-12:30PM
-
Abstract Number: 1359
Association of Coronary Artery Calcium Score and Growth Differentiation Factor 15 in Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 1201
Association of COVID-19 Vaccinations with Osteoarthritis Flares: A Case-Crossover Study
- 10:30AM-12:30PM
-
Abstract Number: 1187
Association of Depressive Symptoms and Multiple Joint Osteoarthritis with Pain Outcomes in the WE-CAN Trial
- 10:30AM-12:30PM
-
Abstract Number: 1270
Association of Disease-Modifying Anti-Rheumatic Drug Selection with Hospitalized Infection in Youth with Childhood-Onset Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 1206
Association of Effusion-synovitis on Knee Pain in Early and Later-stage Knee Osteoarthritis
- 10:30AM-12:30PM
-
Abstract Number: 1561
Association of Large Vessel Vasculitis and Development of SSc and SSc-Associated Antibodies: Impact of Pulmonary Arterial Hypertension
- 10:30AM-12:30PM
-
Abstract Number: 1261
Association of Muscle Biopsies and Functional Recovery Trajectories in Children with Juvenile Dermatomyositis
- 10:30AM-12:30PM
-
Abstract Number: 0907
Association of Rare and Common Genetic Variants in MOCOS with Inadequate Response to Allopurinol
- 10:30AM-12:30PM
-
Abstract Number: 1327
Association of Rheumatoid Arthritis and Frailty Status with Mortality in Patients with Renal Cell Carcinoma
- 10:30AM-12:30PM
-
Abstract Number: 1578
Association of Systemic Sclerosis and Other Systemic Autoimmune Disease Diagnosis with Increasing Anti-RNA Polymerase III Antibodies
- 10:30AM-12:30PM
-
Abstract Number: 1478
Associations Between Clinical Characteristics and Screening MRI Findings: Exploratory Analysis of the Ongoing Phase 4, Multicenter, Randomized, Controlled STAR Study of Biologic-Naïve Patients with PsA with MRI-Confirmed Axial Involvement
- 10:30AM-12:30PM
-
Abstract Number: 1006
Associations Between Rheumatic Diseases and Mental Health Disorders
- 10:30AM-12:30PM
-
Abstract Number: 1572
Associations Between the Gut Microbiota, Ultra-Processed Food Intake, and Gastrointestinal Tract Symptoms in Patients with Systemic Sclerosis
- 10:30AM-12:30PM
-
Abstract Number: 0978
Associations of Fire Smoke and Other Pollutants with Incident Rheumatoid Arthritis and Rheumatoid Arthritis-Associated Interstitial Lung Disease
- 10:30AM-12:30PM
-
Abstract Number: 1424
Associations of Human Leukocyte Antigens (HLA) Class II with Interstitial Lung Disease (ILD) in Patients with Systemic Autoimmune Rheumatic Diseases (SARDs). A Prospective Study in Sequential Patients with SARD-ILD
- 10:30AM-12:30PM
-
Abstract Number: 1144
Autoantibody and Radiological Profiles as Prognostic Indicators in Idiopathic Inflammatory Myopathies: Insights into Mortality and Interstitial Lung Disease Development
- 10:30AM-12:30PM
-
Abstract Number: 1562
Autoantibody Associations with Disease Manifestations in Patients with Early Diffuse Cutaneous Systemic Sclerosis: The Prospective Registry of Early Systemic Sclerosis
- 10:30AM-12:30PM
-
Abstract Number: 1057
Barriers and Facilitators of Access to Physical Therapy: A Scoping Review
- 10:30AM-12:30PM
-
Abstract Number: 1475
Baseline Characteristics and Efficacy in Patients with Radiographic AxSpA (r-axSpA) Stratified by CRP Level: An Analysis from the Ixekizumab Phase III Trial
- 10:30AM-12:30PM
-
Abstract Number: 1597
Baseline Glucocorticoid-Related Toxicity in Newly-Diagnosed and Relapsing ANCA-Associated Vasculitis
- 10:30AM-12:30PM
-
Abstract Number: 1554
Belimumab Increases SLE Responder Index-4 Response Rates versus Placebo in Early Active Systemic Lupus Erythematosus: A Large Integrated Analysis of Belimumab Trials
- 10:30AM-12:30PM
-
Abstract Number: 1530
Belimumab-Treated Patients with Systemic Lupus Erythematosus Without Prior Immunosuppressant Use Have More Favorable Clinical Outcomes Than Those with Prior Use of an Immunosuppressant
- 10:30AM-12:30PM
-
Abstract Number: 1074
Bending the Curve on Inbox Bloat: A Patient Portal Project to Mature-the-Message via Nurse Triage to Reduce Provider Inbox Time
- 10:30AM-12:30PM
-
Abstract Number: 1305
Bingo: A Winning Pediatric Rheumatology Teaching Strategy?
- 10:30AM-12:30PM
-
Abstract Number: 1299
Board-Style Rheumatology Teaching for Medicine Residents: Novel Approach to Curriculum Development
- 10:30AM-12:30PM
-
Abstract Number: 0882
Brepocitinib, a Selective TYK2/JAK1 Inhibitor Under Evaluation for the Treatment of Dermatomyositis, Reduces Inflammatory Cytokine Signaling and Interferon-induced Apoptosis in Primary Human Epidermal Keratinocytes
- 10:30AM-12:30PM
-
Abstract Number: 1058
Bridging the Care Gap Between Hospital Discharge and Outpatient Care Transition for Pediatric Rheumatology Patients: An RN-led Quality Improvement Project
- 10:30AM-12:30PM
-
Abstract Number: 1309
Bridging the Gap: Evaluating Ophthalmology Training Amongst Pediatric Rheumatology Fellows
- 10:30AM-12:30PM
-
Abstract Number: 1013
Burden of Emergency Department Visits and Their Outcomes Among Patients with Rheumatoid Arthritis: Insights from the Nationwide Emergency Department Sample (NEDS)
- 10:30AM-12:30PM
-
Abstract Number: 1430
C57BL/6.NOD-Aec1Aec2 Mice Recapitulate Sjögren’s Serology Better Than NOD.B10Sn-H2b Models and JAK Inhibitor Treatment Improves Immunoglobulins and Salivary Gland Inflammation but Not Salivary Flow in Sjögren’s Mice
- 10:30AM-12:30PM
-
Abstract Number: 1310
Cadaver Lab Improves Rheumatology Trainees’ Skills in Identifying Joint Anatomy and Performance of Joint Procedures
- 10:30AM-12:30PM
-
Abstract Number: 1638
Calprotectin, a Mechanistically Informed Biomarker for Clinically Isolated Aortitis
- 10:30AM-12:30PM
-
Abstract Number: 1178
Can Immersive Virtual Reality Improve the Effect of Meditation for People with Fibromyalgia?
- 10:30AM-12:30PM
-
Abstract Number: 1486
Cardiovascular Risk in Systemic Lupus Erythematosus: Carotid Ultrasonography Is Useful for the Re-stratification of Cardiovascular Risk Determined by Score2
- 10:30AM-12:30PM
-
Abstract Number: 1328
Carpal Tunnel Syndrome Is an Early Unrecognized Feature of Rheumatoid Arthritis: A Population-Based Study
- 10:30AM-12:30PM
-
Abstract Number: 1149
Cause-Specific Proportionate Mortality Trends in Idiopathic Inflammatory Myopathies
- 10:30AM-12:30PM
-
Abstract Number: 0949
CCN1 Is a Novel Therapeutic Target for Reducing Structural Damage in Rheumatoid Arthritis: Demonstration from 2 Preclinical Models
- 10:30AM-12:30PM
-
Abstract Number: 1550
CD19 CAR T Cell Therapy Suppresses the Inflammatory Profile of Neutrophils in Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 0966
CDDO-Me Attenuates Pro-fibrotic Activation in Macrophages and Fibroblasts in Systemic Sclerosis
- 10:30AM-12:30PM
-
Abstract Number: 1228
Central Pain Mechanisms and Physical Function in Early Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 1279
Cerebrovascular Accidents in Pediatric and Adult Systemic Lupus Erythematosus: A Comparison of Epidemiology and Outcomes
- 10:30AM-12:30PM
-
Abstract Number: 1097
CERT Score as a Potential Tool to Predict Cardiovascular Risk in Gout and Hyperuricemia
- 10:30AM-12:30PM
-
Abstract Number: 1189
Certain Dosages of Fasinumab Provides Superior Benefits over Placebo in Mitigating Osteoarthritis Symptoms Albeit at Increased Health Detriments: A Systematic Review and Meta-Analysis
- 10:30AM-12:30PM
-
Abstract Number: 1052
Challenges and Opportunities in Post-Pandemic Remote Therapeutic Monitoring for Musculoskeletal Disease
- 10:30AM-12:30PM
-
Abstract Number: 1619
Challenges in Managing Polymyalgia Rheumatica and Giant Cell Arteritis: Steroid Dependence and Preventive Care
- 10:30AM-12:30PM
-
Abstract Number: 1560
Changes of Cerebral Structure and Perfusion Vary in Different Subtypes of Systemic Sclerosis: A Brain Magnetic Resonance Imaging Study
- 10:30AM-12:30PM
-
Abstract Number: 1601
Changing Spectrum of Systemic Therapies for Eosinophilic Granulomatosis with Polyangiitis from 2006-2023
- 10:30AM-12:30PM
-
Abstract Number: 1340
Characteristics and Long-term Outcomes of Patients with Rheumatoid Arthritis and Concurrent Calcium Pyrophosphate Deposition Disease
- 10:30AM-12:30PM
-
Abstract Number: 1546
Characteristics and Treatment Patterns of Patients with Lupus Nephritis: A Retrospective Claims Database Study in the USA
- 10:30AM-12:30PM
-
Abstract Number: 1609
Characteristics of a Cohort of Patients with Interstitial Lung Disease and ANCA Positivity in a University Hospital
- 10:30AM-12:30PM
-
Abstract Number: 1163
Characteristics of Interstitial Lung Disease Progressors in an Antisynthetase Autoantibody-Positive Population
- 10:30AM-12:30PM
-
Abstract Number: 1605
Characteristics of Relapses in Patients with Eosinophilic Granulomatosis with Polyangiitis
- 10:30AM-12:30PM
-
Abstract Number: 1166
Characteristics, Treatments, and Outcomes of Patients with Dermatomyositis from Two Large, Nationwide US Cohorts
- 10:30AM-12:30PM
-
Abstract Number: 1444
Characterization and Comparison of MRI Findings in Axial Spondyloarthritis, Axial Psoriatic and Chronic Non-inflammatory Back Pain
- 10:30AM-12:30PM
-
Abstract Number: 1161
Characterization of the Clinical Presentation of Idiopathic Inflammatory Myopathies According to the Profile of Specific Autoantibodies with Multiple Positivity
- 10:30AM-12:30PM
-
Abstract Number: 1585
Characterization of the Fecal Metabolome in Early Systemic Sclerosis
- 10:30AM-12:30PM
-
Abstract Number: 0962
Characterizing the Contribution of Myeloid Cells to Limited and Diffuse Cutaneous Systemic Sclerosis
- 10:30AM-12:30PM
-
Abstract Number: 1212
Childhood Maltreatment Increases Risk of Chronic Widespread Pain: Counterfactual Analysis of UK Biobank
- 10:30AM-12:30PM
-
Abstract Number: 1092
Chronic Kidney Disease Is Associated with Increased Glucose Uptake-associated Metabolic Activity of Visceral Adipose and Subcutaneous Adipose Tissue in Gout Patients
- 10:30AM-12:30PM
-
Abstract Number: 1040
Clinic Personnel Perceptions Were Favorable for the Implementation of a Patient Decision-Aid for a Diverse Systemic Lupus Erythematosus Population: A Study in 15 U.S. Rheumatology Clinics
- 10:30AM-12:30PM
-
Abstract Number: 0999
Clinical and Biological Features of VEXAS Syndrome in Women: Study of 9 French Cases Compared with 263 Men
- 10:30AM-12:30PM
-
Abstract Number: 1508
Clinical Characteristics and Prognosis of Late-onset Systemic Lupus Erythematosus in 305 Japanese Patients
- 10:30AM-12:30PM
-
Abstract Number: 0908
Clinical Characteristics of Patients with High SLE-specific and High Multitrait Polygenic Risk – an Investigation of SLE Risk Loci
- 10:30AM-12:30PM
-
Abstract Number: 1151
Clinical Characterization and Recurrence Prediction Model for Immune-Mediated Necrotizing Myopathy
- 10:30AM-12:30PM
-
Abstract Number: 1365
Clinical Conditions Associated with Genetic Predisposition to Rheumatoid Arthritis in Real-World Settings
- 10:30AM-12:30PM
-
Abstract Number: 1122
Clinical Realities in Patients with Adult Onset Still’s Disease: Real-World Diagnosis and Management
- 10:30AM-12:30PM
-
Abstract Number: 1488
Clinical Utility and Performance of Anti-C1q Antibodies for Systemic Lupus Erythematosus: Comparative Analysis of Three Different Assays
- 10:30AM-12:30PM
-
Abstract Number: 1145
Clinico-Immunological Profile and Treatment Outcomes of Clinically Significant Diaphragmatic Weakness in Patients with Idiopathic Inflammatory Myopathies: Results from the Largest Single-Center Cohort of 16 Cases
- 10:30AM-12:30PM
-
Abstract Number: 1618
Co-occurrence of Giant Cell Arteritis and Polymyalgia Rheumatica: Insights from a Retrospective Analysis
- 10:30AM-12:30PM
-
Abstract Number: 1506
Cognitive Impairment Prevalence and Most Affected Domains in Patients with SLE by the ACR Comprehensive Neuropsychological Battery
- 10:30AM-12:30PM
-
Abstract Number: 1389
Cohort Study on Drug Survival and Tolerability of Adalimumab Biosimilar Transitioning: Pharmaceutical Properties Do Matter
- 10:30AM-12:30PM
-
Abstract Number: 1408
Color Doppler Ultrasound Is a Reliable Method for Imaging the Lacrimal Glands in Patients with Suspected Sjögren’s Disease
- 10:30AM-12:30PM
-
Abstract Number: 1223
Community Based Study of Prevalence and Social Factors for Chronic Pain and Fibromyalgia in Women from Western India
- 10:30AM-12:30PM
-
Abstract Number: 1566
Comparative Analysis of Clinical Features and Outcomes in Late Onset vs. Early Onset Scleroderma Renal Crisis – A Multicenter Study
- 10:30AM-12:30PM
-
Abstract Number: 1362
Comparative Effectiveness of Upadacitinib versus Other JAK Inhibitors in Patients with Rheumatoid Arthritis in a Global Real-World Setting
- 10:30AM-12:30PM
-
Abstract Number: 1527
Comparative Harms in Patients with Systemic Lupus Erythematosus Treated with Anifrolumab or Belimumab: A Multicenter Cohort Study Using the TriNetX Research Network
- 10:30AM-12:30PM
-
Abstract Number: 1154
Comparative Transcriptome Analysis of Murine Model and Human Samples in Anti-Melanoma Differentiation Associated Gene 5 Antibody-positive Rapidly Progressive Interstitial Lung Disease
- 10:30AM-12:30PM
-
Abstract Number: 1274
Comparing Performance-Based Measures and Self-Reported Questionnaires for Assessment of Executive Function for Youth with Childhood-Onset Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 0991
Comparing the Prevalence of Sarcoidosis in Canadian Rural, Urban, and Farming Populations
- 10:30AM-12:30PM
-
Abstract Number: 1083
Comparison of a Handheld Ultrasound Device with Cart-Based Ultrasound for the Assessment of Gout Lesions in People with Established Gout
- 10:30AM-12:30PM
-
Abstract Number: 1544
Comparison of Efficacy and Safety Between Belimumab and Telitacicept in the Treatment of Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 1462
Comparison of On-Label Treatment Persistence in Real-World Patients with Psoriatic Arthritis Receiving Guselkumab versus Subcutaneous IL-17A Inhibitors
- 10:30AM-12:30PM
-
Abstract Number: 1376
Comparison of the Efficacy of DMARDs in Phase 3 Trials of Different Populations Used in FDA Approvals for Rheumatoid Arthritis Since 2010
- 10:30AM-12:30PM
-
Abstract Number: 1602
Complications in Eosinophilic Granulomatosis with Polyangiitis (EGPA) Patients: A Nationwide Analysis
- 10:30AM-12:30PM
-
Abstract Number: 1139
Comprehensive Single-cell Profiling of Diverse Circulating Immune Cells in Idiopathic Inflammatory Myopathies Identifies a Novel Pathogenic Subset of Monocytes
- 10:30AM-12:30PM
-
Abstract Number: 1431
Computational Systems Biology Approach to Unveil Molecular Interactions in Sjogren’s Disease Pathogenesis
- 10:30AM-12:30PM
-
Abstract Number: 1170
Computer Aided Lung Informatics, HRCT and PFT in Patients with Interstitial Lung Disease in Idiopathic Inflammatory Myopathies
- 10:30AM-12:30PM
-
Abstract Number: 1167
Construction of a Refractory Myositis Predictive Index (ReMPI) in a Cohort of Patients with Idiopathic Inflammatory Myopathies
- 10:30AM-12:30PM
-
Abstract Number: 1521
Contemporary Lupus Nephritis Treatment and Outcomes Among Patients with Systemic Lupus Erythematosus in the United States
- 10:30AM-12:30PM
-
Abstract Number: 1100
Coronary Dual-Energy Computed Tomography for the Detection of Monosodium Urate Crystal Deposition in the Arteries of Individuals with and Without Gout (CORODECT): A Multi-Center Prospective Imaging Study
- 10:30AM-12:30PM
-
Abstract Number: 0987
Correlates of Depression in Individuals with Chronic Fatigue Syndrome
- 10:30AM-12:30PM
-
Abstract Number: 1244
Creation of a New Patient-reported Outcome for a Combined Response Index for Limited Cutaneous SSc Using the FDA Guidance on Patient Reported Outcome Measures: The CRISTAL PRO
- 10:30AM-12:30PM
-
Abstract Number: 1314
Creation of an Online, Self-Assessment Tool for “Clinical Competencies in Telerheumatology”
- 10:30AM-12:30PM
-
Abstract Number: 1190
Cross-sectional Associations Among Sonographic and Radiographic Features and Symptoms Scores in a Population-Based Cohort
- 10:30AM-12:30PM
-
Abstract Number: 1251
Current Disease Management and Treatment Satisfaction in Axial Spondyloarthritis (axSpA) in Europe: Patient and Rheumatologist Perspectives
- 10:30AM-12:30PM
-
Abstract Number: 1388
CXC Chemokine Ligand 13 and Rheumatoid Factor as Pharmacodynamic Biomarkers for Abatacept Treatment in Patients with Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0881
Cytokine Profile of Newly Diagnosed Patients with Isolated Polymyalgia Rheumatica
- 10:30AM-12:30PM
-
Abstract Number: 0943
Cytosporone B, a Selective Agonist of Nr4a1, Inhibits Th17 Differentiation and Alleviates Experimental Arthritis in SKG Mice
- 10:30AM-12:30PM
-
Abstract Number: 1073
Dashboard Utilization and Order Menu Revision Improve HLA-B*5801 Testing Prior to Allopurinol Initiation in High-Risk Patients in a Veteran-based Primary Care Setting
- 10:30AM-12:30PM
-
Abstract Number: 0941
DC-9476, a Novel Selective BRD4(BD2) Inhibitor, Improves Arthritis Scores in Preclinical Models of Rheumatoid Arthritis by Regulating Key Inflammatory Pathways
- 10:30AM-12:30PM
-
Abstract Number: 1333
Deciphering Variation in Real-World Early RA Outcomes: A Longitudinal Analysis of the Canadian Early Arthritis Cohort (CATCH) Study
- 10:30AM-12:30PM
-
Abstract Number: 1570
Deconvolution of the Lipidomic Signature of Very Early Diagnosis of Systemic Sclerosis (VEDOSS) and Established Disease: Lipid Biomarker Features That Predict Disease Progression in Skin and Lung
- 10:30AM-12:30PM
-
Abstract Number: 0921
Deep Immunologic Profiling of Trisomy 8-associated Autoinflammatory Disease (TRIAD)
- 10:30AM-12:30PM
-
Abstract Number: 1141
Defining a Novel Type of Myositis: Immune Mediated Megaconial Myopathy (IMMM)
- 10:30AM-12:30PM
-
Abstract Number: 0904
Defining the Function of Disease Variants with CRISPR Editing and Multimodal Single Cell Sequencing
- 10:30AM-12:30PM
-
Abstract Number: 1606
Demographic and Treatment Patterns in Patients with Eosinophilic Granulomatosis with Polyangiitis: A Retrospective Cohort Analysis of US Claims and Clinical Data
- 10:30AM-12:30PM
-
Abstract Number: 1007
Demographic, Social, and Disease Factors Associated with Interstitial Lung Disease and Disease-Related Death in Dermatomyositis
- 10:30AM-12:30PM
-
Abstract Number: 1002
Depression Screening in Patients with Rheumatologic Diseases in a Large Tertiary Care Center
- 10:30AM-12:30PM
-
Abstract Number: 0970
Deubiquitylase (DUB) BRCC36 Isopeptidase Complex (BRISC) Inhibitors Prevent IFNAR1 Deubiquitination to Restore Natural Type I IFN Response in Autoimmunity
- 10:30AM-12:30PM
-
Abstract Number: 1135
Deucravacitinib in Plaque Psoriasis: 4-Year Efficacy Results by Prior Biologic Treatment in the Phase 3 POETYK PSO-1, PSO-2, and Long-Term ExtensionTrials
- 10:30AM-12:30PM
-
Abstract Number: 1137
Deucravacitinib, an Oral,Selective,Allosteric Tyrosine Kinase 2 Inhibitor, in Patients WithModerate to Severe Scalp Psoriasis: Efficacy and Safety Results of a Phase 3b/4, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial (PSORIATYK SCALP)
- 10:30AM-12:30PM
-
Abstract Number: 1406
Development and Functional Characterization of Salivary Gland Organoids to Investigate Sjögren’s Disease
- 10:30AM-12:30PM
-
Abstract Number: 1255
Development and Validation of a Brief Measure of Uncertainty Among Patients with Vasculitis and Other Rheumatic Diseases
- 10:30AM-12:30PM
-
Abstract Number: 1066
Development of a Pharmacy-Led Intervention to Improve Osteoporosis Screening in VA Community-Based Outpatient Clinics
- 10:30AM-12:30PM
-
Abstract Number: 1179
Development of an Optimal Physiotherapy Intervention to Reduce Stiffness Following Knee Joint Replacement
- 10:30AM-12:30PM
-
Abstract Number: 1351
Development of Noninvasive Assessment Technology for Rheumatoid Arthritis Based on Contact Property Measurements
- 10:30AM-12:30PM
-
Abstract Number: 1287
Development of the Academy for Workforce Advancement to Enrich Rheumatology Diversity
- 10:30AM-12:30PM
-
Abstract Number: 1403
Development, Validation and Clinical Use of Health-Related Behaviour Health Fitness Questionnaire (HR-BHF) in Indian (Asian) Subjects Attending a Community Rheumatology Center
- 10:30AM-12:30PM
-
Abstract Number: 1517
Diagnostic Performance of Anti-dsDNA Antibodies in Pleural, Ascitic and Pericardial Fluid for Lupus Serositis: Experience of a Tertiary Center in Mexico
- 10:30AM-12:30PM
-
Abstract Number: 1516
Diagnostic Performance of Anti-ribosomal P Antibodies in Cerebrospinal Fluid of Neuropsychiatric Systemic Lupus Erythematosus with Diffuse Central Nervous System Manifestations. Experience in a Tertiary Center in Mexico
- 10:30AM-12:30PM
-
Abstract Number: 1432
Diagnostic Performance of Mayor Salivary Gland Ultrasound for Diagnosis of Sjögren’s Syndrome in Routine Clinical Practice
- 10:30AM-12:30PM
-
Abstract Number: 1199
Diclofenac Sodium 1% Gel Improves Physical Function in the Performance of Important Activities of Daily Living in Patients with Hand or Knee Osteoarthritis
- 10:30AM-12:30PM
-
Abstract Number: 1459
Dietary Modification and Intermittent Fasting Are Common in Patients with Axial Spondylarthritis and May Lead to Reduced Inflammatory Activity
- 10:30AM-12:30PM
-
Abstract Number: 1109
Differences Between Correlation and Causal Inference in Detecting Predictors of Undefined Crystal Arthropathy in Women
- 10:30AM-12:30PM
-
Abstract Number: 1171
Differences in Microbiome Profiles Based on Pain Severity and Inflammatory Biomarkers in Acute Low Back Pain
- 10:30AM-12:30PM
-
Abstract Number: 1421
Differential Impact of B-cell Targeted Monotherapy and Combination Regimen on the Peripheral Blood Transcriptome of Adults with Active Sjögren Disease
- 10:30AM-12:30PM
-
Abstract Number: 1398
Difficult to Treat Rheumatoid Arthritis Incidence and Risk Factors in the Early Arthritis UCLouvain Brussels Cohort
- 10:30AM-12:30PM
-
Abstract Number: 1191
Discordant Associations Among Chronological and Biological Age with Multi-joint Osteoarthritis and Symptom Burden: The Johnston County Health Study
- 10:30AM-12:30PM
-
Abstract Number: 1537
Discovery of VENT-03: A Novel Clinical cGAS Inhibitor for the Treatment of SLE and Other Autoimmune Diseases
- 10:30AM-12:30PM
-
Abstract Number: 1630
Disease Manifestations, Diagnostic Findings, and Mortality of 120 Consecutive Patients Suspected of Giant Cell Arteritis – Results from a Hospital GCA Fast-Track Clinic
- 10:30AM-12:30PM
-
Abstract Number: 1400
Disease Modifying Anti-rheumatic Drug Use and Association with Survival in Patients with Rheumatoid Arthritis and Newly Diagnosed Lung Cancer
- 10:30AM-12:30PM
-
Abstract Number: 1142
Disease Trajectory in anti-MDA5 Dermatomyositis Patients Presented with Different Stage of Interstitial Lung Disease
- 10:30AM-12:30PM
-
Abstract Number: 1384
Disease-modifying Antirheumatic Drugs and Risk of Incident Interstitial Lung Disease Among Patients with Rheumatoid Arthritis: A Systematic Review and Meta-analysis
- 10:30AM-12:30PM
-
Abstract Number: 1181
Disparities in Rehabilitation Outcomes After Knee Arthroplasty
- 10:30AM-12:30PM
-
Abstract Number: 1012
Disparities in Time to Diagnosis for Radiographic Axial Spondyloarthritis
- 10:30AM-12:30PM
-
Abstract Number: 0903
Distinct Impacts of Mosaic Loss of Chromosome Y and Genetic Risk on the Age of Onset in Patients with Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 1099
Distinct Metabolomic Signatures of Insulinemia and Incident Gout Risk: A Prospective Cohort Study Among Women
- 10:30AM-12:30PM
-
Abstract Number: 1568
Distribution of Proteinuria in Scleroderma Renal Crisis: A Multi-Center Study
- 10:30AM-12:30PM
-
Abstract Number: 1030
Diversity in Axial Spondyloarthritis Drug Trials: Examining Enrollment by Sex, Race, Ethnicity and Geographic Region
- 10:30AM-12:30PM
-
Abstract Number: 1371
DMARD Utilization Pattern in Older Adults with Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 1368
Do CsDMARDs Still Play a Significant Role in Managing Rheumatoid Arthritis in the Current Biologic/JAKI Era? A Prospective Observational Study to Estimate the Extent of Response to Conventional Synthetic DMARDs in RA– Experience from a Tertiary Care Center in South India
- 10:30AM-12:30PM
-
Abstract Number: 1331
Does Refractory Rheumatoid Arthritis Status Matter in Modeling Patient Global Assessment Trajectories over 20 Years in a Large US Registry?
- 10:30AM-12:30PM
-
Abstract Number: 1591
Domains and Outcome Measures for the Assessment of Digital Vasculopathy and Raynaud Phenomenon in Juvenile Systemic Sclerosis: A Systematic Review
- 10:30AM-12:30PM
-
Abstract Number: 0972
Downregulated Fli1 in Scleroderma Myeloid Cells Contributes to Cardiac Fibrosis via a Galectin-3/mTOR Dependent Pathway
- 10:30AM-12:30PM
-
Abstract Number: 1323
Drug Abuse Screening in Patients Who Fulfill the 2016 Fibromyalgia Criteria
- 10:30AM-12:30PM
-
Abstract Number: 1316
Dual Therapy with a JAKi and bDMARD in Patients with Standard Treatment Resistant Rheumatic Disease: A Case Series
- 10:30AM-12:30PM
-
Abstract Number: 0897
Dynamic eQTLs from Activated Human B Cells Suggest Cell-state Dependent Effects for GWAS Risk Variants in BLK
- 10:30AM-12:30PM
-
Abstract Number: 1496
Dysregulated Serum Cytokines in Association with Clinical Manifestations in Patients with Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 1165
Dysregulation of Peripheral Blood B-cells Is Associated with Myocarditis in Patients with Idiopathic Inflammatory Myopathies
- 10:30AM-12:30PM
-
Abstract Number: 1346
Early Diagnosis of Rheumatoid Arthritis: Role of Joint Ultrasound Assessment
- 10:30AM-12:30PM
-
Abstract Number: 1079
Early Recognition of Myositis: Time Correlation Between Transaminases and Inflammatory Myopathy in a Community-Based Rheumatology Practice
- 10:30AM-12:30PM
-
Abstract Number: 1573
Early Scleroderma with Non-Raynaud’s Symptoms Prior to Raynaud’s Onset Is Associated with Rapid Progression to Diffuse Skin Disease and Joint Contractures
- 10:30AM-12:30PM
-
Abstract Number: 1525
Early versus Late Lupus Nephritis: A Meta-analysis of Observational Studies
- 10:30AM-12:30PM
-
Abstract Number: 1293
Educational Quality Improvement (QI) Project to Improve Inpatient Purine Restricted Diet Order Placement for Patients Admitted with Gout Flares
- 10:30AM-12:30PM
-
Abstract Number: 1541
Effect of Rituximab on Long-term Damage Acquisition in Patients with Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 1539
Effectiveness & Safety of Early versus Late Use of Rituximab in Extra-renal Lupus: Real World Experience from a Tertiary Care Centre
- 10:30AM-12:30PM
-
Abstract Number: 1479
Effectiveness of B/tsDMARDs Including Ixekizumab Per Line of Therapy and Concomitant CsDMARDs in Psoriatic Arthritis: Real-World Data from a Prospective Observational Study
- 10:30AM-12:30PM
-
Abstract Number: 1296
Effectiveness of Inflammatory Arthritides Educational Modules and Potential for Improved Referral Times
- 10:30AM-12:30PM
-
Abstract Number: 1395
Effects of Butyrate Supplementation in Modulation of Gut Microbiome and Its Metabolites in New Onset Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 1174
Effects of Electroacupuncture on Pain and Joint Deformity in Rat Models of Knee Osteoarthritis: A Study on the Differences in Acupoints Used
- 10:30AM-12:30PM
-
Abstract Number: 1375
Effects of Training with Blood Flow Restriction on Muscle Strength in Women with Rheumatoid Arthritis: A Randomized Clinical Trial
- 10:30AM-12:30PM
-
Abstract Number: 1556
Efficacy and Safety of Anifrolumab Across Organ Domains of Systemic Lupus Erythematosus. A Systematic Review and Meta-Analysis
- 10:30AM-12:30PM
-
Abstract Number: 1136
Efficacy And Safety of Guselkumab Therapy in Patients With Moderately to Severely Active Crohn’s Disease: Results of the Galaxi 2 & 3 Phase 3 Studies
- 10:30AM-12:30PM
-
Abstract Number: 1453
Efficacy and Safety of the Recombinant Anti-human IL-17A/F Humanized Monoclonal Antibody Injection (XKH004) in Patients with Active Ankylosing Spondylitis: Findings from a 24-Week, Phase 2 Multicenter, Randomized, Placebo-Controlled Study
- 10:30AM-12:30PM
-
Abstract Number: 1542
Efficacy and Safety Results from a Phase 2 Trial of Daxdilimab in Patients with Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 1468
Efficacy of bDMARDs in Early versus Established Disease in Axial Spondyloarthritis: A Meta-Analysis of Randomized Trials
- 10:30AM-12:30PM
-
Abstract Number: 1551
Efficacy of Belimumab on Different Phenotypes of Joint and Skin Manifestations of Systemic Lupus Erythematosus: Preliminary Data from a Multicenter, Nationwide, Cohort of Patients: The BElimumab in Real Life Setting Study-New Joint and Skin (BeRLISS-NeJS)
- 10:30AM-12:30PM
-
Abstract Number: 1596
Efficacy of Eosinophil-Targeting Therapies According to Disease Severity in Patients with Eosinophilic Granulomatosis with Polyangiitis
- 10:30AM-12:30PM
-
Abstract Number: 1474
Efficacy of Guselkumab in Bionaive Psoriatic Arthritis Patients with Severe Disease Activity: Post-hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study
- 10:30AM-12:30PM
-
Abstract Number: 1221
Efficacy of Immersive Virtual Reality-based Biofeedback on Chronic Pain and Daily Life Impact in Fibromyalgia: A Pilot Randomized Controlled Trial
- 10:30AM-12:30PM
-
Abstract Number: 1593
Efficacy of Increasing the Dose of Mepolizumab in Eosinophilic Granulomatosis with Polyangiitis
- 10:30AM-12:30PM
-
Abstract Number: 1169
Efficacy of Intravenous Immunoglobulin (Octagam 10%) on Pulmonary Manifestations in Patients with Dermatomyositis: Results from the ProDERM Study
- 10:30AM-12:30PM
-
Abstract Number: 1584
Efficacy of Tofacitinib in the Treatment of Early Diffuse Cutaneous Systemic Sclerosis: A Clinical Study in Bangladesh
- 10:30AM-12:30PM
-
Abstract Number: 1080
Electronic Consults to Rheumatology: A One-Year Analysis of Referral Outcomes and Trends in Access
- 10:30AM-12:30PM
-
Abstract Number: 1577
Elevated Neutrophil Extracellular Traps in Systemic Sclerosis-associated Vasculopathy and Suppression by a Synthetic Prostacyclin Analog
- 10:30AM-12:30PM
-
Abstract Number: 1381
Elimination of CD45RChigh T and B Cells by anti-CD45RC mAb Lead to Efficient Control of Experimental Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 1034
Elucidating the Program Theory of a Successful Interdisciplinary Team-Based Model of Rheumatology Care: An Exploratory Case Study
- 10:30AM-12:30PM
-
Abstract Number: 1089
Endothelial Activation in Gout
- 10:30AM-12:30PM
-
Abstract Number: 0964
Engaging the PD-1 Pathway Attenuates Inflammation Associated Fibrosis in Systemic Sclerosis Fibroblasts and a Preclinical Mouse Model
- 10:30AM-12:30PM
-
Abstract Number: 1143
Epidemiology and Spectrum of Idiopathic Inflammatory Myopathies in Individuals of Sub-Saharan Ancestry: Data from the Tertiary Care Center of the Caribbean Island of Martinique
- 10:30AM-12:30PM
-
Abstract Number: 0953
Establishment of Systemic Sclerosis Associated Pulmonary Arterial Hypertension Specific Endothelial Cells Through iPSCs and Their Functional and Molecular Analyses
- 10:30AM-12:30PM
-
Abstract Number: 1557
Estimation of Cardiovascular Risk in Patients with Systemic Sclerosis – Accuracy of Tools Based on SCORE and Its Modifications Compared to Ultrasound Examination of Subclinical Atherosclerosis
- 10:30AM-12:30PM
-
Abstract Number: 1070
Evaluating & Improving Adherence to Pulmonary Hypertension Screening in Systemic Sclerosis Patients
- 10:30AM-12:30PM
-
Abstract Number: 1449
Evaluating Spine Structural Damage on a Single CT in Patients with Ankylosing Spondylitis, and According to the Presence of Skin Psoriasis
- 10:30AM-12:30PM
-
Abstract Number: 1162
Evaluating the Efficacy of Rituximab in the Treatment of Refractory Adult Idiopathic Inflammatory Myositis Using Total Improvement Score: Data from a Real-World Multi-Centre Registry in the United Kingdom
- 10:30AM-12:30PM
-
Abstract Number: 1147
Evaluation of Adverse Pregnancy Outcomes in Patients with Inflammatory Myopathies and Ro Positivity
- 10:30AM-12:30PM
-
Abstract Number: 1027
Evaluation of Health Disparities in Outcomes of Patients with Juvenile Idiopathic Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 1081
Evaluation of Methods for Ascertainment and Categorization of Race and Ethnicity for Clinical Research: An Umbrella Review
- 10:30AM-12:30PM
-
Abstract Number: 1422
Evaluation of Salivary Gland Focus Score in Sjogren’s Disease Using Deep Learning: A Step Towards Tissue Biomarker Discovery
- 10:30AM-12:30PM
-
Abstract Number: 1377
Evaluation of the Survival and Safety of Biologic and Targeted Synthetic DMARD in Patients with Difficult-to-Treat RA Using Real-World Data from a Nationwide Registry of Rheumatic Diseases
- 10:30AM-12:30PM
-
Abstract Number: 1341
Evaluation of Width Range Index (WRI) and Neutrophil-to-Lymphocyte Ratio (NLR) in Assessing Disease Activity in Patients with Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 1414
Evidence-Based Guidelines for Sjögren’s Disease Peripheral Nervous System Manifestations
- 10:30AM-12:30PM
-
Abstract Number: 1290
Examining the Quality of Surveys Used in Rheumatology Health Professions Education Research
- 10:30AM-12:30PM
-
Abstract Number: 1176
Exploration of Heterogeneity of Treatment Effects Across Exercise-Based Interventions for Knee Osteoarthritis
- 10:30AM-12:30PM
-
Abstract Number: 1231
Exploring Long-term Complications of Lyme Disease – Insights from a Retrospective Cohort Study
- 10:30AM-12:30PM
-
Abstract Number: 1096
Exploring Multi Factorial Model for the Prediction of Gout in Patients with Hyperuricemia
- 10:30AM-12:30PM
-
Abstract Number: 1579
Exploring the Cardiovascular Complications of Pulmonary Arterial Hypertension in Individuals with Systemic Sclerosis
- 10:30AM-12:30PM
-
Abstract Number: 1374
Exploring Two Decades of Therapeutic Challenges: A Monocentric Experience in Rheumatoid Arthritis Patients Battling Cancer
- 10:30AM-12:30PM
-
Abstract Number: 1023
Factors Associated with Delays in Dispensation and Insurance Denials of Janus Kinase Inhibitors
- 10:30AM-12:30PM
-
Abstract Number: 1106
Factors Associated with Relapse in Giant Cell Arteritis Treated with Tocilizumab. Multicenter Open-label Study of 407 Patients
- 10:30AM-12:30PM
-
Abstract Number: 1441
Factors Associated with the Evolution of Degenerative Spinal Lesions in Axial Spondyloarthritis: 10-Year Follow-up of the DESIR Cohort
- 10:30AM-12:30PM
-
Abstract Number: 1225
Fibromyalgia as a Potential Initial Presentation for Autoimmune Conditions
- 10:30AM-12:30PM
-
Abstract Number: 1220
Fibromyalgia’s Under-Representation in Rheumatology Literature: A Ten-Year Analysis of Disease-Specific Article Distribution
- 10:30AM-12:30PM
-
Abstract Number: 1332
Financial Distress and Its Determinants in Adults with Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 1134
First-in-Human Evaluation of the Safety, Tolerability and Pharmacokinetics of the T Cell Receptor Signal Modulator AX-158
- 10:30AM-12:30PM
-
Abstract Number: 1344
Forced Vital Capacity Trajectories and Risk of Lung Transplant and ILD-Related Mortality Among Patients with Rheumatoid Arthritis-Associated Interstitial Lung Disease
- 10:30AM-12:30PM
-
Abstract Number: 1229
Frequency of Fibromyalgia Using Validated Measures in a Sample of Patients with Psoriatic Arthritis and Impact on Disease: A Cross-Sectional Multinational Study
- 10:30AM-12:30PM
-
Abstract Number: 1315
From Presentation to Publication: Tracking the Publication Rate of Abstracts Presented at American College of Rheumatology Convergence Conference in the Years 2015 and 2018
- 10:30AM-12:30PM
-
Abstract Number: 1337
Gender and Ethnic Differences (or Lack Thereof) in Perceived Disease Burden in RA
- 10:30AM-12:30PM
-
Abstract Number: 1498
Gender Disparities in Clinical Manifestations and Outcomes of Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis
- 10:30AM-12:30PM
-
Abstract Number: 1025
Gender Disparities in Disease Impact and Treatment Access for Spondyloarthropathies in Latin America: Insights from a Web Survey
- 10:30AM-12:30PM
-
Abstract Number: 0922
Generation and Pathophysiological Analysis of M694I Variant Knock-in Mice of Human MEFV Gene: Insights from Single-Cell RNA Sequencing
- 10:30AM-12:30PM
-
Abstract Number: 0884
Genetic Architecture Divergence in Sjögren’s Disease Subphenotypes and Populations: Genome-wide Association Study of Ro/SSA+ and Ro/SSA- Cases in European Populations
- 10:30AM-12:30PM
-
Abstract Number: 1485
Genetic Contributions to Systemic Lupus Erythematosus: Concordance Rates in California Twins
- 10:30AM-12:30PM
-
Abstract Number: 0888
Genetically Determined Peptidylglycine Alpha-amidating Monooxygenase (PAM) Mediated Amidation Regulates Tissue Damage by Rheumatoid Arthritis Synovial Fibroblasts
- 10:30AM-12:30PM
-
Abstract Number: 1355
Genetically-determined Variation in C-reactive Protein Impacts Disease Activity Assessment in Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0997
Geographic and Lifestyle Exposures in Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 1637
Giant Cell Arteritis-Polymyalgia Rheumatica Spectrum Disease: Relation with Neoplasms and Role as a Paraneoplastic Syndrome
- 10:30AM-12:30PM
-
Abstract Number: 1599
Glucocorticoids versus Glucocorticoids Plus Cyclophosphamide in Eosinophilic Granulomatosis with Polyangiitis with Poor-Prognosis Factors: A Target Trial Emulation Study
- 10:30AM-12:30PM
-
Abstract Number: 1600
Glucocorticoids versus Glucocorticoids Plus Cyclophosphamide in Eosinophilic Granulomatosis with Polyangiitis Without Poor-Prognosis Factors: A Target Trial Emulation Study
- 10:30AM-12:30PM
-
Abstract Number: 1289
Gout Education for Primary Care Providers: A Scoping Review
- 10:30AM-12:30PM
-
Abstract Number: 0938
Group 2 Innate Lymphoid Cells Promote T Cell Activation and Development of Autoimmune Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 1571
Growth Differentiation Factor 15 Is a Serum Biomarker and Pathogenic Factor of Progressive Fibrosis in Systemic Sclerosis
- 10:30AM-12:30PM
-
Abstract Number: 1132
Guselkumab and Golimumab Combination Induction Therapy in Ulcerative Colitis Results in Early Local Tissue Healing That Is Sustained Through Guselkumab Maintenance Therapy
- 10:30AM-12:30PM
-
Abstract Number: 1464
Guselkumab and IL-17 Inhibitors Show Comparable Treatment Persistence and Effectiveness in Psoriatic Arthritis: 6-month Interim Results of the PsABIOnd Observational Cohort Study
- 10:30AM-12:30PM
-
Abstract Number: 1202
Harnessing MicroRNA and Machine/Deep Learning for Early Prediction of Knee Osteoarthritis Structural Progression
- 10:30AM-12:30PM
-
Abstract Number: 1338
Health Care Utilization and Cost of Herpes Zoster Infection in Patients with Rheumatoid Arthritis, a Retrospective Cohort Study
- 10:30AM-12:30PM
-
Abstract Number: 1020
Health Inequalities Exist Between the United States and Europe for Patients with Axial Spondyloarthritis
- 10:30AM-12:30PM
-
Abstract Number: 1051
Healthcare Costs and Resource Utilization Associated with Long-term Medium-to-high Dose Oral Corticosteroid Use in Patients with Dermatomyositis or Polymyositis
- 10:30AM-12:30PM
-
Abstract Number: 1026
Healthcare Utilization and Childhood Opportunity Index in Patients with Juvenile Idiopathic Arthritis and Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 1343
Heightened Gout Risk in Patients with Rheumatoid Arthritis: A National Cohort Study
- 10:30AM-12:30PM
-
Abstract Number: 1090
Hepatic Fibrosis Before and During Intensive Urate-lowering with Pegloticase in the Presence and Absence of Methotrexate Co-therapy
- 10:30AM-12:30PM
-
Abstract Number: 1213
High Prevalence of and Medication Use in Musculoskeletal and Chronic Multisite Pain in Community-Dwelling Older Adults: The Framingham Heart Study
- 10:30AM-12:30PM
-
Abstract Number: 1188
High Risk of Stroke in Men with Joint Prosthesis Due to Osteoarthritis: The Prospective STRAMBO Study
- 10:30AM-12:30PM
-
Abstract Number: 0905
High-Throughput Proteomic Profiling of Sera as a Non-Invasive Method for Identifying Lupus Nephritis Subtypes
- 10:30AM-12:30PM
-
Abstract Number: 1256
Higher Disease Activity in Pediatric Systemic Lupus Erythematosus Is Associated with a Greater Desire for Social Health Education: An Unmet Need in Pediatric Rheumatology
- 10:30AM-12:30PM
-
Abstract Number: 1493
How Do Lupus Nephritis Patients Who Achieve Renal Remission Fare? A 3-year Comparison in Terms of GFR Decline
- 10:30AM-12:30PM
-
Abstract Number: 0894
HOXD13 Regulation of Primary Cilia in Rheumatoid Arthritis Synovial Fibroblasts: Implications for Joint-Specific Pathogenesis
- 10:30AM-12:30PM
-
Abstract Number: 1547
Hydroxychloroquine and Prednisone Use by Individuals Diagnosed with Systemic Lupus Erythematosus in the TriNetX Research Database
- 10:30AM-12:30PM
-
Abstract Number: 0896
Identification of Immune Pathways Regulated by a Non-Coding Variant at DNASE1L3/PXK/PDHB
- 10:30AM-12:30PM
-
Abstract Number: 0887
Identification of Rare Variants in Lupus-causing Genes in a Mixed Paediatric and Adult Connective Tissue Disease Cohort
- 10:30AM-12:30PM
-
Abstract Number: 1042
Identifying Patient Priorities for Patient-Reported Outcome Measures in Rheumatoid Arthritis: A Modified Delphi Consensus Study
- 10:30AM-12:30PM
-
Abstract Number: 0909
Identifying Predictive Serum Soluble Mediators Signatures Specific to ANA+ at Risk of SLE Individuals with Next Generation Proteomics
- 10:30AM-12:30PM
-
Abstract Number: 1008
Immune Responses to Infection and Autoimmune Diseases in the UK Biobank
- 10:30AM-12:30PM
-
Abstract Number: 0950
Immunization of Arthritis Prone Mice with Malondialdehyde-Acetaldehyde (MAA) Modified Vimentin Induces Fibrotic Lung Changes
- 10:30AM-12:30PM
-
Abstract Number: 0923
Immunization of Arthritis Prone Mice with Malondialdehyde-Acetaldehyde Modified Vimentin Induces Post-Translational Protein Modifications and Extracellular Matrix Deposition in Heart Tissues
- 10:30AM-12:30PM
-
Abstract Number: 1204
Immunobased Profiling of Knee Osteoarthritis Patients to Predict Response to Regenerative Treatment with Autologous Blood-derivative Platelet-Rich Plasma Injection
- 10:30AM-12:30PM
-
Abstract Number: 1009
Immunogenicity of the Recombinant Zoster Vaccine in People with Rheumatoid Arthritis Using Abatacept
- 10:30AM-12:30PM
-
Abstract Number: 1514
Immunosenescent and Exhausted T Cells in Patients with Systemic Lupus Erythematosus and Cognitive Impairment
- 10:30AM-12:30PM
-
Abstract Number: 1038
IMPACT (Impact of eMbedded Pharmacists in an Academic Center sTudy)
- 10:30AM-12:30PM
-
Abstract Number: 1035
Impact in Clinical Practice of the European Medicines Agency Health Alert About the Restriction of the Use of JAK Inhibitors
- 10:30AM-12:30PM
-
Abstract Number: 1032
Impact of a Coordinated Care Model for Addressing Rheumatoid Arthritis and Associated Comorbidities
- 10:30AM-12:30PM
-
Abstract Number: 1510
Impact of Active Lupus Nephritis on the Quality of Life of Patients from a Latin American Lupus Cohort
- 10:30AM-12:30PM
-
Abstract Number: 1146
Impact of COVID-19 on Myositis Testing Trends
- 10:30AM-12:30PM
-
Abstract Number: 1437
Impact of Early Diagnosis in Patients with Axial Spondyloarthritis on Arterial Stiffness Progression
- 10:30AM-12:30PM
-
Abstract Number: 1124
Impact of Genetic Predisposition for Type 2 Diabetes in Plasma Glucose Levels After the Administration of a High Dose of Systemic Glucocorticoids
- 10:30AM-12:30PM
-
Abstract Number: 1319
Impact of Illness Cognition and Self-Esteem on Quality of Life in Reproductive-Age Women with Autoimmune Rheumatic Diseases
- 10:30AM-12:30PM
-
Abstract Number: 1582
Impact of Immunosuppressive Treatment on Development and Survival in Systemic Sclerosis Associated Pulmonary Arterial Hypertension (SSc-PAH)
- 10:30AM-12:30PM
-
Abstract Number: 1360
Impact of Maintaining Low Disease Activity on Patient Outcomes and Healthcare Resource Utilization in Rheumatoid Arthritis Patients Receiving Advanced Treatment
- 10:30AM-12:30PM
-
Abstract Number: 1611
Impact of Mepolizumab on Patient-reported Outcomes in Eosinophilic Granulomatosis with Polyangiitis by Using the ANCA-associated Vasculitis Patient-reported Outcomes (AAV-PRO) Questionnaire: A European Multicentre Prospective Study
- 10:30AM-12:30PM
-
Abstract Number: 1198
Impact of Metabolic Syndrome on Knee Osteoarthritis Severity and Progression: A PROCOAC Cohort Study
- 10:30AM-12:30PM
-
Abstract Number: 1411
Impact of Patient and Physician Alignment on Sjögren’s Disease Severity, a Real-World Survey on Patients’ Clinical Outcomes and Health-Related Quality of Life
- 10:30AM-12:30PM
-
Abstract Number: 1055
Impact of Provider Billing vs. Pharmacy Dispensation for Romosozumab Treatment Discontinuation Among U.S. Postmenopausal Women with Osteoporosis
- 10:30AM-12:30PM
-
Abstract Number: 1111
Impact of Scleroderma, Antiphospholipid Syndrome, Behçet’s Disease, and Dermatomyositis on Mortality Among Hospitalized Patients with Pulmonary Embolism
- 10:30AM-12:30PM
-
Abstract Number: 1045
Impact of Stable Rheumatologic Therapy on Outcomes of Depression in Members with Rheumatoid Arthritis, Psoriatic Arthritis, and Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 1522
Impact of Thrombocytopenia on In-hospital Mortality and Healthcare Resource Utilization in Patients with Systemic Lupus Erythematosus: An Analysis of the National Inpatient Sample Database 2020
- 10:30AM-12:30PM
-
Abstract Number: 1047
Impact of Treatment Switching on Adherence in Members with Rheumatoid Arthritis, Psoriatic Arthritis, or Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 1625
Impacts of a Fast-Track Referral Clinic on Health Care Utilization, Delays and Complications in Patients with Giant Cell Arteritis
- 10:30AM-12:30PM
-
Abstract Number: 1275
Implementing Integrated Mental Health Care in a Juvenile Myositis Clinic: A One-Year Review
- 10:30AM-12:30PM
-
Abstract Number: 1168
Improved Survival in Patients with Myositis-Associated Interstitial Lung Disease (ILD) During the Period 2011 to 2023: Comparative and Integrative Analysis of Three Multicenter Cohorts in Japan
- 10:30AM-12:30PM
-
Abstract Number: 1543
Improvements in BILAG Musculoskeletal and Mucocutaneous Domains at Week 48 in a Phase 2 Double-Blind Placebo-Controlled Trial of ABBV-599 (Elsubrutinib + Upadacitinib Combination) and Upadacitinib Monotherapy for Treatment of Moderately to Severely Active Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 1068
Improving Health Numeracy Literacy in Pediatric Patients with SLE
- 10:30AM-12:30PM
-
Abstract Number: 1264
Improving Mental Health Care for Youth with Juvenile Dermatomyositis Through Integration of Mental Health Screening into Pediatric Rheumatology Clinic
- 10:30AM-12:30PM
-
Abstract Number: 1021
Improving Preoperative Osteoporosis Screening for Orthopedic Patients
- 10:30AM-12:30PM
-
Abstract Number: 1078
Improving SLEDAI-2K Documentation for Childhood-Onset Systemic Lupus Erythematosus (cSLE) in a Pediatric Rheumatology Clinic Using Quality Improvement Methodology
- 10:30AM-12:30PM
-
Abstract Number: 1069
Improving Triage Accuracy of Unclear Rheumatology Referrals: A Quality Improvement Study
- 10:30AM-12:30PM
-
Abstract Number: 1533
Imvotamab, a CD20-Targeted Bispecific IgM T Cell Engager, Effectively Depletes Low-Expressing CD20+ B Cells in Preclinical Models of Autoimmune Disease
- 10:30AM-12:30PM
-
Abstract Number: 0928
In Vitro Study of Fibroblast-Like Synoviocytes and Macrophages-Like Synoviocytes Isolated from Rheumatoid Arthritis, Psoriatic Arthritis Patients and Healthy Subjects
- 10:30AM-12:30PM
-
Abstract Number: 1515
Incidence and Predictors of Neuropsychiatric Lupus—a Contemporary Cohort Study Across the United States
- 10:30AM-12:30PM
-
Abstract Number: 1455
Incidence and Predictors of Secondary Failure to Biologic Therapy in Patients with Psoriatic Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 1505
Incidence of Cardiovascular and Venous Thromboembolic Events in Four Autoantibody-defined Systemic Lupus Erythematosus Clusters
- 10:30AM-12:30PM
-
Abstract Number: 1564
Incidence of Posttraumatic Stress Disorder Secondary to the Diagnosis of Systemic Sclerosis
- 10:30AM-12:30PM
-
Abstract Number: 1519
Incidence, Risk Factors, and Outcomes of Severe Lymphopenia in Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 0957
Increased Collagen Deposition and Altered Immune Cell Profiles Are Present in Early and Late Stage Systemic Sclerosis with Gastrointestinal Involvement
- 10:30AM-12:30PM
-
Abstract Number: 1150
Increased ISG15 Expression in Peripheral Blood from Patients with Positive Dermatomyositis Related Specific Autoantibodies
- 10:30AM-12:30PM
-
Abstract Number: 1330
Increased Levels of F-calprotectin in Patients with Early Rheumatoid Arthritis at Diagnosis
- 10:30AM-12:30PM
-
Abstract Number: 1153
Increased Prevalence of Myositis Specific and Associated Autoantibodies in Patients with Interstitial Lung Disease of Unknown Etiology
- 10:30AM-12:30PM
-
Abstract Number: 0954
Increased Proliferating Natural Killer Cells Exhibit an Aberrant Pro-Inflammatory Gene Signature in Systemic Sclerosis Patients
- 10:30AM-12:30PM
-
Abstract Number: 1024
Increased Social Vulnerability Index Predicts Lower Likelihood of Remission in Rheumatoid Arthritis Patients
- 10:30AM-12:30PM
-
Abstract Number: 1476
Individualizing NSAIDs in Axial Spondyloarthritis Through a Series of N-of-1 Clinical Trials with Bayesian Analysis
- 10:30AM-12:30PM
-
Abstract Number: 0955
Inhibition of Interleukin-2-Inducible T Cell Kinase with Soquelitinib Demonstrates Efficacy in Preventing Lung Damage in Murine Models of Systemic Sclerosis
- 10:30AM-12:30PM
-
Abstract Number: 1067
Initiation of Urate-Lowering Therapy in Patients Hospitalized with Gout Flare at a Single Center: Opportunity for Quality Improvement
- 10:30AM-12:30PM
-
Abstract Number: 1239
Innovative Patient Empowerment: Evaluating the Effect of a Physician-created Educational Video and To-do Lists on Promoting Preventive Health Measures in Rheumatic Disease Patients
- 10:30AM-12:30PM
-
Abstract Number: 1064
Inpatient and Outpatient Palliative Care Referral Practices for Patients with Rheumatic Disease: Retrospective Chart Review at a Single Academic Medical Center
- 10:30AM-12:30PM
-
Abstract Number: 1245
Inpatient Discontinuation of Allopurinol – A Quality Improvement (QI) Initiative
- 10:30AM-12:30PM
-
Abstract Number: 1347
Interest of DAS28-γGT in Assessing Cardiovascular Risk Activity in Rheumatoid Arthritis in Routine Practice
- 10:30AM-12:30PM
-
Abstract Number: 0901
Intergenic Alu Elements Are Uniquely Expressed in Dermatomyositis and Correlate with Interferon Stimulated Genes
- 10:30AM-12:30PM
-
Abstract Number: 1608
Interstitial Lung Disease in ANCA-associated Vasculitis: A Retrospective Study of Clinical Characteristics, Radiographic Features, and Outcomes
- 10:30AM-12:30PM
-
Abstract Number: 1186
Intra-articular Corticosteroid Injections for Knee Osteoarthritis: Does the Dose Matter?
- 10:30AM-12:30PM
-
Abstract Number: 1626
Intracranial Giant Cell Arteritis: A Comprehensive Systematic Review
- 10:30AM-12:30PM
-
Abstract Number: 1258
Investigating Factors Associated with Gaps in Care in Adolescents and Young Adults with Systemic Lupus
- 10:30AM-12:30PM
-
Abstract Number: 1329
Investigating Predictors of Transfusion in Rheumatoid Arthritis and Osteoarthritis Patients Undergoing Knee Arthroplasty
- 10:30AM-12:30PM
-
Abstract Number: 1107
Investigating Pyrexia of Unknown Origin: A Rheumatologist’s Perspective
- 10:30AM-12:30PM
-
Abstract Number: 1282
Investigating the Genetics of Depression and Anxiety in Children and Adolescents with and Without Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 0880
Investigating the SRPK-1-VEGF-A Alternative Splicing Pathway AsaTherapeutic Target in Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 1463
Investigation of the Cardiometabolic-related Mechanism of Action of Apremilast Through Plasma Proteomics Profiling of Patients with Psoriasis or Psoriatic Arthritis from Three Phase 3 Studies
- 10:30AM-12:30PM
-
Abstract Number: 0945
Involvement of Cellular Senescence in Rheumatoid Arthritis-associated Interstitial Lung Disease of SKG Mice
- 10:30AM-12:30PM
-
Abstract Number: 0932
IRAK4 Degrader GS-6791 Inhibits TLR and IL-1R-Driven Inflammatory Signaling, and Ameliorates Disease in a Preclinical Arthritis Model
- 10:30AM-12:30PM
-
Abstract Number: 1615
Is Regular Vascular Imaging Scheduled Essential in the Follow-Up of Takayasu Arteritis? A Large-Scale Multicenter Cohort Study
- 10:30AM-12:30PM
-
Abstract Number: 1446
Is the Remission Achieved with Asdas, Basdaı a Real Remission? Should Ultrasound Be Added to the Parameters?
- 10:30AM-12:30PM
-
Abstract Number: 0916
Isocitrate Dehydrogenase 2 Mutations Are Associated with Autoimmune Rheumatologic Diseases in Chronic Myelomonocytic Leukemia
- 10:30AM-12:30PM
-
Abstract Number: 1164
IVIG Treatment Duration in Immune-mediated Necrotizing Myopathy and a Possible Association of Vacuolar Changes with Black/African American Female Patients
- 10:30AM-12:30PM
-
Abstract Number: 1117
JAK Inhibitor Therapy in Refractory Uveitis Due to Immune-mediated Inflammatory Disorders. Multicenter Study and Literature Review
- 10:30AM-12:30PM
-
Abstract Number: 1357
Kidney Function in Rheumatoid Arthritis: Estimating Glomerular Filtration Rate Using Creatinine versus Cystatin C in a Secondary Analysis of the TARGET Trial
- 10:30AM-12:30PM
-
Abstract Number: 1552
Kinetics of Mucocutaneous and Musculoskeletal Responses to Deucravacitinibin Patients with Active SLE in the Phase 2 PAISLEY Trial
- 10:30AM-12:30PM
-
Abstract Number: 1303
Knee Injection Training for Internal Medicine Residents in Real-world Primary Care Practice
- 10:30AM-12:30PM
-
Abstract Number: 1222
Large Language Model-driven Sentiment Analysis for Facilitating Fibromyalgia Diagnosis
- 10:30AM-12:30PM
-
Abstract Number: 0983
Life Satisfaction in Adults Living with Arthritis – a Cross-Sectional Analysis of the 2022 National Health Interview Survey
- 10:30AM-12:30PM
-
Abstract Number: 0971
Ligand-Receptor Analysis Reveals Myeloid-Mediated Pro-Inflammatory Responses and Loss of Mesenchymal Signaling Driven by TNFR1 in Experimental Pulmonary Hypertension
- 10:30AM-12:30PM
-
Abstract Number: 1271
Linkage of the Childhood Arthritis and Rheumatology Research Alliance Registry with the Pediatric Health Information System: Creation of a Comprehensive Childhood-Onset Lupus Dataset
- 10:30AM-12:30PM
-
Abstract Number: 1240
Living with Antiphospholipid Antibodies: A Photovoice Exploration
- 10:30AM-12:30PM
-
Abstract Number: 1312
Long Term Proficiency and Clinical Outcomes of a Novel Fellow’s Injection Clinic
- 10:30AM-12:30PM
-
Abstract Number: 1345
Long-term Changes in Coronary Calcium Score Levels Among Patients with Rheumatoid Arthritis: A Cohort Study
- 10:30AM-12:30PM
-
Abstract Number: 1120
Long-Term Echocardiographic Findings in Idiopathic Recurrent Pericarditis Patients Treated with Anakinra
- 10:30AM-12:30PM
-
Abstract Number: 1104
Long-term Follow-up of Patients with Positive Cryofibrinogen Test During the COVID-19 Era
- 10:30AM-12:30PM
-
Abstract Number: 1246
Long-Term Outcomes Based on the Sex of the Rheumatologist in a Prospective Cohort of RA Patients Receiving Biological Therapies
- 10:30AM-12:30PM
-
Abstract Number: 1094
Longitudinal Analysis of Serum Urate in Prediabetic Phase
- 10:30AM-12:30PM
-
Abstract Number: 1227
Longitudinal Patterns of Fibromyalgia Phenotypes in Patients with Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 1396
Low CD47 Expression on B Cells, Induces High B Cell Phagocytosis by Macrophages and Is a Predictive Biomarker of Anti-rituximab Antibodies and Lower Response in Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 1607
Low Concentrations of Anti-C5a Complement Receptor Antibodies Are Associated with Relapse in Eosinophilic Granulomatosis with Polyangiitis (EGPA)
- 10:30AM-12:30PM
-
Abstract Number: 1511
Lupus Nephritis and Response to Treatment in Latin America
- 10:30AM-12:30PM
-
Abstract Number: 1489
Lupus Nephritis Clinical and Serological Responses at 12 Months: Implications for Repeat Biopsy, Intensified Immunosuppression or Additional Anti-proteinuric Therapy
- 10:30AM-12:30PM
-
Abstract Number: 1129
Machine Learning Algorithms to Predict Colchicine Resistance in Familial Mediterranean Fever
- 10:30AM-12:30PM
-
Abstract Number: 1364
Machine Learning-Driven Models for Disease Activity Prediction and Therapeutic Response Evaluation in Rheumatoid Arthritis Patients: An Analysis of Data from the Multicentre, Prospective, Egyptian Collage of Rheumatology (ECR) Study Group
- 10:30AM-12:30PM
-
Abstract Number: 0926
Macrophages and Nociceptor Neurons Form a Sentinel Unit Around Fenestrated Capillaries to Defend the Synovium from Systemic Challenges
- 10:30AM-12:30PM
-
Abstract Number: 0925
Macrophages Produce Bone Anabolic Factors in Settings of Inflammation-Induced Bone Formation
- 10:30AM-12:30PM
-
Abstract Number: 1635
Magnetic Resonance Imaging for Therapy Monitoring in Giant Cell Arteritis – Impact on Disease Management
- 10:30AM-12:30PM
-
Abstract Number: 1367
Maintained Improvement of Disease Activity and Patient-reported Outcomes (PROs) with Filgotinib in Patients with Rheumatoid Arthritis (RA) in the Real World: Up to 2-year Interim Data from FILOSOPHY
- 10:30AM-12:30PM
-
Abstract Number: 0989
Malignancy Risk Between JAK Inhibitors and Anti-TNF Therapy Across Disease Indications: A Bayesian Network Meta-analysis
- 10:30AM-12:30PM
-
Abstract Number: 1469
Manhattan Study: Observational, Ambispective Study to Describe Persistence and Effectiveness of a Second-line Guselkumab or TNF Inhibitors After First-line TNF Inhibitors for the Treatment of Active Psoriatic Arthritis in Spain
- 10:30AM-12:30PM
-
Abstract Number: 1558
Mapping in Healthy Subjects Different Body Areas for Dermal Thickness and Skin Hardness by High Frequency Sonography and Durometry
- 10:30AM-12:30PM
-
Abstract Number: 1091
Mapping Monosodium Urate Crystal Deposition Within Joints in Tophaceous Gout: A Dual Energy CT Study
- 10:30AM-12:30PM
-
Abstract Number: 1322
Maternal Antenatal Attachment in Women with Rheumatic Diseases
- 10:30AM-12:30PM
-
Abstract Number: 1308
Measuring the Educational Impact of a Collaboration Between RheumMadness and TheMednet
- 10:30AM-12:30PM
-
Abstract Number: 0973
Mechano-transduction via MRTF-A Pathway Is Required for Cytokine Release by Scleroderma Macrophages
- 10:30AM-12:30PM
-
Abstract Number: 1230
Mediating Role of Pain Catastrophizing in Racial Disparities in Knee Osteoarthritis Pain Among Non-Hispanic White and Asian Americans: A Pilot Study
- 10:30AM-12:30PM
-
Abstract Number: 1217
Medical and Non-Medical Cannabis Use by Rheumatology Patients: A Study of over 2000 Patients in California
- 10:30AM-12:30PM
-
Abstract Number: 1415
Metformin Improves Salivary Gland Infiltration and Objective Measures of Dry Eyes in Sjögren’s Disease: A Retrospective Observational Study
- 10:30AM-12:30PM
-
Abstract Number: 1366
Methotrexate Maintenance in Rheumatoid Arthritis, Two Years After Initiation of a First Targeted Therapy: Results from the Prospective STRATEGE2 Study
- 10:30AM-12:30PM
-
Abstract Number: 1110
Microvascular Abnormalities in COVID-19 Survivors and LONG COVID
- 10:30AM-12:30PM
-
Abstract Number: 1158
Microvascular Differences Between Cancer and Non-cancer Anti-transcriptional Intermediary Factor 1 Gamma Antibody (anti-TIF1-γ) Associated Dermatomyositis Patients
- 10:30AM-12:30PM
-
Abstract Number: 1590
Milder ILD with Preserved Lung Function Significantly Contributes to Respiratory Caused Mortality in SSc
- 10:30AM-12:30PM
-
Abstract Number: 1404
Modeling Diversity in Systemic Lupus Erythematosus (SLE) Clinical Trials Using Real-world Data (RWD) Sources
- 10:30AM-12:30PM
-
Abstract Number: 0935
Molecular Degraders of Extracellular Protein (MoDEsTM) Rapidly and Effectively Remove Interstitial IgG and Disease-Relevant Immune Complexes Through Endo-lysosomal Degradation in the Liver
- 10:30AM-12:30PM
-
Abstract Number: 1614
Mortality in Patients with Giant Cell Arteritis in Spain: Results from the ARTESER Registry
- 10:30AM-12:30PM
-
Abstract Number: 1215
Mortality in US Veterans with Musculoskeletal Conditions Using Cyclobenzaprine or Baclofen
- 10:30AM-12:30PM
-
Abstract Number: 1248
Most Prevalent Self-Reported Comorbidities Among Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Axial Spondyloarthritis
- 10:30AM-12:30PM
-
Abstract Number: 1490
Multi-centered Clinical Validation of T Cell-bound C4d (TC4d) and T Cell Autoantibodies (TIgG and TIgM): Sensitive and Specific Biomarkers of SLE with Enhanced Accuracy Compared to Conventional SLE Tests
- 10:30AM-12:30PM
-
Abstract Number: 0961
Multi-omics Study of Systemic Sclerosis Immunoglobulins G Effects on Endothelial Cells: A Distinct Profile in Anti-Topoisomerase I Positive Patients
- 10:30AM-12:30PM
-
Abstract Number: 1632
Multi-vessel Intimal Medial Thickness in Takayasu Arteritis: A Potential Marker for Disease Modification?
- 10:30AM-12:30PM
-
Abstract Number: 1307
Multidisciplinary Participation in Online Rheumatology Discussion Forums
- 10:30AM-12:30PM
-
Abstract Number: 1203
My Shoulder Hurts, What Should I Do? A Systematic Review and Bayesian Network Meta-analysis of Different Injectables in Glenohumeral Osteoarthritis
- 10:30AM-12:30PM
-
Abstract Number: 0996
Myocarditis Following Pfizer-BioNTech BNT162b2 Vaccine: Epidemiology and Predisposition
- 10:30AM-12:30PM
-
Abstract Number: 1152
Nailfold Videocapillaroscopy Abnormalities in Different Autoimmune Inflammatory Myopathy Subsets
- 10:30AM-12:30PM
-
Abstract Number: 1233
Narrative Medicine Intervention for Mental Wellbeing in Juvenile Myositis and Juvenile Idiopathic Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 1394
Nationwide Retrospective Cohort Study on Clinical Outcomes in Rheumatoid Arthritis Patients Treated with JAK Inhibitors
- 10:30AM-12:30PM
-
Abstract Number: 1443
Natural Course of Degenerative Lesions of the Spine on Radiographs and MRI in Axial SpondyloarthritisFollowed 10 Years in the DESIR Cohort
- 10:30AM-12:30PM
-
Abstract Number: 0948
Neuronal Intestinal Dysplasia Due to Ncx Gene Deficiency Attenuates the Severity of Experimental Arthritis in Mice
- 10:30AM-12:30PM
-
Abstract Number: 1321
Neuropsychological Evaluation of Cognitive Impairment in Patients with Rheumatic Diseases
- 10:30AM-12:30PM
-
Abstract Number: 1268
Neutrophil Lymphocyte Ratio as a Novel Marker of Skin Disease Activity in Older Children with Juvenile Dermatomyositis
- 10:30AM-12:30PM
-
Abstract Number: 1581
Neutrophil-to- lymphocyte Ratio: A Possible Biomarker for Clinical Response After Autologous Hematopoietic Stem Cell Transplantation
- 10:30AM-12:30PM
-
Abstract Number: 1576
New Patient-Reported Outcome Measures for Early Systemic Sclerosis Using the FDA Guidance on Patient Reported Outcome Measures
- 10:30AM-12:30PM
-
Abstract Number: 0912
Next-Generation Sequencing in Molecular Genetics of Adult-Onset Still’s Disease: Data from 23 Patients and Literature Review
- 10:30AM-12:30PM
-
Abstract Number: 1114
Nintedanib in Autoimmune Disease-related Interstitial Lung Disease: Real-life Effectiveness, Safety and Tolerance in a Spanish Multicenter Study
- 10:30AM-12:30PM
-
Abstract Number: 0933
NLRP3 Inflammasome Promotes Release of Peptidyl Arginine Deiminases2 and 4 from Human Neutrophils
- 10:30AM-12:30PM
-
Abstract Number: 1017
Non-Adherence and Missed Appointments in Rheumatology: Pre and Post COVID-19 Pandemic Impact
- 10:30AM-12:30PM
-
Abstract Number: 1125
Non-Classical Complications of Adult-Onset Still’s Disease: A Multicenter Spanish Study
- 10:30AM-12:30PM
-
Abstract Number: 1532
Not yet on Track: Retrospective Chart Analysis Reveals Physician’s Treatment Approaches in SLE Fall Short of New EULAR Guidance
- 10:30AM-12:30PM
-
Abstract Number: 1504
Novel Analytes Associated with Cognitive Impairment in Patients with Systemic Lupus Erythematosus: Serum S100A8/A9, MMP-9 and IL-6
- 10:30AM-12:30PM
-
Abstract Number: 0902
Novel Role of TYK2mechanism in SLE Pathogenesis via T Cell and B Cell Pathways
- 10:30AM-12:30PM
-
Abstract Number: 0974
Number of Days Between Prior Low-dose Weekly Methotrexate Administration and S1-RBD Antibody Response in Adults with Immune Mediated Inflammatory Diseases Vaccinated Against COVID-19: Secondary Analysis of the Vaccine Response On-Off Methotrexate (VROOM) Study Data
- 10:30AM-12:30PM
-
Abstract Number: 1205
OARSI Initiative to Develop Classification Criteria for Early-Stage Symptomatic Knee OA (EsSKOA): What Should Be Considered in the Differential Diagnosis of EsSKOA?
- 10:30AM-12:30PM
-
Abstract Number: 1427
Observed and Simulated Pharmacokinetics and Pharmacodynamics of Nipocalimab, a Fully Human FcRn Blocking Monoclonal Antibody, in Adults with Sjögren’s Disease: Results from a Phase 2, Multicenter, Randomized, Placebo-controlled, Double-blind Study
- 10:30AM-12:30PM
-
Abstract Number: 1224
Occupational Stress and Fibromyalgia Among Healthcare Professionals in Abu Dhabi Region, United Arab Emirates: A Cross-sectional Study
- 10:30AM-12:30PM
-
Abstract Number: 1387
Olokizumab Effect on Chronic Pain in Rheumatoid Arthritis: Results of the Observational Study
- 10:30AM-12:30PM
-
Abstract Number: 1386
Olokizumab in Real Clinical Practice: Efficacy and Safety
- 10:30AM-12:30PM
-
Abstract Number: 1390
One-year Real World Evidence Outcomes from the Cohort RADIUS (Real-world Analysis of Upadacitinib in Rheumatoid Arthritis Patients for Improved Understanding and Safety)
- 10:30AM-12:30PM
-
Abstract Number: 1210
Optimal Definitions of Worsening Cartilage Using Sequential MRI OsteoArthritis Knee Scores (MOAKS)
- 10:30AM-12:30PM
-
Abstract Number: 1241
Optimizing Communication of Methotrexate (MTX) Side Effects: A Patient-Centered Approach Focused on Learning Styles and Preferred Language
- 10:30AM-12:30PM
-
Abstract Number: 1075
Optimizing Herpes Zoster Vaccination in Rheumatoid Arthritis Patients Ages 18-49 Years: A Quality Improvement Approach
- 10:30AM-12:30PM
-
Abstract Number: 1641
Orbital MRI as a Promising Approach for the Diagnosis of Giant Cell Arteritis in Case of Anterior Ischemic Optical Neuropathy or Central Retinal Artery Occlusion
- 10:30AM-12:30PM
-
Abstract Number: 1417
Organ-Specific Autoimmune Involvement in Primary Sjögren’s Disease
- 10:30AM-12:30PM
-
Abstract Number: 1033
Osteoporosis and Cardiovascular Disease: Mortality Trends Among Adults in the United States from 1999 to 2020
- 10:30AM-12:30PM
-
Abstract Number: 1084
Osteoporosis and Osteopenia Diagnosed by Dual-Energy X-Ray Absorptiometry Are Not Increased in Patients with Gout
- 10:30AM-12:30PM
-
Abstract Number: 1499
Outcome of Newly Onset SLE with Neuropsychiatric Symptoms and Its Clinical Features in Daily Clinical Practice: A Single Center Study
- 10:30AM-12:30PM
-
Abstract Number: 1592
Overlapping Forms of Eosinophilic Granulomatosis with Polyangiitis and Granulomatosis with Polyangiitis: Presentation, Management and Outcomes
- 10:30AM-12:30PM
-
Abstract Number: 1580
Overt Polyautoimmunity and Its Risk Factors in a Multicenter Cohort of Systemic Sclerosis Patients
- 10:30AM-12:30PM
-
Abstract Number: 1172
Participation in Baseball/Softball Associates with Increased Risk for Knee Pain and Osteoarthritis as an Adult: Data from the Osteoarthritis Initiative
- 10:30AM-12:30PM
-
Abstract Number: 1234
Patient and Physician Preferences for Pain Relief Treatment for Moderate-to-Severe Pain Associated with Knee Osteoarthritis: A Qualitative Exploration
- 10:30AM-12:30PM
-
Abstract Number: 1318
Patient Anxiety, Fear, and Kinesiophobia: Challenges Shared by UK Physiotherapists in Managing Polymyalgia Rheumatica – Findings from a Qualitative Study
- 10:30AM-12:30PM
-
Abstract Number: 1232
Patient Reported Impact of Psoriatic Arthritis and Desired Treatment Outcomes
- 10:30AM-12:30PM
-
Abstract Number: 1538
Patient Reported Outcomes Analyses from AURORA 1 Clinical Trial: Lupus Impact Tracker and LupusPRO
- 10:30AM-12:30PM
-
Abstract Number: 1249
Patient-Reported Outcomes in Inflammatory Arthritis: A Four-Year Retrospective Analysis via the PatientSpot Research Registry
- 10:30AM-12:30PM
-
Abstract Number: 1473
Patient-Reported Symptoms Improved with Stringent Control of Swollen Joints in Patients with Psoriatic Arthritis: Results from Two Phase 3 Studies of Bimekizumab
- 10:30AM-12:30PM
-
Abstract Number: 1470
Patients with Psoriatic Arthritis from a Phase 4 Head-to-Head Study Stratified by Nail Involvement
- 10:30AM-12:30PM
-
Abstract Number: 1253
Patterns of Patient-reported Outcome Measures in Patients with Systemic Lupus Erythematosus with or Without Concurrent Fibromyalgia
- 10:30AM-12:30PM
-
Abstract Number: 1207
Patterns of Shared Variation in Knee Ultrasound for Osteoarthritis: A Machine Learning Approach
- 10:30AM-12:30PM
-
Abstract Number: 1105
PDGFA and TGFB1, Key Genes to Discriminate Autoimmune Diseases-Related Interstitial Lung Disease from Idiopathic Pulmonary Fibrosis?
- 10:30AM-12:30PM
-
Abstract Number: 0892
Peptides from Candidate Sjögren’s Disease Autoantigens and Salivary Gland Tissue-Enriched Proteins Eluted from Human Salivary Gland HLA-DR
- 10:30AM-12:30PM
-
Abstract Number: 1405
Perceived Healthcare Discrimination Among Individuals with Musculoskeletal Conditions: A Retrospective Cross-Sectional Analysis
- 10:30AM-12:30PM
-
Abstract Number: 1001
Perceived Mistreatment in Patients with Rheumatic Diseases: The Impact of the Underlying Diagnosis
- 10:30AM-12:30PM
-
Abstract Number: 1015
Performance of a Molecular Signal Response Classifier Predicting Inadequate Response to Tumor Necrosis Factor Inhibitors in Hispanic Patients with Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 1438
Performance of Combined MRI SI Joint Active and Structural Lesions in Diagnosing Axial SpA: A Prospective Cohort Study
- 10:30AM-12:30PM
-
Abstract Number: 1617
Persistence of Imaging Abnormality in Patients with Large Vessel Vasculitis Despite Clinical Remission
- 10:30AM-12:30PM
-
Abstract Number: 1369
Persistence, Effectiveness and Treatment Patterns of Upadacitinib in over 2600 Australian Rheumatoid Arthritis Patients: A Retrospective Analysis from the OPAL Dataset
- 10:30AM-12:30PM
-
Abstract Number: 0890
Pervasive Inflammation Poisons Hematopoiesis and Drives Clonal Dominance in VEXAS Syndrome
- 10:30AM-12:30PM
-
Abstract Number: 1016
Pharmacoequity of DMARDs Among Adults with Rheumatoid Arthritis in the U.S
- 10:30AM-12:30PM
-
Abstract Number: 1085
Pharmacokinetics and Pharmacodynamics of Tigulixostat in Participants with Mild, Moderate, and Severe Renal Impairment
- 10:30AM-12:30PM
-
Abstract Number: 1005
Pharmacosurvellience Study of FDA Adverse Event Reporting System (FAERS) Events of Tofacitinib and Upadacitinib
- 10:30AM-12:30PM
-
Abstract Number: 1175
Physical Activity and Symmetry Following Total Knee Arthroplasty:Results of an Exploratory Trial
- 10:30AM-12:30PM
-
Abstract Number: 1302
Physician Knowledge, Attitudes and Perceived Barriers to Recommending the Recombinant Varicella Zoster Vaccine
- 10:30AM-12:30PM
-
Abstract Number: 1053
Pilot Intervention to Improve Medication Adherence Among Patients with Rheumatic Diseases
- 10:30AM-12:30PM
-
Abstract Number: 1413
Pilot Trial of Ustekinumab for Primary Sjogren’s Syndrome
- 10:30AM-12:30PM
-
Abstract Number: 1112
Pleuroparenchymal Fibroelastosis Associated with Connective Tissue Diseases (PPFE-CTD)
- 10:30AM-12:30PM
-
Abstract Number: 1391
Possible Mechanistic Pathways of the Effective “Plants for Joints” Lifestyle and Dietary Intervention for Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 1077
Pragmatic Quantitative Rheumatologist 0–10 Visual Numeric Scale Estimates of Inflammation, Damage, and Patient Distress Have Face Validity and May Be as Informative as Formal 28 Joint Counts in Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 1247
Pre- and Post-Diagnosis Comparison of the Patient Experience of Sjögren’s Syndrome (SS): A Linguistic Analysis of Global Social Media Conversations
- 10:30AM-12:30PM
-
Abstract Number: 0984
Predicting Risk of Infection in Hospitalized Patients with Rheumatic Diseases from the MIMIC-IV Clinical Database: A Machine Learning Approach
- 10:30AM-12:30PM
-
Abstract Number: 1518
Predictive Value of Chronic Histologic Changes in Lupus Nephritis
- 10:30AM-12:30PM
-
Abstract Number: 1451
Predictors and Patterns of Fragility Fracture in an Observational Cohort of Patients with Psoriatic Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0990
Predictors of Adverse Events and Complications in Cirrhotic Patients with Rheumatoid Arthritis: A Nationwide Analysis
- 10:30AM-12:30PM
-
Abstract Number: 1587
Predictors of Body Mass Index in an Early Systemic Sclerosis Cohort
- 10:30AM-12:30PM
-
Abstract Number: 1482
Predictors of Clinical Response to Intravenous Secukinumab Among Patients with Axial Spondyloarthritis: A Post Hoc Analysis of a Phase 3 Trial
- 10:30AM-12:30PM
-
Abstract Number: 1004
Predictors of Post-acute Sequelae of COVID-19 in Patients with Rheumatoid Arthritis: A Retrospective Analysis of a Large Health System in the Midwestern United States
- 10:30AM-12:30PM
-
Abstract Number: 1487
Pregnancy Outcome and Risk Factors Analysis in Patients with Systemic Lupus Erythematosus Complicated with Thrombocytopenia
- 10:30AM-12:30PM
-
Abstract Number: 1549
Prescribing Trends for Novel Treatments in Systemic Lupus from 2017 to 2022
- 10:30AM-12:30PM
-
Abstract Number: 1536
Prescription Rates of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Lupus Nephritis: A Comparative Study Across Specialties
- 10:30AM-12:30PM
-
Abstract Number: 1156
Prevalence and Impact of Fibromyalgia in Patients with Idiopathic Inflammatory Myopathies
- 10:30AM-12:30PM
-
Abstract Number: 1200
Prevalence and Joint Involvement Patterns of Erosive and Non-erosive Hand Osteoarthritis in the General Population in China
- 10:30AM-12:30PM
-
Abstract Number: 0975
Prevalence and Management of Patients with Comorbidities and Frailty in New Onset Polymyalgia Rheumatica
- 10:30AM-12:30PM
-
Abstract Number: 1363
Prevalence and Predictors of Orthopaedic Surgery in Rheumatoid Arthritis After 12-Years’ Follow-Up (ESPOIR Cohort)
- 10:30AM-12:30PM
-
Abstract Number: 1565
Prevalence and Risk Factors of Lower Extremities Arterial Disease in Systemic Sclerosis: Preliminary Data from a Single Centre Multidisciplinary Study
- 10:30AM-12:30PM
-
Abstract Number: 1434
Prevalence of Liver Steatosis in Axial Spondyloarthritis : A Retrospective Study Using Computed Tomography Liver Minus Spleen Attenuation Ratio
- 10:30AM-12:30PM
-
Abstract Number: 1435
Prevalence, Progression, and Associated Factors of Enthesopathy at Hip and Pelvic Regions in Patients with Axial Spondyloarthritis: Computed Tomography-based Assessment
- 10:30AM-12:30PM
-
Abstract Number: 1563
Prevalence, Risk Factors and Associations for Osteoporosis in Postmenopausal Women with Scleroderma
- 10:30AM-12:30PM
-
Abstract Number: 1292
Primary Care Provider Educational Tool to Improve Osteoarthritis Management in the Primary Care Setting
- 10:30AM-12:30PM
-
Abstract Number: 0895
Procoagulant Extracellular Vesicles in Patients with Livedo Reticularis
- 10:30AM-12:30PM
-
Abstract Number: 1624
Prognostic Value of Baseline 18F-FDG PET/CT Scan in Giant Cell Arteritis with Large Vessel Involvement
- 10:30AM-12:30PM
-
Abstract Number: 1098
Prognostic Value of Hyperuricemia in Developing Cardiovascular Events in Patients with Chronic Inflammatory Arthritis: A 10-Year Prospective Study
- 10:30AM-12:30PM
-
Abstract Number: 1540
Project HOPE: HydrOxychloroquine Adherence ProjEct
- 10:30AM-12:30PM
-
Abstract Number: 1598
Projecting the Impact of Standard, Reduced-Dose, and Minimal-Dose Glucocorticoid Regimens in the Treatment of ANCA-Associated Vasculitis Using Simulation Modeling
- 10:30AM-12:30PM
-
Abstract Number: 1088
Prospective Evaluation of Carotid Atherosclerosis, Urate Deposits and Inflammation After One Year of Treatment in Newly Diagnosed Gout
- 10:30AM-12:30PM
-
Abstract Number: 1531
Prospective mRNA SARS-CoV-2 Additional Vaccination in Systemic Autoimmune Disease Patients on Immunosuppressive Medications in a Randomized Controlled Trial
- 10:30AM-12:30PM
-
Abstract Number: 0899
Proteomic Insights into JAK Inhibitor Therapeutic Response in Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0906
Proteomic Signatures of Difficult-to-Treat Rheumatoid Arthritis: Identifying Predictive Biomarkers
- 10:30AM-12:30PM
-
Abstract Number: 0968
Proteomic, Transcriptomic, and Functional Characterization of Circulating Extracellular Vesicles in Progressive Scleroderma Interstitial Lung Disease
- 10:30AM-12:30PM
-
Abstract Number: 1383
Proteomics and Machine Learning Accurately Predict Clinical Response to Etanercept Therapy in Patients with Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 1528
Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus: National Inpatient Sample Analysis
- 10:30AM-12:30PM
-
Abstract Number: 0993
Pulmonary Complications and Mortality Trends in Rheumatoid Arthritis Patients Aged 65 and Older in the United States: A CDC WONDER Database Analysis
- 10:30AM-12:30PM
-
Abstract Number: 1140
Pulmonary Hypertension in Hospitalized Patients with Dermatomyositis & Polymyositis: A Nationwide Cohort Analysis
- 10:30AM-12:30PM
-
Abstract Number: 1242
Qualitative Patient Interview Study in Patients with Systemic Lupus Erythematosus to Assess Patient Perception of Fatigue and Skin-Related Symptoms
- 10:30AM-12:30PM
-
Abstract Number: 1250
Qualitative Study on Patient-Reported Outcome Measures in Patients with Sjögren’s Disease
- 10:30AM-12:30PM
-
Abstract Number: 0914
RAB19 and Azathioprine-Associated Pancreatic Injury in Patients Taking Azathioprine
- 10:30AM-12:30PM
-
Abstract Number: 1450
Radiographic Structural Spine Assessment in Ankylosing Spondylitis According to the Presence or Absence of Psoriasis
- 10:30AM-12:30PM
-
Abstract Number: 0959
Radiomics Non-Invasively Conveys Time-Resolved Molecular Pathway Activity in Experimental Fibrosing Interstitial Lung Disease
- 10:30AM-12:30PM
-
Abstract Number: 1218
Randomized, Double-Blind, Placebo-Controlled Confirmatory Phase 3 Trial of Bedtime Sublingual Cyclobenzaprine (TNX-102 SL) in Fibromyalgia
- 10:30AM-12:30PM
-
Abstract Number: 1071
Rapid Access Microscopy and Real Time Case Discussion via a Secure Messaging App Improves Diagnostic Accuracy and Management of Acute Hot Swollen Joints
- 10:30AM-12:30PM
-
Abstract Number: 1380
Rapid, Clinically Meaningful Pain Improvements Are Associated with Improvements in Other Patient-Reported Outcomes in RA Patients Treated with Upadacitinib
- 10:30AM-12:30PM
-
Abstract Number: 1545
Rates of Sustained Complete Renal Response with Long-term Use of Voclosporin in AURORA 2
- 10:30AM-12:30PM
-
Abstract Number: 1483
Real World Data on Infections from the Indian SLE Inception Cohort for Research (INSPIRE): Spectrum and Risk Factors
- 10:30AM-12:30PM
-
Abstract Number: 1627
Real-World Data on Imaging Tests, Specifically Temporal Artery Ultrasound, in Giant Cell Arteritis in Japan: A Multicenter Retrospective Study
- 10:30AM-12:30PM
-
Abstract Number: 1495
Real-World Reduction in Disease Flares and Oral Corticosteroid Use with Anifrolumab Therapy in Systemic Lupus Erythematosus: A Claims-Based Study
- 10:30AM-12:30PM
-
Abstract Number: 1456
Real-World Treat-to-Target Strategy in Psoriatic Arthritis: Baseline Characteristics from the MONITOR-PsA Cohort
- 10:30AM-12:30PM
-
Abstract Number: 1037
Recommendations for the Perioperative Use of DMARDs in Rheumatic Diseases: A Scoping Review
- 10:30AM-12:30PM
-
Abstract Number: 0910
Reduced Adenosine-Mediated Regulatory Activity Exacerbated by an NT5E Loss of Function Mutation Is Linked to Tissue Inflammation and Hypertension in Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 1157
Reduced Statin Use in Patients with Autoimmune Myopathies and Systemic Lupus Erythematosus Compared to Rheumatoid Arthritis and Non-Inflammatory Diseases
- 10:30AM-12:30PM
-
Abstract Number: 1196
Relation of Different Types of Antidepressants Use to Pain Severity and Measures of Pain Sensitization in Kneeosteoarthritis
- 10:30AM-12:30PM
-
Abstract Number: 1180
Relationship Between Changes in Physical Activity and Early Onset Knee Osteoarthritis in Individuals After ACL Reconstruction
- 10:30AM-12:30PM
-
Abstract Number: 1442
Relationship Between Degenerative Lesions over Time in Axial Spondyloarthritis: 10-year Follow-up of the DESIR Cohort
- 10:30AM-12:30PM
-
Abstract Number: 1393
Relationship Between Disease Activity and Adverse Events in Rheumatoid Arthritis: An Integrated Post Hoc Analysis of Upadacitinib Phase 3 Trials
- 10:30AM-12:30PM
-
Abstract Number: 1192
Relationship Between Measures of Fat Mass and Knee Osteoarthritis Incidence: The Multicenter Osteoarthritis (MOST) Study
- 10:30AM-12:30PM
-
Abstract Number: 1133
Relationship Between Nail Psoriasis Severity Index (NAPSI) and Cardiovascular Risk Assessed by Eight Cardiovascular Risk Calculators
- 10:30AM-12:30PM
-
Abstract Number: 1350
Relationship Between Salivary and Stool Microbiome with Disease Activity and Vascular Function in Patients with Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0885
Reproducible Single Cell Annotation of Programs Underlying T-cell Subsets, Activation States, and Functions
- 10:30AM-12:30PM
-
Abstract Number: 1594
Response to Mepolizumab Therapy in a Single-center Cohort of Eosinophilic Granulomatosis with Polyangiitis Patients: Characterization of Cytokine/Chemokine Pattern and Phenotypic Stratification
- 10:30AM-12:30PM
-
Abstract Number: 1501
Retrospective Cohort Study Identifying Pulmonary Complications in a Cohort of Patients with Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 0947
REX-7117 Is a Highly Potent and Selective Oral STAT3 Inhibitor That Demonstrated Potential Efficacy and Safety Differentiation versus JAK/TYK2 Targeting in Preclinical Models of Inflammatory Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 1235
Rheum to Grow: Supporting Young Adults with Childhood-Onset Rheumatic Disease in Their Transition to Adult Care
- 10:30AM-12:30PM
-
Abstract Number: 1115
Rheumatic Disease Patients: Assessment of Hydroxychloroquine’s Effects on QTc Intervals with Weight Based Dosing (RAISE-QT) Study
- 10:30AM-12:30PM
-
Abstract Number: 1324
Rheumatoid Arthritis Associated Interstitial Lung Disease – Patient Perceptions and Recommendations
- 10:30AM-12:30PM
-
Abstract Number: 1252
Rheuminating About Drugs, Sex, and Alcohol? Assessing the Informational Needs of Adolescents and Young Adults with Rheumatic Disease
- 10:30AM-12:30PM
-
Abstract Number: 1086
Risk Factors Associated with Loss to Follow-up in a Prospective Gout Cohort
- 10:30AM-12:30PM
-
Abstract Number: 1093
Risk of Dementia in Patients with Gout: Potential Impact of Survival Bias
- 10:30AM-12:30PM
-
Abstract Number: 1439
Risk of Hip and Spine Fractures in Axial Spondyloarthritis Is Associated with Treatment Class
- 10:30AM-12:30PM
-
Abstract Number: 1336
Risk of Malignancy Under the Treatments with Janus Kinase Inhibitors in Patients with Rheumatoid Arthritis: An Analysis Using Japanese Health Insurance Database
- 10:30AM-12:30PM
-
Abstract Number: 1401
Risk of Malignancy with TNF-α Inhibitors in Patients with Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 1102
Risk of Mortality and Major Cardiovascular-Kidney Outcomes in Patients with Tophaceous versus Non-Tophaceous Gout
- 10:30AM-12:30PM
-
Abstract Number: 1127
Risk of Ocular Inflammatory Conditions in Patients with Autoimmune Diseases: A Retrospective Study Using the National Inpatient Sample
- 10:30AM-12:30PM
-
Abstract Number: 0969
Role and Mechanism of the Wnt3a-FZD5 Pathway in Regulating the Transformed Intermediate State of Alveolar Epithelial Cells Involved in Pulmonary Fibrosis in Systemic Sclerosis
- 10:30AM-12:30PM
-
Abstract Number: 0917
Role of Mutual Information Profile Shifts in Assessing the Pathogenicity of Mutations on Protein Functions: The Case of Pyrin Mutations in Familial Mediterranean Fever
- 10:30AM-12:30PM
-
Abstract Number: 1238
Role of Patient Reported Outcomes in Predicting Disease Relapse at One Year in Those with Polymyalgia Rheumatica
- 10:30AM-12:30PM
-
Abstract Number: 1014
Rural-dwelling Patients with Rheumatoid Arthritis or Those with Lower Income Are More Likely to Be Admitted for Myocardial Infarction in the U.S. and Have Worse Outcomes
- 10:30AM-12:30PM
-
Abstract Number: 1460
Safety and Effectiveness of 97 Combinations of Targeted Therapies in Immune Mediated Inflammatory Diseases : Preliminary Data from the COMBATT Registry
- 10:30AM-12:30PM
-
Abstract Number: 1392
Safety and Efficacy of Upadacitinib (UPA) in Japanese Patients with Rheumatoid Arthritis (RA) and Inadequate Response to Conventional Synthetic DMARDs: Results Through 5 Years from the SELECT-SUNRISE Study
- 10:30AM-12:30PM
-
Abstract Number: 1197
Safety and Immunogenicity of an Active Anti-IL-6 Immunotherapy in a Phase 1 Clinical Trial in Knee Osteoarthritis Patients
- 10:30AM-12:30PM
-
Abstract Number: 1130
Safety of Bispecific T-cell Engager Therapy in Autoimmune Disease
- 10:30AM-12:30PM
-
Abstract Number: 1173
Safety of Non-Exercise Rehabilitation Interventions for Adults with Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 1481
Safety of Secukinumab in Patients with Psoriasis, Psoriatic Arthritis, Axial Spondyloarthritis and Hidradenitis Suppurativa: Updated Pooled Data from 69 Clinical Trials
- 10:30AM-12:30PM
-
Abstract Number: 1553
Safety, Pharmacokinetics, Clinical Efficacy and Exploratory Biomarker Results from a Randomized, Double-Blind, Placebo-Controlled Phase 1b Study of Enpatoran in Active Systemic and Cutaneous Lupus Erythematosus (SLE/CLE)
- 10:30AM-12:30PM
-
Abstract Number: 0931
Salivary Granular Convoluted Tubules Contribute to Maintain Tissue-specific Tolerance – Implications for the Development of Murine Sjögren´s Syndrome
- 10:30AM-12:30PM
-
Abstract Number: 1409
Salivary Organoids Contain More Diverse Epithelial and Less Mesenchymal Cells Than Adherent Cultures: Choose Your Sjögren’s Disease Research Tool Carefully
- 10:30AM-12:30PM
-
Abstract Number: 0936
Schnurri-3 Inhibition Protects from NF-kB-induced Bone Loss in Inflammatory Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0965
Scleroderma Associated Interstitial Lung Disease Is Characterized by Aberrant Lung Epithelial Remodeling
- 10:30AM-12:30PM
-
Abstract Number: 1569
Scleroderma Renal Crisis – Different Phenotypes and Patient Trajectories
- 10:30AM-12:30PM
-
Abstract Number: 0934
Screening NLRP3 Drug Candidates in Clinical Development:Lessons from Existing and Emerging Technologies
- 10:30AM-12:30PM
-
Abstract Number: 0956
Secreted Frizzled-Related Protein 2 (sFRP2) Regulates Wnt Signaling to Affect Mesenchymal Transition of Lung Epithelial Cells Participates in Interstitial Lung Disease
- 10:30AM-12:30PM
-
Abstract Number: 1048
Self-Perception of Oral Health and Habits in Patients with Sjögren’s Syndrome, Rheumatoid Arthritis, and Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 1491
Self-Reported Cognitive Function Among Older Adults with Systemic Lupus Erythematosus (SLE) Compared to Older Adults with Other Rheumatic and Musculoskeletal Conditions
- 10:30AM-12:30PM
-
Abstract Number: 1123
Serological Elevation of IgG4: Clinical Correlation and Differential Diagnosis
- 10:30AM-12:30PM
-
Abstract Number: 1317
Serum (1-3)-β-D-Glucan Levels in Juvenile Idiopathic Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 1631
Serum IL-6 Levels Correlate with Inflammatory Activity in Computerized Tomography Angiography Scans in Takayasu Arteritis
- 10:30AM-12:30PM
-
Abstract Number: 1087
Sex Differences in Clinical Features and Mortality in Gout: A Nationwide Retrospective Cohort Study
- 10:30AM-12:30PM
-
Abstract Number: 1623
Sex Differences in Phenotypes and Imaging Examination in Giant Cell Arteritis: Data from the ARTESER Registry
- 10:30AM-12:30PM
-
Abstract Number: 1471
Sex-related Differences in Efficacy and Safety Outcomes in Axial Spondyloarthritis Randomized Clinical Trials: A Systematic Literature Review and Meta-analysis
- 10:30AM-12:30PM
-
Abstract Number: 0891
Shared and Disease-Specific Mechanisms of Autoimmunity Using Single Cell Sequencing of Peripheral Immune Cells
- 10:30AM-12:30PM
-
Abstract Number: 1046
Shifting Paradigms in Drug Spending: A Study of Medicare Part D versus Emerging Pharmacy Models in Rheumatology
- 10:30AM-12:30PM
-
Abstract Number: 1160
Short Form-36 Psychometric Properties in Idiopathic Inflammatory Myopathies: Reliability, Validity and Responsiveness
- 10:30AM-12:30PM
-
Abstract Number: 1440
Significant Indicators Identified for Carotid Doppler Ultrasound Use in Axial Spondyloarthritis Patients Without Conventional Cardiovascular Risk Factors
- 10:30AM-12:30PM
-
Abstract Number: 1148
Simplified Cutaneous Dermatomyositis Disease Area and Severity Index Activity Scores for Cutaneous Dermatomyositis
- 10:30AM-12:30PM
-
Abstract Number: 1426
Single Cell RNA-Seq Characterization of Circulating Immune Cells in Sjogren’s Syndrome: Comparison to SLE and Rheumatoid Arhtritis
- 10:30AM-12:30PM
-
Abstract Number: 0952
Single Cell RNA-seq of Scleroderma-associated Interstitial Lung Disease Lung Explants Reveals an Active, Cytotoxic Natural Killer Cell Population
- 10:30AM-12:30PM
-
Abstract Number: 1425
Sjögren’s Syndrome and Interstitial Lung Disease: Experience in a Collaborative Rheumatology-Pulmonology Clinic
- 10:30AM-12:30PM
-
Abstract Number: 1503
Social Connections Among Middle-Aged and Older Adults with Systemic Lupus Erythematosus: A Single Center Cross-Sectional Study
- 10:30AM-12:30PM
-
Abstract Number: 1022
Social Determinants of Health in Osteoporosis Treatment Patterns Among Adults with Rheumatoid Arthritis and Major Osteoporotic Fracture in the All of Us Research Program: A Cross-Sectional Study
- 10:30AM-12:30PM
-
Abstract Number: 1418
Soluble Immune Checkpoint Molecules as Biomarkers for Extraglandular Sjögren’s Disease
- 10:30AM-12:30PM
-
Abstract Number: 0985
Specific Causes for Hospitalization in Persons with Inflammatory Arthritis Conditions and Gout: A Systematic Review
- 10:30AM-12:30PM
-
Abstract Number: 0986
State-and-County-Level Social Vulnerability Index and Trends in Systemic Lupus Erythematosus-Related Mortality in the U.S
- 10:30AM-12:30PM
-
Abstract Number: 1208
Statin Use and Risk of Total Joint Replacement of Knee and Hip in Osteoarthritis Patients: Study Based on the French National Health Insurance Cohort
- 10:30AM-12:30PM
-
Abstract Number: 0963
Stratification According to Autoantibody Status in Systemic Sclerosis Reveals Distinct Molecular Signatures
- 10:30AM-12:30PM
-
Abstract Number: 1155
Stratification of Cancer Risk in Idiopathic Inflammatory Myopathies. Application of the IMACS Guidelines to Enhance Screening
- 10:30AM-12:30PM
-
Abstract Number: 1629
Subclinical Giant Cell Arteritis in Polymyalgia Rheumatica Has a Different Vascular Ultrasound Phenotype Than Giant Cell Arteritis
- 10:30AM-12:30PM
-
Abstract Number: 1216
Subcutaneous Methylnaltrexone Treatment of Opioid-Induced Constipation in Adults with Rheumatic Conditions
- 10:30AM-12:30PM
-
Abstract Number: 1177
Supporting Implementation of Group Physical Therapy for Knee Osteoarthritis: Results of a Multisite Implementation Trial
- 10:30AM-12:30PM
-
Abstract Number: 1412
Survival and Predictive Markers of Prognosis in Patients with Cancer Occurrence After Sjögren Syndrome: A Long-term Observational Study
- 10:30AM-12:30PM
-
Abstract Number: 1184
Sustained Clinical Effects After a Single Intra-articular Injection of PCRX-201 for Moderate-to-Severe Osteoarthritis of the Knee
- 10:30AM-12:30PM
-
Abstract Number: 1555
Sustained Functional Assessment of Chronic Illness Therapy–Fatigue Response in Patients with SLE Receiving Anifrolumab Alongside Standard Therapy
- 10:30AM-12:30PM
-
Abstract Number: 1480
Sustained Improvements with Bimekizumab in Spinal Mobility, Physical Function and Health-Related Quality of Life in Patients with Axial Spondyloarthritis: 2-Year Results from Two Phase 3 Studies
- 10:30AM-12:30PM
-
Abstract Number: 1382
Synovial Expression Levels of PD-1, the Target of Rosnilimab, Correlate with Disease Activity and Persist Across Disease Stages and Lines of Therapy in Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0927
Synovial Macrophage Heterogeneity and Dynamics in Steady Stateand Rheumatoid Arthritis Mouse Model Time Course
- 10:30AM-12:30PM
-
Abstract Number: 1458
Synovial Transcriptomic Sex-Specific Differences in the Response to Biologics in Psoriatic Arthritis Patients
- 10:30AM-12:30PM
-
Abstract Number: 1445
Systematic Characterization of MRI Lesions Per ASAS Definitions in the Sacroiliac Joints of Patients with Axial Spondyloarthritis and Comparisons Among Subgroups with Psoriasis, Iritis, Colitis, AxSpA Alone, and Matched Back Pain Controls
- 10:30AM-12:30PM
-
Abstract Number: 1529
Systemic Lupus Erythematous and Neuromyelitis Optica Overlap and Risk of Infection in Hospitalized Patients
- 10:30AM-12:30PM
-
Abstract Number: 1567
Systemic Sclerosis Is Associated with Sub-Clinical Abnormalities in Myocardial Energetics, Perfusion and Increased Fibrosis
- 10:30AM-12:30PM
-
Abstract Number: 1300
Tackling Rheumatology Workforce Shortages with a Case-Based Primary Care Rheumatology Curriculum
- 10:30AM-12:30PM
-
Abstract Number: 0944
Targeting Defective Macrophages to Restore Resolution of Inflammation in Rheumatoid Arthritis -Perspectives for an Autologous Secretome Therapy
- 10:30AM-12:30PM
-
Abstract Number: 0958
TCR Motifs Identify Unique Clones in African Americans with Systemic Sclerosis
- 10:30AM-12:30PM
-
Abstract Number: 1397
Temporal Trends in Early Rheumatoid Arthritis (ERA) Patients with Moderate to Severe Disease Activity: A Multicenter Cohort Study of Treatment Strategies and Outcomes in Chinese Patients in the Modern Era
- 10:30AM-12:30PM
-
Abstract Number: 1595
Tezepelumab for Relapsing or Refractory Eosinophilic Granulomatosis with Polyangiitis: A European Retrospective Study
- 10:30AM-12:30PM
-
Abstract Number: 0920
TGF-β Activated Kinase 1 Inhibition by Pentagalloyl Glucose Inhibits NLRP3 Inflammasome Formation and Ameliorates MSU-Induced Inflammation
- 10:30AM-12:30PM
-
Abstract Number: 1237
The Art of Choosing Together: Unveiling the Patient’s Perspective in Rheumatology
- 10:30AM-12:30PM
-
Abstract Number: 0913
The Association Between PTPN2 and Leukopenia in New Users of Azathioprine
- 10:30AM-12:30PM
-
Abstract Number: 1325
The Association Between the Number of Teeth and All-Cause as Well as Cardiovascular Mortality Among Patients with RA: NHANES from 1999 to 2004
- 10:30AM-12:30PM
-
Abstract Number: 1436
The Association of Cigarette Smoking with Radiographic Progression in Psoriatic Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 1354
The Association of Genetic Variation in PTPN22 and Rheumatoid Arthritis Disease Activity
- 10:30AM-12:30PM
-
Abstract Number: 1335
The Association of Patient-Reported Non-Articular Pain with Musculoskeletal Pain Diagnoses and RA Disease Activity in a Prospective Real-World Cohort of Patients with Early RA
- 10:30AM-12:30PM
-
Abstract Number: 1583
The Association of Weakpositive Anti-RNA Polymerase III Antibodies with the Diagnosis and Complications of Systemic Sclerosis and Other Systemic Autoimmune Diseases
- 10:30AM-12:30PM
-
Abstract Number: 1352
The Associations Between Genetic Factors and Rheumatoid Arthritis Treatment Patterns: Data from Two Large Healthcare Systems
- 10:30AM-12:30PM
-
Abstract Number: 1281
The Brazilian Registry of Juvenile Dermatomyositis: Relationship Between Ultraviolet Radiation and Laboratory Markers of Juvenile Dermatomyositis in a Tropical Country
- 10:30AM-12:30PM
-
Abstract Number: 0981
The Causal Effect of Sex Hormone-related Drugs on the Risk of Osteoarthritis – A Mendelian Randomization Study
- 10:30AM-12:30PM
-
Abstract Number: 0930
The Common Form of the Inflammatory Skin Disease Hidradenitis Suppurativa Is Associated with Low Nicastrin Expression in Dermal Fibroblasts
- 10:30AM-12:30PM
-
Abstract Number: 1101
The Contemporary Prevalence of Comorbid Gout and Chronic Kidney Disease, Two Common Conditions with High Morbidity, in the US General Population
- 10:30AM-12:30PM
-
Abstract Number: 1050
The Cost-effectiveness of Glucagon-Like Peptide-1 Receptor Agonists (GLP1RAs) for Patients with Knee Osteoarthritis and Obesity
- 10:30AM-12:30PM
-
Abstract Number: 0924
The Cytosolic DNA Sensor AIM2 Regulates Bone Homeostasis Through Bone Progenitor Cell Differentiation
- 10:30AM-12:30PM
-
Abstract Number: 1361
The Effect of Disease Activity on Cardiovascular Risk Varies According to Rheumatoid Factor and Anticitrullinated Protein Antibody Status in Patients with Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 1373
The Effect of Methotrexate on Lipid and Apolipoprotein Levels in RA Goes Hand-in-hand with EULAR Response
- 10:30AM-12:30PM
-
Abstract Number: 1183
The Effectiveness of Orthosis for the Management of Hand Osteoarthritis-a Systemic Review and Meta-analysis
- 10:30AM-12:30PM
-
Abstract Number: 0919
The Effects of CB2R Activation on Inflammatory Pathways in Dermatomyositis
- 10:30AM-12:30PM
-
Abstract Number: 1278
The Effects of Fatigue on Self-Reported Mental and Physical Health in Childhood-Onset Systemic Lupus Erythematosus: A Cross-Sectional Study
- 10:30AM-12:30PM
-
Abstract Number: 0960
The Esophageal Epithelium in Systemic Sclerosis: Cellular and Molecular Dysregulation Revealed by Single-Cell RNA Sequencing
- 10:30AM-12:30PM
-
Abstract Number: 1447
The Frequency of Diffuse Idiopathic Skeletal Hyperostosis (DISH) in Spondyloarthritis in Comparison to Age and Sex-matched Controls and Impact of SpA on Onset Age of DISH
- 10:30AM-12:30PM
-
Abstract Number: 1257
The Immune and Growth Characteristics of Children Born to Mothers with Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 1254
The Impact of Eosinophilic Granulomatosis with Polyangiitis on the Health-Related Quality of Life of Patients and Their Ability to Work: Evidence from a Real-World Survey in Clinical Practice
- 10:30AM-12:30PM
-
Abstract Number: 1019
The Impact of Race and Ethnicity and Historical Redlining on Psoriatic Disease Burden
- 10:30AM-12:30PM
-
Abstract Number: 1285
The Impact of Race and Social Determinants of Health on Patient Reported Outcomes in Pediatric Lupus: A CARRA Registry Study
- 10:30AM-12:30PM
-
Abstract Number: 1313
The Impact of Rheumatology Fellow Initiated Curriculum Design on Resident Education for R1 versus R2-R4 Learners
- 10:30AM-12:30PM
-
Abstract Number: 1095
The Incidence of Gout Among Individuals with Hyperuricemia over Time – an Insight from a Nationwide Cohort Study
- 10:30AM-12:30PM
-
Abstract Number: 1520
The Influence of Trauma on Features of Type 2 SLE
- 10:30AM-12:30PM
-
Abstract Number: 0979
The Joint Project: A Community-Based, Barangay Health Worker-Led Screening Program for Childhood Musculoskeletal Disorders in a Barangay in San Pedro, Laguna, Philippines
- 10:30AM-12:30PM
-
Abstract Number: 1082
The Journey of a Patient with Psoriatic Arthritis: The Path from Diagnosis to Treatment
- 10:30AM-12:30PM
-
Abstract Number: 1108
The Needed Daily Dose of Colchicine in Patients with Familial Mediterranean Fever May Be Higher in Women, a Study on Behalf of the JIR Cohort
- 10:30AM-12:30PM
-
Abstract Number: 1059
The Negative Impact of Physicians’ Neuroticism and Conscientiousness on Shared Decision Making in Patients with Systemic Lupus Erythematosus: The TRUMP2-SLE Project
- 10:30AM-12:30PM
-
Abstract Number: 1126
The Outcomes of Carpal Tunnel Injections and Carpal Tunnel Surgery
- 10:30AM-12:30PM
-
Abstract Number: 1118
The Performance of Behcet’s Disease Clinical Diagnostic Criteria in a Low Prevalence Region. A Retrospective Single Center Cohort Study
- 10:30AM-12:30PM
-
Abstract Number: 1226
The Problem of Pain in Systemic Lupus Erythematosus: A Comprehensive Analysis of Pain Distribution Using the CHOIR Body Map and PROMIS Measures
- 10:30AM-12:30PM
-
Abstract Number: 1448
The Proportion of Inflammatory Back Pain Patients with an Abnormal Sacral MRI in a Community-Based Primary Care Setting
- 10:30AM-12:30PM
-
Abstract Number: 1195
The Relations of Analgesic Antidepressants Use to Knee or Hip Replacement Among Osteoarthritis Patients Compared to Selective Serotonin Reuptake Inhibitors in a Large Prospective Cohort
- 10:30AM-12:30PM
-
Abstract Number: 1262
The Relationship Between Child Opportunity Index and Burden of Pediatric Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 1586
The Relationship Between the Presence, Quantity and Distribution of Cutaneous Telangiectasia and Other Vascular Manifestations of Systemic Sclerosis
- 10:30AM-12:30PM
-
Abstract Number: 1103
The Role of Renal Dual-Energy CT in Exploring the Gouty Kidney: The RENODECT Study
- 10:30AM-12:30PM
-
Abstract Number: 0883
The Study of 62 Circulating Soluble Factors Is Able to Predict the Lack of Response to MTX Treatment in Recently Diagnosed DMARD Naïve Rheumatoid Arthritis Smoker and Non-Smoker Patients
- 10:30AM-12:30PM
-
Abstract Number: 1502
The Systemic Lupus International Collaborating Clinics (SLICC) Frailty Index (SLICC-FI) Predicts Hospitalizations. Data from the Almenara Lupus Cohort
- 10:30AM-12:30PM
-
Abstract Number: 1465
The Use of Disease Activity Thresholds for the Psoriatic Arthritis Impact of Disease Questionnaire to Assess Patient Perceptions of Disease Burden in Patients with Early Oligoarticular Psoriatic Arthritis Treated with Apremilast in a Phase 4 Trial
- 10:30AM-12:30PM
-
Abstract Number: 1276
Therapeutic Drug Monitoring (TDM) of Rituximab to Predict Early B-Cell Repopulation in Children
- 10:30AM-12:30PM
-
Abstract Number: 1060
Therapeutic Hydroxychloroquine Blood Levels Predict Lower Mean Frequency of Recurrent Acute Care Utilization in Lupus
- 10:30AM-12:30PM
-
Abstract Number: 1524
Thrombocytopenia and Systemic Lupus Erythematosus: A Meta-analysis of Observational Studies
- 10:30AM-12:30PM
-
Abstract Number: 1039
Through the LuCIN Lens: Defining Barriers and Forging Solutions for Lupus Clinical Trials in North America
- 10:30AM-12:30PM
-
Abstract Number: 1467
Time to First Clinically Meaningful Efficacy Responses in Musculoskeletal and Patient Reported Outcomes in Patients with Active Psoriatic Arthritis Treated with Risankizumab: A Post Hoc Analysis of the Phase 3 KEEPsAKE 1 and KEEPsAKE 2 Trials
- 10:30AM-12:30PM
-
Abstract Number: 1209
Time to Knee Replacement by Kellgren-Lawrence Grade and Presence of Frequent Knee Pain in Two Large and Diverse Longitudinal Cohorts: Data from MOST and OAI
- 10:30AM-12:30PM
-
Abstract Number: 1492
Timing of SLEDAI-2K Item Improvements During the First Year of Intravenous Anifrolumab Treatment of Moderate to Severe SLE
- 10:30AM-12:30PM
-
Abstract Number: 0946
Tissue Resident Monocyte-lineage Cells (TR-MC) Exist as Two Different Subpopulations
- 10:30AM-12:30PM
-
Abstract Number: 1507
To Develop a Method for Estimating Interferon Signatures in SLE from Routine Clinical Laboratory Tests
- 10:30AM-12:30PM
-
Abstract Number: 1378
Tocilizumab Effect on the Three Pathways of the Complement System in Patients with Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 1628
Tocilizumab for Giant Cell Arteritis in Japan over 2 Years: A Multicenter Retrospective Study
- 10:30AM-12:30PM
-
Abstract Number: 1010
Total Cost Risk Scores and Barrier Categories in Patients with Axial Spondyloarthritis and Associated Factors
- 10:30AM-12:30PM
-
Abstract Number: 1260
Toward a Treat-to-target Strategy in Juvenile Dermatomyositis: Seeking for Suitable Targets and Optimal Timing of Their Achievement
- 10:30AM-12:30PM
-
Abstract Number: 1494
Trajectories of Disease Evolution upon Treatment Initiation in Systemic Lupus Erythematosus: Pooled Results from Three Randomized Clinical Trials of Belimumab
- 10:30AM-12:30PM
-
Abstract Number: 0940
Trans-endothelial Migration of Synovial Fibroblasts Promotes Arthritis Severity Through a PKD1-mediated Feedback Loop
- 10:30AM-12:30PM
-
Abstract Number: 0967
Transcriptional Heterogeneity of Immune Cells in the Esophagus of Systemic Sclerosis Patients: A Comparison of Upper and Lower Esophageal Regions
- 10:30AM-12:30PM
-
Abstract Number: 1457
Treat-to-Target Approaches in Early Psoriatic Arthritis: Early Secukinumab versus Standard Care – 12- and 24-Week Results from a Multicenter, Open-Label, Randomized Controlled Trial
- 10:30AM-12:30PM
-
Abstract Number: 1194
Treatment Effect of Lorecivivint Across Multiple Trials in Patients with Knee OA: A Meta-analysis
- 10:30AM-12:30PM
-
Abstract Number: 1119
Treatment Outcomes of TNF-α Inhibitors in Cardiac Sarcoidosis
- 10:30AM-12:30PM
-
Abstract Number: 1454
Treatment Patterns, Clinical Characteristics, and Patient-Reported Outcomes Among Patients with Axial Spondyloarthritis Treated in Real-World Rheumatology Practices in the US
- 10:30AM-12:30PM
-
Abstract Number: 1523
Trend Analysis of Lupus Nephritis Flares, Mortality, and Disparities: 2016-2020
- 10:30AM-12:30PM
-
Abstract Number: 0998
Trends and Disparities in Cardiovascular Deaths in Systemic Lupus Erythematosus: A Population-Based Retrospective Study in the United States from 1999 to 2021
- 10:30AM-12:30PM
-
Abstract Number: 1349
Two Composite Cytokine Scores Predict Flare and Drug-free Remission in Patients with Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 1497
Type I Interferon Status and Clinical Manifestations in a Large Cohort of Patients with Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 1416
Ultrasound (US)-guided Core-needle Biopsy (CNB) of the Non-swollen Parotid Gland: A Feasible and Well-tolerated Technique for Diagnosing and Stratifying Sjögren’s Disease (SjD)
- 10:30AM-12:30PM
-
Abstract Number: 1639
Ultrasound Fast-Track Giant Cell Arteritis Clinic Experience in the United States
- 10:30AM-12:30PM
-
Abstract Number: 1193
Ultrasound-Guided Corticosteroid Injection versus Iontophoresis in Rhizarthrosis: A Prospective Comparative Multicentric Study
- 10:30AM-12:30PM
-
Abstract Number: 0893
Uncovering Common and Distinctive Molecular Profiles Between Early and Stablished Rheumatoid Arthritis Through Integrative Multi-omics Analysis and Its Association with Disease Status and Clinical Response
- 10:30AM-12:30PM
-
Abstract Number: 1116
Understanding the Prevalence, In-Hospital Mortality and Readmission Rates Amongst Pulmonary vs Cardiac Sarcoidosis Patients: Insights from a Nationwide Registry
- 10:30AM-12:30PM
-
Abstract Number: 1284
Unlocking Insights into Juvenile Dermatomyositis: Clinical and Demographic Profiles Paired with Total Improvement Scores at a Tertiary Center
- 10:30AM-12:30PM
-
Abstract Number: 0889
Unraveling the Progression of Sjögren’s Disease at the Cellular and Histological Level Using Single-cell and Spatial Transcriptomics
- 10:30AM-12:30PM
-
Abstract Number: 1620
Unveiling of a New Molecular Imaging Biomarker? Vascular Adhesion Protein-1 and [68Ga]Ga-DOTA-Siglec-9 PET/CT in Detecting Giant Cell Arteritis Relapse
- 10:30AM-12:30PM
-
Abstract Number: 1372
Upadacitinib and Other JAK Inhibitors in the Treatment of Rheumatoid Arthritis – Interstitial Lung Disease. National Multicenter Study Clinical Practice.
- 10:30AM-12:30PM
-
Abstract Number: 1370
Upadacitinib vs TNFi and Other JAKi Treatment Outcomes in Australian Rheumatoid Arthritis Patients: Descriptive Comparison of Persistence and Effectiveness Using the OPAL Dataset
- 10:30AM-12:30PM
-
Abstract Number: 0982
Urinary Incontinence Among Individuals with Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 1534
Use and Safety of Sodium-Glucose Cotransporter-2 Inhibitors Among Patients with Lupus Nephritis and Clinical Indications
- 10:30AM-12:30PM
-
Abstract Number: 1011
Use of the Shingrix Vaccine Among Patients with Inflammatory Arthritis and Risk of Cardiovascular Events Following Herpes Zoster
- 10:30AM-12:30PM
-
Abstract Number: 1294
Using Case-Based Continuing Education to Identify and Address Knowledge and Behavior Gaps in ANCA-associated Vasculitis
- 10:30AM-12:30PM
-
Abstract Number: 1410
Using Social Listening to Understand the Patient Voice: The Daily Impacts of Sjögren’s Disease
- 10:30AM-12:30PM
-
Abstract Number: 1342
Utility of Anti-Carbamylated Antibodies in Early Rheumatoid Arthritis in South Asian Population
- 10:30AM-12:30PM
-
Abstract Number: 1061
Utilization of Electronic Health Record System to Improve Glucocorticoid Induced Osteoporosis Screening and Treatment
- 10:30AM-12:30PM
-
Abstract Number: 1054
Utilization of Rehabilitation Services in Patients with Common Rheumatic Conditions: A Systematic Review
- 10:30AM-12:30PM
-
Abstract Number: 1526
Utilizing Electronic Health Records to Identify Clinical Features of ANA-Positive Patients Imparting High Risk for Progression to Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 1604
Utilizing Machine Learning with Claims Data to Diagnose and Quantify the Prevalence of Eosinophilic Granulomatosis with Polyangiitis
- 10:30AM-12:30PM
-
Abstract Number: 0929
UVB-Induced Keratinocyte-Derived Extracellular Vesicles: Cytokeratin 10 as a Marker of Epidermal Origin
- 10:30AM-12:30PM
-
Abstract Number: 1461
Uveitis in Axial Spondyloarthritis: Study of 309 Patients in a Single University Center
- 10:30AM-12:30PM
-
Abstract Number: 0977
Vaccine Effectiveness and Safety of Recombinant Zoster Vaccine (RZV) in Rheumatoid Arthritis (RA) Patient Populations Aged 50 Years and Older
- 10:30AM-12:30PM
-
Abstract Number: 1588
Validation of a Lung Ultrasound Interpretation Criteria for Interstitial Lung Disease Screening in Systemic Sclerosis and Inflammatory Myopathy
- 10:30AM-12:30PM
-
Abstract Number: 1509
Validation of a Score for the Prediction of Serious Infection in Patients with Systemic Lupus Erythematosus: Data from a Latin American Lupus Cohort
- 10:30AM-12:30PM
-
Abstract Number: 1535
Variations in Tacrolimus Whole Blood Concentrations During Pregnancy and Its Implications for Therapeutic Drug Monitoring: A Systematic Review and Meta-analysis
- 10:30AM-12:30PM
-
Abstract Number: 1559
Vectorcardiography for Identification of Systemic Sclerosis Patients at Risk for Pulmonary Hypertension
- 10:30AM-12:30PM
-
Abstract Number: 1049
Very Low Uptake of Biosimilar Adalimumab in the First 9 Months of Availability in Rheumatology
- 10:30AM-12:30PM
-
Abstract Number: 0992
Visceral Adipose Tissue Measured by DXA Predicts Metabolic Syndrome in Low-Income Community-Dwelling Elderly: Insights from the São Paulo Ageing & Health (SPAH) Study
- 10:30AM-12:30PM
-
Abstract Number: 1616
Vitamin D Supplementation in the Prevention of Severe Adverse Effects Caused ByGlucocorticoids: Study from the ARTESER Registry of Giant Cell Arteritis
- 10:30AM-12:30PM
-
Abstract Number: 1185
Walking Is Associated with Less Knee Pain: A Cross-sectional Study from the Osteoarthritis Initiative
- 10:30AM-12:30PM
-
Abstract Number: 1288
Wellness, Resilience and Burnout Among Pediatric Rheumatology Fellows
- 10:30AM-12:30PM
-
Abstract Number: 1298
What Is an ANA and Why Should I Care? Strategies to Increase Understanding of Basic Rheumatologic Labs Within Medical Education
- 10:30AM-12:30PM
-
Abstract Number: 0995
What Is the Carbon Footprint of Adalimumab Originator and Its Various Biosimilar Drugs?
- 10:30AM-12:30PM
-
Abstract Number: 1339
When Medications Fail: A Mixed Methods Study Evaluating the Experience and Health-Related Quality of Life (HRQOL) of Adults with Rheumatoid Arthritis Non-Responsive to Treatment
- 10:30AM-12:30PM
-
Abstract Number: 1326
Which Biomarkers Indicate Imminent Progression to Inflammatory Arthritis in High Risk CCP Positive Persons?
- 10:30AM-12:30PM
-
Abstract Number: 1589
Whole Skin Gene Expression Analysis Identifies Discrete Modules That Differentiate Antinuclear Antibody Subsets in Systemic Sclerosis
- 10:30AM-12:30PM
-
Abstract Number: 1277
Why Did You Choose That Score? – Associations Between Patient Global Assessment Scores and Mental Health in Patients with Juvenile Idiopathic Arthritis and Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 1500
Work-Related Disability and Function in Systemic Lupus Erythematosus (SLE): Outcomes of an Exploratory Study from Different Canadian Centres
- 10:30AM-12:30PM
-
Abstract Number: 0878
YY1 a Potential Modulator of IL17/IL23 Axis in Psoriasis Disease
- 10:30AM-12:30PM
-
Abstract Number: 0877
Zasocitinib (TAK-279) Displays High Levels of TYK2 Inhibition and No Inhibition of JAK 1/3 Compared with Licensed TYK2 and JAK Inhibitors
- 10:30AM-12:30PM
-
Abstract Number: 1477
Zasocitinib (TAK-279), a Highly Selective Oral Tyrosine Kinase 2 (TYK2) Inhibitor, Elicits Early Skin Responses and Minimal Disease Activity in Patients with Active Psoriatic Arthritis: Results from a Randomized Phase 2b Study
- 10:30AM-12:30PM
-
Abstract Number: 1131
Zasocitinib (TAK-279), a Selective Oral Tyrosine Kinase 2 Inhibitor, Reduces Body Surface Area Involvement in a Phase 2b Trial in Moderate-to-Severe Plaque Psoriasis
- 1:00PM-2:30PM
-
Abstract Number: 1683
68Ga-FAPI PET/CT Imaging for Assessing Renal Tubulointerstitial Fibrosis in Lupus Nephritis
- 1:00PM-2:30PM
-
Abstract Number: 1699
Anakinra in Giant Cell Arteritis: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial
- 1:00PM-2:30PM
-
Abstract Number: 1671
Are Patient-reported Outcomes for Dactylitis, Uveitis, Psoriatic Skin and Nail Disease Valid in Patients with Psoriatic Arthritis?
- 1:00PM-2:30PM
-
Abstract Number: 1673
Assessing the Feasibility of a Mediterranean-Style Diet for Patients with Rheumatoid Arthritis in a Racially and Culturally Diverse Population Across the United States
- 1:00PM-2:30PM
-
Abstract Number: 1698
Assessment of the Remission Maintenance After Tocilizumab Withdrawal in Polymyalgia Rheumatica Patients Receiving a 6-month Treatment
- 1:00PM-2:30PM
-
Abstract Number: 1668
Association of Wearable-Sensor Derived Gait Measures with Widespread Pain over 2 Years: A Machine Learning Analysis in the Multicenter Osteoarthritis Study
- 1:00PM-2:30PM
-
Abstract Number: 1684
Autoantibodies to Transcription Factor a Mitochondria Are Associated with Damage Accrual, Malignancy Risk and Mortality in SLE
- 1:00PM-2:30PM
-
Abstract Number: 1649
B Cell Subset Contribution to Autoantibodies in Lupus
- 1:00PM-2:30PM
-
Abstract Number: 1693
Change in Forced Vital Capacity at Week 12 or 24 Has Prognostic Value for Outcome at Week 52 in Patients with Autoimmune Disease-Related Interstitial Lung Diseases
- 1:00PM-2:30PM
-
Abstract Number: 1676
Changing Patients’ Mindsets About Non-Severe Side Effects of Methotrexate: A Randomized Controlled Trial
- 1:00PM-2:30PM
-
Abstract Number: 1700
Comparative Effectiveness of Sarilumab vs. Methotrexate as a Glucocorticoid-Sparing Agent in Patients with Polymyalgia Rheumatica
- 1:00PM-2:30PM
-
Abstract Number: 1696
Comparison of Mycophenolate Mofetil Plus Methotrexate versus Cyclophosphamide with Sequential Azathioprine for Active Takayasu’s Arteritis: An Open-Label, Randomized-Controlled Trial
- 1:00PM-2:30PM
-
Abstract Number: 1667
Correlates of Physical Activity (PA) in Persons Undergoing Total Knee Arthroplasty (TKA): Does Pain Matter?
- 1:00PM-2:30PM
-
Abstract Number: 1654
CRTAC1 in Osteoarthritis: Implications for Disease Severity and miRNA Regulation
- 1:00PM-2:30PM
-
Abstract Number: 1679
Differential Pharmacodynamic Changes of Circulated Immune Subsets After Treatment with Abatacept or Adalimumab in Patients with ACPA+ Early RA in the AMPLIFIED Study
- 1:00PM-2:30PM
-
Abstract Number: 1688
Discovery and Validation of a New Classification of ANA-RMDs That Better Predict Long Term Outcomes Compared to Legacy Diagnoses
- 1:00PM-2:30PM
-
Abstract Number: 1682
Early Development of Ocadusertib, a Selective Receptor-Interacting Serine/Threonine-Protein Kinase 1 Inhibitor
- 1:00PM-2:30PM
-
Abstract Number: 1695
Efficacy of Upadacitinib in Patients with Giant Cell Arteritis: Subgroup Analysis of the SELECT-GCA Phase 3 Trial
- 1:00PM-2:30PM
-
Abstract Number: 1678
Efficacy, Safety, Pharmacokinetics of Anti-CD40 Antibody Abiprubart in Patients with Rheumatoid Arthritis: A Phase 2, Randomized, Placebo-Controlled 12-week-treatment Proof-of-Concept Study
- 1:00PM-2:30PM
-
Abstract Number: 1675
Extended Validation of the IgG4-Related Disease Symptom Severity Index (SSI)
- 1:00PM-2:30PM
-
Abstract Number: 1652
Extracellular Vesicles from Lymphocyte B and Neutrophil Presents Ro52, Ro60 and La Autoantigens in Patient Suffering from Sjögren Syndrome
- 1:00PM-2:30PM
-
Abstract Number: 1690
FAPI-PET/CT as a Predictor of Accelerated Lung Function Deterioration in Systemic Sclerosis Related Interstitial Lung Disease (ILD): Preliminary-interim Analysis from a Confirmatory Risk Factor Study
- 1:00PM-2:30PM
-
Abstract Number: 1664
Identification of Spatial Determinants of Treatment Response in Rheumatoid Arthritis Synovia
- 1:00PM-2:30PM
-
Abstract Number: 1658
IGF1 Drives Wnt-induced Joint Damage and Is a Therapeutic Target for Osteoarthritis
- 1:00PM-2:30PM
-
Abstract Number: 1687
IgG and IgA anti-LIN28A Outperform Anti-dsDNA and anti-Sm in Distinguishing SLE from Health and Other Autoimmune Diseases
- 1:00PM-2:30PM
-
Abstract Number: 1650
IL-33 Expands Plasma Cells, Disrupts Germinal Centers and Increases Autoantibody Production
- 1:00PM-2:30PM
-
Abstract Number: 1657
Immunological Profiling of Pain in Knee Osteoarthritis: Treg Cells as Potential New Key Players in Symptomatic Knee Osteoarthritis
- 1:00PM-2:30PM
-
Abstract Number: 1648
In Vitro Expansion of ACPA-positive B Cells from Rheumatoid Arthritis Patients and Effect of Small Molecule NF-κB Inhibitors on Differentiation and Survival of (Autoreactive) Memory B Cells into Plasma Cells
- 1:00PM-2:30PM
-
Abstract Number: 1656
Loss of Nr4a1 Expression Protects Cartilage During Post-traumatic Osteoarthritis
- 1:00PM-2:30PM
-
Abstract Number: 1665
Multicenter Randomized Controlled Trial of Physical Therapy (PT) or Sham PT in Persons with Knee Pain, Meniscal Tear, and Osteoarthritic Imaging Changes
- 1:00PM-2:30PM
-
Abstract Number: 1663
Notch—mediated Fibrogenic Activation Is a Spatial Determinant of RA Treatment Response
- 1:00PM-2:30PM
-
Abstract Number: 1694
One-Year Survival Following Single versus Double Lung Transplantation in Adults with Systemic Autoimmune Rheumatic Disease-related Interstitial Lung Disease: A Nationwide Cohort Study
- 1:00PM-2:30PM
-
Abstract Number: 1653
Osteoarthritis Drives Inflammatory Imprinting of Synovial Fibroblasts, Exacerbating Gouty Arthritis Through m6A Modification of S100A4
- 1:00PM-2:30PM
-
Abstract Number: 1655
Peroxisome Proliferator-Activated Receptor α Is a Disease-Modifying Target for Osteoarthritis
- 1:00PM-2:30PM
-
Abstract Number: 1670
Predictors of 6-Minute Walk Test Performance in Adults with Arthritis
- 1:00PM-2:30PM
-
Abstract Number: 1666
Preliminary Effects of a Fully-Remote Online Physical Activity Program Following Knee Replacement
- 1:00PM-2:30PM
-
Abstract Number: 1689
Pulmonary Function Test Reference Equations May Drive Inequitable Classification of Restrictive Lung Disease Severity in Systemic Sclerosis
- 1:00PM-2:30PM
-
Abstract Number: 1680
Reporting Quality of Non-inferiority and Equivalence Rheumatoid Arthritis Randomized Clinical Trials: A Systematic Review
- 1:00PM-2:30PM
-
Abstract Number: 1697
Results of a One Year Randomized Double-Blind Placebo-Controlled Trial with Methotrexate 25mg Per Week for Recently Diagnosed PolyMyalgia Rheumatica
- 1:00PM-2:30PM
-
Abstract Number: 1661
Rheumatoid Arthritis Synovial Fibroblast Modulation of T Cell Activation
- 1:00PM-2:30PM
-
Abstract Number: 1681
Safe Switching from Originator Tocilizumab to MSB11456 Tocilizumab Biosimilar in Subjects with Moderate-to-Severe Rheumatoid Arthritis: Efficacy, Safety and Immunogenicity Data Following Treatment Transition in a Pivotal, Randomized, Double-blind, Phase III Study
- 1:00PM-2:30PM
-
Abstract Number: 1677
Safety and Efficacy of FNS007, a Non-T Cell Receptor Contacting Peptide, for Patients with Active Rheumatoid Arthritis: A Randomized, Double-blind, Placebo-controlled, Proof-of-concept Trial
- 1:00PM-2:30PM
-
Abstract Number: 1659
Shared Lung and Joint T Cell Repertoire in Early Rheumatoid Arthritis Driven by Cigarette Smoking
- 1:00PM-2:30PM
-
Abstract Number: 1692
Single Cell RNA-seq Identifies Circulating Double-negative-2 B-cell Population Associated with Progressive Scleroderma Interstitial Lung Disease
- 1:00PM-2:30PM
-
Abstract Number: 1660
Systemic Inflammation and Transcriptional Reprogramming Contribute to Progression to Active Rheumatoid Arthritis in ACPA+ Individuals
- 1:00PM-2:30PM
-
Abstract Number: 1672
The Evaluation of SLE Outcome Measures in Telemedicine
- 1:00PM-2:30PM
-
Abstract Number: 1685
The Renal Activity Index for Lupus (RAIL) Identifies Active Renal Disease in SLE Patients and Its Longitudinal Score Associates with Achievement of Renal Responses in Lupus Nephritis
- 1:00PM-2:30PM
-
Abstract Number: 1691
Treatment Response Biomarkers for Systemic Sclerosis-Associated Interstitial Lung Disease
- 1:00PM-2:30PM
-
Abstract Number: 1651
Unlocking the Secrets of Breg Dysfunction in Lupus: Glycosylation Patterns as Therapeutic Targets
- 1:00PM-2:30PM
-
Abstract Number: 1686
Urine Proteomics in Class II Lupus Nephritis Reveals Immune Activation and Pro-Fibrotic Signatures
- 1:00PM-2:30PM
-
Abstract Number: 1662
Using Circulating Soluble Serum Mediator Profiles to Understand the Mechanisms Driving Disease Flare and Drug-free Remission in Rheumatoid Arthritis
- 1:00PM-2:30PM
-
Abstract Number: 1674
Variability in Pain and Depression Measures Between Adolescent Patients with Rheumatic Disease and Caregivers
- 1:00PM-2:30PM
-
Abstract Number: 1669
Will Investigators Enroll? A Vignette Study to Gauge Investigator Equipoise in a Trial of Surgery vs. Nonoperative Therapy in Subjects with Meniscal Tear and Persistent Pain Following Physical Therapy
- 3:00PM-4:30PM
-
Abstract Number: 1753
A Phase 1, Multicenter, Open-Label Study to Establish the Preliminary Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of CC-97540 (BMS-986353), a CD19-directed CAR T Cell Therapy Manufactured Using a Next-generation Process, for Severe, Refractory Autoimmune Diseases
- 3:00PM-4:30PM
-
Abstract Number: 1760
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of a Mitogen-activated Protein Kinase-Activated Protein Kinase 2 (MK2) Inhibitor in Active Ankylosing Spondylitis
- 3:00PM-4:30PM
-
Abstract Number: 1739
Adult and Pediatric Rheumatology Fellow Education on Temporomandibular Joint (TMJ) Arthritis in Patients with Juvenile Idiopathic Arthritis
- 3:00PM-4:30PM
-
Abstract Number: 1744
Artificial Intelligence: A Novel Tool in the Belt for Improving Rheumatoid Arthritis Outcomes in the National Health Service, United Kingdom
- 3:00PM-4:30PM
-
Abstract Number: 1714
Avoidable Hospitalizations by Persons with Rheumatoid Arthritis: A Population-Based Study Using Administrative Data
- 3:00PM-4:30PM
-
Abstract Number: 1731
Baricitinib in the Treatment of Adult Idiopathic Inflammatory Myopathy: A Randomized, Treatment Delayed-Start Clinical Trial
- 3:00PM-4:30PM
-
Abstract Number: 1757
Bimekizumab Treatment Resulted in Improvements in MRI Inflammatory and Structural Lesions in the Sacroiliac Joints of Patients with Axial Spondyloarthritis: 52-Week Results and Post Hoc Analyses from Two Phase 3 Studies
- 3:00PM-4:30PM
-
Abstract Number: 1704
Cluster Analysis of Peripheral Blood Mononuclear Cell Subpopulations Using Deep Immunophenotyping, Multiplex Serum Cytokines and Small Lipid Mediators at the Very Early Stages of Steroid Treatment in Polymyalgia Rheumatica and Giant Cell Arteritis
- 3:00PM-4:30PM
-
Abstract Number: 1723
Clustering Analysis with Unsupervised Machine Learning Process to Phenotype the Cardiovascular Risk of Patients with Rheumatoid Arthritis Beyond the 10-year Prediction Algorithm
- 3:00PM-4:30PM
-
Abstract Number: 1754
Comparing the Molecular Landscape of the CAR-T Cell and Rituximab Mediated Remission in Systemic Lupus Erythematosus
- 3:00PM-4:30PM
-
Abstract Number: 1716
Comparing the Risk of Severe Infections Associated with Different Classes of Biologic or Targeted Synthetic Agents for Inflammatory Arthritis: A Population-based Study
- 3:00PM-4:30PM
-
Abstract Number: 1713
Comparisons of Non-TNFi Biologic and Targeted Synthetic DMARDs in Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Propensity Score-Matched Study Using National Veterans Affairs Data
- 3:00PM-4:30PM
-
Abstract Number: 1719
Cumulative Glucocorticoid Exposure and Major Adverse Cardiovascular Events in a Cohort of Veterans with Rheumatoid Arthritis: A Nested Case-Control Study
- 3:00PM-4:30PM
-
Abstract Number: 1705
Deep Phenotyping Characterization of Peripheral Natural Killer Cells Reveals Impaired Cytotoxicity and Exhaustion During VEXAS Syndrome
- 3:00PM-4:30PM
-
Abstract Number: 1727
Duration of SARS-CoV-2 Viral Shedding After Infection Among Patients with Rheumatic Disease Using Tumor Necrosis Factor Inhibitors or Rituximab
- 3:00PM-4:30PM
-
Abstract Number: 1717
Early Antimalarial Adherence Reduces Future Hospitalization Cost in Rheumatoid Arthritis and Systemic Lupus Erythematosus Patients: Evidence from a Population-based Study
- 3:00PM-4:30PM
-
Abstract Number: 1736
Effectiveness and Safety of Tofacitinib vs. Calcineurin Inhibitor in Interstitial Lung Disease Secondary to Anti-Melanoma Differentiation-Associated Gene 5-Positive Dermatomyositis: A Multi-Center Cohort Study with Propensity Score-Based Inverse Probability of Treatment Weighting
- 3:00PM-4:30PM
-
Abstract Number: 1725
Exploring Risks of Polymyalgia Rheumatica (PMR), Giant Cell Arteritis (GCA) and Complications While Receiving Immune Checkpoint Inhibitors: Comparative Analysis
- 3:00PM-4:30PM
-
Abstract Number: 1710
Extl3 Involved in the Regulation of Endochondral Ossification in Axial SpA
- 3:00PM-4:30PM
-
Abstract Number: 1748
Fracture Incidence Rates in Persons with Rheumatoid Arthritis by Disease Activity Level
- 3:00PM-4:30PM
-
Abstract Number: 1746
Global Recruiting Patterns Are Associated with Placebo Response Rates in Clinical Trials of Rheumatoid Arthritis
- 3:00PM-4:30PM
-
Abstract Number: 1720
Herpes Zoster Risk Following Initiation of Immunosuppressive Therapy Among Adults with Rheumatic Disease
- 3:00PM-4:30PM
-
Abstract Number: 1735
High-Intensity Interval Training Outperforms Moderate Exercise in Aerobic Capacity for Recent-Onset Idiopathic Inflammatory Myopathies: A Randomized Controlled Trial
- 3:00PM-4:30PM
-
Abstract Number: 1728
Higher Oral Steroid Dose Is Associated with Worse Survival in Immune Checkpoint Inhibitor-Treated Rheumatoid Arthritis Patients with Metastatic Non-Small Cell Lung Cancer
- 3:00PM-4:30PM
-
Abstract Number: 1738
How Do Resident Physicians Choose a Career in Rheumatology?A Qualitative Analysis of Journey Maps
- 3:00PM-4:30PM
-
Abstract Number: 1711
Identification of Psoriatic Arthritis-related Pathways Using Multi-omics Data Integration
- 3:00PM-4:30PM
-
Abstract Number: 1741
Implementing Strengths-Based, Positive Approaches Within Rheumatology Fellowship Training: A Realist Evaluation of Appreciative Inquiry-Based Interventions
- 3:00PM-4:30PM
-
Abstract Number: 1732
In Vitro Screening of siRNAs Designed to Knockdown Interferon Beta as a Novel Therapeutic Approach for Treatment of Adult and Juvenile Dermatomyositis
- 3:00PM-4:30PM
-
Abstract Number: 1722
Machine Learning-based Risk Stratification Tool to Predict Early Flare for Rheumatic and Musculoskeletal Diseases
- 3:00PM-4:30PM
-
Abstract Number: 1758
Minimal Spinal Radiographic Progression in Patients with Radiographic Axial Spondyloarthritis over 2 Years of Bimekizumab Treatment: Results from a Phase 3 Open-Label Extension Study
- 3:00PM-4:30PM
-
Abstract Number: 1715
Mortality Trends for Systemic Connective Tissue Diseases Across the United States from 1999 to 2020: A CDC-Wonder Database Analysis
- 3:00PM-4:30PM
-
Abstract Number: 1742
Multi-Center Use of an Online Case-Based Simulation to Educate Pediatric Trainees on Musculoskeletal Complaints and High-Value Care
- 3:00PM-4:30PM
-
Abstract Number: 1706
Multi-omic Study in Patients with SITRAME Syndrome
- 3:00PM-4:30PM
-
Abstract Number: 1747
Native Americans Experience Profound Premature Mortality from Rheumatoid Arthritis
- 3:00PM-4:30PM
-
Abstract Number: 1730
Osteoarthritis Is a Risk Factor for Inflammatory Arthritis in Cancer Patients Treated with Immune Checkpoint Inhibitors
- 3:00PM-4:30PM
-
Abstract Number: 1724
Performance of a Novel Cardiovascular Risk Calculator in Rheumatoid Arthritis
- 3:00PM-4:30PM
-
Abstract Number: 1740
Performance of Large Language Models in Rheumatology Board-Like Questions: Accuracy, Quality, and Safety
- 3:00PM-4:30PM
-
Abstract Number: 1702
Placental Developmental Defects in a Humanized-TLR8 Mouse Model of Spontaneous Anti-Phospholipid Antibody Induced Pregnancy Loss
- 3:00PM-4:30PM
-
Abstract Number: 1751
Precision Targeting of Autoreactive 9G4 B Cells in Systemic Lupus Erythematosus Using Engineered Chimeric Antigen Receptor (CAR)- and Chimeric T Cell Receptor (cTCR)-T Cells
- 3:00PM-4:30PM
-
Abstract Number: 1759
Predictors of Radiographic Spinal Progression in Patients with Axial Spondyloarthritis Receiving IL-17A Inhibitor or TNF Inhibitor Therapy over 2 Years: A Post Hoc Analysis of a Phase IIIb Study
- 3:00PM-4:30PM
-
Abstract Number: 1729
Prophylaxis Against Pneumocystis Jerovecii Pneumonia for Patients with Systemic Autoimmune Diseases: Analysis of the Veterans Affairs Database
- 3:00PM-4:30PM
-
Abstract Number: 1718
Randomization to Holding versus Continuing (JAKi, IL17) and Autoimmune Patient Responses to COVID-19 Boosters: Results from the Covid-19 VaccinE Response in Rheumatology Patients (COVER) Study
- 3:00PM-4:30PM
-
Abstract Number: 1721
Recombinant Zoster Vaccine Uptake in US Adults with Rheumatic Disease: A Mixed Methods Analysis
- 3:00PM-4:30PM
-
Abstract Number: 1737
RheumMadness 2024: The Practical Impact of the Practically Perfect Season
- 3:00PM-4:30PM
-
Abstract Number: 1734
Safety and Efficacy Data from a Phase I Trial of Umbilical Lining-Derived Stem Cells (ULSC) in Adult Dermatomyositis/Polymyositis
- 3:00PM-4:30PM
-
Abstract Number: 1733
Safety and Efficacy of CABA-201, a Fully Human, Autologous 4-1BB Anti-CD19 CAR T Cell Therapy in Patients with Immune-Mediated Necrotizing Myopathy and Systemic Lupus Erythematosus from the RESET-MyositisTM and RESET-SLETM Clinical Trials
- 3:00PM-4:30PM
-
Abstract Number: 1749
Safety and Long-term Efficacy of CD19-CAR T-cell Therapy in 30 Patients with Autoimmune Disease
- 3:00PM-4:30PM
-
Abstract Number: 1750
Safety and Preliminary Efficacy of CD19 CAR-T Cell Treatment in Rheumatic Disease – Data from the First Part of the Phase I/II CASTLE Basket Study
- 3:00PM-4:30PM
-
Abstract Number: 1726
Safety, Cancer Progression, and Autoimmune Disease Activity in Patients with Pre-Existing Autoimmune Disease Undergoing CD19 CAR T Cell Therapy for Lymphoma: A Retrospective Comparative Cohort Study
- 3:00PM-4:30PM
-
Abstract Number: 1709
Sex Differences in Serum Proteomic Profiles of Males and Females with Psoriatic Arthritis
- 3:00PM-4:30PM
-
Abstract Number: 1703
Single Cell and Spatial Transcriptomics Implicate Vascular Cell Orchestration of Inflammatory Changes After Ultraviolet Light Exposure
- 3:00PM-4:30PM
-
Abstract Number: 1755
Single Cell TCR Sequencing Suggests Potential Limitations of TRBV9-depleting Therapies in Axial Spondyloarthritis
- 3:00PM-4:30PM
-
Abstract Number: 1701
STING Pathway Activity in SLE Patient Serum Correlates with NFkB Activation, Autoantibody Levels, and a Unique Cytokine Profile That Drives Disease Activity
- 3:00PM-4:30PM
-
Abstract Number: 1752
T Cell-Engaging Bispecific Antibodies to Target Autoreactive 9G4 Idiotope B Cells in Systemic Lupus Erythematosus
- 3:00PM-4:30PM
-
Abstract Number: 1712
Transcriptome Analysis Characterizes the Role of Monocytes in Ankylosing Spondylitis with TNF-blocker Treatment
- 3:00PM-4:30PM
-
Abstract Number: 1707
TRBV9-Targeted Bispecific T Cell-Engaging Antibodies to Reset the Autoreactive T Cell Compartment in Spondyloarthritis and HLA-DQ8 Celiac Disease
- 3:00PM-4:30PM
-
Abstract Number: 1708
Unveiling the Uterine-Joint Axis: Dysbiosis and Subclinical Uterine Inflammation in Female Axial Spondyloarthritis Pathogenesis
- 3:00PM-4:30PM
-
Abstract Number: 1745
Use of Statins and Its Association with Major Adverse Cardiovascular Outcomes with Tofacitinib versus TNF Inhibitors in a Risk-Enriched Population of Patients with Rheumatoid Arthritis
- 3:00PM-4:30PM
-
Abstract Number: 1743
What Are the Benefits of Treating Rheumatoid Arthritis Patients to Remission After Achieving Low Disease Activity in Clinical Practice?
- 3:00PM-4:30PM
-
Abstract Number: 1756
What Is the Impact of Prior TNF Inhibitor Treatment on the Time to Achieve Low Disease Activity and the Durability of Low Disease Activity? Real-world Results Based on 17 858 European Patients with Axial Spondyloarthritis Initiating a TNF Inhibitor or an IL-17A Inhibitor
- 9:00AM-10:30AM
-
Abstract Number: 2528
Activation of the Hes1/Piezo1 Pathway Promotes Mechanical Stress Response and Prevents Glucocorticoid-induced Osteoporosis
- 9:00AM-10:30AM
-
Abstract Number: 2531
CRISPR Deletion Screen in Fibroblasts Identifies Novel Regulators of Inflammation
- 9:00AM-10:30AM
-
Abstract Number: 2527
Efficacy and Safety of Nipocalimab, an Anti-FcRn Monoclonal Antibody, in Primary Sjogren’s Disease: Results from a Phase 2, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study (DAHLIAS)
- 9:00AM-10:30AM
-
Abstract Number: 2529
Improving Outcomes and Narrowing Disparities in Juvenile Idiopathic Arthritis (JIA): A Division-Wide, Equity-Focused Quality Improvement Project
- 9:00AM-10:30AM
-
Abstract Number: 2532
Mortality in Patients with Pre-existing Autoimmune Disease on Immune Checkpoint Inhibitor Therapy
- 9:00AM-10:30AM
-
Abstract Number: 2530
Single-cell Multi-omics Analysis of Reactive Lymph Nodes, Affected Tissues, and Blood Reveals a Naive-like CD4+TRAIL+ T Cell Population That Differentially Directs Effector Anti-nuclear Antigen Reactive Responses in Patients with Sjogren’s Syndrome and Systemic Sclerosis
- 10:30AM-12:30PM
-
Abstract Number: 1855
Identification of Autoreactive Cytotoxic T Cells in ANCA-Associated Vasculitis
- 10:30AM-12:30PM
-
Abstract Number: 2363
“How Quickly Will I Feel Better with This New Drug?” – Rapidity of Treatment Response in Patients with Axial Spondyloarthritis Treated with Bimekizumab: Analysis from Two Phase 3 Studies
- 10:30AM-12:30PM
-
Abstract Number: 2154
“I Have Taken Five Different Kinds of Tablets and Injections, and I Still Have Foot Pain”: An International Outcome Measures in Rheumatology (OMERACT) Qualitative Study Exploring Patient Perspectives of Foot and Ankle Disorders
- 10:30AM-12:30PM
-
Abstract Number: 1882
30-Day Readmission Among Patients with Rheumatoid Arthritis and Their Independent Predictors: Insights from National Readmission Database
- 10:30AM-12:30PM
-
Abstract Number: 1959
A 3-arm, Randomized, Open-label, Parallel Active Controlled, Multicentre International Study to Compare the Response of Ultrasound-assessed Synovitis to Baricitinib, Alone and Combined with Methotrexate versus Etanercept in Rheumatoid Arthritis Patients
- 10:30AM-12:30PM
-
Abstract Number: 2031
A Contemporary Assessment of the Burden of Malignancy in IgG4-Related Disease
- 10:30AM-12:30PM
-
Abstract Number: 2243
A Cross-sectional Study of the Association Between Anxiety State and Various Factors in Patients with Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 2242
A Cross-sectional Study on Predictors of COVID-19 Infection, Admission and Mortality and Effect of Immunomodulating Treatments in Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 2099
A Longitudinal Study of Infrapatellar Fat Pad Morphologies as Predictive Markersin Knee Osteoarthritis
- 10:30AM-12:30PM
-
Abstract Number: 2096
A Model Based on Clinical and Molecular Data Predcits the Risk of Total Joint Replacement Progression in Knee OA Patients from the OAI
- 10:30AM-12:30PM
-
Abstract Number: 2267
A Novel Blood-based Assay That Predicts Clinical Response to TNFα Inhibitors or Janus Kinase Inhibitors in Patients with Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 2172
A Novel Cohort to Assess Longitudinal Glucocorticoid Toxicity in Individuals with Rheumatic Diseases: Objectives, Design, and Initial Baseline Characteristics
- 10:30AM-12:30PM
-
Abstract Number: 2401
A Novel Modeling Approach to Elucidate the Role of Autoantibodies in Complement Activation in SLE
- 10:30AM-12:30PM
-
Abstract Number: 2083
A Novel Scoring System to Predict a Cancer Development in Patients with Idiopathic Inflammatory Myopathy
- 10:30AM-12:30PM
-
Abstract Number: 2410
A Novel Treatment Response Measure for SLE Clinical Trials (TRM-SLE): Selection of Domains and Candidate Measures
- 10:30AM-12:30PM
-
Abstract Number: 1778
A Novel Variant in IRAK2 Results in Immune Dysregulation in Systemic Juvenile Idiopathic Arthritis (sJIA)
- 10:30AM-12:30PM
-
Abstract Number: 2023
A PEGylated Mammalian Uricase Suitable for Intramuscular Administration to Patients with Refractory Chronic Gout
- 10:30AM-12:30PM
-
Abstract Number: 2253
A Phase 1 Single Ascending Dose Study to Evaluate the Safety and Pharmacokinetics of ZB002, an Anti-TNFα mAb Designed for Extended Half-life, in Healthy Volunteers
- 10:30AM-12:30PM
-
Abstract Number: 2254
A Phase 1 Single Ascending Dose Study to Evaluate the Safety and Pharmacokinetics of ZB004, a CTLA-4-Ig Fusion Protein Designed for Increased Binding Affinity and Extended Half-life, in Healthy Volunteers
- 10:30AM-12:30PM
-
Abstract Number: 2008
A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of a Single Dose of ABP-671 in Participants with Chronic Kidney Disease (CKD)
- 10:30AM-12:30PM
-
Abstract Number: L08
A Phase 2b, Randomized, Double-blind, Placebo-controlled, Dose-ranging and Parallel-group Study to Evaluate the Safety and Efficacy of XG005 in Subjects with Painful Osteoarthritis of the Knee
- 10:30AM-12:30PM
-
Abstract Number: 2108
A Pilot Randomized Controlled Trial for Hand Osteoarthritis
- 10:30AM-12:30PM
-
Abstract Number: 2462
A Potent Inhibitor of PAI-1, MDI-2517, Mitigates Disease Severity in Preclinical Models of Systemic Sclerosis
- 10:30AM-12:30PM
-
Abstract Number: 1768
A Potential Role of Longstanding IL-18 Stimulation in the Susceptibility for Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 2171
A Qualitative Exploration of Oral Healthcare Needs Amongst Canadian Patients with Rheumatic Diseases and Their Providers
- 10:30AM-12:30PM
-
Abstract Number: 2132
A Quality Improvement Initiative to Increase Osteoporosis Screening in Internal Medicine Resident Led Primary Care Clinics
- 10:30AM-12:30PM
-
Abstract Number: 1988
A Randomized, Open-Label Study on the Effect of Nipocalimab on Vaccine Responses in Healthy Participants
- 10:30AM-12:30PM
-
Abstract Number: 2359
A Real-World Study on the Clinical Characteristics and Patient Reported Outcomes of Patients with Active AxSpA Prescribed CT-P13 SC in Five European Countries
- 10:30AM-12:30PM
-
Abstract Number: 2075
A Retrospective Cohort Study Assessing Outcomes and Safety in Patients Receiving Low Dose vs High Dose Cyclophosphamide in Myositis Interstitial Lung Disease (ILD)
- 10:30AM-12:30PM
-
Abstract Number: 2414
A Retrospective Comparative Analysis of Cardiovascular Risk Factors, Atherosclerotic Cardiovascular Disease and Statin Use as Secondary Prevention in a Cohort of Patients with Systemic Lupus Erythematosus versus Without Rheumatological Disease from a Single-Center Patient Registry
- 10:30AM-12:30PM
-
Abstract Number: 1871
A Seropositive RA Polygenic Risk Score Does Not Predict Progression to RA in an ACPA Positive Population
- 10:30AM-12:30PM
-
Abstract Number: 2217
A Significant Alteration in Circulating Endocannabinoid Levels in Rheumatoid Arthritis and Fibromyalgia Syndrome Patients and Its Correlation with Diseases Severity
- 10:30AM-12:30PM
-
Abstract Number: 2302
A Specific Molecular Profiling of Secreted Rheumatoid Factors in Sjögren’ S Disease Patients with Lymphoma
- 10:30AM-12:30PM
-
Abstract Number: 2032
A Systematic Review of Treatment Strategies in VEXAS Syndrome
- 10:30AM-12:30PM
-
Abstract Number: 1791
A Transcriptomic Lupus Activity Signature Associates with Cardiovascular Function
- 10:30AM-12:30PM
-
Abstract Number: L14
A Withdrawal Study of Colchicine in Behçet Syndrome
- 10:30AM-12:30PM
-
Abstract Number: L12
A-319, a CD3 X CD19 T Cell Engager (TCE), for the Treatment of Severe/Refractory SLE: Early Evidence of Rapid Reset of Disease-Specific Autoimmunity
- 10:30AM-12:30PM
-
Abstract Number: 1851
Aberrant Tfh Cells Generated by Th17 Cell Plasticity in the Gut Promote Autoimmune Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 1917
Access to Rheumatology Care near Indian Health Service Hospitals for American Indian Communities
- 10:30AM-12:30PM
-
Abstract Number: 2183
Accuracy of AI Tools for Diagnosis of Connective Tissue Disease
- 10:30AM-12:30PM
-
Abstract Number: 1975
Accurate Detection of Arthritis Using Hand-held Thermal Imaging and Machine Learning
- 10:30AM-12:30PM
-
Abstract Number: 2362
Achievement of Remission Defined by Absence of Objective Signs of Inflammation versus ASDAS ID in Patients with Active Axial Spondyloarthritis Treated with Bimekizumab: 52-Week Results from Two Phase 3 Studies
- 10:30AM-12:30PM
-
Abstract Number: 2449
Acid Reflux Triggers Type I Interferon and Persistent Epithelial-mesenchymal Transition in Esophageal Epithelial Cells. a Novel Microenvironment Contribution to the Pathogenesis of Systemic Sclerosis
- 10:30AM-12:30PM
-
Abstract Number: 1817
Activated Macrophages Mediate Loss of Dermal White Adipose Tissue in Fibrotic Skin
- 10:30AM-12:30PM
-
Abstract Number: 2300
Activation of Tissue-Resident T Cells in Sjögren’s Disease with Human Salivary Organoids
- 10:30AM-12:30PM
-
Abstract Number: 2269
Adalimumab Dose Reduction Using Therapeutic Drug Monitoring to Manage Low Disease Activity in Rheumatoid Arthritis: A Single-Blind, Non-Inferiority, Randomized Clinical Trial
- 10:30AM-12:30PM
-
Abstract Number: 2216
Additive Impact of Rheumatoid Arthritis and HBcAb+ on All-cause and Cardiovascular Mortality
- 10:30AM-12:30PM
-
Abstract Number: 2409
Adherence to EULAR Recommendations and Sub Optimal Management of Systemic Lupus Erythematosus in a Network of Community-Based Rheumatology Practices in the United States
- 10:30AM-12:30PM
-
Abstract Number: 1920
Admixture Mapping and Gene-Based Analysis Identifies Rare Variants in Genes in the IL-13 and TGFβ Signaling Pathways in African Americans with Systemic Sclerosis
- 10:30AM-12:30PM
-
Abstract Number: 1967
Advanced Imaging in the Evaluation of Lupus Arthritis: A Systematic Literature Review and Meta-Analysis
- 10:30AM-12:30PM
-
Abstract Number: 2224
Age of Onset of Rheumatoid Arthritis and Radiographic Changes
- 10:30AM-12:30PM
-
Abstract Number: 2454
Age-Adjusted Mortality Rate Trends in Systemic Sclerosis in the United States from 1999 to 2020
- 10:30AM-12:30PM
-
Abstract Number: 2239
Age, Seropositivity and Inflammation Determine Risk versus Benefit of Endogenous Estrogens on Coronary Atherosclerosis in Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 2293
Altered Expression of the MicroRNA Biogenesis Machinery Components Correlates with Inflammatory Parameters in Salivary Glands of Patient with Sjögren’s Disease
- 10:30AM-12:30PM
-
Abstract Number: 1834
Altered Mechanotransduction via Myosin II Contributes to Collagen and IL-6 Production in Systemic Sclerosis Skin
- 10:30AM-12:30PM
-
Abstract Number: 2440
Ambispective, Multicenter Registry of Treatment with Anifrolumab in Real Life in Patients with Systemic Lupus Erythematosus from Spanish Rheumatology Departments (ANIFRO-Reu): Efficacy, Safety and Patient’s Characteristics
- 10:30AM-12:30PM
-
Abstract Number: 2111
An International Patient Survey to Identify Candidate Items for Classifying Early-Stage Symptomatic Knee Osteoarthritis
- 10:30AM-12:30PM
-
Abstract Number: 2158
An MVPA Is MVPA Is MVPA, or Is It? Impact of the Definition of Moderate to Vigorous Physical Activity (MVPA) on Its Amount in Persons with Advanced Knee Osteoarthritis
- 10:30AM-12:30PM
-
Abstract Number: 1822
Analysis of Differential Activation of Lysophosphatidic Acid Regulated Genes in Diffuse and Limited Cutaneous Systemic Sclerosis
- 10:30AM-12:30PM
-
Abstract Number: 2143
Analysis of Effectiveness and Safety of Romosozumab in Patients with Very High Risk of Fracture in a Spanish Population
- 10:30AM-12:30PM
-
Abstract Number: 1869
Analysis of Short-Term Side Effects Following COVID-19 Vaccination in Pregnancies Complicated by Autoimmune Inflammatory Rheumatic Diseases
- 10:30AM-12:30PM
-
Abstract Number: 2126
Analysis of the Evolution of Bone Mineral Density in the Spanish Population: Results of the OsteoSER Study
- 10:30AM-12:30PM
-
Abstract Number: 2492
ANCA Associated Tracheobronchial Disease
- 10:30AM-12:30PM
-
Abstract Number: 2424
Anifrolumab Effects on Response to Influenza Vaccine in SLE
- 10:30AM-12:30PM
-
Abstract Number: L13
Anifrolumab Long-Term Treatment Is More Effective Against Organ Damage Than Standard of Care Alone: Results from an External Control Arm Study on Organ Damage in Phase 3 Clinical Trials and the University of Toronto Lupus Clinic Cohort
- 10:30AM-12:30PM
-
Abstract Number: 1776
Animal Models of Pediatric MOGAD
- 10:30AM-12:30PM
-
Abstract Number: 2427
Anti-CD19 Chimeric Antigen Receptor T Cell Therapy Induces Multicompartmental B Cell Depletion in Peripheral Blood, Bone Marrow and Lymph Nodes of Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 2305
Anti-Ku Positivity in Primary Sjögren’s Disease Is Associated with a More Systemic Active Disease
- 10:30AM-12:30PM
-
Abstract Number: 2232
Anti-RA33 Autoantibodies Are Unique, Sensitive Biomarkers for the Identification of Seronegative Rheumatoid Arthritis in a U.S. Cohort
- 10:30AM-12:30PM
-
Abstract Number: 2390
Anti-Sm Antibody Titers Vary During SLE Disease Course
- 10:30AM-12:30PM
-
Abstract Number: 1888
Anti-Spike Antibodies Protect Against COVID-19 Infection in Immune-Mediated Inflammatory Diseases: Findings from the SUCCEED Study
- 10:30AM-12:30PM
-
Abstract Number: 2522
Anticoagulant Treatment May Decrease the Relapse Rate in Pulmonary Arterial Involvement of Behçet’s Disease When Added After the First Event
- 10:30AM-12:30PM
-
Abstract Number: 2097
Application of Machine Learning Methods to Predict the Risk of Rapid Pain Progression in Patients with Knee OA. Study Using Patients from the OAI and PROCOAC
- 10:30AM-12:30PM
-
Abstract Number: 2176
Applying Similarity Network Fusion to Identify Patient Clusters for People with Systemic Inflammatory Disease
- 10:30AM-12:30PM
-
Abstract Number: 1910
Appointment Adherence: Impact of Health Portal Access, Letters, Phone Calls and Text Message Reminders in Underserved Population
- 10:30AM-12:30PM
-
Abstract Number: 2229
Aptamer Based Proteomic Profiling Demonstrates Significant Differences in Methotrexate Responders versus Non-responders in Newly Diagnosed Rheumatoid Arthritis and Adds Potential Value to Clinical Examination
- 10:30AM-12:30PM
-
Abstract Number: 2472
Are Anti-centromere Antibodies (aCENP) Predictive of Systemic Sclerosis Development in Patients Without Raynaud´s Phenomenon?
- 10:30AM-12:30PM
-
Abstract Number: 1976
Artificial Intelligence Analysis of HRCT Images Reflects Pulmonary Involvement in Systemic Sclerosis Interstitial Lung Disease
- 10:30AM-12:30PM
-
Abstract Number: 1965
Artificial Intelligence Assisted Interpretation of Lung Ultrasound Imaging for the Detection of Interstitial Lung Disease
- 10:30AM-12:30PM
-
Abstract Number: 2116
Artificial Intelligence Classifier for Osteoporosis Detection from Chest Radiographs: Performance Evaluation and Literature Comparison with Quantitative Ultrasound
- 10:30AM-12:30PM
-
Abstract Number: 1956
Artificial Intelligence Enhanced Analysis of Nailfold Capillaries by Dermatoscopy in Rheumatology Centers
- 10:30AM-12:30PM
-
Abstract Number: 2437
Aryl Hydrocarbon Receptor as an Intrinsic Novel Checkpoint That Inhibits TLR7-induced B-cell Activation in SLE
- 10:30AM-12:30PM
-
Abstract Number: 1957
Assessing Left Ventricular Hemodynamic Forces in Systemic Sclerosis Patients: Pilot Study
- 10:30AM-12:30PM
-
Abstract Number: 1981
Assessing Major Adverse Cardiovascular Events (MACE) Risk in Common Rheumatology Treatments
- 10:30AM-12:30PM
-
Abstract Number: 1770
Assessing S100A4 and Myofibroblast Phenotypes in the Pathogenesis of Cardiac and Cutaneous Neonatal Lupus
- 10:30AM-12:30PM
-
Abstract Number: 1875
Assessing the PULSAR (Program to Understand the Longterm Outcomes in Spondyloarthritis) Registry for Environmental Determinants of Heath Research
- 10:30AM-12:30PM
-
Abstract Number: 2281
Assessment of Comparative Efficacy Between Candidate Biosimilar AVT05 and Reference Golimumab
- 10:30AM-12:30PM
-
Abstract Number: 2249
Assessment of Interstitial Lung Disease in Rheumatoid Arthritis Patients Treated with JAK Inhibitors: A National Multicenter Observational Study from the MAJIK-SFR Registry
- 10:30AM-12:30PM
-
Abstract Number: 2361
Assessment of Laboratory Parameter Changes in a Phase 2b Trial of Zasocitinib (TAK-279), an Oral, Highly Selective TYK2 Inhibitor, in Patients with Active Psoriatic Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 2331
Assessment of the Likelihood of Joint Inflammation Recurrence in Previously Affected Joints During Psoriatic Arthritis Disease Course
- 10:30AM-12:30PM
-
Abstract Number: 1895
Association Between a History of Mental Illness and the Risk of Systemic Autoimmune Rheumatic Diseases: A Nationwide, Population-based Case-control Study
- 10:30AM-12:30PM
-
Abstract Number: 2218
Association Between Frailty and Peri-Operative Inpatient Adverse Outcomes Among Patients with and Without Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 2221
Association Between Serum Uric Acid/Serum Creatinine Index and Carotid Plaque in Patients with Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 1998
Association Between Small Interfering RNA Therapy and Autoimmune Diseases: U.S. Prospective Cohort Study
- 10:30AM-12:30PM
-
Abstract Number: 2110
Association Between Symptomatic Knee Osteoarthritis and Blood Glucose Control in Persons with Type 2 Diabetes
- 10:30AM-12:30PM
-
Abstract Number: 2058
Association of Anti-Synthetase Antibody Subtypes with Radiographic Progression of Interstitial Lung Disease in Anti-Synthetase Syndrome: An Analysis of the CLASS Project Database
- 10:30AM-12:30PM
-
Abstract Number: 2219
Association of Chondrocalcinosis with Disease Activity and Drug Response in Rheumatoid Arthritis: Baseline Characteristics of the Swiss Rheumatoid Arthritis Outcomes Cohort
- 10:30AM-12:30PM
-
Abstract Number: 2295
Association of Early Markers in Patients with Sjögren’s Syndrome in a Diverse Academic Cohort
- 10:30AM-12:30PM
-
Abstract Number: 2248
Association of Integrative Health Practices with Health-Related Quality of Life in Women with Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 2087
Association of MRI-Defined Structure Features at Baseline with Knee Pain and Function Trajectories: Data from the Osteoarthritis Initiative (OAI)
- 10:30AM-12:30PM
-
Abstract Number: 1891
Association of Physical Activity Levels on Chronic Opioid Use in Radiographic Axial Spondylitis Patients
- 10:30AM-12:30PM
-
Abstract Number: 2194
Association of Reticular Dermis and Subcutis Inflammatory Infiltrate with Musculoskeletal Involvement in Pediatric Localized Scleroderma
- 10:30AM-12:30PM
-
Abstract Number: 2471
Association of Telangiectasias with Autoantibodies and Clinical Manifestations in Systemic Sclerosis
- 10:30AM-12:30PM
-
Abstract Number: 2423
Associations Between Cytometric Interferon Signature and Clinical Response in a Cohort of Anifrolumab-treated Patients with Lupus
- 10:30AM-12:30PM
-
Abstract Number: 2241
Associations Between Disease Activity, Physical Function and Anti-rheumatic Medications with All-cause Mortality in Rheumatoid Arthritis (RA): Data from a Canadian RA Registry
- 10:30AM-12:30PM
-
Abstract Number: 2061
Associations Between Intramyocellular Lipid and Muscle Function in Patients with Osteoarthritis
- 10:30AM-12:30PM
-
Abstract Number: 2289
Associations Between Protein Quantitative Trait Loci and Risk of Primary Sjögren’s Syndrome: A Mendelian Randomization Study
- 10:30AM-12:30PM
-
Abstract Number: 2411
Attainment of Complete Renal Response in Patients with Active Lupus Nephritis: A Multi-Center Cohort Study
- 10:30AM-12:30PM
-
Abstract Number: 2435
Attainment of Remission, Use of Immunomodulatory/suppressive Agents and Gradual Dose Tapering May Facilitate Flare-free Withdrawal of Glucocorticoids in Patients with Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 2468
Audio-Guided Imagery Positively Impacted Patients with Raynaud’s Phenomenon Associated Connective Tissue Disease
- 10:30AM-12:30PM
-
Abstract Number: 1876
Automated Case Identification of Patients with End-Stage Renal Disease and Systemic Lupus Erythematosus Using Machine Learning
- 10:30AM-12:30PM
-
Abstract Number: 2025
Autonomic Nervous System Dysfunction Common Among Patients with Long COVID:Diagnosis and Treatment Implications
- 10:30AM-12:30PM
-
Abstract Number: 2489
Avacopan for Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) in a Real-World Setting
- 10:30AM-12:30PM
-
Abstract Number: 2480
Avacopan versus a Prednisone Taper in Patients with ANCA-Associated Vasculitis and Ear, Nose, or Throat Involvement in a Phase 3 Trial
- 10:30AM-12:30PM
-
Abstract Number: 2478
Avacopan versus a Prednisone Taper in Patients with ANCA-Associated Vasculitis Without Kidney Involvement in a Phase 3 Trial
- 10:30AM-12:30PM
-
Abstract Number: 2356
Baseline Characteristics of Patients with Psoriatic Arthritis Treated with Ixekizumab or Interleukin-23 Inhibitors and Interim Effectiveness Results from an Observational Study in the US
- 10:30AM-12:30PM
-
Abstract Number: 1837
Baseline Multiome Sequencing of CD45RO+CD45RA-CD4+ T Cell Reveals Distinct Immune Profiles Associated with Subsequent Response to Secukinumab Treatment
- 10:30AM-12:30PM
-
Abstract Number: 1906
Bayesian Algorithm to Identify Osteoarthritis in Administrative Health Data Without Requiring Chart Review
- 10:30AM-12:30PM
-
Abstract Number: 2518
Behçet’s Disease Immune Landscape Exhibits a Universal NF-kB-mediated Hyperactivation Pattern with Cell-specific TNFAIP3 Responses and a Superimposed IFN-regulated Endotype
- 10:30AM-12:30PM
-
Abstract Number: 2402
Belimumab Reduces Disease Flares versus Placebo in Adults with Early Active Systemic Lupus Erythematosus: Results of a Large Integrated Analysis
- 10:30AM-12:30PM
-
Abstract Number: 2365
Benefits of Achieving Early versus Late Clinical Response After Treatment with Biologic and Targeted Synthetic DMARDs Among Patients with PsA in the CorEvitas PsA/Spondyloarthritis Registry
- 10:30AM-12:30PM
-
Abstract Number: 2348
Bimekizumab Efficacy and Safety Through 4 Years in Moderate to Severe Plaque Psoriasis: Long-Term Results from a Phase 3 Study and Open-Label Extension
- 10:30AM-12:30PM
-
Abstract Number: 2352
Bimekizumab Treatment Was Efficacious to 2 Years Regardless of Duration of axSpA Symptoms: Results from Two Phase 3 Studies
- 10:30AM-12:30PM
-
Abstract Number: 2368
Bimekizumab-Treated Patients with Active Psoriatic Arthritis Showed Sustained Improvements in Pain and Fatigue: Up to 2-Year Results from Two Phase 3 Studies
- 10:30AM-12:30PM
-
Abstract Number: 1794
Biobehavioral Basis and Outcomes of Cognitive Dysfunction in Childhood Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 2523
Biological Treatment May Be an Option as First Steroid-Sparing Agent in a Subgroup of Young Takayasu Arteritis Patients with Prominent Acute Phase Reactants and Constitutional Symptoms
- 10:30AM-12:30PM
-
Abstract Number: 2387
Biomarkers of Lupus Nephritis Are Less Predictive in APOL1 High Risk Genotype Lupus
- 10:30AM-12:30PM
-
Abstract Number: 1806
Bisphenol a Methylation Scores Associate with SLE and ClinicalSubphenotypes
- 10:30AM-12:30PM
-
Abstract Number: 2420
Blood Transcriptome Analysis Reveals Enhanced B Cell and Complement Cascade Signatures in Patients with Major Neuropsychiatric Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 2509
Bone Marrow Failure in VEXAS Is Associated with the Degree of UBA1b Deficiency
- 10:30AM-12:30PM
-
Abstract Number: 2164
Boosting Adherence to “Sick Day Rules”: A Quality Improvement Study in Rheumatology Outpatients on Immunosuppressive Medications, Results of Post-intervention Phase
- 10:30AM-12:30PM
-
Abstract Number: 1777
Broad Proteomic Analysis Reveals Top Differential Protein Modules and Functional Annotations with Clinical Traits in Juvenile Dermatomyositis (JDM) and Myositis-Specific Autoantibody (MSA) Groups
- 10:30AM-12:30PM
-
Abstract Number: 2505
C5 Signaling Pathway Genes as Key Drivers of the Pathogenesis of IgA Vasculitis?
- 10:30AM-12:30PM
-
Abstract Number: 2375
Can Damage Items Be Graded According to Severity in a Revised Organ Damage Index for Lupus?
- 10:30AM-12:30PM
-
Abstract Number: 2037
Can Tofacitinib Be the Saviour in Treatment of Refractory IgG4-Related Disease : A Multicentre Experience from India
- 10:30AM-12:30PM
-
Abstract Number: 2039
Canakinumab Treatment in Patients with Familial Mediterranean Fever: A Tertiary Center Experience
- 10:30AM-12:30PM
-
Abstract Number: 2069
Cancer Risk and Screening Effectiveness in Idiopathic Inflammatory Myopathy: Validating IMACS Guidelines in a Retrospective Indian Cohort
- 10:30AM-12:30PM
-
Abstract Number: 2275
Cardiovascular and Cancer Safety of JAKi Compared to TNFi in Patients with Rheumatoid Arthritis: Results from a National Registry of Advanced Therapies
- 10:30AM-12:30PM
-
Abstract Number: 2026
Cardiovascular Risk Measured by PREVENT Calculator and Disease Activity in Patients with Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 2379
Causal Proteomics-Assisted Machine Learning Model Enhances Flare Risk Prediction in Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 2250
Cause Specific Mortality Differs in Rheumatoid Arthritis by Sex and Seropositivity
- 10:30AM-12:30PM
-
Abstract Number: 2036
CCN6 Gene Mutation Induces Mitochondrial Dysfunction: The Cause of Progressive Pseudo-rheumatoid Dysplasia
- 10:30AM-12:30PM
-
Abstract Number: 1792
CD14+ Monocytes Demonstrate Subclinical Erythrocyte Uptake in Childhood Onset Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 2177
CD59 Complement Membrane Regulator Deficiency: 12 Years of Clinical and Molecular Follow-up of 29 Patients
- 10:30AM-12:30PM
-
Abstract Number: 1765
CD8+ T Cells and Monocytes from Children with Macrophage Activation Syndrome Demonstrate Specific Transcriptional Changes Consistent with T Cell Activation and Expansion of Monocytes Shaped by Interferon and TLR Signaling
- 10:30AM-12:30PM
-
Abstract Number: 1861
CD8T Cells Depletion Promotes Human Tph/Tfh Cells Proliferation and Sjogren Syndrome Like Symptoms Without Graft versus Host Diseases in PBMC Transferred-humanized Mice
- 10:30AM-12:30PM
-
Abstract Number: L03
CD9 Expressing T Follicular Helper Cells Are a Highly Functional Subset Expanded in Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 2286
Certolizumab Inhibits Radiographic Progression Even in RA Patients with High Rheumatoid Factor Levels: A Pooled, Post-Hoc Analysis of Two Phase 3 Trials
- 10:30AM-12:30PM
-
Abstract Number: 2525
Challenges and Opportunities in Integrating Sleep Recommendations into Counselling Patients with Arthritis: A Survey of Physical Therapists and Physical Therapy Students
- 10:30AM-12:30PM
-
Abstract Number: 2091
Changes in Analgesic Prescriptions for the Treatment of Osteoarthritis During the COVID-19 Pandemic
- 10:30AM-12:30PM
-
Abstract Number: 2334
Characteristics of Patients with Psoriatic Arthritis Presenting with Axial Involvement: Results of a Prospective International Multicenter Study (AXIS)
- 10:30AM-12:30PM
-
Abstract Number: 2374
Characteristics, Treatment Responses and Prognosis in a Single Center Cohort of SLE Patients with Thrombocytopenia
- 10:30AM-12:30PM
-
Abstract Number: 2308
Characterization of Damage in a Primary Sjogren’s Syndrome Cohort
- 10:30AM-12:30PM
-
Abstract Number: 1827
Characterization of Fibroblast Subpopulations and Their Cellular Local Environments in Systemic Sclerosis Using Imaging Mass Cytometry
- 10:30AM-12:30PM
-
Abstract Number: 1771
Characterization of Pathogenic Immune Mechanisms in Oligoarticular Juvenile Idiopathic Arthritis Applying Single-cell Transcriptomics and Proteomics
- 10:30AM-12:30PM
-
Abstract Number: 2436
Characterization of RO7507062, a CD19-Targeting T-Cell Bispecific Antibody (CD19TCB), and Design of Its Ongoing Phase 1 Trial in Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 2283
Characterization of Second-Line Therapy After First Janus Kinase Inhibitor Use: Results from the CorEvitas RA Registry
- 10:30AM-12:30PM
-
Abstract Number: 2502
Characterization of the Tissue Fibroblast Repertoire in IgG4-Related Ophthalmic Disease
- 10:30AM-12:30PM
-
Abstract Number: 1848
Characterization of Treg Phenotype, Function and Its Transcriptome Signatures in Treatment-naïve Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 1797
Characterizing Memory T Cell Subsets Associated with SLE Etiopathogenesis
- 10:30AM-12:30PM
-
Abstract Number: 2380
Characterizing SLE Patients into Type 1 and Type 2 Disease States: Insights from a Single Lupus Cohort
- 10:30AM-12:30PM
-
Abstract Number: 2415
Characterizing the Population with Suspected Lupus Nephritis in Care of a Community Rheumatology Network
- 10:30AM-12:30PM
-
Abstract Number: 2405
Chat-GPT Performance in Diagnosis of Rheumatological Diseases: A Comparison with Specialist’s Opinion
- 10:30AM-12:30PM
-
Abstract Number: 1775
Childhood-onset Sjögren Disease Has an Altered Peripheral Blood Immune Landscape Compared to Adult-onset Disease Characterized by Activated CD4+ T-cells Which Could Drive B-cell Dysregulation
- 10:30AM-12:30PM
-
Abstract Number: 2389
Choroidal Thickness in Active Lupus Nephritis
- 10:30AM-12:30PM
-
Abstract Number: 2317
Chronic Kidney Disease in Patients with Psoriatic Arthritis: A Cohort Study
- 10:30AM-12:30PM
-
Abstract Number: 1763
Circulating NK and CD8+ Cytotoxic T Cells in Treatment Naïve JDM Demonstrate Higher Cytotoxic and Interferon Signature as Compared to Childhood-Onset SLE
- 10:30AM-12:30PM
-
Abstract Number: 1846
Citrullinated Vimentin-reactive Immune-regulatory CD4+CD39+TIGIThi T Cells Expand During Drug Free Remission in HLA-DR Shared-epitope+ ACPA+ Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 2067
Clinical and Laboratory Characterization of Overlap Connective Tissue Disease in Patients with Idiopathic Inflammatory Myopathies: Results from the MYOTReCSZ Cohort
- 10:30AM-12:30PM
-
Abstract Number: 2072
Clinical and Laboratory Features Associated with Pulmonary Involvement in Patients with Inflamatory Myopathy
- 10:30AM-12:30PM
-
Abstract Number: 2419
Clinical and Patient-reported Outcomes in Systemic Lupus Erythematosus: An Analysis of the SLE Prospective Observational Cohort Study (SPOCS) US Data
- 10:30AM-12:30PM
-
Abstract Number: 2299
Clinical and Serological Characteristics of Sjögren’s Disease-related Lymphocytic Interstitial Pneumonia: A Large Multicenter Study
- 10:30AM-12:30PM
-
Abstract Number: 2497
Clinical Characteristics and Outcomes of Hydralazine-induced ANCA-associated Vasculitis. a Single Center Retrospective Cohort Analysis from the US
- 10:30AM-12:30PM
-
Abstract Number: 2511
Clinical Characteristics and Outcomes of Patients with Clinically Isolated Aortitis
- 10:30AM-12:30PM
-
Abstract Number: 2392
Clinical Characteristics and Outcomes of Systemic Lupus Erythematosus When Accompanying Myositis: A Retrospective Real-Life Study
- 10:30AM-12:30PM
-
Abstract Number: 2494
Clinical Characteristics, Predictors for Mortality and Comparison of the Birmingham Vasculitis Activity Score and the Five-Factor Score on Survival in ANCA-associated Vasculitis in Hong Kong : A Multi-centre Retrospective Cohort Study
- 10:30AM-12:30PM
-
Abstract Number: 2381
Clinical Characteristics, Readmission Rates, and Outcomes in Lupus Patients with and Without Nephritic Involvement: Analysis from a National Database
- 10:30AM-12:30PM
-
Abstract Number: 2245
Clinical Efficacy and Molecular Cardiovascular Changes of Baricitinib in Biologic-naïve Patients with Rheumatoid Arthritis. Direct Comparative Analysis with TNF Inhibitors and Conventional DMARDs
- 10:30AM-12:30PM
-
Abstract Number: 2050
Clinical Enthesitis Concerns Half the Patients with Psoriatic Arthritis, Is More Frequent in Trials Than in Observational Studies and Is Assessed Heterogeneously: A Systematic Review with Meta-analysis of 84,262 Patients from 212 Studies
- 10:30AM-12:30PM
-
Abstract Number: 2496
Clinical Features and Outcomes of Hydralazine-associated Vasculitis: A Case-Control Study
- 10:30AM-12:30PM
-
Abstract Number: 2027
Clinical Features and Treatment of Retroperitoneal Fibrosis in a Referral Hospital and Literature Review
- 10:30AM-12:30PM
-
Abstract Number: 2057
Clinical Features of Autoimmune Uveitis and Associated Factors with Reactivation Subtype Presentation from a Peruvian Multidisciplinary Reference Center
- 10:30AM-12:30PM
-
Abstract Number: 2115
Clinical Impact of Acute Symptomatic Vertebral Fractures in the United States: An Observational Study
- 10:30AM-12:30PM
-
Abstract Number: 2051
Clinical Outcomes and Predictors of Relapse in Patients with IgG4-Related Disease Treated with Rituximab: A Real-World Experience
- 10:30AM-12:30PM
-
Abstract Number: 1994
Clinical Patterns and Long-term Outcomes of Arthritis Triggered by Immune Checkpoint Inhibitors. A Multicenter Study
- 10:30AM-12:30PM
-
Abstract Number: 2044
Clinical Practice Patterns, Rilonacept Appropriate Use for Recurrent Pericarditis
- 10:30AM-12:30PM
-
Abstract Number: 1930
Clinical Significance of Positive ENA Testing in ANA-Negative Patients: A Retrospective Analysis of Rheumatologic Diagnoses
- 10:30AM-12:30PM
-
Abstract Number: 2407
Clinical Utility of Repeat Renal Biopsies in Lupus Nephritis: The NIH Chronicity Index at First Biopsy Predicts Future End Stage Renal Disease in a Large South Asian Cohort of SLE
- 10:30AM-12:30PM
-
Abstract Number: 2208
Clinical, Imaging and Treatment Characteristics of Patients with Progressive Systemic Autoimmune Rheumatic Disease-related Interstitial Lung Diseases (SARD-ILDs) in the ILD-PRO Registry
- 10:30AM-12:30PM
-
Abstract Number: 2521
Clinicopathologic Associations Between Macrophage Location and Functional Profile in Giant Cell Arteritis
- 10:30AM-12:30PM
-
Abstract Number: 1859
Clonal Relationships Between Tph and Tfh Cells in Patients with SLE and in Murine Lupus
- 10:30AM-12:30PM
-
Abstract Number: 2442
Clustering Algorithm as an Exploratory Analysis of Different Clinical Phenotypes in Systemic Sclerosis. Data from the PRECISESADS Study
- 10:30AM-12:30PM
-
Abstract Number: 2060
Clustering Analysis of Immune Cell Subtypes and Clinical Phenotypes in Idiopathic Inflammatory Myopathy
- 10:30AM-12:30PM
-
Abstract Number: 1858
Co-modification of Citrullinated Proteins with Malondialdehyde-Acetaldehyde Leads to Amplified T Cell Responses and Increased Disease-specific Autoantibody Concentrations
- 10:30AM-12:30PM
-
Abstract Number: 2345
Combination of Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs in Psoriatic Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 1905
Combining Three Peripheral Biomarkers to Stratify Rheumatoid Arthritis-Associated Interstitial Lung Disease Risk
- 10:30AM-12:30PM
-
Abstract Number: 1907
Community-Engaged Curriculum Development Using Racial Justice and Biomedical Lenses to Address COVID-19 Vaccine Hesitancy in Black Individuals with Rheumatologic Conditions
- 10:30AM-12:30PM
-
Abstract Number: 2066
Comparative Diagnostic Efficacy of Quantitative Measurement of Echo Intensity and Texture versus Qualitative Analysis of Ultrasound Images in Myositis
- 10:30AM-12:30PM
-
Abstract Number: 1785
Comparative Immuno-Metabolomics Shows Singular Changes in Systemic Lupus Erythematosus Metabolic Phenotype Induced by T-Cell Activation
- 10:30AM-12:30PM
-
Abstract Number: 2487
Comparing Circulating Protein Profiles in Patients with Active Myeloperoxidase (MPO) vs Proteinase-3 (PR3) Antineutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis
- 10:30AM-12:30PM
-
Abstract Number: 2076
Comparing the Efficacy of Conventional Immunosuppression and Rituximab in Anti-SRP Myositis: Insights from a Tertiary Care Centre Experience
- 10:30AM-12:30PM
-
Abstract Number: 1966
Comparison of a Dynamic Optical System with Physician Physical Assessment of PIP Joints of Systemic Lupus Erythematosus Patients
- 10:30AM-12:30PM
-
Abstract Number: 2142
Comparison of Bone Mineral Density at the Distal Radius, Hip, and Lumbar Spine in Female Patients Undergoing Surgery for Proximal Femur or Distal Radius Fractures: Implications for Osteoporosis Diagnosis
- 10:30AM-12:30PM
-
Abstract Number: 1982
Comparison of COVID-19 Infection and Mortality Rates in Vaccinated and Unvaccinated Patients with Autoimmune Inflammatory Rheumatic Disease (AIRD) Using Conventional and Biologic DMARD Therapy at an Urban Tertiary Care Hospital
- 10:30AM-12:30PM
-
Abstract Number: 2210
Comparison of Dual RF and Anti-CCP Seropositive, Single Seropositive, and Seronegative RA on Radiographic Changes, Flares, and Mortality
- 10:30AM-12:30PM
-
Abstract Number: 2077
Comparison of Janus Kinase Inhibitors to Block the Type I and II Interferon Pathways in Human Myoblasts
- 10:30AM-12:30PM
-
Abstract Number: 1964
Comparison of Knee Minimum Joint Space Width Measurements Using Deep Learning in Patients with Rheumatoid Arthritis and Osteoarthritis Undergoing Total Knee Arthroplasty
- 10:30AM-12:30PM
-
Abstract Number: 2257
Comparison of the Safety and Effectiveness of Originator Rituximab (Mabthera®) versus Biosimilar (Riximyo®) in Rheumatoid Arthritis: A Retrospective Unicentric Analysis
- 10:30AM-12:30PM
-
Abstract Number: 2001
Complications and Treatment Use Associated with Long-term Oral Corticosteroid Therapy Among Patients with Dermatomyositis or Polymyositis
- 10:30AM-12:30PM
-
Abstract Number: 1963
Computer Vision on Standardized Smartphone Photographs as a Screening Tool for Inflammatory Arthritis of the Hand: Results from an Indian Patient Cohort
- 10:30AM-12:30PM
-
Abstract Number: 2214
Confirming a Value for Rheumatoid Arthritis Flares Based on Changes in CDAI, SDAI and RAPID3
- 10:30AM-12:30PM
-
Abstract Number: 2153
Construct Validity of the IDEOM Musculoskeletal Questionnaire (IDEOM MSK-Q) Using Data from the Cohort for Psoriasis and Psoriatic Arthritis Registry (COPPAR)
- 10:30AM-12:30PM
-
Abstract Number: 2448
Content Validity and Sensitivity to Change of ScleroID Through the Natural History of Scleroderma. a Validated Tool to Measure the Impact of SSc on How Patients Feel and Function
- 10:30AM-12:30PM
-
Abstract Number: 1870
Costs and Healthcare Resource Utilization Associated with Inpatient and Day Hospitalizations of Patients with Lupus and Psychiatric Manifestations in France
- 10:30AM-12:30PM
-
Abstract Number: 2022
Could Initiation of Sodium Glucose Co-Transporter-2 Inhibitors Reduce the Need for Conventional Urate-Lowering Therapy and Flare Medications in Patients with Gout?Population-Based Target Trial Emulation Studies
- 10:30AM-12:30PM
-
Abstract Number: 2473
Criterion Validity of Modified Rodnan Skin Score: Does It Capture Skin Thickness or Hardening? Results of a Large Skin Histology Study
- 10:30AM-12:30PM
-
Abstract Number: 2094
Cross-sectional Associations of Radiographic Multiple Joint Osteoarthritis and Pain with Demographic and Clinical Characteristics: Design of a Multi-modal Study in Human and Pet Dogs
- 10:30AM-12:30PM
-
Abstract Number: 1881
Cross-State Comparative Assessment of Burden of Rheumatoid Arthritis in the United States and It’s Trend from 1990-2021: A Benchmarking Analysis for the Global Burden of Disease Study 2022
- 10:30AM-12:30PM
-
Abstract Number: 2114
CT and DXA Bone Fragility Evaluation After Bariatric Surgery
- 10:30AM-12:30PM
-
Abstract Number: 2003
Cumulative Incidence of Immune Checkpoint Inhibitor-Induced Inflammatory Arthritis in Lung Cancer Patients with and Without Hip Osteoarthritis and Impacts on Survival
- 10:30AM-12:30PM
-
Abstract Number: 2174
Current Treatment of Macrophage Activation Syndrome Worldwide: The METAPHOR Project, a PReS/PRINTO Real-life International Survey
- 10:30AM-12:30PM
-
Abstract Number: 1798
CXCL6 Synthesized by Proximal Tubule Cells May Promote Fibrosis in Lupus Nephritis
- 10:30AM-12:30PM
-
Abstract Number: 2118
Cytotoxic T Lymphocyte Antigen-4 Improves Osteoporosis in Patient with Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 2309
Damage Accrual Predicts the Development of Lymphoma in Primary Sjogren’s Syndrome
- 10:30AM-12:30PM
-
Abstract Number: 2430
Dapirolizumab Pegol Impacts Important Immunologic Pathways in Systemic Lupus Erythematosus: Pharmacodynamic Analysis of T Cell and Antigen Presenting Cell Pathways from a Phase 2b Trial
- 10:30AM-12:30PM
-
Abstract Number: 1783
Deciphering the Roles of Mitochondrial-Related Genes and Ferroptosis in Systemic Lupus Erythematosus: Integrated Analysis for Diagnostic Biomarker Identification and Therapeutic Insights
- 10:30AM-12:30PM
-
Abstract Number: 2306
Deconstruction and Reconstruction of Sjögren’s Disease: AMP®-AIM Partnership
- 10:30AM-12:30PM
-
Abstract Number: 2107
Deep Immunophenotyping of Knee Osteoarthritis Patients Reveals Alterations in T Cell, Treg, and Monocyte Subpopulations
- 10:30AM-12:30PM
-
Abstract Number: 2307
Deep Spatial Profiling Unveils Dominant Double Negative B Cells in Severe Forms of Sjögren’s Syndrome
- 10:30AM-12:30PM
-
Abstract Number: 2282
Defining a Personalized Treatment Approach to Rheumatoid Arthritis: Using Genetic Markers of TNFi Response
- 10:30AM-12:30PM
-
Abstract Number: 2055
Demographic and Ocular Characteristics of Scleritis Patients with Systemic Rheumatologic Disease in the IRIS® Registry (Intelligent Research in Sight)
- 10:30AM-12:30PM
-
Abstract Number: 2393
Demographic Differences in Trends of Systemic Lupus Erythematosus In-hospital Patient Outcomes
- 10:30AM-12:30PM
-
Abstract Number: 2256
Depletion of Citrullinated Vimentin-reactive Follicular Helper T Cells with Treatment-induced Remission of Recent-onset Rheumatoid Arthritis When Compared to Non-remission at 6 Months
- 10:30AM-12:30PM
-
Abstract Number: 2499
Description of Patients with Kawasaki Disease Shock Syndrome at a Large Tertiary Center
- 10:30AM-12:30PM
-
Abstract Number: 2500
Description of Patients with Refractory Kawasaki Disease at a Large Tertiary Center
- 10:30AM-12:30PM
-
Abstract Number: 2045
Descriptive Study on the Use of Serum Levels of Immunoglobulin G4, Immunoglobulin E and Eosinophil Count as Serum Biomarkers Across Four Clinical Phenotypes of IgG4-Related Disease
- 10:30AM-12:30PM
-
Abstract Number: 1894
Detection of Fibrotic Lung Changes and Bronchiectasis in RA Patients Screened for Lung Cancer with Low-dose CT Chest: Results from a Large Multi-hospital System
- 10:30AM-12:30PM
-
Abstract Number: 2056
Deucravacitinib Treatment Did Not Impact Immune Response to SARS-CoV-2 Vaccines and Infection in Patients with Plaque Psoriasis: Results from the Phase 3 POETYK Long-Term Extension Trial
- 10:30AM-12:30PM
-
Abstract Number: 1921
Devastating Morbidity and Mortality Rates in the Hmong Population with a Diagnosis of Gout Who Had a COVID-19 Infection
- 10:30AM-12:30PM
-
Abstract Number: 2326
Development and Evaluation of a Machine Learning Model for the Early Identification of Psoriatic Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 1968
Development and Validation of an Arthritis-Detection Algorithm Using Thermal Imaging in Adults and Children
- 10:30AM-12:30PM
-
Abstract Number: 2280
Development of a Blood-based Cell-free DNA Classifier Assay to Predict Biologic and Targeted Synthetic DMARDs Response in Rheumatoid Arthritis Patients (PRIMA-102)
- 10:30AM-12:30PM
-
Abstract Number: 2160
Development of a Lupus Chatbot
- 10:30AM-12:30PM
-
Abstract Number: 2422
Development of a Multiplexed-engineered, Off-the-shelf CAR NK Cell with Unique Multi-Pathogenic Cell Targeting Capacity for the Treatment of Autoimmune Diseases in the Absence of Conditioning Chemotherapy
- 10:30AM-12:30PM
-
Abstract Number: 1842
Development of Next Generation CAR T Cell Therapy for the Off-the-shelf Treatment of Autoimmune Diseases Without Conditioning Chemotherapy
- 10:30AM-12:30PM
-
Abstract Number: 2526
Development of the Hospital Emergency Advocacy & Treatment Kit (HEAT Kit) for Patients with Vasculitis
- 10:30AM-12:30PM
-
Abstract Number: 2089
Diagnostic Performance of ACR and NICE Criteria for Hip Osteoarthritis
- 10:30AM-12:30PM
-
Abstract Number: 1900
Dietary Exposures Associated with Incident Spondyloarthritis
- 10:30AM-12:30PM
-
Abstract Number: 2255
Differences in Pharmacological Prescription to Patients with Recent-onset Arthritis: Analysis from the Gender Perspective
- 10:30AM-12:30PM
-
Abstract Number: 2082
Different Clinical Phenotypes of Patients with Anti-synthetase Syndrome: Unsupervised Cluster Analysis in the CLASS Database
- 10:30AM-12:30PM
-
Abstract Number: 2169
Different Trajectories of Patient Reported Outcomes in Patients with RA in a Stable Phase of Disease – an Observational Study
- 10:30AM-12:30PM
-
Abstract Number: 2304
Differential Diagnosis of Sjogren’s vs Non-Sjogren’s Dry Eye
- 10:30AM-12:30PM
-
Abstract Number: 2156
Differential Item Functioning of Inflammatory Back Pain Criteria in US Subpopulations
- 10:30AM-12:30PM
-
Abstract Number: 2327
Differential Quantitative Profile of Myeloid Derived Suppressor Cells and Monocyte Subsets Relate to Clinical Phenotype and Disease Activity in Psoriatic Arthritis Patients
- 10:30AM-12:30PM
-
Abstract Number: 2495
Diffuse Alveolar Hemorrhage in Patient with ANCA-associated Vasculitis AndInterstitial Lung Disease
- 10:30AM-12:30PM
-
Abstract Number: 2157
Dimensionality of Inflammatory Back Pain Criteria in the US Population
- 10:30AM-12:30PM
-
Abstract Number: 2155
Direct Comparison of Sleep Quality and Risk Factors for Poor Sleep Across Rheumatoid Arthritis, Axial Spondyloarthritis and Psoriatic Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 2340
Direct to Patient Screening for Psoriatic Arthritis in Patients with Psoriasis: Diagnosis Rates, Referral Pathways, and Educational Value of Screening
- 10:30AM-12:30PM
-
Abstract Number: 2135
Disability, Functional Limitation, and Use of Anti-fracture Drug Therapies in a Cohort of 3651 U.S. Adults with Osteogenesis Imperfecta
- 10:30AM-12:30PM
-
Abstract Number: 2112
Discontinuation and Non-Publication of Osteoporosis Studies: An Observational Analysis of 7,670,624 Patients
- 10:30AM-12:30PM
-
Abstract Number: 2113
Discontinuation and Non-publication of Postmenopausal Osteoporosis Clinical Studies: A Cross-sectional Analysis of 345,435 Patients
- 10:30AM-12:30PM
-
Abstract Number: 2279
Discontinuation Pattern of Glucocorticoids in Patients with Rheumatoid Arthritis Initiating Biologics or Targeted Synthetic DMARDs in Routine Care
- 10:30AM-12:30PM
-
Abstract Number: 1986
Disease Flare Following Immune Checkpoint Inhibition in Patients with Cancer and Preexisting Vasculitis
- 10:30AM-12:30PM
-
Abstract Number: 2450
Disease Progression in Anti-Centromere Positive Systemic Sclerosis Patients
- 10:30AM-12:30PM
-
Abstract Number: 1820
Disruption of Ca2+ Homeostasis and Enhanced Ca2+ Signaling in Scleroderma Fibroblasts Is Due to the Vicious Cycle Formed by Mitochondrial-derived Reactive Oxygen Species, CaMKII, and ER Extrusion Pump RYR2
- 10:30AM-12:30PM
-
Abstract Number: 2136
Distal Radius Correlation with Femur and Lumbar Spine T-scores: A Comprehensive Analysis
- 10:30AM-12:30PM
-
Abstract Number: L06
Distinct Cytokine and Cytokine Receptor Expression Patterns Characterize Different Subtypes of Inflammatory Myopathies
- 10:30AM-12:30PM
-
Abstract Number: 1856
Distinct Proliferative and Special Properties of Peripheral Helper T Cells in RA Synovium
- 10:30AM-12:30PM
-
Abstract Number: 1818
Distribution and Morphological Changes of Adventitial Fibroblasts in Healthy and Scleroderma Skin
- 10:30AM-12:30PM
-
Abstract Number: 1773
Divergent Genetic Architecture in Boys and Girls with NEMO-deleted Exon 5 Autoinflammatory Syndrome (NEMO-NDAS) Implies Role for Wildtype Effector Cells
- 10:30AM-12:30PM
-
Abstract Number: 2328
Do Patients That Develop PsA Before Psoriasis Have Different Disease Outcomes?
- 10:30AM-12:30PM
-
Abstract Number: 2350
Do Smoking and Obesity Impact Secukinumab Treatment Outcomes? Real-world Data from 1,202 European Patients with Psoriatic Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 1782
DOCK2 Mutations and Hyper-Inflammatory Syndromes
- 10:30AM-12:30PM
-
Abstract Number: 2318
Does the Time Interval Between the Onset of Psoriasis and Psoriatic Arthritis Impact Disease Presentation and Outcomes?
- 10:30AM-12:30PM
-
Abstract Number: 2431
DORIS Remission in Patients with SLE Treated with Anifrolumab: Post Hoc Analysis from TULIP-1 and TULIP-2 Trials in Patents with No Reported History of Prior Immunosuppressant Use
- 10:30AM-12:30PM
-
Abstract Number: 2347
Drug Survival in Spondyloarthritis: Anti-IL17 Outperforms Anti-TNF in First Biologic Treatment
- 10:30AM-12:30PM
-
Abstract Number: 2046
Duration of Disease and Long-term Outcomes in Patients with Difficult-to-treat Recurrent Pericarditis: A Chronic Condition Treated with NSAIDs, Colchicine, Corticosteroids, and Anti-IL-1 Agents
- 10:30AM-12:30PM
-
Abstract Number: 2138
DXA-derived 3D Parameters of the Hip Discriminate Prevalent Fragility Fractures in Individuals with Axial Spondyloarthritis
- 10:30AM-12:30PM
-
Abstract Number: 1892
Early Tumor Necrosis Factor Inhibitor Initiation and Chronic Opioid Use in Individuals with Axial Spondyloarthritis
- 10:30AM-12:30PM
-
Abstract Number: 2014
Effect of a Whole Food Plant-Based Diet in Patients with Gout: A Pilot Randomized Controlled Trial
- 10:30AM-12:30PM
-
Abstract Number: 1885
Effect of Physical Activity on Mortality in Rheumatoid Arthritis: A Dose-Response Analysis
- 10:30AM-12:30PM
-
Abstract Number: 2040
Effective Management of Idiopathic Recurrent Pericarditis with Anakinra in Clinical Practice
- 10:30AM-12:30PM
-
Abstract Number: 2034
Effectiveness and Tolerability of Tocilizumab in Systemic Autoimmune Rheumatic Disease Associated Intertistial Lung Disease
- 10:30AM-12:30PM
-
Abstract Number: 2445
Effects of Aminaphtone on TGF-beta1 Serum Concentration as Concomitant Treatment to Standard Therapy in Systemic Sclerosis Patients: A Pilot Study
- 10:30AM-12:30PM
-
Abstract Number: 2259
Effects of Anti-Obesity Medications in RA Patients
- 10:30AM-12:30PM
-
Abstract Number: 1932
Effects of Clinical Decision Support on Transition Readiness Assessment in Pediatric Rheumatology
- 10:30AM-12:30PM
-
Abstract Number: 2353
Effects of Guselkumab on cDAPSA Disease Activity State and Its Association with Long-Term Radiographic Progression in a Cohort of Patients with Moderately-Highly Active Psoriatic Arthritis: Post Hoc Analyses of Phase 3 Randomized Controlled Studies
- 10:30AM-12:30PM
-
Abstract Number: 1999
Effects of JAK Inhibitors on Subsets of the Innate Immune System
- 10:30AM-12:30PM
-
Abstract Number: 2084
Efficacy and Safety of a Step-down Regimen of Low Dosage of Glucocorticoids Combined with Early Administration of Synthetic or Biologic Immunosuppressants in Anti-synthetase Syndrome: A Pilot Study
- 10:30AM-12:30PM
-
Abstract Number: 2483
Efficacy and Safety of Avacopan over 12 Months in Japanese Patients with MPA/GPA: A Single-center Study
- 10:30AM-12:30PM
-
Abstract Number: 1980
Efficacy and Safety of Methotrexate in Immune Checkpoint Inhibitor-induced Arthritis: A Retrospective Longitudinal Monocentric Study
- 10:30AM-12:30PM
-
Abstract Number: 2274
Efficacy and Safety of the Biased Melanocortin Receptor Agonist AP1189/resomelagon in Combination with Methotrexate in DMARD-naïve Rheumatoid Arthritis Patients: The EXPAND Trial
- 10:30AM-12:30PM
-
Abstract Number: L09
Efficacy and Safety of Tofacitinib in Patients with Active Systemic Juvenile Idiopathic Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 2355
Efficacy of Risankizumab Across Distinct PsA Phenotypes Identified with Machine Learning Analytics Using Data from Biologic DMARD-Naive Patients in Two Phase 3 Clinical Trials
- 10:30AM-12:30PM
-
Abstract Number: 2467
Elderly Systemic Sclerosis. Clinical Presentation and Outcome
- 10:30AM-12:30PM
-
Abstract Number: 1942
Electronic Health Literacy and Its Association with Disease Activity in RMD Patients – a Cross Sectional Study
- 10:30AM-12:30PM
-
Abstract Number: 2013
Elevated Serum Allantoin and Allantoin/uric Acid Ratio as Indicators of Oxidative Stress in Severe Gout and Cardiovascular Comorbidities
- 10:30AM-12:30PM
-
Abstract Number: 1813
Elucidating the Molecular Correlates of Treatment Response in Lupus Nephritis via Imaging Mass Cytometry Proteomics and Machine Learning
- 10:30AM-12:30PM
-
Abstract Number: 1890
Emergency Department Visits for Ambulatory Care Sensitive Conditions by Persons with Rheumatoid Arthritis: A Population-Based Study
- 10:30AM-12:30PM
-
Abstract Number: 1767
Endothelial Cell-Driven JAG/NOTCH Signaling in Localized Scleroderma Patients
- 10:30AM-12:30PM
-
Abstract Number: 1944
Enhancing Rheumatology Consultations with AI-Powered Triage: The ReumAI Pilot Study
- 10:30AM-12:30PM
-
Abstract Number: 2106
EP-104IAR (Long-Acting Intra-Articular Injection of Fluticasone Propionate) Shows Sustained Improvement in Pain for Subjects with Moderate Baseline Pain and BMI Less Than 30 in SPRINGBOARD, a Phase 2, Randomized, 24-Week Study of Osteoarthritis of the Knee
- 10:30AM-12:30PM
-
Abstract Number: 2123
Epidemiology of Bone Health and Fracture in Gout Patients
- 10:30AM-12:30PM
-
Abstract Number: 2434
ESK-001, an Allosteric TYK2 Inhibitor, Maximally Suppresses Type 1 Interferon, a Therapeutic Pathway Central to SLE and CLE
- 10:30AM-12:30PM
-
Abstract Number: 1927
Ethnic and Racial Minorities in Clinical Trials for Autoimmune Connective Tissue Disease Therapeutic Agents
- 10:30AM-12:30PM
-
Abstract Number: 1938
Evaluating Diagnostic Performance of Mycobacterium Tuberculosis Derived Cell-free DNA (CF-DNA) for Diagnosis of Osteoarticular Tuberculosis (OATB): A Novel Method
- 10:30AM-12:30PM
-
Abstract Number: 2178
Evaluating the Non-Inferiority of Mycophenolate Mofetil Compared to Methotrexate in Treating Juvenile Localized Scleroderma
- 10:30AM-12:30PM
-
Abstract Number: 2179
Evaluation of Diagnostic Concordance Between Telehealth Encounters and In-Person Follow-up Assessments in Pediatric Rheumatology
- 10:30AM-12:30PM
-
Abstract Number: 2043
Evaluation of Medication Adherence of FMF Patients Transitioned from a Pediatric Clinic to an Adult Clinic: A Cross-sectional Study
- 10:30AM-12:30PM
-
Abstract Number: 1904
Evaluation of the Economic Burden of Psoriatic Arthritis: Assessment of Direct Costs Using National Administrative Databases at National Level
- 10:30AM-12:30PM
-
Abstract Number: 2120
EvaluationofBone Mineral Densityand Trabecular Bone Score in JuvenileSystemicLupusErythematosusPatientsUsing Dual-Energy X-rayAbsorptiometry
- 10:30AM-12:30PM
-
Abstract Number: 2272
Evolution of Methotrexate and Prednisone Use in the Era of Biologic Therapy: 15-Year Findings from a Large Rheumatoid Arthritis Registry
- 10:30AM-12:30PM
-
Abstract Number: 2202
Evolving Phenotypic and Genotypic Spectrum of Human ISG15 and USP18 Deficiencies
- 10:30AM-12:30PM
-
Abstract Number: 1954
Examination of Rehabilitation Referrals from Rheumatology Practices for Adults with Rheumatoid Arthritis in the RISE Registry: A Feasibility and Descriptive Study
- 10:30AM-12:30PM
-
Abstract Number: 1850
Exhausted T-cells Are Increased in Autoimmune Diseases and Predict Response to Anti-TNF in RA and SPA Patients
- 10:30AM-12:30PM
-
Abstract Number: 2516
Exome-Wide Rare Variant Association Study of Takayasu’s Arteritis
- 10:30AM-12:30PM
-
Abstract Number: 2074
Experience on the Use of Obinutuzumab off Label in Patients with Refractory Idiopathic Inflammatory Myopathy
- 10:30AM-12:30PM
-
Abstract Number: 2315
Exploring Antibodies in Psoriatic Arthritis: A Novel Autoimmune Biomarker Discovered
- 10:30AM-12:30PM
-
Abstract Number: 2162
Exploring Barriers to Rheumatoid Arthritis Treatment Changes: Insights into Patient Concerns
- 10:30AM-12:30PM
-
Abstract Number: 2100
Exploring the Association Between Basketball Participation and Knee Osteoarthritis: Data from the Osteoarthritis Initiative
- 10:30AM-12:30PM
-
Abstract Number: 1918
Exploring the Childhood Opportunity Index and Distance to Care in a Cohort of Children with Rheumatic Disease
- 10:30AM-12:30PM
-
Abstract Number: 1847
Expression Levels of the ATP-Gated Ion Channel P2RX7 Do Not Predict T Cell Sensitivity to Extracellular ATP and NAD
- 10:30AM-12:30PM
-
Abstract Number: 2152
Factors Associated with Health-related Quality of Life in Adults with SAPHO and Chronic Nonbacterial Osteomyelitis – a Cross Sectional Analysis from the SAPHO-CNO Study
- 10:30AM-12:30PM
-
Abstract Number: 2324
Familial Aggregation in Psoriatic Arthritis: Phenotypic Differences in Patients with and Without First-degree Relatives with Psoriatic Disease
- 10:30AM-12:30PM
-
Abstract Number: 2329
Feasibility of a Streamlined Approach for Psoriatic Arthritis Screening and Symptom Assessment
- 10:30AM-12:30PM
-
Abstract Number: 2228
Feasibility, Safety, and Application for Clinical Indication and Research Purposes of Synovial Tissue Analysis in Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 2447
Features of Anti-Fibrillarin Positive Systemic Sclerosis Patients and Ethnic Differences: A European Multicenter Cohort
- 10:30AM-12:30PM
-
Abstract Number: 1997
Features of interleukin-1 and interleukin-6 Inhibitor (IL-1i/IL-6i) Related Severe Delayed Adverse Reactions in Subjects with or Without Reaction-risk Associated HLA-DRB1*15
- 10:30AM-12:30PM
-
Abstract Number: 2165
Fertility Concerns in Adolescents and Young Adults Receiving Gonadotoxic Medications for Rheumatic Disease
- 10:30AM-12:30PM
-
Abstract Number: 2298
Fibroblast-driven Ttek Activation May Drive Acinar Cell Dysfunction in Sjögren’s Disease, Prior to Lymphocytic Infiltration
- 10:30AM-12:30PM
-
Abstract Number: 2292
Fibroblasts with High Expression of CD74 Promote Lymphocytes Infiltration in Salivary Gland in Sjӧgren’s Disease
- 10:30AM-12:30PM
-
Abstract Number: 1862
Folate Receptor β CAR-Tregs Induce Monocyte Apoptosis and Immune Polarization: Potential for Therapeutic Application in Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 1835
FoxP3Hi CTLA4+ ICOS+ Regulatory T Cells Are Expanded in Patients with Sarcoidosis but Not Systemic Sclerosis or IgG4-Related Disease
- 10:30AM-12:30PM
-
Abstract Number: 2129
Fracture Risk Assessment Tool (FRAX®) Scores Predict Mortality in Community-Dwelling Elderlies
- 10:30AM-12:30PM
-
Abstract Number: 2137
Fractures Post Lung Transplant: A Retrospective Cohort Study Conducted at an International Transplant Center
- 10:30AM-12:30PM
-
Abstract Number: 2140
Frailty Is Associated with Lower Bone Mineral Density in US Veterans with Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 2512
French Multicenter Retrospective Study of Patients with Cocaine- and/or Levamisole-induced Vasculitis and Vasculopathy
- 10:30AM-12:30PM
-
Abstract Number: 2417
Frequency and Associated Factors of Herpes Zoster Infection in Systemic Lupus Erythematosus Patients from Latin-America
- 10:30AM-12:30PM
-
Abstract Number: 2513
Frequency, Diagnosis, and Management of Polymyalgia Rheumatica in Germany – Database Analysis of Medical Insurance Data
- 10:30AM-12:30PM
-
Abstract Number: 2453
Gastrointestinal Symptom Severity and Intestinal Permeability in Systemic Sclerosis: A Single Center Prospective Study
- 10:30AM-12:30PM
-
Abstract Number: 2316
Gene Expression Profile Is Different Between Men and Women in Psoriatic Disease
- 10:30AM-12:30PM
-
Abstract Number: 2481
General, Nervous System, Eye, and Skin Involvement in the Phase 3 Trial of Avacopan for the Treatment of ANCA-Associated Vasculitis
- 10:30AM-12:30PM
-
Abstract Number: 2139
Generation of a Human 3D Bone Model to Mimic Glucocorticoid- induced Osteoporosis In Vitro
- 10:30AM-12:30PM
-
Abstract Number: 2049
Genetically Proxied Glucose‑lowering Drug Target and Risk of Immune Mediated Inflammatory Disease: A Mendelian Randomization Study
- 10:30AM-12:30PM
-
Abstract Number: 1803
Genetics of eGFR Variability as a Proxy for Lupus Nephritis in Patients with Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 1829
Genomic Analysis of Skin Biopsies Differentiates Major Anti-Nuclear Autoantibody Subsets in Limited Cutaneous Systemic Sclerosis
- 10:30AM-12:30PM
-
Abstract Number: 2041
Global Prevalence and Clinical Outcomes of Cogan Syndrome
- 10:30AM-12:30PM
-
Abstract Number: 2141
Glucocorticoid Therapy-Associated Bone Fractures Are Associated with Osteoporosis Underscreening in Patients with Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 2486
Glucocorticoids May Mitigate the Risk of Avacopan-Induced Liver Dysfunction in ANCA-Associated Vasculitis: Data from a Multicenter Observational Study in Japan
- 10:30AM-12:30PM
-
Abstract Number: 1812
Glycosylation Changes as Non-Invasive Biomarkers for Lupus Nephritis Detection and Prognosis
- 10:30AM-12:30PM
-
Abstract Number: 2006
Gout Flares After Stopping Anti-inflammatory Prophylaxis During the Early Phases of Urate-Lowering Therapy
- 10:30AM-12:30PM
-
Abstract Number: 1992
Gout FlaresFollowingImmune Checkpoint Inhibitors Treatment
- 10:30AM-12:30PM
-
Abstract Number: 1996
Granulomatous Reactions in Cancer Patients Treated with Immune Checkpoint Inhibitors: A Systematic Literature Review
- 10:30AM-12:30PM
-
Abstract Number: 1912
Greater Glucocorticoid and Less Biologic/Targeted Therapy Use in Midwest PsA Patients Despite Prevalent Comorbidity
- 10:30AM-12:30PM
-
Abstract Number: 2204
Guidance for Stem Cell Therapy for Juvenile Systemic Sclerosis Patients
- 10:30AM-12:30PM
-
Abstract Number: 2342
Guselkumab Shows Similar Domain-Specific Efficacy in Females and Males with Active Psoriatic Arthritis: Post Hoc Analyses of Three Phase 3, Randomized, Double-blind, Placebo-Controlled Studies
- 10:30AM-12:30PM
-
Abstract Number: 2335
Hand Function and Development of Psoriatic Arthritis in Skin Psoriasis Patients, a Prospective Cohort Study
- 10:30AM-12:30PM
-
Abstract Number: 1969
Harmonising Consensus and Reliability Studies in Musculoskeletal Ultrasound
- 10:30AM-12:30PM
-
Abstract Number: 1913
Health Literacy and Disease, Clinical, Functional and Management Outcomes in Inflammatory Arthritis: A Systematic Literature Review
- 10:30AM-12:30PM
-
Abstract Number: 1931
Health System Improvement in Appropriate Test Utilization Involving ANA Testing in the Inpatient and Outpatient Setting
- 10:30AM-12:30PM
-
Abstract Number: 2015
Health-Related Quality of Life in Patients with Gout Receiving Treat-to-Target Urate-Lowering Therapy
- 10:30AM-12:30PM
-
Abstract Number: 2403
Health-related Quality of Life in Women with Systemic Lupus Erythematosus with Permanent Skin Damage and Its Association with Self-esteem and Symptoms of Depression and Anxiety – a Cross-sectional Study
- 10:30AM-12:30PM
-
Abstract Number: 1916
Healthcare Disparities and Clinical Outcomes in Cardiac Sarcoidosis. a Retrospective Cohort Study
- 10:30AM-12:30PM
-
Abstract Number: 1958
Hemodynamic Forces: A Novel Cardiac MRI Parameter to Assess Cardiac Involvement in Sarcoidosis Patients
- 10:30AM-12:30PM
-
Abstract Number: 1886
Heterogeneity of VEXAS Syndrome: A Multicenter Case-series of 299 Cases from the French VEXAS Study Group (FRENVEX)
- 10:30AM-12:30PM
-
Abstract Number: 1802
Heterogeneous Neutrophil Subsets Infiltrate Glomeruli of Lupus Nephritis Patients and Are Elevated in the Kidneys and Urine of Sunlight-induced Nephritis Flares
- 10:30AM-12:30PM
-
Abstract Number: 2456
High Levels of Circulating IFNα Are Associated with Increased Mortality in Patients with Diffuse Cutaneous Systemic Sclerosis
- 10:30AM-12:30PM
-
Abstract Number: 1887
High Rates of Cost-Related Medication Non-Adherence Among Younger Patients Receiving Immunosuppression Are Exacerbated by Other Chronic Conditions
- 10:30AM-12:30PM
-
Abstract Number: 2474
High-throughput Screening Identifies Specific Molecular Markers for ILD in Patients with Rheumatic Diseases
- 10:30AM-12:30PM
-
Abstract Number: 1989
Higher Early Cumulative Glucocorticoid Exposure Is Associated with Worse Progression-Free Survival in Patients with Immune Checkpoint Inhibitor Inflammatory Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 2311
Higher Rates of Psoriatic Arthritis in Patients with Calcium Pyrophosphate Deposition Disease Than Controls: A Retrospective Cohort Study in US Veterans
- 10:30AM-12:30PM
-
Abstract Number: 2080
HLA-DRB1*11:01 Association Differenciates Anti-hmgcr Immune-mediated Necrotizing Myopathy from Non-immune Mediated Statin Myotoxicity
- 10:30AM-12:30PM
-
Abstract Number: 2173
Hope and Health in Adolescents with Chronic Musculoskeletal Pain
- 10:30AM-12:30PM
-
Abstract Number: 1863
Human Endogenous Retroviruses Promote the Aberrant T Cell Differentiation in Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 1990
Human Umbilical Cord Mesenchymal Stem Cell-derived Microvesicles Alleviate Pulmonary Fibrosis by Inhibiting Monocyte-macrophage Migration Through ERK1/2 Signaling-mediated Suppression of CCL2 Expression
- 10:30AM-12:30PM
-
Abstract Number: 2287
Hydroxychloroquine and the Risk of Lymphoma Progression in Sjogren’s Disease: A Retrospective Case Control Study
- 10:30AM-12:30PM
-
Abstract Number: 1893
Hydroxychloroquine Use in Early Pregnancy and Risk of Preterm Delivery in a Californian Cohort of Lupus Pregnancy
- 10:30AM-12:30PM
-
Abstract Number: 1898
Hyperuricemia Is Associated with Higher Levels of Fasting Plasma Glucose and Insulin Resistance in Non-diabetic Subjects
- 10:30AM-12:30PM
-
Abstract Number: 2503
Hypothalamic-Pituitary-Adrenal Axis Suppression by Prednisolone Reversed by the 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor Clofutriben
- 10:30AM-12:30PM
-
Abstract Number: 2425
Ianalumab Induced Durable Depletion of Circulating B Cell Subsets and Associated Changes in B Cell and Neutrophil Transcriptomic and Proteomic Profiles in Patients with Systemic Lupus Erythematosus: 52-Week Treatment Results from a Phase 2 Trial
- 10:30AM-12:30PM
-
Abstract Number: 1823
Identification and Prediction of Systemic Sclerosis Intrinsic Subtypes Using Semi-Supervised and Supervised Learning on Gene Expression Data of Multiple Cohorts
- 10:30AM-12:30PM
-
Abstract Number: 2418
Identification of Co-expressed Molecular Markers That Predict Risk of Severe Flare in Patients with Systemic Lupus Erythematosus (SLE)
- 10:30AM-12:30PM
-
Abstract Number: 1993
Identification of Elevated Soluble Factors in Immune Checkpoint Inhibitor-Induced Inflammatory Arthritis and Their Association with Severity and Persistence
- 10:30AM-12:30PM
-
Abstract Number: 1807
Identification of HDAC Inhibitor Targeting Type I Interferon and B-cell Abnormalities in Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 2391
Identification of Patients with ANA Negative and Double Stranded DNA Positive: What Is the Significance in Daily Rheumatology Practise
- 10:30AM-12:30PM
-
Abstract Number: 1866
Identification of Sjögren’s Disease-Associated CD4+ T Cell Receptor (TCR) Motifs and Repertoire Landscape Through TCR Deep Sequencing
- 10:30AM-12:30PM
-
Abstract Number: 2211
Identifying Clinical Predictors of Difficult-to-Treat Rheumatoid Arthritis Using Machine Learning-based Techniques
- 10:30AM-12:30PM
-
Abstract Number: 1971
Identifying Educational Opportunities Through Examination of Referrals to Rheumatology Musculoskeletal US Clinic
- 10:30AM-12:30PM
-
Abstract Number: 2196
Identifying Specific Criteria for Juvenile Systemic Sclerosis: A Comparison of Adult and Pediatric Ratings
- 10:30AM-12:30PM
-
Abstract Number: 2507
IgG4-related Disease Features and Immunological Profile in a Tertiary Center in Sao Paulo-Brazil
- 10:30AM-12:30PM
-
Abstract Number: 2119
IL-17 Blockade Therapy Improves Symptoms in Patients with Active Axial Spondyloarthritis Without Occurrence of New Vertebral Fractures
- 10:30AM-12:30PM
-
Abstract Number: 1983
Immune Checkpoint Inhibitor Associated Vasculitis and Polymyalgia Rheumatica: A Systematic Review
- 10:30AM-12:30PM
-
Abstract Number: 1833
Immune Complexes of Antibodies Directed to Angiotensin Receptor type-1 and Extracellular Vesicles Are Unique Modulators Contributing to Systemic Sclerosis
- 10:30AM-12:30PM
-
Abstract Number: 1795
Immune Complexes-Mediated Activation of Neutrophils in Systemic Lupus Erythematosus Is Dependent on RNA Recognition by TLR8
- 10:30AM-12:30PM
-
Abstract Number: 1843
Immune Responses to Herpes Zoster Vaccine Responses in Rheumatic Patients on JAK Inhibitors: Insights in Humoral and Cellular Response
- 10:30AM-12:30PM
-
Abstract Number: 2201
Immunodeficiency-Related Monogenic Autoinflammatory Diseases; Expanding Spectrum of Immunodysregulation Disorders
- 10:30AM-12:30PM
-
Abstract Number: 2266
Immunosuppressive Medications and Common Infections in Patients with Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 2005
Impact of Anti-drug Antibodies on the Efficacy of SEL-212 in Patients with Chronic Gout Refractory to Conventional Therapy
- 10:30AM-12:30PM
-
Abstract Number: 2369
Impact of Baseline Factors on Disease Progression and Apremilast Efficacy in Early Oligoarticular Psoriatic Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 2209
Impact of Common Infections on Medication Interruptions, Quality of Life, and Disease Flares in Patients with Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 2148
Impact of Hip Fractures in the Elderly Population: Functional Status, Readmission, and One-Year Mortality
- 10:30AM-12:30PM
-
Abstract Number: 2429
Impact of Hydroxychloroquine Level on ECG QTC Interval in Patients with Rheumatic Systemic Autoimmune Diseases: A Real-life Study
- 10:30AM-12:30PM
-
Abstract Number: 2144
Impact of Immunogenicity on Clinical Outcomes in Postmenopausal Women with Osteoporosis: Results from a Randomized Controlled Phase 3 Study to Compare CT-P41 (Proposed Denosumab Biosimilar) and Reference Denosumab
- 10:30AM-12:30PM
-
Abstract Number: 1903
Impact of Multimorbidity on Targeted Synthetic and Biologic Disease-modifying Antirheumatic Drug (ts/bDMARD) Effectiveness in Patients with Rheumatoid Arthritis: A Two Year Follow-up Study from Mexican Adverse Events Registry BIOADAMEX
- 10:30AM-12:30PM
-
Abstract Number: 2377
Impact of Neighborhood Area Deprivation Index on Outcomes in Lupus Patients in Bronx, NY
- 10:30AM-12:30PM
-
Abstract Number: 2408
Impact of Pain and Fatigue on Quality of Life Among Patients with Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 1949
Implementation of Pharmacist-Led Comprehensive Medication Management for Puerto Ricans with Rheumatic Diseases
- 10:30AM-12:30PM
-
Abstract Number: 2455
Improvement Across Multi-organ Domains and Patient Reported Outcomes in Refractory Juvenile-Onset Systemic Sclerosis (jSSc) up to 4 Years After Autologous Stem Cell Transplantation (ASCT)
- 10:30AM-12:30PM
-
Abstract Number: 2207
Improvement Across Physician and Patient Reported Outcome Measures over a 24 Months-time Period in the Juvenile Systemic Scleroderma Inception Cohort
- 10:30AM-12:30PM
-
Abstract Number: 2366
Improvement in Pain-Associated Biomarkers with Deucravacitinib, a First-in-Class, Oral, Selective, Allosteric Tyrosine Kinase 2 Inhibitor, in Patients with PsA in a Double-Blind Phase 2 Study (IM011-084)
- 10:30AM-12:30PM
-
Abstract Number: 1911
Improving Healthcare Access in Underserved Brooklyn Communities: A Comprehensive Multispecialty Patient Navigator Program
- 10:30AM-12:30PM
-
Abstract Number: 2432
In Vitro and In Vivo Evidence of the Steroid-Sparing Potential of Afimetoran, an Equipotent Toll-Like Receptor 7/8 Dual Antagonist
- 10:30AM-12:30PM
-
Abstract Number: 1799
In VitroEvidence for the Restoration of Glucocorticoid Sensitivity by Toll-Like Receptor 7 and 8 Inhibition in Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 2372
Incidence and Predictors of Recurrent Pericarditis in Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 2397
Increase of IL10 and IFNa2 Are Associated to Clinical Activity in Systemic Lupus Erythematous Patients
- 10:30AM-12:30PM
-
Abstract Number: 2070
Increased Circulating Levels of Fatty Acid-binding Proteins as a Potential Biomarker of Disease Damage in Inflammatory Myopathies Patients
- 10:30AM-12:30PM
-
Abstract Number: 2121
Increased Fracture Rates in Patients Continuing Methotrexate After Methotrexate-associated Lower Limb Insufficiency Fractures: A Retrospective Follow-up Study
- 10:30AM-12:30PM
-
Abstract Number: 2078
Increased RAGE Expression in Myositis
- 10:30AM-12:30PM
-
Abstract Number: 2339
Increased Risk of Psoriatic Arthritis in Patients with Familial Mediterranean Fever: A Population-Based Cohort Study
- 10:30AM-12:30PM
-
Abstract Number: 2385
Increased Type I Interferon Inducible Genes Expression in the Peripheral Blood of Patients Presenting Cutaneous Lupus Erythematosus Manifestations
- 10:30AM-12:30PM
-
Abstract Number: 2000
Induction of Systemic Inflammatory Diseases with Dupilumab Therapy
- 10:30AM-12:30PM
-
Abstract Number: 2341
Influence of Patient Baseline Characteristics on Zasocitinib (TAK-279) Efficacy, a Selective Oral Tyrosine Kinase 2 Inhibitor: A Randomized Phase 2b Trial in Psoriatic Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 1801
Inhibitory Effects of Dapirolizumab Pegol, a Monovalent Anti-CD40L PEG-Conjugated Antigen-Binding Fragment Lacking a Functional Fc Domain, on In Vitro T Follicular Helper/B Cell Interactions and Cytokine Production in Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 1991
Initial Corticosteroid Dosing and Effects on Disease Activity, Survival, and Tumor Progression in Immune Checkpoint Inhibitor-induced Inflammatory Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 1978
Insertional and Midportion Achilles Tendinopathy Have Differences in Presence of Calcifications and Neovascularization
- 10:30AM-12:30PM
-
Abstract Number: 1922
Insights into Rheumatology Practice in Uganda
- 10:30AM-12:30PM
-
Abstract Number: 1819
Insulin-like Growth Factor Binding Protein-7 (IGFBP7) Plays a Pathogenic Role in Dermal Fibrosis and Is Increased in Systemic Sclerosis
- 10:30AM-12:30PM
-
Abstract Number: 2358
Integration of Single-cell Multi-omics Profiling for Investigating Treatment Response to Tumor Necrosis Factor Alpha Inhibitors in Patients with Axial Spondyloarthritis
- 10:30AM-12:30PM
-
Abstract Number: 1952
Interest in Clinical Trial Participation Among People with Lupus: Results from the Research Accelerated by You (RAY) Registry
- 10:30AM-12:30PM
-
Abstract Number: 2288
Interferon Gamma Signaling Is Associated with Development of Extraglandular Manifestations in Sjögren’s Disease
- 10:30AM-12:30PM
-
Abstract Number: 2463
Interstitial Lung Disease in Very Early Systemic Sclerosis – a Clinical and Radiological Characterization
- 10:30AM-12:30PM
-
Abstract Number: 2271
Intra-Articular Injection of Human Bone Marrow-Derived Mesenchymal Stem Cells in Knee Osteoarthritis: A Randomized, Double-Blind, Controlled Trial
- 10:30AM-12:30PM
-
Abstract Number: 1804
Investigating Adaptive Immune Receptor Repertoires by Deep Immune Cell Phenotyping in Preclinical Autoimmunity Development
- 10:30AM-12:30PM
-
Abstract Number: 2441
Investigating Kidney Disease Risks in Systemic Sclerosis (SSc) – Effects of Proton Pump Inhibitors (PPI): Retrospective Analysis
- 10:30AM-12:30PM
-
Abstract Number: 2319
Investigating the Association of Serum Metabolites with Psoriatic Arthritis Musculoskeletal Disease Patterns
- 10:30AM-12:30PM
-
Abstract Number: 2029
Iron Deficiency in Familial Mediterranean Fever: A Study on 211 Adult Patients from the JIR Cohort
- 10:30AM-12:30PM
-
Abstract Number: 2378
Is Urinary Protein-creatinine Relation Reliable for Diagnosis or Follow up of Lupus Nephritis?
- 10:30AM-12:30PM
-
Abstract Number: 1902
Ixekizumab for the Treatment of Patients with Spondyloarthritis – Real-world Evidence from the Nationwide Danish Registry, DANBIO
- 10:30AM-12:30PM
-
Abstract Number: 1761
Juvenile Idiopathic Arthritis Genetic Risk Haplotypes: Relevance to Children of African Ancestry
- 10:30AM-12:30PM
-
Abstract Number: 1796
Kidney Hematopoietic Stem and Progenitor Cells Contribute to Immune Cell Development and Pathology in Lupus Nephritis
- 10:30AM-12:30PM
-
Abstract Number: 1934
Knee Symptom Phenotyping Incorporating Pain and Function: A Multiple-Trajectory Modeling-Based Study Using Data from the Osteoarthritis Initiative (OAI)
- 10:30AM-12:30PM
-
Abstract Number: 2386
Landscape of Immune Cells and Autoimmunity in Systemic Lupus Erythematosus Patients with Obesity
- 10:30AM-12:30PM
-
Abstract Number: 2181
Large Pediatric Cohort with ANCA-associated Vasculitis at a Single Institution: Patient Characteristics, Clinical Course, and Outcomes
- 10:30AM-12:30PM
-
Abstract Number: 1815
Leveraging Novel Systemic Sclerosis Disease Signatures to Build a Humanized Drug Discovery Funnel
- 10:30AM-12:30PM
-
Abstract Number: 1787
Linking Transcriptomic Profiles of Kidney and Blood Samples Provides Insight into Identification of Lupus Nephritis
- 10:30AM-12:30PM
-
Abstract Number: 2252
Long-term Efficacy of Filgotinib Monotherapy and Combination Therapy: Interim Results from a Post Hoc Analysis of the FINCH 4 Study
- 10:30AM-12:30PM
-
Abstract Number: 2501
Long-term Remission off Therapy (LTROT) Is Possible in Non-infectious Aortitis with DMARDs with Low Risk of Secondary Adrenal Insufficiency
- 10:30AM-12:30PM
-
Abstract Number: 2482
Long-Term Safety of Mepolizumab in Eosinophilic Granulomatosis with Polyangiitis (EGPA): Pooled Results from Two Open-Label Extension Studies
- 10:30AM-12:30PM
-
Abstract Number: 2357
Longitudinal Evaluation of Neutrophil-to-Lymphocyte Ratio in Guselkumab-Treated Patients with Psoriatic Disease and Levels of Systemic Inflammation Associated with Elevated Cardiovascular Risk: Post-hoc Analysis of 4 Phase 3, Randomized, Controlled Studies
- 10:30AM-12:30PM
-
Abstract Number: 2490
Longitudinal Kidney Function Trajectories in Patients Enrolled in the Plasma Exchange and Glucocorticoids in ANCA-Associated Vasculitis Trial
- 10:30AM-12:30PM
-
Abstract Number: 2184
Loss to Follow up After Transfer from Pediatric to Adult Care in Patients with JIA or jSLE
- 10:30AM-12:30PM
-
Abstract Number: 2351
Low Uveitis Rates in Patients with Axial Spondyloarthritis or Psoriatic Arthritis Treated with Bimekizumab: Long-Term Results from Phase 2b/3 Trials
- 10:30AM-12:30PM
-
Abstract Number: 2270
Low Yield of Routine Serological Screening for Hepatitis B in Patients with Rheumatoid Arthritis Starting Rituximab Therapy in a Non-Endemic Country
- 10:30AM-12:30PM
-
Abstract Number: 1838
M5542: A Potent CD80, CD86, and OX40L Antagonist Fusion Molecule for the Treatment of Autoimmune Diseases
- 10:30AM-12:30PM
-
Abstract Number: 2469
Machine Learning Identifies Oesophageal Symptoms as a New Red Flag for for Very Early Diagnosis of Systemic Sclerosis (VEDOSS): A EUSTAR Analysis
- 10:30AM-12:30PM
-
Abstract Number: 1908
Male Sex, Medical Comorbidity and Post-procedure Complications Are Associated with Higher In-hospital Mortality After Primary Total Knee Arthroplasty for Osteoarthritis
- 10:30AM-12:30PM
-
Abstract Number: 1844
Manufacturing of IMPT-514, a CD19/CD20 Bispecific CAR T Cell Product Candidate as a Potential Treatment of Patients with Autoimmune Diseases
- 10:30AM-12:30PM
-
Abstract Number: 2233
Maximizing Diagnostic Sensitivity: Combined Anti-RA33, Anti-CarP, and Anti-PAD4 Autoantibodies in Seronegative Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 1809
Melanocytes Are Driven Toward an Antigen Presentation Phenotype Through UV-Induced Keratinocyte Crosstalk and Exposure to Type I Interferons in Patients with Cutaneous Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 1788
Memory B Cell Activation and Dysregulation in Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 2330
Mental Health, Sex, and Comorbidities as Determinants of Recalcitrant PsA
- 10:30AM-12:30PM
-
Abstract Number: 2479
Mepolizumab Treatment Decreased Oral Corticosteroid Use and Improved Clinical Response, Control Status, and Remission in Patients with Eosinophilic Granulomatosis with Polyangiitis: Results up to 24 Months from a Large Network of US Allergy Practices
- 10:30AM-12:30PM
-
Abstract Number: 2524
Metabolite Profiling of Saliva for the Discrimination of Behcet’s Disease, Sjogren’s Syndrome, and Recurrent Aphthous Stomatitis
- 10:30AM-12:30PM
-
Abstract Number: 1774
Metabolomics and Lipidomics in Juvenile Localized Scleroderma
- 10:30AM-12:30PM
-
Abstract Number: 2240
Methotrexate Use Influenced the Effect of Inflammation on Cardiovascular Risk Differently in Anticitrullinated Protein Antibody Negative and Positive Patients with Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 2213
Microvascular and Macrovascular Endothelial Dysfunction in Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 2189
Migratory Arthritis in Children: What Besides Rheumatic Fever?
- 10:30AM-12:30PM
-
Abstract Number: 1772
Modeling and Predicting HLH Through Measurement of Immune Synapse Duration, Cytokine Production, and Target Cell Death
- 10:30AM-12:30PM
-
Abstract Number: 1810
Modulation of Type I Interferon Signaling by Anifrolumab Alters the Spatial Immune Landscape in Cutaneous Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 1782.5
Monocytes from HLA B27 Positive Enthesitis Related Arthritis Patients Are More Activated Than HLA B27 Negative Patients
- 10:30AM-12:30PM
-
Abstract Number: 2297
Mortality and Its Predictor Variables in Patients with Sjögren Disease: Data from SjögrenSER-Pros Prospective Registry
- 10:30AM-12:30PM
-
Abstract Number: 2493
Mortality in Anti-neutrophil Cytoplasmic Antibody-Associated Vasculitis: Study from a Single University Hospital
- 10:30AM-12:30PM
-
Abstract Number: 1762
Multi-omic Analysis Defines Heterogeneous and Cell Specific Type I Interferon Signalling in Juvenile-onset SLE Patients Associated with Biomarkers of Cardiovascular Risk
- 10:30AM-12:30PM
-
Abstract Number: 1789
Multi-omic Profiling Identifies Pathogenic Pro-inflammatory Human Monocytes/Macrophages in Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 2426
Multi-OMICs Analysis Including Lipidomics to Correlate Baseline OMICs Profiles with Disease Activity and Response to Different Immunomodulatory Treatments in Patients with Systemic Lupus Erythematosus – An Exploratory Pilot Study Using a Multi-OMICs Approach
- 10:30AM-12:30PM
-
Abstract Number: 2452
Multimodal Ultrasound in the Assessment of Sarcopenia-related Muscle Involvement in Patients with Systemic Sclerosis: A Multicentric Study
- 10:30AM-12:30PM
-
Abstract Number: 1853
Mutated Nod2 Enhances Pathogenic Th17 Responses That Promote Experimental Blau Syndrome
- 10:30AM-12:30PM
-
Abstract Number: 2199
Mycobacterial Infection and Renal and Bladder Malignancy in 2 IFNopathy Patients on High Doses of JAK Inhibitors
- 10:30AM-12:30PM
-
Abstract Number: 2404
Nailfold Dermoscopy: A Valuable Tool for Differentiating Dermatomyositis from Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 2446
Nailfold Videocapillaroscopy Findings in Patients with Limited Cutaneous versus Diffuse Cutaneous Systemic Sclerosis: The First Detailed Retrospective Study
- 10:30AM-12:30PM
-
Abstract Number: 2320
Nailfold Videocapillaroscopy Findings in Patients with Psoriatic Disease: Is There a Distinctive Psoriatic Pattern?
- 10:30AM-12:30PM
-
Abstract Number: 2312
National Prevalence of Psoriatic Arthritis in the United States: Data from National Health and Nutrition Examination Survey [NHANES]
- 10:30AM-12:30PM
-
Abstract Number: 2038
Nationwide Analysis of Adult Hospitalizations with Rheumatologic Conditions and Spontaneous Coronary Artery Dissection
- 10:30AM-12:30PM
-
Abstract Number: 2399
Nationwide Analysis of Endovascular Thrombectomy in Ischemic Stroke Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis: Mortality and Healthcare Utilization
- 10:30AM-12:30PM
-
Abstract Number: 1872
Nationwide Analysis of Prosthetic Joint Complications with and Without Inflammatory Arthritis
- 10:30AM-12:30PM
-
Abstract Number: L10
Neuroimmune Modulation in Adults with Rheumatoid Arthritis and Inadequate Response or Intolerance to Biological or Targeted Synthetic DMARDs: Results at 12 and 24 Weeks from a Randomized, Sham-Controlled, Double-Blind Pivotal Study
- 10:30AM-12:30PM
-
Abstract Number: 2406
Neuropsychiatric Manifestations in Indian SLE Inception Cohort for Research: Prevalence, Predictors and Outcomes
- 10:30AM-12:30PM
-
Abstract Number: 1780
Next Generation Sequencing Analysis Reveals Complex Genetic Architecture of Childhood-onset Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 1941
No Show QI at Hoxworth Rheumatology Clinic: Evaluating the Impact of Live Telephone Calls Combined with Automated Reminders
- 10:30AM-12:30PM
-
Abstract Number: 2166
Nominal Group Technique to Identify What Adolescents with JIA and Parents of Children with JIA Consider When Making Treatment Change Decisions
- 10:30AM-12:30PM
-
Abstract Number: 2018
Non-adherence to Urate Lowering Therapy in Gout After 5 Years Is Related to Poor Outcomes – Results from the NOR-Gout Study
- 10:30AM-12:30PM
-
Abstract Number: 1808
Not Only Type-I Interferon Regulated Genes Are Differentially Expressed in Circulating Monocytes from Active Lupus Nephritis Patients
- 10:30AM-12:30PM
-
Abstract Number: 2035
Older Age and Higher Erythrocyte Sedimentation Rate Are Associated with Increased Disease Burden at Diagnosis in a Cohort of IgG4-Related Disease Patients
- 10:30AM-12:30PM
-
Abstract Number: 1868
Opioid Prescription Rates in Patients with Radiographic Axial Spondyloarthritis in the US Between 2008-2021: A Joinpoint Regression Analysis
- 10:30AM-12:30PM
-
Abstract Number: 2191
Optimizing Inpatient Kawasaki Disease Care
- 10:30AM-12:30PM
-
Abstract Number: 1947
Optimizing Osteoarthritis Care Through Clinical and Community Partnership: Results of an Exploratory Trial
- 10:30AM-12:30PM
-
Abstract Number: 2485
Orbital Pseudotumor in Granulomatosis with Polyangiitis. Interim Analysis of Clinical Outcomes from a European Collaborative Observational Study
- 10:30AM-12:30PM
-
Abstract Number: 2197
Outcome Measures for the Assessment of Cutaneous and Musculoskeletal Manifestations of Juvenile Systemic Sclerosis: An International Collaborative Scoping Review and Survey of Current Practice
- 10:30AM-12:30PM
-
Abstract Number: 2187
Outcomes Following Tonsillectomy in Children with Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis (PFAPA) Syndrome
- 10:30AM-12:30PM
-
Abstract Number: 2220
Outcomes in Seronegative Rheumatoid Arthritis and Undifferentiated Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 2383
Outcomes of Systemic Lupus Erythematosus Hospitalizations: Insights from a Multinational Tertiary Center Experience
- 10:30AM-12:30PM
-
Abstract Number: 2042
Overview of Lung Manifestations in Sarcoidosis and Various Treatment Approaches at a University Center
- 10:30AM-12:30PM
-
Abstract Number: 2002
Pain and Physical Function, but Not Fatigue, Track with Disease Activity in Immune Checkpoint Inhibitor-Induced Inflammatory Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 1816
Paracrine WNT Signaling Drives Pro-fibrotic Metabolic Activation of Systemic Sclerosis Macrophages
- 10:30AM-12:30PM
-
Abstract Number: 2161
Parent and Youth Report of Psychosocial Functioning in Chronic Childhood Vasculitis
- 10:30AM-12:30PM
-
Abstract Number: 2188
Parent Verses Patient Perspectives of Health-Related Quality of Life Among Children with Vasculitis
- 10:30AM-12:30PM
-
Abstract Number: 2337
Patient Characteristics and Outcomes of Emergency Visits in Psoriatic Arthritis: Results from the U.S. Nationwide Emergency Department Sample (NEDS)
- 10:30AM-12:30PM
-
Abstract Number: 2488
Patient Characteristics and Treatment Patterns Before and After Initiation of Avacopan in the United States: An Early View Based on a Claims Database Analysis
- 10:30AM-12:30PM
-
Abstract Number: 2101
Patient Characteristics Associated with Objectively-Assessed Physical Activity in Veterans with Knee Osteoarthritis
- 10:30AM-12:30PM
-
Abstract Number: 2095
Patient Perceptions of an Osteoarthritis Management Program at a Midwest Medical Center
- 10:30AM-12:30PM
-
Abstract Number: 2360
Patient Selection and Treatment Outcomes Using Preliminary Data-driven Definition versus the Established ASAS Definition of a Positive MRI of the Sacroiliac Joint in axSpA: Post-hoc Analysis from COAST-X
- 10:30AM-12:30PM
-
Abstract Number: 1951
Patient-Reported Barriers to Care Across Pediatric Rheumatology Patients at a Tertiary Academic Medical Center
- 10:30AM-12:30PM
-
Abstract Number: 1915
Patient-reported Difficulties Regarding Reproductive Health Discussions in an Urban Outpatient Setting
- 10:30AM-12:30PM
-
Abstract Number: 1919
Patient-reported Social Risk Factor Screening Among Rheumatology Outpatients
- 10:30AM-12:30PM
-
Abstract Number: 2265
Patient’s Global Assessment of Disease Activity Is the Most Relevant Factor for Near-Miss of Boolean 2.0 Remission in Patients with Rheumatoid Arthritis: Post Hoc Analysis from the Observational UPwArds Study
- 10:30AM-12:30PM
-
Abstract Number: 1939
Patient’s Satisfaction with a Telerheumatology Program in a Remote Rural Area of Northern Pakistan
- 10:30AM-12:30PM
-
Abstract Number: 2336
Patients with Psoriasis with a Positive Psoriasis Epidemiology Screening Tool (PEST): Similarities and Differences Compared to PsA and Patients with Psoriasis and a Negative PEST
- 10:30AM-12:30PM
-
Abstract Number: 2182
PECOS (Pediatric SARS-CoV-2 MIS-C Long-term Outcomes Study): Preliminary Results
- 10:30AM-12:30PM
-
Abstract Number: 2175
Pediatric Rheumatology Clinic Referral Patterns at a Large Midwestern Center
- 10:30AM-12:30PM
-
Abstract Number: 2195
Pediatric Rheumatology Graduation: A One-Way Bridge to Adult Care?
- 10:30AM-12:30PM
-
Abstract Number: 1897
People Living with Autoimmune Disease Are at Higher Risk of Suffering from Post-Acute Sequelae of SARS-CoV-2 but Immunization Is Protective
- 10:30AM-12:30PM
-
Abstract Number: 2384
Performance and Concordance of Two Different Methods of Detecting the Commonest Autoantibodies in Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: L04
Performance of an Artificial Intelligence Model Compared to Multiple Human Experts in Scoring Synovitis Severity and Osteophyte Severity on Joint Ultrasound Images
- 10:30AM-12:30PM
-
Abstract Number: 2444
Performance of the DETECT Algorithm and Cluster Analysis in Screening for Systemic Sclerosis Pulmonary Hypertension Groups
- 10:30AM-12:30PM
-
Abstract Number: 2062
Performance of the Patient Self-Assessment Tools for Cutaneous Dermatomyositis: Patient CDASI and Rash Mapping
- 10:30AM-12:30PM
-
Abstract Number: 2394
Perioperative Stress Dose vs Therapeutic Dose Comparison: One-Month Postoperative Outcomes in Moderate and Major Surgeries for Systemic Lupus Erythematous and Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: L02
Persistent Articular Infection and Host Reactive Responses Contribute to Brucella-Induced Spondyloarthritis in SKG Mice
- 10:30AM-12:30PM
-
Abstract Number: 2088
Personalized Prediction of Pain and Function for Knee Osteoarthritis Patients 1 Year After Total Knee Arthroplasty Using Machine Learning
- 10:30AM-12:30PM
-
Abstract Number: 2134
PEX5 Acts as a Negative Regulator of RANKL-induced Osteoclastogenesis In Vitro and Inflammatory Calvarial Bone Destruction In Vivo
- 10:30AM-12:30PM
-
Abstract Number: 2294
Pharmacodynamic Effects of Nipocalimab on Disease Biomarkers in Patients with Moderate-to-Severe Active Sjögren’s Disease: Results from a Multicenter, Randomized, Double-blinded, Placebo-controlled Phase 2 Study
- 10:30AM-12:30PM
-
Abstract Number: 2054
Phenotypical Differences in VEXAS Syndrome, Where Are We a Year Later? Results from a National Cohort Focused on Rheumatological Patients
- 10:30AM-12:30PM
-
Abstract Number: 2109
Pincer Grip and Metacarpophalangeal Patterns Emerge as New Phenotypes of Hand Osteoarthritis Using a Data Driven Approach: Data from the Osteoarthritis Initiative
- 10:30AM-12:30PM
-
Abstract Number: 2068
Poloxamers 188 & 182 Are Effective in Repairing the Membrane Resealing Defect in Myositis
- 10:30AM-12:30PM
-
Abstract Number: 2504
Polyarteritis Nodosa Associated with VEXAS Syndrome and Chronic Myelomonocytic Leukemia Compared with Primary Forms: A Case-Control Study
- 10:30AM-12:30PM
-
Abstract Number: 2457
Polypharmacy, Drug-drug Interactions, and Adverse Drug Reactions Among Systemic Sclerosis Patients: A Cross-sectional Risk Factor Study
- 10:30AM-12:30PM
-
Abstract Number: 2130
Post-fracture Survival for Rheumatoid Arthritis Patients Is Not Improving
- 10:30AM-12:30PM
-
Abstract Number: 1978.5
Post-Hoc Analysis of Clinically Relevant Anti-Vaccine Antibodies in Participants with Rheumatoid Arthritis Treated with Nipocalimab
- 10:30AM-12:30PM
-
Abstract Number: 1839
PPP2R3C Overexpression Suppresses TCR -mediated CD4+ T Cell Abnormal Activation in Systemic Lupus Erythematosus via JNK and AKT-mTOR Pathways
- 10:30AM-12:30PM
-
Abstract Number: 1841
Preclinical Evaluation of ALLO-329: Allogeneic CD19 CAR T Cells Expressing an Anti-Rejection CD70 CAR for the Treatment of Autoimmune Diseases
- 10:30AM-12:30PM
-
Abstract Number: 2400
Predicting Adverse Pregnancy Outcomes in Women with Systemic Lupus Erythematosus: External Validation of the PROMISSE Model Using Multiple Independent Cohorts
- 10:30AM-12:30PM
-
Abstract Number: 2020
Prediction of the Response of Patients with Chronic Uncontrolled Gout to Pegloticase
- 10:30AM-12:30PM
-
Abstract Number: 2349
Predictive Potential of Serum Metabolites Associated with Treatment Response to Interleukin -17 Inhibitors in Patients with PsA
- 10:30AM-12:30PM
-
Abstract Number: 2354
Predictors of Clinical Response to Intravenous Secukinumab Among Patients with PsA: A Post Hoc Analysis of a Phase 3 Trial
- 10:30AM-12:30PM
-
Abstract Number: 2163
Predictors of Patient Engagement and Usability in a Chronic Musculoskeletal Pain Management App
- 10:30AM-12:30PM
-
Abstract Number: 2325
Predictors of Treatment Response and Continuation in Patients with Psoriatic Arthritis Initiating Secukinumab – Results from the EuroSpA Collaboration
- 10:30AM-12:30PM
-
Abstract Number: 2322
Predictors of Work Impairment and Absence Amongst People with Psoriatic Arthritis (PsA) – Evidence from the British Society for Rheumatology PsA Register (BSR-PsA)
- 10:30AM-12:30PM
-
Abstract Number: 2439
Preliminary Analysis of Open-Label Dose-Titration Phase of SLE Treatment with N-Acetylcysteine (SNAC) Shows Evidence for Potential Improvement of SLEDAI, BILAG, ADHD and Fatigue Scores in Patients with Active SLE
- 10:30AM-12:30PM
-
Abstract Number: 2170
Preliminary Evaluation of a Patient-Reported Version for the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI): The Systemic Lupus Erythematosus Disease Activity Questionnaire (SLEDAQ)
- 10:30AM-12:30PM
-
Abstract Number: 2053
Presence of ANA to Development of Rheumatic Diseases
- 10:30AM-12:30PM
-
Abstract Number: 2205
Presence of Nailfold Capillary Changes Correlates with More Severe Organ Involvement in Juvenile Systemic Scleroderma. Results of the Juvenile Scleroderma Inception Cohort
- 10:30AM-12:30PM
-
Abstract Number: 2461
Prevalence and Impact of Peripheral Neuropathy in SSc: A Frequent and Disabling Manifestation in SSc, and a Potential Surrogate Marker for Autonomic Neuropathy
- 10:30AM-12:30PM
-
Abstract Number: 2520
Prevalence and Incidence of Giant Cell Arteritis Among Medicare Fee-For-Service Beneficiaries: United States, 2014–2019
- 10:30AM-12:30PM
-
Abstract Number: 2321
Prevalence and Risk Factors of Metabolic Dysfunction-associated Steatotic Liver Disease
- 10:30AM-12:30PM
-
Abstract Number: 1889
Prevalence of Physician-Diagnosed versus Clinically Confirmed Primary Sjögren’s Syndrome (SS) Among Adults in the United States
- 10:30AM-12:30PM
-
Abstract Number: 1879
Prevalence of Relapsing Polychondritis in Colombia: Data from the National Health Registry 2018 – 2023
- 10:30AM-12:30PM
-
Abstract Number: 2090
Prevalence of Steatotic Liver Disease and Liver Fibrosis Among Patients with Osteoarthritis (OA)
- 10:30AM-12:30PM
-
Abstract Number: 2147
Primary and Secondary Prevention of Osteoporotic Fracture in the Elderly Patients
- 10:30AM-12:30PM
-
Abstract Number: 2222
Primary Lung Involvement in Early Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 2247
Pro-inflammatory Monocytes and CD11c Expression in ACPA Positive Individuals with Arthralgia and Their Associations with Subclinical Synovitis Preceding the Onset of Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 2048
Prognostic Value of Bronchoalveolar Lavage in CTD-related Interstitial Lung Disease: An Observational Study
- 10:30AM-12:30PM
-
Abstract Number: 2451
Prognostic Value of Functional Outcomes in a Italian Multicentric Cohort of Early SSc-ILD Patients
- 10:30AM-12:30PM
-
Abstract Number: 2470
Progression Patterns in Systemic Sclerosis – Associated Interstitial Lung Diseases
- 10:30AM-12:30PM
-
Abstract Number: L05
Prolonged Plasma Urate-Lowering After a Single Intravenous Administration of PRX-115, a Novel PEGylated Uricase, in Participants with Elevated Urate Levels
- 10:30AM-12:30PM
-
Abstract Number: 2396
PROMISing Outcomes: Understanding the Concordance Between Provider-assessment and Patient-reported Disease Activity in SLE
- 10:30AM-12:30PM
-
Abstract Number: 2065
Proposed Pathways Involved in the Pathogenesis of Juvenile Dermatomyositis (JDM)
- 10:30AM-12:30PM
-
Abstract Number: 2310
Prospective Evaluation of Pulmonary Involvement in Patients with Primary Sjögren’s Disease, Using Pulmonary Function Tests and High Resolution Computed Tomography, Reveals High Prevalence of Subclinical Interstitial Lung Disease, Along with Small Airways Disease
- 10:30AM-12:30PM
-
Abstract Number: 2193
Prospective Evaluation of Reactogenicity and Safety Following COVID-19 Vaccination in Children with a History of MIS-C
- 10:30AM-12:30PM
-
Abstract Number: 1825
Proteomic and Transcriptomic Analysis Reveal Elevated Senescent Signature in Systemic Sclerosis Fibrosis
- 10:30AM-12:30PM
-
Abstract Number: 2081
Proteomic Profiling of Urine Reveals Biomarker Candidates for Idiopathic Inflammatory Myopathies
- 10:30AM-12:30PM
-
Abstract Number: 2332
PsAID12 Thresholds Defining Disease Impact Severity in Psoriatic Arthritis Developed in an Observational Setting Showed Higher Sensitivity but Lower Specificity Than Those Developed in a Randomized Controlled Trial Setting
- 10:30AM-12:30PM
-
Abstract Number: 1883
Psoriatic Arthritis Flare Incidence, Definitions and Risk Factors: A Systematic Review
- 10:30AM-12:30PM
-
Abstract Number: 2234
Pulmonary Damage Biomarkers and Progression of Rheumatoid Arthritis-associated Interstitial Lung Disease in a Prospective Longitudinal Cohort
- 10:30AM-12:30PM
-
Abstract Number: 2064
Quantifying Cutaneous Dermatomyositis: A Novel 3D Image-based Approach
- 10:30AM-12:30PM
-
Abstract Number: 1972
Quantifying Sjogren’s Disease Burden: UHFUS Evaluation of the Number and Severity of Involved Exocrine Gland
- 10:30AM-12:30PM
-
Abstract Number: 2477
Quantifying Tissue Microstructural Changes in Scleroderma Skin Using a Novel, Point-of-care, High-frequency-ultrasound Instrument
- 10:30AM-12:30PM
-
Abstract Number: 2313
Race and Ethnicity as Predictors of Diagnostic Delay in Psoriatic Arthritis and Axial Spondyloarthritis
- 10:30AM-12:30PM
-
Abstract Number: 2017
Race, Ethnicity, and Rheumatology Care Predict Long-term Urate-Lowering Treatment Persistence Following a Treat-to-Target Intervention in a Large, Multicenter Randomized Trial
- 10:30AM-12:30PM
-
Abstract Number: 1873
Race/Ethnicity and Household Income at the County Level Interacts with the Association of Urbanicity and Lupus Nephritis Mortality
- 10:30AM-12:30PM
-
Abstract Number: 1926
Race/ethnicity Is Associated with Disease Severity in Pediatric Patients with ANCA-associated Vasculitis Hospitalized in the United States
- 10:30AM-12:30PM
-
Abstract Number: 1914
Racial and Ethnic Differences in the Prevalence of Disease Features in Systemic Sclerosis
- 10:30AM-12:30PM
-
Abstract Number: 1924
Racial and Gender Disparities in Psoriatic Arthritis Clinical Trials
- 10:30AM-12:30PM
-
Abstract Number: 1909
Racial Disparities in Ocular Complications of Systemic Rheumatic Diseases: A Retrospective Cross-Sectional Study
- 10:30AM-12:30PM
-
Abstract Number: 2388
Racial/Ethnic Variation in Multimorbidity Risk and Accrual and Comorbid Conditions Among Patients with Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 1973
Radioisotopic Synoviorthesis: Factors Associated with Good Response Evaluated by Ultrasound
- 10:30AM-12:30PM
-
Abstract Number: 2466
Ranked Composite Important Difference (RCID) Scores in Patients with Diffuse Cutaneous Systemic Sclerosis and Interstitial Lung Disease
- 10:30AM-12:30PM
-
Abstract Number: 2159
Reaching Those in Need: Understanding the Reach of a Digital Program for Lupus Self-Management Education
- 10:30AM-12:30PM
-
Abstract Number: 2284
Real-World Evidence of the Antifibrotic Nintedanib in Rheumatoid Arthritis-Interstitial Lung Disease. National Multicenter Study of 74 Patients from Clinical Practice
- 10:30AM-12:30PM
-
Abstract Number: 2484
Real-World Use of Avacopan for ANCA-Associated Vasculitis Beyond 52 Weeks
- 10:30AM-12:30PM
-
Abstract Number: 1899
Recurrent Heart Failure Hospitalization in Rheumatoid Arthritis: A National Veterans Affairs Matched Cohort Study
- 10:30AM-12:30PM
-
Abstract Number: 2370
Redefining Clinical Trial Inclusion Criteria Using Quality of Life in Cutaneous Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 1865
Reduction in CD4+T Cell Expression of CD28 and CD2 by Antibody-induced Internalization of CD6: A Potential Step Towards Immune Tolerance
- 10:30AM-12:30PM
-
Abstract Number: 1764
Reduction in Circulating Neutrophil Extracellular Traps and Restored Degradation Post-treatment in Pediatric Lupus
- 10:30AM-12:30PM
-
Abstract Number: 2438
Reduction in Oral Corticosteroid Use During Anifrolumab Therapy: Observations from a Real-world Cohort of Adults with Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 1936
Referral and Diagnostic Delays of Patients with Chronic Inflammatory Rheumatic Diseases: A Cross-sectional Study in Eight Countries
- 10:30AM-12:30PM
-
Abstract Number: 2236
Relation Between Sociodemographic Factors and Hand Function in Patients with Early Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 2007
Relationship Between Gout Flare Burden and Patient-Reported Outcome Following Allopurinol Initiation
- 10:30AM-12:30PM
-
Abstract Number: 2127
Relationship Between Serum Uric Acid and Trabecular Bone Score (TBS) in Healthy Population
- 10:30AM-12:30PM
-
Abstract Number: 2230
Relationship Between the Complement System and Serum Lipid Profile in Patients with Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 2092
Remote-Delivered Tai Chi and Gut Microbiota in Osteoarthritis: A Randomized Mechanistic Trial
- 10:30AM-12:30PM
-
Abstract Number: 2364
Reporting Mental Health and Associated Disorders from Trials of Bimekizumab in Patients with Active Axial Spondyloarthritis and Psoriatic Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 1790
Response Gene to Complement-32 Expression Is Upregulated in Lupus T Cells and Promotes Th17 Differentiation
- 10:30AM-12:30PM
-
Abstract Number: 2122
Rheum for Improvement: Screening and Treatment of Glucocorticoid Induced Osteoporosis
- 10:30AM-12:30PM
-
Abstract Number: 2004
Rheumatic Complications Post-CAR-T Cell Therapy. Experience of a Single Center
- 10:30AM-12:30PM
-
Abstract Number: 2149
Rheumatoid Arthritis: Patient’s Voice First! An Original Approach Based on Infodemiology Using Social Media Content – Results from the PRIMA Study
- 10:30AM-12:30PM
-
Abstract Number: L11
Rheumatology Diagnostics Utilizing Artificial Intelligence (ANA Reader©) for ANA Pattern Identification and Titer Quantification
- 10:30AM-12:30PM
-
Abstract Number: 2151
Rheumatology on Reddit: A Descriptive Analysis
- 10:30AM-12:30PM
-
Abstract Number: 2458
Risk Factors for Progression of Interstitial Lung Disease in Patients with Early Diffuse Cutaneous Systemic Sclerosis
- 10:30AM-12:30PM
-
Abstract Number: 2261
Risk of Cervical Intraepithelial Neoplasia During Janus Kinase (JAK) Inhibitor Treatment in Patients with Rheumatoid Arthritis: A Retrospective Cohort Study
- 10:30AM-12:30PM
-
Abstract Number: 2009
Risk of Incident Gout and Cardiovascular Events Within 120 Days of Incident Gout with the Use of Insulin Glargine, Glucagon-like Peptide-1 Receptor Agonists, or Sodium-Glucose Cotransporter-2 Inhibitors in Veterans with Type 2 Diabetes
- 10:30AM-12:30PM
-
Abstract Number: 1867
RNA Polymerase III Specific CD8+ T Cells at the Interface Between Scleroderma and Cancer
- 10:30AM-12:30PM
-
Abstract Number: 2225
Role of Fatigue in Difficult to Treat Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 2131
Role of LECT2 in the Regulation of Bone Metabolism In Vitro and In Vivo
- 10:30AM-12:30PM
-
Abstract Number: 1831
Role of Long Non-Coding RNA H19 in Mediating Skin Fibrosis in Systemic Sclerosis
- 10:30AM-12:30PM
-
Abstract Number: 2052
Role of Scleroderma/myositis-related Autoantibodies Detected by Immunoblot to the Diagnosis of Systemic Autoimmune Rheumatic Diseases in 410 Patients from a Single Referral Center
- 10:30AM-12:30PM
-
Abstract Number: 1864
S-4321, a Novel Dual-cell Bidirectional PD-1:FcγRIIb Selective Agonist Antibody for the Treatment of Autoimmune Disease
- 10:30AM-12:30PM
-
Abstract Number: 1979
Safety and Effectiveness of Immune Checkpoint Inhibitor Therapy in Patients with Pre-existing Autoimmune Disease
- 10:30AM-12:30PM
-
Abstract Number: 2246
Safety and Efficacy of Cannabidiol in Rheumatoid Arthritis Patients: A Phase 1B Pilot Randomized Placebo Controlled Trial
- 10:30AM-12:30PM
-
Abstract Number: 2019
Safety and Efficacy of SEL-212 in the US and ex-US Subgroups: Results from the Phase 3 DISSOLVE Studies
- 10:30AM-12:30PM
-
Abstract Number: 2285
Safety and Tolerability of a Combination of Curcumin, Omega-3 and Vitamin-D: Results from the PASCOD Study, an RA Prevention Protocol
- 10:30AM-12:30PM
-
Abstract Number: 2047
Safety in Patients with Latent Tuberculosis Who Received Concomitant Anti-Tuberculosis Medications: Analysis of 11 Studies of Guselkumab in Psoriatic Disease
- 10:30AM-12:30PM
-
Abstract Number: 2012
Safety, Tolerability and Efficacy of Pegloticase Administered with a Shorter Infusion Duration in Subjects with Uncontrolled Gout Receiving Methotrexate: Primary Findings of the AGILE Open-label Trial
- 10:30AM-12:30PM
-
Abstract Number: 1961
Salivary and Lacrimal Glands Ultrasonography in Systemic Lupus Erythematosus Patients
- 10:30AM-12:30PM
-
Abstract Number: 2033
Scleritis and the Rheumatologist. Does the Type of Scleritis Help to Distinguish an Infectious Cause from an Immune Cause? Among the Immune Causes, Does It Help Differentiate Between Systemic Causes and Those Limited to the Eye?
- 10:30AM-12:30PM
-
Abstract Number: 2344
Secukinumab Retention and Effectiveness in Patients with Psoriatic Arthritis and Radiographic Axial Spondyloarthritis: 5-year Final Results of a Prospective Real-world Study
- 10:30AM-12:30PM
-
Abstract Number: 1786
Select Immune Cell Dysregulation Identifies Clinically Quiescent Patients at Risk of Flare Who Stop Mycophenolate Mofetil While Continuing Hydroxychloroquine
- 10:30AM-12:30PM
-
Abstract Number: 1849
Selective Targeting of One-Carbon Metabolism to Combat Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 2071
Self-Efficacy Contributes to Better Health Outcomes in Patients of Idiopathic Inflammatory Myopathies: Insights from the COVAD 3 Dataset
- 10:30AM-12:30PM
-
Abstract Number: 2433
Sequential Pneumococcal Vaccination in SLE: Immunogenicity, Side Effects and Comparison with PPSV23 Vaccination
- 10:30AM-12:30PM
-
Abstract Number: 2212
Seropositive Arthralgias: A Comprehensive Analysis of the Reuma-Check Cohort
- 10:30AM-12:30PM
-
Abstract Number: 2314
Serum Calprotectin (S100A8/9) and Complement Factor C3 as Potential Inflammatory Markers in Obese and “CRP Negative” Early PsA Patients: Data from a Multicenter METAPSA Cohort
- 10:30AM-12:30PM
-
Abstract Number: 2063
Serum Glutamate Dehydrogenase in Idiopathic Inflammatory Myopathy Patients
- 10:30AM-12:30PM
-
Abstract Number: 2024
Serum Urate Change Among Patients with Gout Treated with Anti-Hypertensive Medications: A Comparative Effectiveness Analysis
- 10:30AM-12:30PM
-
Abstract Number: 2198
Severe and Long-Term Outcomes of COVID-19 Infection and Vaccine Hesitancy and Adverse Events in Children with Pediatric Rheumatic Diseases: Insights from a COVID-19 Global Rheumatology Alliance Caregiver Survey
- 10:30AM-12:30PM
-
Abstract Number: 2460
Severe Gastrointestinal Involvement in Systemic Sclerosis: A New “Transversal” Subset of Disease to Be Prioritised for Intervention Trials
- 10:30AM-12:30PM
-
Abstract Number: 1946
Shaping the Future of the National Musculoskeletal (MSK) Triage Initiative: Exploring the Impact of a Hybrid Model (Virtual and Face to Face) of MSK Triage
- 10:30AM-12:30PM
-
Abstract Number: 2278
Similar Etanercept Adherence in Individuals with Rheumatic Disease Initiating Originator and Biosimilar: A Population-Based Study
- 10:30AM-12:30PM
-
Abstract Number: 1830
Single-cell RNA Sequencing Profiling of Very Early-Stage Systemic Sclerosis Skin Reveals a Fibroblast Pro-inflammatory Gene Signature and Keratinocyte Dysregulation
- 10:30AM-12:30PM
-
Abstract Number: 1821
Single-Cell RNA SequencingBioinformatic Pipeline Optimized for Non-Coding GenesIdentified LINC01503 and MIR193-BHG as Potential Pathogenic Effectors in Systemic Sclerosis Fibroblasts
- 10:30AM-12:30PM
-
Abstract Number: 1779
Single-Nuclear RNA-Sequencing of Treatment Naïve JDM Muscle Highlights Dysregulated Vascular Integrity and Angiogenesis in Endothelial Cells and Decreased Nitric Oxide Synthase Signaling in Type II Muscle Fibers
- 10:30AM-12:30PM
-
Abstract Number: 2226
Site-specific Differences in the Association of Non-vertebral Major Osteoporotic Fractures and Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 1824
Skin Macrophage Subtypes and Impact of Tofacitinib in Early Diffuse Cutaneous Systemic Sclerosis: Results from Single-cell Analyses of an Observational Data Set and a Phase I/II Randomized Controlled Trial
- 10:30AM-12:30PM
-
Abstract Number: 2517
Skin Microbiome Shows Differences Between Pathergy Positive and Negative Patients with Behçet’s Syndrome
- 10:30AM-12:30PM
-
Abstract Number: 1793
SLE Patient Serum and SLE-associated Danger Signals Impair Efferocytosis in Human Macrophages
- 10:30AM-12:30PM
-
Abstract Number: 1923
Social Determinants of Health Documentation and Prevalence Among Rheumatology Patients Seen in a Southern Medical Center
- 10:30AM-12:30PM
-
Abstract Number: 2086
Specific Transcriptomic Profile Associated with Disease Activity in Muscle Biopsies from Patients with Sarcoid Myopathy
- 10:30AM-12:30PM
-
Abstract Number: 1828
SSc Fibroblasts Trigger a Systemic Type I Interferon Response in SSc Patients Through Canonical TGF-β Receptor Signalling
- 10:30AM-12:30PM
-
Abstract Number: 1766
STAT2-Associated Type I Interferonopathy: A Masquerade of Infectious Susceptibility
- 10:30AM-12:30PM
-
Abstract Number: 1880
Statewide Burden of Osteoarthritis in India and Its Trend from 1990-2021: A Benchmarking Analysis
- 10:30AM-12:30PM
-
Abstract Number: 2260
Statin Use in Patients with Rheumatoid Arthritis (RA) and Osteoarthritis: Are RA Patients More Likely to Receive Statins?
- 10:30AM-12:30PM
-
Abstract Number: 2125
Strengthening Fracture Risk Prediction in Rheumatoid Arthritis: Integrating a Self-report Sarcopenia Screening Tool (SARC-F) and Fracture Risk Assessment Tool (FRAX) Scores
- 10:30AM-12:30PM
-
Abstract Number: 2251
Stress-Related Neural Activity Measured with FDG-PET/CT Is Associated with Articular Disease Activity, Systemic Inflammation, and Treatment-associated Change in Arterial Inflammation in Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 2145
Study of Bone Metabolism in Patients Diagnosed with Osteogenesis Imperfecta.
- 10:30AM-12:30PM
-
Abstract Number: 2465
Subclinical Loss of Lung Volumes in Very Early SSc: Evidence from Two Independent Cohorts in EUSTAR
- 10:30AM-12:30PM
-
Abstract Number: 2277
Switching to a Targeted Drug with a Different Mode of Action After Discontinuation of the First TNF Inhibitor Is Associated with Better Drug Survival Compared to a Second TNF Inhibitor in Rheumatoid Arthritis: A Propensity Score-matched Analysis from the Czech ATTRA Registry
- 10:30AM-12:30PM
-
Abstract Number: 2103
Synovial Inflammation Is Increased in Females with Knee Osteoarthritis
- 10:30AM-12:30PM
-
Abstract Number: 1840
Synovial Resident Memory T Cell Formation During Inflammation Requires Cell Contact with Fibroblast-Like Synoviocytes
- 10:30AM-12:30PM
-
Abstract Number: 2376
Systemic Lupus Erythematosus Patients Exhibit Dynamic Changes in Disease-Associated Transcripts Following Total Knee or Total Hip Arthroplasty
- 10:30AM-12:30PM
-
Abstract Number: 1784
T-bet Expressing B Cells as a Putative Prognostic and Therapeutic Biomarker for Human SLE
- 10:30AM-12:30PM
-
Abstract Number: L01
Targeted Exosite Inhibition of STING Activation of TBK1 Selectively Blocks Type I Interferon and NFκB Responses for Treatment of Autoimmune Diseases
- 10:30AM-12:30PM
-
Abstract Number: 1832
Targeting Hippo Pathway Diminishes Disease Signaling in Scleroderma Skin
- 10:30AM-12:30PM
-
Abstract Number: 1860
Targeting Th1 Effector Cytokines, TNF-α and IFN-γ, Attenuates Experimental Autoimmune Myeloperoxidase ANCA Associated Vasculitis
- 10:30AM-12:30PM
-
Abstract Number: 1854
TCR-Nck Modulators: Pioneering Oral Modulation of T Cell Receptor Activation Holding the Promise of Treating Autoimmune Diseases
- 10:30AM-12:30PM
-
Abstract Number: 1781
Tear Proteomics as a Classifier of Disease Type and Activity Status in Pediatric Uveitis
- 10:30AM-12:30PM
-
Abstract Number: 1950
Telehealth Physical Therapy Intervention to Increase Physical Activity in Adults with Knee OA: The Delaware PEAK Randomized Controlled Trial
- 10:30AM-12:30PM
-
Abstract Number: 1933
Telemedicine for Under-resourced Patients with Systemic Lupus Erythematosus: A Qualitative Study Exploring the Views and Experiences of Patients and Rheumatology Health Care Professionals
- 10:30AM-12:30PM
-
Abstract Number: 2343
Temporal Trends in and Associations with NSAID Prescription in Adult and Pediatric Patients with IBD
- 10:30AM-12:30PM
-
Abstract Number: 2301
The Added Value of anti-Ro52 Antibody Titer in the Diagnosis of Sjögren’s Disease
- 10:30AM-12:30PM
-
Abstract Number: 2180
The Association Between Age at Diagnosis and Patient-Reported Outcomes in Patients with Vasculitis
- 10:30AM-12:30PM
-
Abstract Number: 2237
The Association Between Bariatric Surgery and Incident Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 2203
The Association of Autoantibodies with Clinical Manifestations and Long-term Outcomes in Juvenile- and Adult-onset Systemic Sclerosis
- 10:30AM-12:30PM
-
Abstract Number: 1878
The Associations Between Gout and Ischemic Colitis Among Hospitalized Patients: A Retrospective Nationwide Analysis
- 10:30AM-12:30PM
-
Abstract Number: 1945
The Bridge to Adult Care from Childhood for Young Adults with Rheumatic Disease (BACC YARD) Program, a Pediatric-to-Adult Rheumatology Transition Program: 2024 Updates
- 10:30AM-12:30PM
-
Abstract Number: L07
The Classification Criteria for Anti-Synthetase Syndrome (Class) Project
- 10:30AM-12:30PM
-
Abstract Number: 2443
The Clinical Phenotype of Anti-Th/To+ Patients in Systemic Sclerosis: A Case-control Study Within the European Scleroderma Trials and Research (EUSTAR) Cohort
- 10:30AM-12:30PM
-
Abstract Number: 2373
The Construction and Validation of Sub-phenotype-specific Genetic Risk Scores in Systemic Lupus Erythematosus: A Novel Approach Using Large-scale Biobank Data
- 10:30AM-12:30PM
-
Abstract Number: 2475
The Critical Role of Annual HRCT in Identifying ILD Progression and Assessing Outcome in SSc
- 10:30AM-12:30PM
-
Abstract Number: 2030
The Development of the EULAR Score for the Definition of Disease Activity in Adult-onset Still’s Disease; The “DAVID” Project
- 10:30AM-12:30PM
-
Abstract Number: 2268
The Discontinuation and Effectiveness of Sequential Advanced Therapy in Rheumatoid Arthritis, a Real-World Data
- 10:30AM-12:30PM
-
Abstract Number: 2021
The Dual Benefits of Sodium-Glucose Cotransporter-2 Inhibitors for Recurrent Nephrolithiasis and Gout Flares Among Gout Patients with Type 2 Diabetes: New User, Active Comparator Target Trial Emulation Studies
- 10:30AM-12:30PM
-
Abstract Number: 2323
The Effect of Biologic Therapies on Serum Metabolic Biomarkers in Patients with Psoriatic Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 2510
The Effect of Coronary Artery Aneurysms and IVIG Use on Long-term Cardiovascular Disease and Mortality Following Kawasaki Disease in Childhood: A Systematic Review and Meta-analysis
- 10:30AM-12:30PM
-
Abstract Number: 2238
The Effect of Inflammation on Cardiovascular Risk in Rheumatoid Arthritis Varies According to Sex and Anticitrullinated Protein Antibody Status
- 10:30AM-12:30PM
-
Abstract Number: 2085
The Effects of Pioglitazone on Metabolic Dysregulation in Inclusion Body Myositis: An Open-Label Pilot Study
- 10:30AM-12:30PM
-
Abstract Number: 2186
The Exploration of Secondary Amplified Musculoskeletal Pain Syndrome (AMPS) in Pediatric Patients with Rheumatologic Disease
- 10:30AM-12:30PM
-
Abstract Number: 2105
The Identity, Impact, and Management of OA and OA Pain from the Perspective of People with OA: A Systematic Literature Review of Qualitative Studies
- 10:30AM-12:30PM
-
Abstract Number: 1811
The Immune Map of Lupus Nephritis: A Spatially Resolved Kidney Proteomic Approach
- 10:30AM-12:30PM
-
Abstract Number: 2416
The Impact of Active Lupus Nephritis on Work Productivity in Patients from a Latin American Lupus Cohort
- 10:30AM-12:30PM
-
Abstract Number: 1974
The Impact of Concomitant Shoulder Osteoarthritis in Polymyalgia Rheumatica
- 10:30AM-12:30PM
-
Abstract Number: 2508
The Impact of Lipid Profile Parameters on the Incidence of Major Adverse Cardiovascular Events in Rheumatoid Arthritis Patients: A Single-arm Meta-Analysis
- 10:30AM-12:30PM
-
Abstract Number: 2476
The Impact of Systemic Sclerosis Manifestations on Survival and Humanistic Burden: A Targeted Literature Review
- 10:30AM-12:30PM
-
Abstract Number: 2010
The Influence of Treat-to-target Urate Lowering Therapy and Anti-inflammatory Prophylaxis on Circulating Measures of Inflammation in Gout
- 10:30AM-12:30PM
-
Abstract Number: 2498
The Methylome Profile of B-cells as a Biomarker of Nephritis in IgA Vasculitis
- 10:30AM-12:30PM
-
Abstract Number: 1953
The National Trend of Using Prescription Immunosuppressives
- 10:30AM-12:30PM
-
Abstract Number: 2413
The Natural History of SLE Has Changed Since the 1970s
- 10:30AM-12:30PM
-
Abstract Number: 2514
The Pattern of Renal Involvement in Relapsing Cryoglobulinemic Vasculitis After Successful Sustained Viral Response by Direct-Acting Antiviral Treatments
- 10:30AM-12:30PM
-
Abstract Number: 2263
The Potential Use of Circulating Extracellular Vesicles for Improved Diagnosis and Therapy in Rheumatic Inflammatory/autoimmune Diseases: Proof of Concept Studies
- 10:30AM-12:30PM
-
Abstract Number: 1896
The Prevalence, Incidence, Risk Factors and Time to Diagnosis of Behcet’s Syndrome in England: A Retrospective Nested Case Control Study in Clinical Practice Research Datalink and Hospital Episode Statistics
- 10:30AM-12:30PM
-
Abstract Number: 2011
The Relationship Between Anti-drug Antibodies, Infusion Reactions, and Loss of Urate-lowering Response in Patients with Uncontrolled Gout Treated with Pegloticase
- 10:30AM-12:30PM
-
Abstract Number: 2398
The Relationship Between First-Trimester Maternal Serum 25-Hydroxyvitamin D and Maternal/Fetal Outcomes in Patients with Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 2104
The Relationship of Soluble Biomarkers to OA Pain: A Systematic Literature Review
- 10:30AM-12:30PM
-
Abstract Number: 2291
The Relationship of the ESSDAI to Health-Related Quality of Life in People Living with Sjogren’s Disease
- 10:30AM-12:30PM
-
Abstract Number: 1948
The Rheumatology Physician Assistant/Associate Workforce
- 10:30AM-12:30PM
-
Abstract Number: 2264
The Risk of Malignancy and Major Adverse Cardiovascular Events with the Use of Janus Kinase Inhibitors in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of Real-World Evidence
- 10:30AM-12:30PM
-
Abstract Number: 2117
The Risk of Medication-related Osteonecrosis of the Jaw (MRONJ) in a Patient with Osteoporosis Treated with Antiresorptive Therapy and Undergoing Dental Care Is Negligible with a CTX Threshold Above 260
- 10:30AM-12:30PM
-
Abstract Number: 2371
The Role of Intracytoplasmic Toll- Like Receptors (TLR) and MyD88 in B Cell Subsets as Renal Response Predictors in Patients with Lupus Nephritis
- 10:30AM-12:30PM
-
Abstract Number: 2059
The Rs35705950 Promoter Variant of Muc5b Is Associated with Usual Interstitial Pneumonia in Antisynthetase Syndrome
- 10:30AM-12:30PM
-
Abstract Number: 2235
The Updated PREVENT (Predicting Risk of CVD EVENTs) Algorithm Is Not Able to Indicate Subclinical Coronary or Carotid Atherosclerosis Better Than the Traditional Pooled Cohort Equations in Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 2296
The Value of Ultrasound to Follow Glandular Disease in Sjogren’s Disease Patients
- 10:30AM-12:30PM
-
Abstract Number: 2258
The Window of Opportunity: A Concept Also Applicable to Undifferentiated Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 2028
Therapeutic Insights in VEXAS Syndrome from a Multicenter Study in Spain: Moving Towards Amore Specific and Effective Treatment
- 10:30AM-12:30PM
-
Abstract Number: 2206
There Is No Difference in Major Organ Involvement Andantibody Pattern Between Diffuse and Limited Subtypejuvenile Onsetsystemic Scleroderma Patients
- 10:30AM-12:30PM
-
Abstract Number: 2506
THP1-derived Macrophage Polarization in Takayasu Arteritis – Impact of Disease Status and Therapy
- 10:30AM-12:30PM
-
Abstract Number: 1977
Three-dimensional Stereophotogrammetry Has Utility in Tracking Upper Eyelid Involvement and Overall Disease Worsening in Patients with Craniofacial Localized Scleroderma
- 10:30AM-12:30PM
-
Abstract Number: 1857
Thymic Mimetic Cells in Humans, Mice and Fish Are Evolutionarily Ancient with Species-specific Adaptations
- 10:30AM-12:30PM
-
Abstract Number: 2464
Thymic Size Longitudinal Changes on Chest High-resolution Computed Tomography After Autologous Hematopoietic Stem Cell Transplantation for Diffuse Cutaneous Systemic Sclerosis
- 10:30AM-12:30PM
-
Abstract Number: 2273
Time-Trends in Real-World Glucocorticoid Treatment Strategies in Patients with Early Rheumatoid Arthritis: Results from the Canadian Early Arthritis Cohort(CATCH) Study
- 10:30AM-12:30PM
-
Abstract Number: 1940
Timely Initiation of Steroid Sparing Therapy in Uveitis Patients – a Quality Improvement Initiative
- 10:30AM-12:30PM
-
Abstract Number: 1935
Timely Referral of Patients with Inflammatory Rheumatic Diseases to Rheumatology: Validation of a Referral Algorithm with Frontline Physicians
- 10:30AM-12:30PM
-
Abstract Number: 2338
TNF Inhibitor Therapy Increases Absolute Lymphocyte Count Which Is Associated with Lower Mortality in Patients with Psoriatic Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 1960
To Biopsy or Not to Biopsy: Imaging Features of Chronic Nonbacterial Osteomyelitis of the Clavicle
- 10:30AM-12:30PM
-
Abstract Number: 1769
Top Peripheral Blood Transcriptomic Gene Modules Reveal Functional Annotation and Correlation with Clinical Traits in Juvenile Dermatomyositis (JDM) and Myositis-Specific Autoantibody (MSA) Groups
- 10:30AM-12:30PM
-
Abstract Number: 2128
Trabecular Bone Score Curve from a Qatari Population, Data from Qatar Biobank
- 10:30AM-12:30PM
-
Abstract Number: 2185
TRACER: Transition to Adulthood Through Coaching and Empowerment in Rheumatology, a Feasibility Study
- 10:30AM-12:30PM
-
Abstract Number: 1836
Transcriptional Changes in the Formation of Tissue Resident Memory T Cells in the Joint
- 10:30AM-12:30PM
-
Abstract Number: 2215
Treat (Depression to Reach)-to-Target in Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 2016
Treat to Target in Gout Yields Superior Outcomes Compared to Treat to Avoid Symptoms Approach (results from the Gout TrEatment Strategy Overture Trial)
- 10:30AM-12:30PM
-
Abstract Number: 2346
Treatment Effect on Predictors of Ankylosis in Axial Spondyloarthritis
- 10:30AM-12:30PM
-
Abstract Number: 2093
Treatment of Advanced Knee OA with Lorecivivint Leads to Improved Long-Term Patient Acceptable Symptom State (PASS) Compared to Placebo: Data from Phase 3 Extension Trial
- 10:30AM-12:30PM
-
Abstract Number: 2491
Treatment Outcomes of Eosinophilic Granulomatosis with Polyangiitis (EGPA):A Retrospective Analysis of US Health Insurance Claims Data
- 10:30AM-12:30PM
-
Abstract Number: 2231
Treatment Response over the First 6 Months in Newly Diagosed RA Patients by Pain, Anxiety, Depression & Fatigue (PADF) Symptom Clusters: Results from the Canadian Early Arthritis Cohort
- 10:30AM-12:30PM
-
Abstract Number: 1845
Treg Expansion and IL-6 Induced STAT3 Phosphorylation in CD4+ T Cells Is a Biomarker of Disease Flare in Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 2421
Trends in Glucocorticoid Use in Systemic Lupus Erythematosus in a Population-Based Inception Cohort from 1976 to 2018: The Lupus Midwest Network
- 10:30AM-12:30PM
-
Abstract Number: 1877
Trends in Rheumatoid Arthritis Incidence, Prevalence, DALY and Death Rates (1991-2021) in the United States: A Comprehensive Analysis of State-Level Disparities
- 10:30AM-12:30PM
-
Abstract Number: 2167
Trust and Shared Decision-Making in Adolescents with Systemic Lupus Erythematosus: Findings from a Pilot Survey Design Study
- 10:30AM-12:30PM
-
Abstract Number: 2168
Two Year Data on Quality of Life, Pain and Mobility Scores After Rituximab Treatment in the Preclinical Phase of Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 2303
Type I Interferon Signature Drives Phenotypic Clusters of Sjögren’s Disease and Can Predict Systemic Evolution Among the “B-cell Active with Low Symptoms” Subgroup
- 10:30AM-12:30PM
-
Abstract Number: 2073
Ultrasound Findings of Activity in Patients with Inflammatory Myopathies and Clinical and Laboratory Comparison
- 10:30AM-12:30PM
-
Abstract Number: 1955
Ultrasound for Screening of Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Systematic Review and Meta Analysis
- 10:30AM-12:30PM
-
Abstract Number: 2290
Umbilical Cord-derived Mesenchymal Stem Cells Suppress Sjogren’s Syndrome Pathology
- 10:30AM-12:30PM
-
Abstract Number: 1852
Uncovering a MAIT-Treg Axis in Skin UV Response: Implications for Photosensitive Reactions in Cutaneous Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 2190
Uncovering Inborn Errors of Immunity in Pediatric Rheumatology
- 10:30AM-12:30PM
-
Abstract Number: 1985
Underlying Autoimmune Disease Has Not Limited Immune Checkpoint Inhibitor Use or Increased Mortality Risk During Cancer Treatment of US Veterans
- 10:30AM-12:30PM
-
Abstract Number: 1814
Understanding Monocyte Derived Macrophages in the Skin of SSc Patients Through Single Cell Analysis of Blister Fluid Immune Cell Populations
- 10:30AM-12:30PM
-
Abstract Number: 2079
Understanding Relapse Patterns in Anti-HMGCR Statin-induced IMNM: A Detailed Comparative Study
- 10:30AM-12:30PM
-
Abstract Number: 2150
Understanding Unmet Needs and Quality of Life Impact of Giant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR) Using Social Media: A Patient and Caregiver Perspective
- 10:30AM-12:30PM
-
Abstract Number: 2102
Unraveling Knee Osteoarthritis Subtypes: Differential Effect of Oral Salmon Calcitonin Treatment
- 10:30AM-12:30PM
-
Abstract Number: 2333
Unveiling New Molecular Signatures in Psoriatic Arthritis Using Comprehensive Proteomic Analysis of Peripheral Mononuclear Cells
- 10:30AM-12:30PM
-
Abstract Number: 2244
Unveiling Synovial Protein Contributions to Serum Inflammation, Disease Activity, and Treatment Outcomes in RA Patients
- 10:30AM-12:30PM
-
Abstract Number: 2133
Unveiling the Association Between Low-Density Lipoprotein Cholesterol Lowering and Fracture Risk Among Patients with Hyperlipidaemia in a Population-Based Cohort Study: The Lower, the Better
- 10:30AM-12:30PM
-
Abstract Number: 1826
Unveiling the Primary Cilia Signature Driving Systemic Sclerosis Pathogenesis
- 10:30AM-12:30PM
-
Abstract Number: 2515
Upadacitinib for Refractory Behçet’s Syndrome: A Multi-center, Prospective, Open-label, Pilot Study
- 10:30AM-12:30PM
-
Abstract Number: 2367
Updated Long-Term Safety and Tolerability of Bimekizumab in Patients with Axial Spondyloarthritis and Psoriatic Arthritis: Pooled Results from Phase 2b/3 Studies
- 10:30AM-12:30PM
-
Abstract Number: 1995
Use of Abatacept for the Treatment of Severe Immune-related Adverse Events from Immune Checkpoint Inhibitors for Cancer: A Case Series
- 10:30AM-12:30PM
-
Abstract Number: 1929
Use of Digital Health Tools for Health Promotion Among Individuals with Rheumatologic Diseases in the United States
- 10:30AM-12:30PM
-
Abstract Number: 1925
Use of Geocoded Social Deprivation Indices to Understand Health Disparities in Pediatric Rheumatology
- 10:30AM-12:30PM
-
Abstract Number: 1984
Use of ICD Codes for the Identification of Patients with Immune Checkpoint Inhibitor Induced Inflammatory Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 2276
Use of Methotrexate and TNF-α Inhibitors in Patients with Rheumatoid Arthritis-associated Interstitial Lung Disease: A Survey of Rheumatologists
- 10:30AM-12:30PM
-
Abstract Number: 2459
Use of Nailfold Capillaroscopy as a Predictor of Cardiovascular Events and Mortality in Systemic Sclerosis
- 10:30AM-12:30PM
-
Abstract Number: 1962
Utility of 18 FDG-PET/CT Scans in the Diagnosis of Polyarteritis Nodosa and Other Medium Vessel Vasculitis
- 10:30AM-12:30PM
-
Abstract Number: 2382
Utility of Urinary Biomarkers to Predict Long-term Renal Outcomes in Lupus Nephritis
- 10:30AM-12:30PM
-
Abstract Number: 1928
Utilization of Rapid Telehealth Visits by Advanced Practice Providers for New Patients Referred to a Large Academic Practice with Low Suspicion for Rheumatologic Disease
- 10:30AM-12:30PM
-
Abstract Number: 2192
Utilizing Electronic Health Record Pre-Consultation Data to Create a Predictive Algorithm for Diagnosis of Chronic Pediatric Rheumatic Conditions
- 10:30AM-12:30PM
-
Abstract Number: 1874
Validation Analysis of the Expanded Risk Score for Rheumatoid Arthritis in a Multicentre Italian Cohort
- 10:30AM-12:30PM
-
Abstract Number: 2395
Validation Cohort of a Tool to Predict Proliferative Histological Class in Lupus Nephritis Based on Clinical and Laboratory Data – LUCAS Study (Lupus Nephritis Class Assessment System)
- 10:30AM-12:30PM
-
Abstract Number: 1970
Validation of Handheld Ultrasound Devices for Point of Care Use in Rheumatology: Interim Analysis for Enthesitis
- 10:30AM-12:30PM
-
Abstract Number: 2412
Validation of Proposals for Definitions of Moderate and Severe Disease Activity in Systemic Lupus Erythematosus, Based on Data Gathered from the RELESSER-PROS Register Database
- 10:30AM-12:30PM
-
Abstract Number: 2146
Validation of the Simple Calculated Osteoporosis Risk Estimation and Osteoporosis Self-assessment Tool Among People Aging with HIV in Peru
- 10:30AM-12:30PM
-
Abstract Number: 2223
Validation Study in Early Rheumatoid Arthritis Patients of the Spanish Society of Rheumatology (SER)/Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) Screening Criteria for Interstitial Lung Disease
- 10:30AM-12:30PM
-
Abstract Number: 1901
Venous Thromboembolism Risk Is Consistently Increased in People with Rheumatoid Arthritis Across Different Ages, Sexes and Obesity Status: United Kingdom Population Based Study
- 10:30AM-12:30PM
-
Abstract Number: 1943
Virtual Rheumatology in the Real World: Use of Telemonitoring to Optimize the Management of Patients with Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 2098
Vitamin D Deficiency Is Associated with Progression of Radiographic Hand Osteoarthritis in a 6-year Follow-up of the Dong-gu Study
- 10:30AM-12:30PM
-
Abstract Number: 2428
Vitamin-D Effect on SLE- Scoping Review
- 10:30AM-12:30PM
-
Abstract Number: 1884
VIVA QI: Vaccination In Vasculitis: Applying a Quality Improvement Approach
- 10:30AM-12:30PM
-
Abstract Number: 1937
Wellness and Burnout Among Pediatric Rheumatologists in North America- A 2024 CARRA Study
- 10:30AM-12:30PM
-
Abstract Number: 2519
What Do We Know About Malignancies in IgA Vasculitis?
- 10:30AM-12:30PM
-
Abstract Number: 2200
Whole Blood Transcriptome Profiling in Juvenile Systemic Sclerosis Patients Reveals Active Immune Upregulation and Enhanced Fibrotic Signature
- 10:30AM-12:30PM
-
Abstract Number: 2262
Window of Opportunity in the Treatment of Rheumatoid Arthritis – Interstitial Lung Disease with Abatacept. National Multicenter Study of 526 Patients
- 10:30AM-12:30PM
-
Abstract Number: 2124
WITHDRAWN
- 10:30AM-12:30PM
-
Abstract Number: 2227
Worrisome Mortality Trends over 20 Years Among Patients with Underlying Ischemic Heart Disease and Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 1800
WWC1 Regulates Type I Interferon Production Through Modulation of cGAS-STING Signaling in Keratinocytes
- 1:00PM-2:30PM
-
Abstract Number: 2556
A Multi-center Study of Associations Between Neighborhood-Level Child Opportunity, Initial Disease Severity and Acute Care Utilization Among Children with SLE
- 1:00PM-2:30PM
-
Abstract Number: 2589
A Nationwide Analysis of Risk of Acute Coronary Syndrome in RA Patients with Interstitial Lung Disease
- 1:00PM-2:30PM
-
Abstract Number: 2569
A Novel Hyperferritinemia Screen to Aid Differentiation of Hyperinflammatory Disorders
- 1:00PM-2:30PM
-
Abstract Number: 2587
A Proprietary AI Rule Engine Assisted by an OpenAI-based ML Model Can Speed up and Better Inform the Prior Authorization Process for Rheumatology Investigations and Medications
- 1:00PM-2:30PM
-
Abstract Number: 2565
A Randomized, Double-blind, Multicenter, Parallel-arm Phase 3 Study to Compare the Efficacy, Pharmacodynamics, Safety, and Immunogenicity Between Bmab-1000 and Prolia in Postmenopausal Women with Osteoporosis
- 1:00PM-2:30PM
-
Abstract Number: 2555
Addressing Economic Insecurities Could Improve Patient-Reported Outcomes in Lupus
- 1:00PM-2:30PM
-
Abstract Number: 2583
Apremilast Reduces Axial Inflammation in Patients with Psoriatic Arthritis as Assessed by CANDEN MRI Scoring: Results from a Phase 4 Study
- 1:00PM-2:30PM
-
Abstract Number: 2572
Biomarker-guided Treatment-and-stop-strategy for Recombinant IL-1Receptor Antagonist (Anakinra) in Patients with Systemic Juvenile Idiopathic Arthritis
- 1:00PM-2:30PM
-
Abstract Number: 2575
Can Immunosuppressive Therapy Be Safely Discontinued in Patients with Lupus Nephritis?
- 1:00PM-2:30PM
-
Abstract Number: 2552
Changes in Social Determinants of Health Needs Uncovered by a Rheumatology-Based Screening and Assistance Program
- 1:00PM-2:30PM
-
Abstract Number: 2540
Characterizing the Functional Role of Type I Interferons in Inflammatory Arthritis
- 1:00PM-2:30PM
-
Abstract Number: 2561
Circulating Proteomic Profiles and Incident Gout Risk: Prospective Cohort Study of >48,000 Men and Women
- 1:00PM-2:30PM
-
Abstract Number: 2570
Comparison of the Clinical Features and Biomarker Profiles of the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Systemic Juvenile Idiopathic Arthritis- Associated Lung Disease (SJIA-LD) Cohort to CARRA Registry SJIA Patients Without Lung Disease
- 1:00PM-2:30PM
-
Abstract Number: 2560
Continuous Reduction in Ultrasound Detected Crystal Depositions over 5 Years Follow-up: Results from the NOR-Gout Study
- 1:00PM-2:30PM
-
Abstract Number: 2534
Deciphering Complement-dependent Macrophage Phenotypes in Human Rheumatoid Arthritis Using Combined Computational-experimental Single-cell Omics
- 1:00PM-2:30PM
-
Abstract Number: 2566
Detrimental Effects of Proton Pump Inhibitors on Bone Mineral Density Are Not Mediated by Changes in Serum Calcium or Parathyroid Hormone in Patients with Inflammatory Rheumatic Diseases: A Cross-sectional Study
- 1:00PM-2:30PM
-
Abstract Number: 2558
Development of Non-genetic Risk Stratification Model of Severe Allopurinol Hypersensitivity Syndrome, a Multicenter Study in Thailand
- 1:00PM-2:30PM
-
Abstract Number: 2577
Efficacy and Safety of ABBV-599 (Elsubrutinib and Upadacitinib Combination) and Upadacitinib Monotherapy for the Treatment of Systemic Lupus Erythematosus: Results Through 104 Weeks in a Long-Term Extension Study
- 1:00PM-2:30PM
-
Abstract Number: 2573
Efficacy and Safety of Ixekizumab in Children with Active Juvenile Psoriatic Arthritis and Enthesitis Related Arthritis (COSPIRIT-JIA): 16-week Results of a Multicentre, Randomised, Open-label Study
- 1:00PM-2:30PM
-
Abstract Number: 2582
Efficacy and Safety of Sonelokimab, a Novel IL-17A- and IL-17F-Inhibiting Nanobody, in Patients with Active PsA: 24-Week Results from a Global, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial
- 1:00PM-2:30PM
-
Abstract Number: 2562
Efficacy and Safety of Tocilizumab in the Treatment of Chronic Inflammatory Forms of CPPD: Retrospective Study of 55 Cases
- 1:00PM-2:30PM
-
Abstract Number: 2563
Efficacy and Safety Results of CT-P41 (Proposed Denosumab Biosimilar) Compared to Reference Denosumab in Postmenopausal Women with Osteoporosis: 78-Week Results from Phase 3 Randomized Controlled Trial
- 1:00PM-2:30PM
-
Abstract Number: 2588
Examining the Influence of Socioeconomic Status on Osteoarthritis Prevalence and Risk Factors Among New York Residents
- 1:00PM-2:30PM
-
Abstract Number: 2567
Gene Expression in Osteonecrosis of the Femoral Head: A Region-matched RNA-sequencing Study
- 1:00PM-2:30PM
-
Abstract Number: 2533
Genome-wide Association of Rheumatoid Arthritis in the African Ancestry Identifies HLA Amino Acid Polymorphisms of Risk
- 1:00PM-2:30PM
-
Abstract Number: 2576
Glucagon-Like Peptide-1 Receptor Agonist Use and the Risk of Adverse Cardiac and Kidney Outcomes Among Patients with Systemic Lupus Erythematosus and Lupus Nephritis
- 1:00PM-2:30PM
-
Abstract Number: 2542
Group 2 Innate Lymphoid Cells Aggravates Development of Inflammatory Arthritis
- 1:00PM-2:30PM
-
Abstract Number: 2585
Guselkumab and IL-17 Inhibitors Improve Patient-perceived Impact of Psoriatic Arthritis Similarly: 6-month Interim Results of the PsABIOnd Observational Cohort Study
- 1:00PM-2:30PM
-
Abstract Number: 2538
HLA-DRB1 Rheumatoid Arthritis (RA) Risk Alleles Preferentially Select TRBJ2-3-containing CD4 T Cells in RA Patients
- 1:00PM-2:30PM
-
Abstract Number: 2568
Incidence of First Fracture in RA Is Increasing Faster Than the General Population
- 1:00PM-2:30PM
-
Abstract Number: 2550
Infiltrating and Resident Macrophages in Lupus Nephritis: Scar Associated Macrophage Phagocytic Dysfunction and Fibroblast Activation
- 1:00PM-2:30PM
-
Abstract Number: 2546
Lipocalin-2 Drives Neuropsychiatric and Cutaneous SLE Through Regulation of Immune Cell Recruitment in Target Organs
- 1:00PM-2:30PM
-
Abstract Number: 2591
Lupus-Related Reproductive Health Experiences and Needs of Women of Childbearing Age: A Qualitative Study
- 1:00PM-2:30PM
-
Abstract Number: 2551
Modified Delphi Process to Propose an Equity Measurement Roadmap in Rheumatology
- 1:00PM-2:30PM
-
Abstract Number: 2548
NADPH Oxidase in B Cells and Macrophages Protects Against Murine Lupus by Regulation of TLR7
- 1:00PM-2:30PM
-
Abstract Number: 2547
Neurophysiological Phenotypes Are Uncoupled from Toll-like Receptor-Mediated Peripheral Disease in a Mouse Model of Neuropsychiatric Symptoms of Systemic Lupus Erythematosus
- 1:00PM-2:30PM
-
Abstract Number: 2543
Novel IgG Degrader BHV-1300 Demonstrates the Ability to Remove Anti-bDMARD ADA and Allows for Co-administration with Fc-containing Biologics
- 1:00PM-2:30PM
-
Abstract Number: 2590
Pesticide Use and Incident Rheumatoid Arthritis Among Spouses in the Agricultural Health Study: An Updated Analysis
- 1:00PM-2:30PM
-
Abstract Number: 2545
Phosphodiesterase 1B Contributes to Neuropsychiatric Manifestations in Lupus-Prone Mice Through Microglial Activation
- 1:00PM-2:30PM
-
Abstract Number: 2553
Predictors of Biologic and Targeted Synthetic DMARD Initiation for Rheumatoid Arthritis Across Underserved Patient Groups: Insights from a National Cohort Study
- 1:00PM-2:30PM
-
Abstract Number: 2554
Prevalence and Clinical Characteristics of Vasculitis in the Alaska Native and American Indian Peoples of Alaska
- 1:00PM-2:30PM
-
Abstract Number: 2541
Probiotic Modulation of Gut Microbiota Mitigates Early Rheumatoid Arthritis Progression: Insights from Pre-Clinical Models
- 1:00PM-2:30PM
-
Abstract Number: 2564
Providing Optimal and Equitable Osteoporosis Treatment Using a Programmatic Approach -A 20 Year Longitudinal Study
- 1:00PM-2:30PM
-
Abstract Number: 2559
Relationship Between Serum Urate and Changes in Dual Energy Computed Tomography MSU Crystal Volume over One Year in People with Gout: An Individual Participant Data Analysis
- 1:00PM-2:30PM
-
Abstract Number: 2586
Results from the Biopsy Driven Ebio Study: Entheseal Tissue Signature in Response to IL-17 Blockade in Psoriatic Arthritis
- 1:00PM-2:30PM
-
Abstract Number: 2579
Risk of End-Stage Renal Disease Among Patients with Lupus Nephritis on GLP-1 Receptor Agonists: A Retrospective Cohort Study
- 1:00PM-2:30PM
-
Abstract Number: 2580
Safety and Efficacy of Subcutaneous Ianalumab (VAY736) for up to 68 Weeks in Patients with Systemic Lupus Erythematosus: Results from Phase 2 Study
- 1:00PM-2:30PM
-
Abstract Number: 2578
Safety, Biomarker Response, and Efficacy of E6742, a Dual Antagonist of Toll-Like Receptor 7 and 8, in a First-in-Patient, Randomized, Double-Blind, Phase1/2 Study in Systemic Lupus Erythematosus
- 1:00PM-2:30PM
-
Abstract Number: 2537
Sjögren’s Disease and Non-Sjögren’s Sicca Patient Subsets Exhibit Cell Type-specific Transcriptional Dysregulations That May Identify Early Molecular Predictors of Disease Transition
- 1:00PM-2:30PM
-
Abstract Number: 2544
Spatial Transcriptomics Suggests Synovial Macrophage Niches Are Sexually Dimorphic in a Mouse Inflammatory Arthritis Model
- 1:00PM-2:30PM
-
Abstract Number: 2574
Tear Biomarkers for Monitoring Disease Activity and Progression of Noninfectious Chronic Anterior Uveitis in Children
- 1:00PM-2:30PM
-
Abstract Number: 2539
Telocytes Integrated into Mast Cells and Joint-Draining Lymphatic Vessels Potentially Regulate Lymphatic Clearance
- 1:00PM-2:30PM
-
Abstract Number: 2592
The Effects of Early Life Trauma and Socioeconomic Position on Systemic Lupus Erythematosus Risk in Adulthood
- 1:00PM-2:30PM
-
Abstract Number: 2535
The Lipidomic and Proteomic Profiles in Antiphospholipid Syndrome Patients Are Intricately Linked to Disease Pathogenesis and Modulated by Ubiquinol Supplementation
- 1:00PM-2:30PM
-
Abstract Number: 2557
The Relation of Colchicine to Knee/hip Replacement Among People with Gout in a Population-based Cohort Study
- 1:00PM-2:30PM
-
Abstract Number: 2571
Trajectories of Physical Function in Children with Juvenile Idiopathic Arthritis: Results from the CAPRI Registry
- 1:00PM-2:30PM
-
Abstract Number: 2536
Trans-Disease Microbial Biomarkers of Protection and Pathogenesis in Autoimmune Conditions: Results from the AMP AIM Consortium
- 1:00PM-2:30PM
-
Abstract Number: 2549
VISTA Deficiency Alters the Skin Immune Cell Composition and Confers Skin Sensitivity to UV Light
- 1:00PM-2:30PM
-
Abstract Number: 2581
Vunakizumab in Patients with Active Psoriatic Arthritis: A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study
- 1:00PM-2:30PM
-
Abstract Number: 2584
Zasocitinib (TAK-279), an Oral, Selective Tyrosine Kinase 2 Inhibitor: Achievement of Remission and Additional Improvements in Disease Activity in Patients with Psoriatic Arthritis Enrolled in a Phase 2b Trial
- 3:00PM-4:30PM
-
Abstract Number: 2603
A Human Lupus Gut Pathobiont Accelerates Systemic Inflammation, Autoantibody Production and T Cell Dysregulation
- 3:00PM-4:30PM
-
Abstract Number: 2593
A Long-term Synovial Tissue 3D Model Incorporating Fibroblasts, Macrophages, Endothelial Cells, and Other Immune Cells Such as Innate Lymphoid Cells Enables Animal Model-Independent Rheumatoid Arthritis Research
- 3:00PM-4:30PM
-
Abstract Number: 2594
A Novel Therapeutically Active CSF-1R Agonist Promotes Tissue Macrophages Inflammation Resolution and Induces Tissue Repair Pathways
- 3:00PM-4:30PM
-
Abstract Number: 2654
Adapting and Testing a Cognitive Rehabilitation Intervention Tailored for People with Systemic Sclerosis: Acceptability, Feasibility, & Impact on Health-related Outcomes
- 3:00PM-4:30PM
-
Abstract Number: 2604
Altered Expression of Ecto-5′-Nucleotidase (NT5E) in SLE Patients Based on Disease-associated Genotype
- 3:00PM-4:30PM
-
Abstract Number: 2616
Associations of Circulating Inflammatory Cytokines with Long COVID Among Patients with Systemic Autoimmune Rheumatic Diseases
- 3:00PM-4:30PM
-
Abstract Number: 2644
Baseline Fibroblast Immunophenotype Predicts Clinical Improvement Among Individuals with Early Diffuse Cutaneous Systemic Sclerosis
- 3:00PM-4:30PM
-
Abstract Number: 2625
Brain Injury Markers Correlate with Impaired Executive Function and Disease Activity in Children with Systemic Lupus Erythematosus
- 3:00PM-4:30PM
-
Abstract Number: 2623
Cardiovascular Health Is Suboptimal in Most Patients with Juvenile-Onset Lupus and Dermatomyositis: Baseline Visit Findings from the Lupus Erythematous and Dermatomyositis Stress and Cardiovascular Health Cohort Study
- 3:00PM-4:30PM
-
Abstract Number: 2606
Changes in Long-term GC Use Among Older Adults After New Diagnosis of Late-onset Rheumatoid Arthritis
- 3:00PM-4:30PM
-
Abstract Number: 2637
Chaperone-mediated Autophagy in Synovitis Distinguishes Psoriatic Arthritis from Rheumatoid Arthritis
- 3:00PM-4:30PM
-
Abstract Number: 2652
Characteristics of Relapse and Therapeutic Management in Giant Cell Arteritis in Modern Era, NEWTON Study
- 3:00PM-4:30PM
-
Abstract Number: 2605
Clarifying Misbeliefs & Resolving Decisional Conflicts About Hydroxychloroquine (HCQ) Through a Shared Decision-Making Tool (HCQ-SAFE©)
- 3:00PM-4:30PM
-
Abstract Number: 2647
Clinical Characteristics , Treatment Outcomes and Predictors of Mortality in a DADA2 Cohort of 101 Patients
- 3:00PM-4:30PM
-
Abstract Number: 2628
Clinical Features, Treatments, and Outcomes of a Large International Cohort of Childhood-onset Takayasu Arteritis: A PedVas Study
- 3:00PM-4:30PM
-
Abstract Number: 2607
Clinical Outcomes and Costs of Care for Patients Within the Rheumatoid Arthritis Care Pathway Cohort at a Tertiary Care Integrated Delivery Network: A Comparison to Usual Care
- 3:00PM-4:30PM
-
Abstract Number: 2596
Clock Gene Bmal1 Contributes to Inflammation via Phosphorylation of NF-κB/p65 in RA-FLS
- 3:00PM-4:30PM
-
Abstract Number: 2640
Comparative Safety and Use of Non-conventional Combination Targeted Therapy in Adults with Psoriatic Arthritis
- 3:00PM-4:30PM
-
Abstract Number: 2611
Continuation versus Temporary Interruption of Immunomodulatory Agents in Case of an Infection in IRD Patients: Results of a Randomized Controlled Trial
- 3:00PM-4:30PM
-
Abstract Number: 2629
Deciphering Salivary Gland Inflammation in Sjögren’s Syndrome Reveals Shared and Autoantibody-Specific Immune Cell Heterogeneity
- 3:00PM-4:30PM
-
Abstract Number: 2649
Defining Clinical Subgroups of Patients with Relapsing Polychondritis: A Latent Class and Decision Tree Analysis in Two Independent Prospective Cohorts
- 3:00PM-4:30PM
-
Abstract Number: 2638
Defining Sonographic Enthesitis in Psoriatic Arthritis: Developing a Data- and Expert-driven Diagnostic Criteria for Inflammatory Enthesitis at the Single Enthesis Level
- 3:00PM-4:30PM
-
Abstract Number: 2627
Development and Validation of a Novel Score System to Guide Diagnostic Procedures in Children with Concerns of Chronic Nonbacterial Osteomyelitis
- 3:00PM-4:30PM
-
Abstract Number: 2648
Diagnosis of Giant Cell Arteritis by 18F-FDG PET/CT in Patients on Glucocorticoid Therapy: Importance of Delayed Imaging
- 3:00PM-4:30PM
-
Abstract Number: 2655
Diagnostic Challenges of Dermatomyositis: A Retrospective Study of Its Dermatologic Mimics and Misdiagnoses
- 3:00PM-4:30PM
-
Abstract Number: 2635
Direct to Patient Screening for Psoriatic Arthritis in Patients with Psoriasis: Appropriateness of Rheumatology Referrals and Treatment Outcomes
- 3:00PM-4:30PM
-
Abstract Number: 2609
Drivers of Infliximab Biosimilar Uptake: A Comparative Analysis of New Biosimilar Initiations versus Switching in a National Rheumatology Registry
- 3:00PM-4:30PM
-
Abstract Number: 2620
Education and Medication Access Needs in Rheumatology Patients Starting New Medications: Quality Improvement Data from a Pharmacist Intervention
- 3:00PM-4:30PM
-
Abstract Number: 2608
Evolution of Rheumatoid Arthritis Pharmacotherapy: A Ten-Year Analysis of Biologic and Targeted Synthetic DMARD Use and Its Predictors in a National Sample of Rheumatology Practices
- 3:00PM-4:30PM
-
Abstract Number: 2639
Exploring Weight Trends in Psoriatic Arthritis: Unraveling Effects of Drugs
- 3:00PM-4:30PM
-
Abstract Number: 2650
Extent of Vascular Inflammation on Cranial Vessel Wall MRI and Ophthalmic Complications in Giant Cell Arteritis
- 3:00PM-4:30PM
-
Abstract Number: 2632
Genetically-engineered Ro-specific Regulatory T Cells to Treat Primary Sjögren’s Disease
- 3:00PM-4:30PM
-
Abstract Number: 2602
Genetics of Sex Dimorphism in Clinical Manifestations of Systemic Lupus Erythematosus
- 3:00PM-4:30PM
-
Abstract Number: 2617
Higher Engagement with the RISE Registry Clinician Dashboard Is Associated with Higher Performance on Rheumatology Quality Measures, Analysis of Data from 2020 – 2022
- 3:00PM-4:30PM
-
Abstract Number: 2645
Human NCF1-p.R90H Variant Promotes Pulmonary Fibrosis in the Bleomycin-induced Mouse Model and Systemic Sclerosis Patients via Expansion of SPP1+Monocytes-derived Macrophages
- 3:00PM-4:30PM
-
Abstract Number: 2658
Hypovitaminosis D in Lupus Nephitis
- 3:00PM-4:30PM
-
Abstract Number: 2630
Identification of Molecular Biomarkers for Sjögren’s Disease Stratification via a Deep Learning Foundation Model Dedicated to Immune-Mediated and Inflammatory Disease
- 3:00PM-4:30PM
-
Abstract Number: 2641
Identification of Systemic Sclerosis Intrinsic Subtypes in the ASSET Clinical Trial Using PBC Gene Expression
- 3:00PM-4:30PM
-
Abstract Number: 2626
Identifying Homogeneous Endophenotypes in Childhood-Onset Systemic Lupus Erythematosus with Similarity Network Fusion
- 3:00PM-4:30PM
-
Abstract Number: 2642
Identifying Systemic Sclerosis Molecular Subtypes by Their Cellular Signature – Deconvoluting the Puzzle
- 3:00PM-4:30PM
-
Abstract Number: 2653
Impact of Insurance on Time to Biological Drug (bDMARD) Initiation and Inactive Disease Achievement in Patients with Juvenile Idiopathic Arthritis
- 3:00PM-4:30PM
-
Abstract Number: 2643
Integrated Bulk and Single Cell RNA Sequencing Defines Key Pathways Regulating Myofibroblast Differentiation Across ANA Subgroups in Diffuse Systemic Sclerosis
- 3:00PM-4:30PM
-
Abstract Number: 2624
Measuring Clinically Inactive Disease at One Year in Patients with Juvenile Dermatomyositis (JDM) in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry
- 3:00PM-4:30PM
-
Abstract Number: 2636
Multi-centre Validation of a Serum Protein Biomarker Signature (RAPsA Dx), Which Discriminates Psoriatic Arthritis (PsA) from Rheumatoid Arthritis (RA)
- 3:00PM-4:30PM
-
Abstract Number: 2633
Multicenter Validation of a Machine Learning Foundation Model to Diagnose Sjögren’s Disease and Identify Histological Biomarkers for Disease Stratification
- 3:00PM-4:30PM
-
Abstract Number: 2598
p300 KAT Inhibition Selectively Targets Multiple Cell Types Involved in Chronic Inflammation and Downregulates Key Inflammatory Cytokines
- 3:00PM-4:30PM
-
Abstract Number: 2601
Platelets Specifically Interact with Remigrating Neutrophils and Promote Immunogenic Cellular Death in Systemic Lupus
- 3:00PM-4:30PM
-
Abstract Number: 2618
Population Health Management for Juvenile Idiopathic Arthritis in the Pediatric Rheumatology Care and Outcomes Improvement Network
- 3:00PM-4:30PM
-
Abstract Number: 2615
Prevalence of and Factors Associated with Developing Long COVID Among Patients with Autoimmune Rheumatic Diseases: A Retrospective Cohort Analysis of National U.S. Data
- 3:00PM-4:30PM
-
Abstract Number: 2657
Prevalence of Anxiety, Depression, and Fatigue in Patients with Rheumatic Diseases: A Cross-Sectional Study of 1014 Cases
- 3:00PM-4:30PM
-
Abstract Number: 2622
Quality of Care for Childhood-Onset Lupus Nephritis: Suboptimal Completion of Disease Activity Monitoring
- 3:00PM-4:30PM
-
Abstract Number: 2646
Rare Variants in the IL1RAP Gene Implicate the IL-1 Signaling Pathway in the Pathogenesis of Systemic Sclerosis in African and European Ancestries
- 3:00PM-4:30PM
-
Abstract Number: 2600
Repression of the Aryl-hydrocarbon Receptor Prevents Oxidative Stress and Ferroptosis of Intestinal γδT Cells and Alleviates Systemic Lupus Erythematosus
- 3:00PM-4:30PM
-
Abstract Number: 2631
Risk of Atherosclerotic Cardiovascular Events and Venous Thromboembolism in People with Primary Sjögren’s Syndrome: A Danish Cohort Study
- 3:00PM-4:30PM
-
Abstract Number: 2614
Risk of New Onset of Immune-Mediated Diseases After Sars-Cov-2 Infection: A Systematic Review and Meta-Analysis
- 3:00PM-4:30PM
-
Abstract Number: 2619
Safety Outcomes of Routine Blood Tests for Monitoring of Biologic and Targeted Synthetic Therapies in Inflammatory Arthritis Patients
- 3:00PM-4:30PM
-
Abstract Number: 2656
Short-Term Effectiveness of a Walk with Ease Program Delivered by Telephone on Arthritis-Related Symptoms, Function, and Physical Activity
- 3:00PM-4:30PM
-
Abstract Number: 2595
TGF-β Activated Kinase 1 (TAK1) Inhibition Suppresses Synovial Inflammation and Tissue Destruction Mediated by Activated Juvenile Idiopathic Arthritis Synovial Fibroblasts
- 3:00PM-4:30PM
-
Abstract Number: 2597
The Stromal-cell Derived Cytokine interleukin-17D Attenuates Joint Inflammation
- 3:00PM-4:30PM
-
Abstract Number: 2634
Transcriptomic Stratification Predicts Response to Rituximab, Abatacept or the Association of Hydroxychloroquine and Leflunomide in 3 Randomized Controlled Clinical Trials in Sjögren’s Disease
- 3:00PM-4:30PM
-
Abstract Number: 2610
Treatment Concordance of Asynchronous Virtual Visits Compared to Traditional In-person Visits in Patients with Rheumatoid Arthritis: Results of the Prospective, Multi-center, Randomized Controlled TELERA Trial
- 3:00PM-4:30PM
-
Abstract Number: 2621
Trends in Disease Activity in Rheumatoid Arthritis over 2009-2023 Utilizing DAS28-CRP Inferred from Electronic Health Records
- 3:00PM-4:30PM
-
Abstract Number: 2612
Two-Week Methotrexate Discontinuation in Autoimmune Rheumatic Diseases Patients Vaccinated with Recombinant Herpes Zoster Vaccine: An Interim Analysis of a Prospective Randomized Phase 4 Study
- 3:00PM-4:30PM
-
Abstract Number: 2613
Vaccination Is Associated with Lower Risk of Parenchymal Lung Disease in Patients with Rheumatoid Arthritis After COVID-19: Results from a Prospective Study
- 3:00PM-4:30PM
-
Abstract Number: 2651
Vasculitis Associated with VEXAS Syndrome
- 3:00PM-4:30PM
-
Abstract Number: 2599
Xist Deletion in B Cells Results in Systemic Lupus Erythematosus Phenotypes
- 8:00AM-9:30AM
-
Abstract Number: L17
Allogenic CD19 CAR NK Cells Therapy in Refractory Systemic Lupus Erythematosus: An Open-label, Single Arm, Prospective and Interventional Clinical Trial
- 8:00AM-9:30AM
-
Abstract Number: L20
Automated Ultrasound System ARTHUR with AI Analysis DIANA Matches Expert Rheumatologist in Hand Joint Assessment of Rheumatoid Arthritis Patients
- 8:00AM-9:30AM
-
Abstract Number: L18
CCL19+ Fibroblasts Orchestrate Fibrotic Microenvironment via CCL19-CCR7 Axis in Systemic Sclerosis
- 8:00AM-9:30AM
-
Abstract Number: L16
Dapirolizumab Pegol Demonstrated Significant Improvement in Systemic Lupus Erythematosus Disease Activity: Efficacy and Safety Results of a Phase 3 Trial
- 8:00AM-9:30AM
-
Abstract Number: L19
Efficacy and Safety of Emapalumab in Children and Adults with Macrophage Activation Syndrome (MAS) in Still’s Disease: Results from a Phase 3 Study and a Pooled Analysis of Two Prospective Trials
- 8:00AM-9:30AM
-
Abstract Number: L15
LEVI-04, a Novel neurotrophin-3 Inhibitor, Substantially Improves Pain and Function Without Deleterious Effects on Joint Structure in People with Knee Osteoarthritis: A Randomized Controlled Phase II Trial
- 11:00AM-12:30PM
-
Abstract Number: 2659
A Comprehensive Approach Utilizing a Combination of Genetics, Cytological Analysis, and Imaging Techniques to Speed up the Diagnostic Process in VEXAS Patients
- 11:00AM-12:30PM
-
Abstract Number: 2663
ADI-001: An Allogeneic CD20-targeted γδ CAR T Cell Therapy with Potential for Improved Tissue Homing in Autoimmune Indications
- 11:00AM-12:30PM
-
Abstract Number: 2690
ANCA IgG Promotion of Neutrophil Recruitment, Migration and Vascular Damage in ANCA Associated Vasculitis May Be Enhanced by Hypoxia
- 11:00AM-12:30PM
-
Abstract Number: 2667
Anti-Mi2 Autoantibodies in Dermatomyositis Patients Also Recognize Autoimmune Regulator (AIRE) Protein
- 11:00AM-12:30PM
-
Abstract Number: 2684
Assessment of Skin in Patients with Systemic Sclerosis Using High Frequency Ultrasound : A Comparative Study with Histology and Clinical Parameters of Skin Disease
- 11:00AM-12:30PM
-
Abstract Number: 2685
Association Between Gastrointestinal Bacterial Species and Radiological Features of Systemic Sclerosis-Interstitial Lung Disease (SSc-ILD): A Multicenter Study from the SSc Microbiome Consortium Project
- 11:00AM-12:30PM
-
Abstract Number: 2681
Association of Social Determinants of Health with Systemic Lupus Erythematosus in the United States: Nationally Representative Estimates for 2017-2021
- 11:00AM-12:30PM
-
Abstract Number: 2694
Associations Between Immune Checkpoint Molecules and Nasal Microbiome in ANCA-associated Vasculitis
- 11:00AM-12:30PM
-
Abstract Number: 2665
Autoantibody Titers Against Specific Epitope Peptides Predict Treatment Resistance in Interstitial Lung Disease Associated with Anti-MDA5 Dermatomyositis
- 11:00AM-12:30PM
-
Abstract Number: 2664
BCMA-targeted Bispecific T Cell-engager Therapy of Autoimmune Disease
- 11:00AM-12:30PM
-
Abstract Number: 2661
Changes in Krebs Von Den Lungen 6 Levels (∆KL6) Predict Fibrosing Progression of Interstitial Lung Disease in Patients with an Underlying Connective Tissue Disease (CTD-ILD)
- 11:00AM-12:30PM
-
Abstract Number: 2673
Changes in Mortality Risk After Stopping Glucocorticosteroids – a Population-based Study in Rheumatoid Arthritis
- 11:00AM-12:30PM
-
Abstract Number: 2689
Characterization of Alpha-1 Antitrypsin Function in ANCA-Associated Vasculitis
- 11:00AM-12:30PM
-
Abstract Number: 2660
Developing Predictive Models for the Diagnosis of VEXAS Syndrome
- 11:00AM-12:30PM
-
Abstract Number: 2668
Do Levels of anti-Jo1 Autoantibodies Have a Prognostic Role? Longitudinal Assessment of anti-Jo1 and HisRS Protein Levels in a Cohort of anti-Jo1 Positive Patients with Anti-synthetase Syndrome
- 11:00AM-12:30PM
-
Abstract Number: 2686
Dose Escalation Safety Study of Brentuximab Vedotin for Diffuse Cutaneous Systemic Sclerosis:Clinical Results and Mechanistic Analysis of Skin and Peripheral Blood Mononuclear Cells
- 11:00AM-12:30PM
-
Abstract Number: 2669
Dysferlin Autoantibodies Compromise Sarcolemmal Repair Capacity and Contribute to the Pathogenesis of Idiopathic Immune Myopathies
- 11:00AM-12:30PM
-
Abstract Number: 2678
History of Cutaneous Lupus Promotes Blood and Skin Interferon Signatures in SLE Patients
- 11:00AM-12:30PM
-
Abstract Number: 2688
HLA-DRB4: A Novel Susceptibility Locus in Systemic Sclerosis Patients with Severe Calcinosis
- 11:00AM-12:30PM
-
Abstract Number: 2662
In Vivo Generation of B Cell Depleting CAR T Cell Therapies for Treatment of Autoimmune Diseases
- 11:00AM-12:30PM
-
Abstract Number: 2677
N-Acetylcysteine Blocks the Mechanistic Target of Rapamycin in Pro-Inflammatory Effector-Memory CD4 and CD8 T Cells Re-Expressing CD45RA in Patients with Active Systemic Lupus Erythematosus
- 11:00AM-12:30PM
-
Abstract Number: 2683
Optical Coherence Angiography: A Non-invasive, Safe Method for Assessing the Systemic Sclerosis Related Vasculopathy Beyond Nailfold Capillaries
- 11:00AM-12:30PM
-
Abstract Number: 2679
Predictors of Fracture in SLE: A Longitudinal Cohort Study
- 11:00AM-12:30PM
-
Abstract Number: 2672
Prevention of the Development of Rheumatoid Arthritis by a 1-year Course of Methotrexate in ACPA-negative Arthralgia Patients at Increased Risk for Rheumatoid Arthritis: 4 Year Results of the TREAT EARLIER Trial
- 11:00AM-12:30PM
-
Abstract Number: 2674
Real-World Analysis of Initial Clinical Response and Future Outcomes Among Patients with Rheumatoid Arthritis Initiating and Remaining on a 1st-Line Tumor Necrosis Factor Inhibitor in the United States
- 11:00AM-12:30PM
-
Abstract Number: 2693
Risk Factors for Relapse in ANCA-Associated Vasculitis Among Patients with Relapse After Induction of Remission with Rituximab
- 11:00AM-12:30PM
-
Abstract Number: 2670
Sera from Patients with Idiopathic Inflammatory Myopathy Induces Muscle Weakness, Mitochondrial Dysfunction and Induction of Cytokines in Isolated Skeletal Muscle
- 11:00AM-12:30PM
-
Abstract Number: 2671
Subcutaneous Abatacept vs Adalimumab Head-to-Head Comparison in Adults with Early, Dual Seropositive Rheumatoid Arthritis, Positive for the Shared Epitope HLA Class II Risk Alleles, and an Inadequate Response to Methotrexate: Results from a Phase 3 Trial
- 11:00AM-12:30PM
-
Abstract Number: 2682
The Forgotten Costs of SLE: Estimating Indirect Costs in a National SLE Cohort
- 11:00AM-12:30PM
-
Abstract Number: 2666
The Risk for Development of Myositis Is Not Increased After COVID-19 Vaccination Among U.S. Veterans
- 11:00AM-12:30PM
-
Abstract Number: 2687
Therapeutic Choices in Systemic Sclerosis Associated Interstitial Lung Disease, a Survey of International Experts
- 11:00AM-12:30PM
-
Abstract Number: 2680
Thrombocytopenia in Patients with Systemic Lupus ErythematosusReal-World Data Based on a Nationwide Database, RISE
- 11:00AM-12:30PM
-
Abstract Number: 2676
Timeframe for Initiating Methotrexate and Vaccine Response Against Pneumococcus in Rheumatoid Arthritis: The VACIMRA Study
- 11:00AM-12:30PM
-
Abstract Number: 2691
Transcriptomic Changes in CD4+ T Lymphocytes in Eosinophilic Granulomatosis with Polyangiitis
- 11:00AM-12:30PM
-
Abstract Number: 2692
Transcriptomic Profiling of Kidney Biopsies Implicates Th17 and IL-17 in ANCA-Associated Vasculitis
- 11:00AM-12:30PM
-
Abstract Number: 2675
Which Arthralgia Patients at Risk for RA Benefited from Treatment with Methotrexate?; Results from the TREAT EARLIER Trial